data_5nbb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5nbb _Structure_validation_residue.Date_analyzed 2017-04-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.608 0.242 . . . . 6.05 110.538 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.3 t 64.27 19.29 11.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.836 -0.62 . . . . 3.09 109.487 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.668 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 36.7 m-20 69.25 147.71 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.644 -1.162 . . . . 1.83 110.921 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -67.23 -66.45 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.03 0.443 . . . . 1.15 110.237 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.8 m -108.17 -72.35 0.73 Allowed 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.891 -0.595 . . . . 1.72 111.436 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -124.41 0.47 8.29 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.898 -1.519 . . . . 1.04 106.898 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.557 HD13 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -171.21 -179.18 2.6 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 112.81 -1.995 . . . . 1.03 108.985 -172.227 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.668 ' OG1' ' HA ' ' A' ' 182' ' ' ASP . 6.8 m -122.33 171.71 8.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.861 0.839 . . . . 1.0 112.09 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.751 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 58.2 t -81.08 133.74 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 114.247 -1.342 . . . . 1.03 108.805 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.17 19.26 79.84 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.322 -1.308 . . . . 0.14 110.527 -170.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.584 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -74.29 -51.52 15.0 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.47 -0.567 . . . . 0.9 109.47 178.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.3 126.11 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.991 -1.459 . . . . 1.01 111.718 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.572 HD11 ' N ' ' A' ' 192' ' ' LEU . 0.1 OUTLIER -159.33 -149.02 0.19 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.512 -1.222 . . . . 1.04 111.178 -173.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.663 ' HG3' ' HB1' ' A' ' 200' ' ' ALA . 6.7 ttpt -114.69 146.15 41.23 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.651 0.739 . . . . 4.11 111.019 -173.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.452 ' N ' ' HG2' ' A' ' 193' ' ' LYS . 1.5 p -113.94 -34.13 2.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.129 -1.396 . . . . 1.66 109.64 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 19.1 ttmt 60.37 99.21 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 111.692 -2.504 . . . . 4.04 110.68 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.66 88.91 2.84 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.749 -1.569 . . . . 1.48 110.755 -173.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 199' ' ' ASN . . . 94.32 54.85 1.53 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.866 -0.683 . . . . 2.12 111.903 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 73.76 -27.88 0.19 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.395 0.678 . . . . 3.89 112.703 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.41 ' H ' ' C ' ' A' ' 197' ' ' GLY . 42.5 m-80 -106.09 153.63 21.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.819 -0.437 . . . . 2.05 109.819 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.663 ' HB1' ' HG3' ' A' ' 193' ' ' LYS . . . -69.89 170.75 10.54 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.723 0.773 . . . . 1.45 109.168 174.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.647 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 30.7 tpp -146.91 -57.79 0.27 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.679 -1.146 . . . . 1.96 110.634 -165.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 201' ' ' MET . 3.2 m-20 108.39 136.22 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 111.51 -2.586 . . . . 1.86 107.939 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.654 ' HB3' ' CG2' ' A' ' 215' ' ' VAL . . . -151.41 148.61 28.31 Favored 'General case' 0 N--CA 1.422 -1.828 0 C-N-CA 120.673 -0.411 . . . . 1.03 110.459 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 22.7 m -114.45 127.79 56.01 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.132 0.491 . . . . 1.01 111.525 -170.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.751 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 87.2 t -65.32 121.76 14.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 112.8 0.667 . . . . 1.02 112.8 -170.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 -35.96 7.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.867 0.841 . . . . 1.3 109.643 175.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.703 ' O ' HG11 ' A' ' 213' ' ' VAL . 37.3 mt-10 -151.1 158.84 44.55 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.601 -2.0 . . . . 2.2 105.601 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.62 HD12 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -123.35 155.43 29.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 O-C-N 123.558 0.536 . . . . 1.03 111.767 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.7 p -108.14 -160.78 0.74 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.627 -0.715 . . . . 0.95 110.536 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -51.04 -37.8 47.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.298 0.571 . . . . 4.37 110.899 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.576 ' C ' ' HB1' ' A' ' 227' ' ' ALA . 3.5 t0 -161.17 -19.75 0.05 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.991 -1.004 . . . . 1.67 109.315 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.459 ' HA2' HD11 ' A' ' 230' ' ' LEU . . . -94.36 -153.1 30.0 Favored Glycine 0 CA--C 1.478 -2.227 0 N-CA-C 107.936 -2.066 . . . . 0.12 107.936 173.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.703 HG11 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -145.65 -178.83 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 C-N-CA 119.905 -0.718 . . . . 1.04 111.149 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.435 ' H ' HG11 ' A' ' 213' ' ' VAL . 85.3 mtt180 -130.18 86.57 2.41 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.873 -1.528 . . . . 3.9 106.873 163.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.654 ' CG2' ' HB3' ' A' ' 203' ' ' ALA . 25.5 m -87.51 178.65 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 114.838 -1.074 . . . . 1.03 111.859 -174.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 0.7 OUTLIER -105.2 112.12 25.13 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.216 -0.902 . . . . 2.31 108.969 173.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.505 ' HB2' ' H ' ' A' ' 221' ' ' MET . 8.4 mp -71.34 138.75 49.5 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.688 0.756 . . . . 1.1 111.752 -174.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -71.2 -16.78 62.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.608 -1.633 . . . . 1.28 109.249 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 71.8 m -67.97 -24.96 65.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.897 -1.047 . . . . 1.35 109.562 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.16 25.25 5.39 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.258 -0.883 . . . . 0.84 112.308 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.505 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 27.7 ttp -115.12 -163.12 0.86 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.315 -0.995 . . . . 1.56 108.315 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 17.9 m -160.84 126.43 3.84 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.407 -0.96 . . . . 1.12 108.407 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 214' ' ' ARG . 37.9 tp 176.2 -44.99 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.826 1.417 . . . . 1.18 114.826 -168.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.673 HG23 ' N ' ' A' ' 225' ' ' VAL 0.329 0.1 OUTLIER 34.28 -97.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.188 0.995 . . . . 1.1 113.446 -154.547 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.737 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 14.9 p 160.42 -158.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 118.994 0.815 . . . . 1.42 109.581 -160.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.737 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 20.2 ttm180 -105.89 161.24 14.62 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.333 -0.988 . . . . 4.06 108.333 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.576 ' HB1' ' C ' ' A' ' 211' ' ' ASP . . . -55.51 -20.86 14.3 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 113.695 0.998 . . . . 1.08 113.695 -166.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -92.24 19.1 7.33 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.385 1.088 . . . . 2.57 110.181 -173.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.538 ' HB2' HG23 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -136.5 -19.24 1.42 Allowed 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 113.741 -1.572 . . . . 3.05 111.082 -178.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.573 HD13 ' CE2' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -82.0 141.07 33.57 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 120.817 0.342 . . . . 1.45 110.218 175.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.424 ' CG2' ' HD3' ' A' ' 193' ' ' LYS . 20.6 m -123.52 69.01 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 122.005 0.907 . . . . 1.5 111.221 170.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.573 ' CE2' HD13 ' A' ' 230' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.439 -0.997 0 CA-C-N 114.859 -1.064 . . . . 1.3 111.177 172.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.326 0.584 . . . . 6.05 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.0 p -99.8 14.88 28.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.703 -0.681 . . . . 3.09 109.23 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.55 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 27.0 m-20 72.58 142.83 0.06 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.292 -1.322 . . . . 1.83 111.146 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.446 ' HB ' HD13 ' A' ' 208' ' ' ILE . 4.0 mm -73.62 -50.86 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 108.768 -0.827 . . . . 1.15 108.768 172.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.5 t -125.44 -78.23 0.59 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.816 -1.084 . . . . 1.72 110.737 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -116.93 0.37 12.43 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.006 -1.479 . . . . 1.04 107.006 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.524 HD13 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.24 -179.25 3.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 112.664 -2.062 . . . . 1.03 108.563 -171.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.606 ' C ' HD11 ' A' ' 208' ' ' ILE . 5.3 m -122.62 170.99 9.46 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.909 0.861 . . . . 1.0 112.806 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.766 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.4 t -84.54 131.52 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.173 -1.376 . . . . 1.03 109.162 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.83 18.23 79.06 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 113.975 -1.466 . . . . 0.14 110.471 -169.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -73.46 -53.15 11.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.092 -0.707 . . . . 0.9 109.092 178.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.47 128.71 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.487 -1.688 . . . . 1.01 111.698 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.53 HD11 ' N ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -150.42 -151.03 0.37 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 113.842 -1.526 . . . . 1.04 108.839 -174.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 15.5 mttt -136.71 146.54 45.98 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.678 -0.692 . . . . 4.11 109.928 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 9.1 p -127.33 148.14 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.901 -0.59 . . . . 1.66 110.278 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 199' ' ' ASN . 3.6 ttmt -95.68 91.58 6.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.724 -0.843 . . . . 4.04 108.724 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.465 ' HB2' ' HE1' ' A' ' 201' ' ' MET . . . -116.51 89.32 3.08 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.47 -0.786 . . . . 1.48 110.57 -176.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 198' ' ' GLN . . . 104.05 44.54 1.61 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.291 -0.868 . . . . 2.12 111.301 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.421 ' HB3' ' O ' ' A' ' 197' ' ' GLY . 10.2 tt0 77.89 -23.92 0.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.622 0.769 . . . . 3.89 112.287 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 16.6 m120 -115.64 143.63 45.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.907 0.385 . . . . 2.05 111.888 -173.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -74.13 131.8 41.64 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.645 -0.872 . . . . 1.45 108.645 173.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 217' ' ' LEU . 54.4 ttm -91.67 -85.16 0.25 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.198 -1.364 . . . . 1.96 110.964 -166.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 146.75 110.21 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 125.891 1.676 . . . . 1.86 106.915 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.696 ' HB2' ' CG2' ' A' ' 215' ' ' VAL . . . -143.69 147.99 35.08 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.975 -0.69 . . . . 1.03 111.988 -169.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 21.9 m -116.49 128.37 55.4 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 120.974 0.416 . . . . 1.01 112.052 -172.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.766 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 94.3 t -64.89 120.92 12.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 113.252 0.834 . . . . 1.02 113.252 -171.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -101.72 -36.33 8.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.456 -0.793 . . . . 1.3 109.999 175.219 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.643 ' O ' HG12 ' A' ' 213' ' ' VAL . 28.8 tt0 -157.47 157.68 34.33 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 105.316 -2.105 . . . . 2.2 105.316 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.606 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.01 158.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 112.104 0.409 . . . . 1.03 112.104 -173.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.424 ' N ' HG23 ' A' ' 208' ' ' ILE . 61.8 p -111.86 -160.78 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.159 -0.473 . . . . 0.95 111.387 -174.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -53.68 -30.46 43.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 4.37 111.985 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.629 ' C ' ' HB3' ' A' ' 227' ' ' ALA . 8.9 t0 -163.57 -25.84 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.022 -1.103 . . . . 1.67 108.022 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 230' ' ' LEU . . . -93.53 -148.56 23.83 Favored Glycine 0 CA--C 1.475 -2.443 0 N-CA-C 107.836 -2.106 . . . . 0.12 107.836 177.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -146.29 -177.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 C-N-CA 119.886 -0.726 . . . . 1.04 111.011 -178.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.412 ' H ' HG12 ' A' ' 213' ' ' VAL . 58.4 ttt180 -130.14 90.83 3.01 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.066 -1.457 . . . . 3.9 107.066 158.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.776 ' O ' ' HA ' ' A' ' 222' ' ' SER . 22.1 m -87.35 -176.95 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 113.966 -1.47 . . . . 1.03 109.969 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -105.24 112.41 25.51 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 108.024 -1.102 . . . . 2.31 108.024 169.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.673 ' HB2' ' H ' ' A' ' 221' ' ' MET . 10.2 mp -70.96 155.5 40.74 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.632 -0.827 . . . . 1.1 110.889 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.44 ' HB3' ' HG2' ' A' ' 201' ' ' MET . 15.6 t-20 -60.46 -36.46 78.3 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.724 -0.671 . . . . 1.28 109.418 173.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 66.4 m -70.62 -7.98 48.28 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.477 -0.783 . . . . 1.35 110.253 170.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 74.51 37.1 47.52 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 114.968 -1.015 . . . . 0.84 112.902 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.673 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 4.4 mtp -84.55 -50.48 7.67 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 122.018 0.914 . . . . 1.56 109.732 -176.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.776 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 19.4 m 70.89 117.75 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 112.82 -1.991 . . . . 1.12 111.186 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 222' ' ' SER . 57.8 tp 162.77 -40.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.819 -1.082 . . . . 1.18 113.533 -161.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.65 ' O ' ' HB ' ' A' ' 225' ' ' VAL 0.288 0.2 OUTLIER 32.99 -92.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.522 1.129 . . . . 1.1 113.249 -157.666 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.674 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 9.8 p 160.71 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 118.925 0.784 . . . . 1.42 110.341 -165.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.674 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 0.1 OUTLIER -99.66 154.1 18.55 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.636 -1.166 . . . . 4.06 108.293 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.629 ' HB3' ' C ' ' A' ' 211' ' ' ASP . . . -61.56 -18.14 58.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.042 1.127 . . . . 1.08 114.042 -170.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -102.76 31.47 4.13 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 122.787 1.28 . . . . 2.57 108.936 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.573 ' CB ' HG22 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -140.59 -25.02 0.77 Allowed 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 113.747 -1.57 . . . . 3.05 110.549 178.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.6 ' C ' HD12 ' A' ' 230' ' ' LEU . 1.2 pp -93.29 163.84 13.45 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 116.056 -0.52 . . . . 1.45 110.994 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.86 72.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 113.439 0.903 . . . . 1.5 113.439 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.522 ' HB3' HD22 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.896 0 CA-C-N 115.115 -0.948 . . . . 1.3 110.697 164.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 121.153 0.501 . . . . 6.05 110.367 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.0 t -118.95 20.63 12.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.683 -0.69 . . . . 3.09 109.234 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.701 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 51.2 m-20 73.1 143.7 0.07 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.704 -1.135 . . . . 1.83 110.944 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.8 mt -73.48 -49.89 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.547 -0.751 . . . . 1.15 110.325 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 t -124.36 -74.44 0.61 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.527 -0.76 . . . . 1.72 111.276 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -121.88 0.55 9.76 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.383 -1.71 . . . . 1.04 106.383 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.585 HD12 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -170.12 179.68 3.44 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.851 -1.977 . . . . 1.03 109.342 -171.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.701 ' OG1' ' HA ' ' A' ' 182' ' ' ASP . 4.5 m -121.18 170.91 9.11 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.808 0.813 . . . . 1.0 112.353 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.768 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 50.5 t -83.49 131.5 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.183 -1.371 . . . . 1.03 109.017 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.04 16.83 79.29 Favored Glycine 0 C--N 1.301 -1.366 0 CA-C-N 114.159 -1.382 . . . . 0.14 110.691 -169.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -72.85 -50.26 25.05 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.927 -0.768 . . . . 0.9 108.927 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 71.99 124.94 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.089 -1.414 . . . . 1.01 111.794 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -145.86 -149.99 0.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.687 -1.597 . . . . 1.04 108.779 -174.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -127.13 145.96 50.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.33 0.586 . . . . 4.11 110.547 177.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 5.0 p -115.88 146.92 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.841 -1.072 . . . . 1.66 109.357 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.533 ' HD3' ' N ' ' A' ' 200' ' ' ALA . 0.0 OUTLIER -89.75 91.58 8.7 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.38 -0.97 . . . . 4.04 108.38 177.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -115.51 96.28 5.56 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.962 -1.017 . . . . 1.48 109.967 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 199' ' ' ASN . . . 94.84 38.71 4.83 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.034 -0.827 . . . . 2.12 111.034 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 73.82 -18.3 0.4 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.649 0.78 . . . . 3.89 111.974 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' A' ' 197' ' ' GLY . 39.4 m-80 -111.39 142.06 44.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.033 -0.531 . . . . 2.05 111.059 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -71.5 132.79 45.22 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.241 -1.022 . . . . 1.45 108.241 173.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.529 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 37.6 tpp -107.02 -76.99 0.6 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.726 -1.125 . . . . 1.96 109.61 -169.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 4.2 t70 162.04 149.71 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 105.384 -2.08 . . . . 1.86 105.384 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.695 ' HB2' ' CG2' ' A' ' 215' ' ' VAL . . . -165.21 149.68 8.87 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 118.974 0.806 . . . . 1.03 111.774 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 21.1 m -117.96 126.93 53.28 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.454 -0.498 . . . . 1.01 112.143 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.768 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 99.9 t -64.39 121.5 13.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 113.248 0.833 . . . . 1.02 113.248 -169.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -104.94 -35.07 7.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.629 -0.714 . . . . 1.3 110.059 175.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.707 ' O ' HG13 ' A' ' 213' ' ' VAL . 29.0 tt0 -153.6 156.81 38.66 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.128 -2.175 . . . . 2.2 105.128 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.571 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.13 160.68 20.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 112.135 0.42 . . . . 1.03 112.135 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.412 ' N ' HG22 ' A' ' 208' ' ' ILE . 29.5 p -115.39 -160.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.95 111.571 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -53.44 -31.58 46.02 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.824 -0.626 . . . . 4.37 111.727 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.616 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 2.0 t70 -164.61 -22.04 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.61 -0.885 . . . . 1.67 108.61 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -94.39 -150.91 27.64 Favored Glycine 0 CA--C 1.475 -2.437 0 N-CA-C 107.784 -2.126 . . . . 0.12 107.784 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -146.83 -177.08 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.64 0 C-N-CA 119.797 -0.761 . . . . 1.04 111.077 -176.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.407 ' HA ' ' C ' ' A' ' 223' ' ' LEU . 42.2 ttt-85 -129.78 92.25 3.29 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.085 -1.45 . . . . 3.9 107.085 159.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.695 ' CG2' ' HB2' ' A' ' 203' ' ' ALA . 23.3 m -90.58 -176.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 114.325 -1.307 . . . . 1.03 110.612 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.5 OUTLIER -105.43 106.65 17.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.339 -0.846 . . . . 2.31 108.718 170.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.536 ' HB2' ' H ' ' A' ' 221' ' ' MET . 8.9 mp -66.28 140.97 58.16 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.943 0.878 . . . . 1.1 111.555 -174.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.566 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 23.6 t-20 -75.75 -18.94 59.38 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.612 -1.631 . . . . 1.28 108.378 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 37.4 m -63.98 -17.17 63.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.35 -1.295 . . . . 1.35 108.914 164.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.05 17.16 16.9 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 114.695 -1.138 . . . . 0.84 113.303 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.536 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 18.4 ttp -111.39 -159.25 0.67 Allowed 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.069 -0.715 . . . . 1.56 109.069 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 20.0 m -161.77 128.98 3.94 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.586 -1.264 . . . . 1.12 107.586 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 222' ' ' SER . 39.6 tp 162.97 -38.66 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.815 1.043 . . . . 1.18 113.815 -165.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.645 ' O ' ' HB ' ' A' ' 225' ' ' VAL 0.279 0.2 OUTLIER 34.22 -91.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.525 1.13 . . . . 1.1 112.973 -157.258 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.655 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 9.3 p 160.09 -156.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 118.548 0.613 . . . . 1.42 109.584 -164.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.655 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 14.3 ttm180 -104.34 163.46 12.41 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.442 -0.948 . . . . 4.06 108.442 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.616 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -66.93 -17.27 64.83 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.275 0.843 . . . . 1.08 113.275 -170.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.57 25.11 8.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 122.575 1.179 . . . . 2.57 109.315 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.585 ' CB ' HG23 ' A' ' 225' ' ' VAL . 0.9 OUTLIER -140.02 -22.24 0.86 Allowed 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 113.769 -1.56 . . . . 3.05 111.238 -179.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -92.28 171.38 9.1 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.179 0.514 . . . . 1.45 111.414 -176.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.658 HG21 ' O ' ' A' ' 231' ' ' VAL . 0.2 OUTLIER -136.98 93.81 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 CA-C-O 122.455 1.121 . . . . 1.5 109.857 176.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.52 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.833 -1.076 . . . . 1.3 110.173 161.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.58 -0.155 . . . . 6.05 110.58 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.9 t 70.4 13.95 7.47 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.803 0.689 . . . . 3.09 110.701 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.582 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 23.2 m-20 69.43 157.47 0.15 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.195 -0.911 . . . . 1.83 111.545 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.4 mt -77.67 -66.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.887 -0.597 . . . . 1.15 110.529 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 93.9 p -94.94 -79.48 0.43 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.414 1.102 . . . . 1.72 110.717 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -126.15 -1.73 7.05 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 105.059 -2.2 . . . . 1.04 105.059 171.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.551 HD12 ' CG1' ' A' ' 213' ' ' VAL . 0.6 OUTLIER -160.22 -178.0 6.66 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 113.658 -1.61 . . . . 1.03 110.575 -175.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.626 ' C ' HD11 ' A' ' 208' ' ' ILE . 6.2 m -124.18 172.01 9.38 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.189 -0.914 . . . . 1.0 112.58 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.783 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 48.6 t -84.19 132.92 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.267 -1.333 . . . . 1.03 109.762 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.89 14.92 82.09 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.027 -1.442 . . . . 0.14 110.68 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.5 HE22 ' HB3' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -72.71 -51.24 20.07 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.076 0.465 . . . . 0.9 109.752 -178.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 77.68 128.46 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.26 -1.336 . . . . 1.01 112.051 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.569 HD13 ' N ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -156.22 -150.02 0.27 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.194 -1.366 . . . . 1.04 110.464 -173.301 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.445 ' HE2' HG22 ' A' ' 231' ' ' VAL . 22.5 ttpt -111.33 144.41 40.56 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.526 -0.761 . . . . 4.11 110.467 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.53 HG22 ' CD2' ' A' ' 217' ' ' LEU . 1.5 p -106.07 -32.74 2.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 122.615 1.198 . . . . 1.66 109.295 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 1.2 ttpp 62.2 97.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 111.708 -2.496 . . . . 4.04 110.309 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -111.23 116.78 31.62 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.964 -1.471 . . . . 1.48 110.066 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 199' ' ' ASN . . . 76.29 48.54 9.34 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.729 -0.748 . . . . 2.12 111.791 -177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 73.88 -31.58 0.22 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.355 0.662 . . . . 3.89 112.67 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 197' ' ' GLY . 12.3 m120 -99.56 168.25 10.08 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.265 -0.272 . . . . 2.05 110.265 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -71.19 177.39 3.85 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.502 0.668 . . . . 1.45 109.706 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.527 ' O ' ' HB3' ' A' ' 202' ' ' ASP . 38.5 tpp -154.03 -66.12 0.14 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.195 -0.911 . . . . 1.96 109.796 -170.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.527 ' HB3' ' O ' ' A' ' 201' ' ' MET . 0.7 OUTLIER 122.79 141.37 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 126.597 2.436 . . . . 1.86 108.071 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.697 ' HB3' ' CG2' ' A' ' 215' ' ' VAL . . . -160.67 148.34 15.95 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 116.106 -0.497 . . . . 1.03 111.299 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 20.9 m -119.27 127.38 53.18 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 112.441 0.534 . . . . 1.01 112.441 -170.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.783 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 98.4 t -61.86 122.81 13.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.405 0.891 . . . . 1.02 113.405 -170.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.437 HD11 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -105.58 -37.57 6.73 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.461 -0.791 . . . . 1.3 109.873 174.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.661 ' O ' HG12 ' A' ' 213' ' ' VAL . 6.5 tp10 -152.09 154.21 35.46 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.118 -2.178 . . . . 2.2 105.118 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.626 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -117.17 162.21 15.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 112.653 0.612 . . . . 1.03 112.653 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.452 ' N ' HG23 ' A' ' 208' ' ' ILE . 30.3 p -112.41 -161.49 0.76 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.95 109.938 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 210' ' ' LYS . 12.6 mptt -63.31 -29.45 70.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.766 0.317 . . . . 4.37 111.567 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.61 ' C ' ' HB3' ' A' ' 227' ' ' ALA . 8.1 p-10 -151.01 -33.7 0.15 Allowed 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.589 -0.893 . . . . 1.67 108.589 -172.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.428 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -98.49 -146.78 21.15 Favored Glycine 0 CA--C 1.47 -2.75 0 N-CA-C 107.981 -2.048 . . . . 0.12 107.981 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -149.29 -175.11 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.667 0 C-N-CA 119.846 -0.742 . . . . 1.04 111.725 -177.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.423 ' H ' HG12 ' A' ' 213' ' ' VAL . 16.1 ttt180 -130.06 94.18 3.65 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.985 -1.487 . . . . 3.9 106.985 158.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.697 ' CG2' ' HB3' ' A' ' 203' ' ' ALA . 23.9 m -90.91 -179.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 114.274 -1.33 . . . . 1.03 110.748 -176.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 0.7 OUTLIER -104.09 110.8 23.12 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.538 -0.912 . . . . 2.31 108.538 172.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.547 HD23 ' HB3' ' A' ' 221' ' ' MET . 8.8 mp -68.7 143.67 54.66 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.597 0.713 . . . . 1.1 111.571 -175.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.475 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 11.0 t-20 -65.3 -30.78 71.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.116 -1.402 . . . . 1.28 108.569 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.8 m -57.59 -22.53 45.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.265 -1.334 . . . . 1.35 109.651 169.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.81 19.97 10.44 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.935 -1.03 . . . . 0.84 112.426 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.547 ' HB3' HD23 ' A' ' 217' ' ' LEU . 19.7 ttp -108.63 -161.2 0.75 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.283 -1.006 . . . . 1.56 108.283 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.69 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 13.6 m -163.11 128.55 3.16 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.692 -0.855 . . . . 1.12 108.692 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 222' ' ' SER . 61.4 tp 167.36 -42.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.224 1.194 . . . . 1.18 114.224 -166.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.646 ' CG2' ' H ' ' A' ' 225' ' ' VAL 0.274 0.1 OUTLIER 35.25 -93.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.487 1.115 . . . . 1.1 113.938 -158.869 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.658 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 9.7 p 160.91 -158.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 118.636 0.653 . . . . 1.42 110.494 -162.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.658 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 7.0 ptp180 -105.27 165.17 11.3 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.96 -1.018 . . . . 4.06 109.484 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.61 ' HB3' ' C ' ' A' ' 211' ' ' ASP . . . -69.23 -17.76 63.81 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.307 -0.86 . . . . 1.08 112.806 -166.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.413 ' H ' ' HG3' ' A' ' 226' ' ' ARG . 36.4 tt0 -101.2 25.65 7.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.749 1.262 . . . . 2.57 109.201 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.595 ' CB ' HG23 ' A' ' 225' ' ' VAL . 1.2 m-70 -135.76 -25.25 1.28 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.721 -1.581 . . . . 3.05 110.809 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.649 HD13 ' O ' ' A' ' 230' ' ' LEU . 1.0 OUTLIER -93.91 160.58 14.67 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.048 0.452 . . . . 1.45 111.084 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 231' ' ' VAL . 30.3 m -131.62 82.5 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.939 0.876 . . . . 1.5 111.814 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.535 ' CE2' HD12 ' A' ' 230' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.557 -0.747 . . . . 1.3 111.561 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 121.648 0.737 . . . . 6.05 110.293 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.0 p -130.19 26.55 5.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.129 -0.941 . . . . 3.09 109.666 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -47.5 126.82 10.39 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.342 1.068 . . . . 1.83 112.501 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 22.5 mt -78.29 -51.55 17.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 113.23 -1.805 . . . . 1.15 109.042 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 211' ' ' ASP . 47.3 t -112.75 -80.97 0.59 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.816 -1.084 . . . . 1.72 110.187 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.409 ' HB2' HD21 ' A' ' 186' ' ' LEU . . . -116.85 -0.34 12.29 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.915 -1.513 . . . . 1.04 106.915 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.553 HD13 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -168.02 -178.59 3.79 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 113.29 -1.777 . . . . 1.03 109.797 -170.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.62 ' C ' HD13 ' A' ' 208' ' ' ILE . 2.2 m -119.37 170.4 9.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.798 0.809 . . . . 1.0 112.836 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.771 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 43.4 t -86.18 132.61 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 114.124 -1.398 . . . . 1.03 108.67 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.98 19.64 79.76 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.466 -1.243 . . . . 0.14 110.248 -169.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 2.1 tt0 -74.44 -47.03 36.13 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.739 -0.837 . . . . 0.9 108.739 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 69.94 125.86 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.16 -1.382 . . . . 1.01 111.574 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -146.8 -149.51 0.29 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.885 -1.507 . . . . 1.04 108.904 -175.126 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 202' ' ' ASP . 13.5 mttt -127.92 140.8 51.79 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.934 -0.575 . . . . 4.11 110.307 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.515 HG13 ' HG ' ' A' ' 217' ' ' LEU . 6.3 p -110.16 141.53 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-O 121.607 0.717 . . . . 1.66 109.493 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.447 ' H ' ' HG3' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -76.98 50.99 0.76 Allowed 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 124.615 1.166 . . . . 4.04 111.578 177.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -61.72 102.93 0.29 Allowed 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 113.496 -1.684 . . . . 1.48 110.374 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 79.78 27.34 54.09 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.14 -0.784 . . . . 2.12 111.14 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 71.78 2.04 4.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.934 0.894 . . . . 3.89 111.112 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.473 ' N ' HD21 ' A' ' 199' ' ' ASN . 0.9 OUTLIER -106.09 129.9 54.09 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.373 -0.83 . . . . 2.05 109.629 176.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -70.74 118.45 13.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 122.364 1.078 . . . . 1.45 109.464 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.575 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 30.0 tpp -102.3 -79.15 0.53 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.335 -1.757 . . . . 1.96 110.253 -166.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.575 ' HB2' ' O ' ' A' ' 201' ' ' MET . 3.7 t70 158.29 142.46 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 113.714 -1.584 . . . . 1.86 106.979 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.719 ' HB2' ' CG2' ' A' ' 215' ' ' VAL . . . -163.56 150.54 12.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 120.315 -0.554 . . . . 1.03 112.151 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 18.9 m -117.49 127.12 53.69 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.67 -0.412 . . . . 1.01 112.032 -175.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.771 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 91.0 t -63.85 122.25 14.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 113.025 0.75 . . . . 1.02 113.025 -171.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -103.16 -35.17 8.58 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.473 -0.785 . . . . 1.3 109.76 175.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.674 ' O ' HG12 ' A' ' 213' ' ' VAL . 8.1 tp10 -159.03 157.57 31.46 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.904 -1.887 . . . . 2.2 105.904 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.62 HD13 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -118.66 157.37 20.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 112.426 0.528 . . . . 1.03 112.426 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.406 ' N ' HG22 ' A' ' 208' ' ' ILE . 39.5 p -111.43 -158.51 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.77 -0.65 . . . . 0.95 111.476 -175.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -59.96 -25.81 65.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 4.37 112.015 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.651 ' C ' ' HB1' ' A' ' 227' ' ' ALA . 5.4 t0 -163.2 -29.44 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.292 -1.373 . . . . 1.67 107.292 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.477 ' HA2' HD23 ' A' ' 230' ' ' LEU . . . -95.56 -149.36 25.57 Favored Glycine 0 CA--C 1.474 -2.48 0 N-CA-C 108.134 -1.986 . . . . 0.12 108.134 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.674 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -146.47 -177.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.601 0 C-N-CA 119.903 -0.719 . . . . 1.04 111.211 -177.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -128.96 93.17 3.54 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.833 -1.543 . . . . 3.9 106.833 158.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.719 ' CG2' ' HB2' ' A' ' 203' ' ' ALA . 23.8 m -88.8 -177.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 114.089 -1.414 . . . . 1.03 110.108 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.8 OUTLIER -104.07 113.23 26.62 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 108.093 -1.077 . . . . 2.31 108.093 170.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.583 ' HB2' ' H ' ' A' ' 221' ' ' MET . 11.1 mp -75.95 142.89 41.87 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 119.744 -0.782 . . . . 1.1 110.823 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -66.01 -31.57 72.54 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.537 -1.21 . . . . 1.28 108.334 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.5 m -60.85 -20.12 61.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.48 -1.236 . . . . 1.35 109.902 169.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.82 29.97 11.09 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 114.654 -1.157 . . . . 0.84 112.117 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.583 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 36.6 ttm -94.87 -62.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.451 -0.5 . . . . 1.56 111.941 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 23.8 m 76.72 123.15 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.085 0.865 . . . . 1.12 110.675 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 222' ' ' SER . 57.2 tp 157.01 -38.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.333 -0.849 . . . . 1.18 113.049 -162.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.653 ' O ' ' HB ' ' A' ' 225' ' ' VAL 0.3 0.2 OUTLIER 33.47 -93.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.864 1.266 . . . . 1.1 113.307 -157.23 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.654 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 8.5 p 160.51 -156.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 118.887 0.767 . . . . 1.42 109.656 -165.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.654 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 35.5 ttt180 -103.05 164.01 11.87 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.14 -1.059 . . . . 4.06 108.14 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.651 ' HB1' ' C ' ' A' ' 211' ' ' ASP . . . -72.05 -14.72 61.94 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.719 0.637 . . . . 1.08 112.719 -166.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -101.02 25.05 8.5 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.666 1.222 . . . . 2.57 109.215 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.539 ' CB ' HG23 ' A' ' 225' ' ' VAL . 0.7 OUTLIER -137.67 -24.02 1.05 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.775 -1.557 . . . . 3.05 110.818 178.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.622 ' C ' HD11 ' A' ' 230' ' ' LEU . 1.2 pp -94.16 164.99 12.83 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 116.163 -0.471 . . . . 1.45 110.79 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 18.5 m -134.16 73.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 113.356 0.873 . . . . 1.5 113.356 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 232' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.039 0 CA-C-N 115.689 -0.687 . . . . 1.3 110.301 165.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.562 0.696 . . . . 6.05 110.787 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.0 m -89.69 27.71 1.47 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.333 -0.849 . . . . 3.09 110.302 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.562 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 11.0 m-20 72.4 141.88 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.092 -0.958 . . . . 1.83 111.337 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.6 mt -76.42 -49.31 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 115.738 -0.665 . . . . 1.15 109.305 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' A' ' 211' ' ' ASP . 35.5 t -124.95 -77.04 0.59 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.344 -0.844 . . . . 1.72 111.132 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -117.41 -0.08 12.05 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.107 -1.442 . . . . 1.04 107.107 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.565 HD13 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.78 -178.8 3.08 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 112.791 -2.004 . . . . 1.03 109.07 -171.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.625 ' C ' HD11 ' A' ' 208' ' ' ILE . 6.1 m -124.38 171.13 10.16 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.881 0.848 . . . . 1.0 112.243 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.754 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 61.7 t -82.92 131.84 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.139 -1.391 . . . . 1.03 109.411 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.1 14.3 80.77 Favored Glycine 0 C--N 1.302 -1.342 0 CA-C-N 113.955 -1.475 . . . . 0.14 110.725 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.569 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -70.7 -51.8 25.19 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.847 -0.798 . . . . 0.9 108.847 -178.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.83 125.82 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.377 -1.738 . . . . 1.01 111.593 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 192' ' ' LEU . 0.1 OUTLIER -152.4 -146.98 0.21 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 113.687 -1.597 . . . . 1.04 109.209 -174.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 202' ' ' ASP . 10.3 mtmt -130.26 149.33 52.01 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.541 0.686 . . . . 4.11 111.065 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.697 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 8.1 p -116.63 149.01 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.633 -1.167 . . . . 1.66 108.191 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 4.3 ttmt -101.06 89.27 3.76 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.265 -1.013 . . . . 4.04 108.265 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -85.3 73.06 10.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.681 -1.145 . . . . 1.48 109.584 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 113.2 -103.46 1.39 Allowed Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.911 -1.04 . . . . 2.12 111.188 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -110.15 -18.0 13.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.515 0.674 . . . . 3.89 110.765 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -117.75 142.3 47.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.779 -0.646 . . . . 2.05 112.312 -171.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.697 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -74.71 144.07 43.87 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.976 -1.12 . . . . 1.45 107.976 170.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.467 ' HG3' ' HB3' ' A' ' 218' ' ' ASN . 34.7 tpp -117.28 -79.03 0.58 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.959 -1.019 . . . . 1.96 109.347 -171.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.9 OUTLIER 162.95 151.32 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.707 -1.59 . . . . 1.86 106.707 173.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.646 ' HB3' ' CG2' ' A' ' 215' ' ' VAL . . . -165.82 151.66 9.15 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 118.814 0.734 . . . . 1.03 112.141 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 17.4 m -115.67 129.78 56.61 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 120.979 0.418 . . . . 1.01 111.635 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.754 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 86.3 t -69.0 118.97 14.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 112.911 0.708 . . . . 1.02 112.911 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.467 HD23 ' HB2' ' A' ' 216' ' ' GLN . 8.3 mt -101.94 -36.14 8.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.274 0.559 . . . . 1.3 110.771 174.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.683 ' O ' HG12 ' A' ' 213' ' ' VAL . 40.1 mt-10 -150.35 162.17 41.05 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 105.501 -2.037 . . . . 2.2 105.501 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.625 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -126.16 155.28 36.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 123.373 0.421 . . . . 1.03 111.987 -175.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.6 p -111.05 -160.95 0.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.949 -0.569 . . . . 0.95 111.422 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -49.8 -35.47 22.83 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.385 -0.825 . . . . 4.37 111.626 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.638 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 5.3 t70 -162.1 -24.19 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.02 -1.104 . . . . 1.67 108.02 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.497 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.43 -150.14 26.24 Favored Glycine 0 CA--C 1.473 -2.574 0 N-CA-C 108.085 -2.006 . . . . 0.12 108.085 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.688 ' CG1' HG13 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -144.37 -178.33 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 C-N-CA 119.787 -0.765 . . . . 1.04 111.139 -177.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.415 ' H ' HG12 ' A' ' 213' ' ' VAL . 23.7 ttt85 -129.6 91.79 3.22 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.119 -1.438 . . . . 3.9 107.119 159.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 222' ' ' SER . 25.8 m -89.11 -176.45 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.881 -1.509 . . . . 1.03 110.297 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.467 ' HB2' HD23 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -104.06 108.71 20.19 Favored 'General case' 0 N--CA 1.425 -1.703 0 O-C-N 124.196 0.935 . . . . 2.31 108.549 168.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.511 ' HB2' ' H ' ' A' ' 221' ' ' MET . 8.5 mp -67.74 138.1 55.97 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.805 0.812 . . . . 1.1 111.593 -175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.467 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 24.8 t-20 -72.37 -21.66 61.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.758 -1.565 . . . . 1.28 108.642 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.444 ' OG ' ' HG2' ' A' ' 201' ' ' MET . 17.8 m -60.84 -19.03 59.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.646 -1.161 . . . . 1.35 109.036 166.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 108.01 14.86 15.85 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.729 -1.123 . . . . 0.84 112.633 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.555 ' HG2' ' H ' ' A' ' 222' ' ' SER . 26.9 ttm -103.59 -146.24 0.37 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.39 0.614 . . . . 1.56 109.759 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 69.0 m 176.61 123.4 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 126.171 1.788 . . . . 1.12 107.134 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 222' ' ' SER . 33.2 tp 160.89 -40.93 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.402 0.89 . . . . 1.18 113.402 -161.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.672 ' O ' ' HB ' ' A' ' 225' ' ' VAL 0.289 0.2 OUTLIER 32.54 -91.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.523 1.129 . . . . 1.1 112.924 -155.814 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.684 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 7.3 p 159.03 -153.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 118.788 0.722 . . . . 1.42 109.16 -167.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.684 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 8.4 mtt180 -104.32 162.15 13.46 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.496 -0.774 . . . . 4.06 109.023 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.638 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -67.91 -16.29 64.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.61 -0.723 . . . . 1.08 112.597 -169.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -101.18 28.1 5.63 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 122.254 1.026 . . . . 2.57 109.745 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.556 ' HB3' HG21 ' A' ' 225' ' ' VAL . 12.1 t60 -143.85 -25.41 0.56 Allowed 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 114.231 -1.349 . . . . 3.05 109.635 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.636 ' C ' HD13 ' A' ' 230' ' ' LEU . 1.1 pp -89.93 170.38 10.42 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.042 0.448 . . . . 1.45 111.319 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.76 77.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 113.406 0.891 . . . . 1.5 113.406 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 232' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.714 -0.66 . . . . 1.3 109.834 163.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.63 0.728 . . . . 6.05 109.939 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.5 m -130.41 30.33 4.74 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.39 -0.823 . . . . 3.09 109.429 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.61 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 9.5 m-20 -111.19 -159.46 0.68 Allowed 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.99 -1.004 . . . . 1.83 109.281 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 6.0 mt -84.68 -62.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 120.999 0.428 . . . . 1.15 110.107 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.6 t -118.37 -73.66 0.64 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.76 -0.655 . . . . 1.72 110.677 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.435 ' HB2' HD22 ' A' ' 186' ' ' LEU . . . -120.4 0.81 10.63 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.079 -1.452 . . . . 1.04 107.079 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.61 ' C ' ' HB3' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -170.35 -179.91 3.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.968 -1.924 . . . . 1.03 109.382 -170.071 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.579 ' C ' HD12 ' A' ' 208' ' ' ILE . 7.6 m -123.99 170.84 10.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.892 0.853 . . . . 1.0 111.994 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.767 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 61.0 t -80.76 132.85 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 114.256 -1.338 . . . . 1.03 109.384 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.24 15.46 80.98 Favored Glycine 0 C--N 1.302 -1.331 0 CA-C-N 113.806 -1.543 . . . . 0.14 110.815 -170.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 190' ' ' GLN . 2.1 tt0 -70.11 -49.13 53.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.603 -0.518 . . . . 0.9 109.603 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 74.76 125.28 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.576 -1.193 . . . . 1.01 112.092 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.551 HD13 ' N ' ' A' ' 192' ' ' LEU . 0.1 OUTLIER -161.24 -150.97 0.21 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.147 -1.388 . . . . 1.04 111.199 -172.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.476 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -114.87 144.36 43.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.33 0.586 . . . . 4.11 110.808 -173.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.536 HG11 ' HG ' ' A' ' 217' ' ' LEU . 2.2 p -111.6 -37.6 2.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.633 1.206 . . . . 1.66 110.097 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 21.1 ttmt 54.52 99.86 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 112.047 -2.342 . . . . 4.04 111.074 -171.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.471 ' HB1' ' CE ' ' A' ' 201' ' ' MET . . . -134.78 109.17 8.39 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.634 -1.621 . . . . 1.48 110.246 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.33 41.06 2.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.917 -0.659 . . . . 2.12 111.687 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 62.35 12.67 5.42 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.277 0.631 . . . . 3.89 111.87 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 36.0 m-80 -145.56 151.53 38.27 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.957 -0.565 . . . . 2.05 110.401 -174.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -76.56 156.13 33.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.521 -0.918 . . . . 1.45 108.521 173.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.534 ' O ' ' HB3' ' A' ' 202' ' ' ASP . 51.8 ttm -129.15 -58.01 1.14 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.759 -1.11 . . . . 1.96 110.116 -164.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 3.0 t70 101.16 126.35 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 111.209 -2.723 . . . . 1.86 109.153 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.652 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -145.94 148.78 33.14 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.112 -1.404 . . . . 1.03 111.086 -168.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 25.9 m -115.56 124.98 52.37 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-O 120.92 0.391 . . . . 1.01 112.001 -169.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.767 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 87.8 t -59.22 122.93 10.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 113.046 0.758 . . . . 1.02 113.046 -171.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.4 HD21 ' OE1' ' A' ' 216' ' ' GLN . 0.0 OUTLIER -104.89 -39.96 6.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.569 -0.741 . . . . 1.3 109.877 173.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.708 ' O ' HG13 ' A' ' 213' ' ' VAL . 20.3 mt-10 -148.19 153.58 38.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.268 -2.123 . . . . 2.2 105.268 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.579 HD12 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -117.31 157.27 18.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 O-C-N 123.313 0.383 . . . . 1.03 111.924 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 p -112.57 -164.34 0.91 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.585 . . . . 0.95 111.365 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -53.43 -25.17 14.86 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.868 0.692 . . . . 4.37 112.868 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.609 ' C ' ' HB3' ' A' ' 227' ' ' ALA . 19.6 t0 -166.23 -26.0 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.784 -1.191 . . . . 1.67 107.784 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -94.16 -148.88 24.6 Favored Glycine 0 CA--C 1.475 -2.423 0 N-CA-C 107.86 -2.096 . . . . 0.12 107.86 177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -147.8 -176.15 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 C-N-CA 119.897 -0.721 . . . . 1.04 111.198 -178.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.493 ' HG3' ' N ' ' A' ' 223' ' ' LEU . 26.6 ttp180 -131.14 94.04 3.5 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.331 -1.359 . . . . 3.9 107.331 159.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.813 ' O ' ' HA ' ' A' ' 222' ' ' SER . 28.1 m -89.58 178.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 114.46 -1.246 . . . . 1.03 111.783 -175.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 204' ' ' THR . 22.3 tp60 -101.84 104.44 15.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.189 -1.041 . . . . 2.31 108.189 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.566 ' HB2' ' H ' ' A' ' 221' ' ' MET . 9.2 mp -62.86 146.91 51.68 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.575 0.702 . . . . 1.1 111.82 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 1.7 t-20 -63.04 -30.33 71.51 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.117 -1.402 . . . . 1.28 109.562 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 39.7 m -68.53 -15.28 63.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.449 -0.796 . . . . 1.35 110.056 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.52 24.1 9.67 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.453 -0.794 . . . . 0.84 112.776 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.566 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 28.7 ttp -104.84 -166.1 1.2 Allowed 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.763 -1.199 . . . . 1.56 107.763 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.813 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 1.5 m -157.26 131.38 8.32 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.007 -0.738 . . . . 1.12 109.007 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.493 ' N ' ' HG3' ' A' ' 214' ' ' ARG . 57.5 tp 170.39 -44.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.995 1.109 . . . . 1.18 113.995 -168.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.658 ' CG2' ' H ' ' A' ' 225' ' ' VAL 0.281 0.2 OUTLIER 33.67 -98.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.105 0.962 . . . . 1.1 113.553 -158.185 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.658 ' H ' ' CG2' ' A' ' 224' ' ' ILE . 12.8 m 178.94 -164.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.877 0.846 . . . . 1.42 111.176 -158.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 225' ' ' VAL . 8.6 tpt85 -97.16 165.96 11.8 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.867 -1.901 . . . . 4.06 105.867 166.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.609 ' HB3' ' C ' ' A' ' 211' ' ' ASP . . . -69.64 -14.38 62.79 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.216 0.531 . . . . 1.08 112.392 -172.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.77 24.99 5.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.047 0.927 . . . . 2.57 110.278 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.03 -23.84 1.49 Allowed 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.33 -1.305 . . . . 3.05 111.062 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 230' ' ' LEU . 1.1 pp -94.78 153.35 17.8 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 122.995 0.518 . . . . 1.45 111.114 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.448 HG21 ' HE3' ' A' ' 193' ' ' LYS . 21.5 m -126.62 65.02 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.765 0.793 . . . . 1.5 112.402 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 232' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.17 -0.923 . . . . 1.3 111.806 172.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.489 0.661 . . . . 6.05 111.158 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.0 m -119.12 17.98 13.14 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.902 -0.59 . . . . 3.09 109.865 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.673 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 39.7 m-20 73.95 153.11 0.14 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 114.986 -1.007 . . . . 1.83 111.101 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.93 -68.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.543 0.687 . . . . 1.15 109.962 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.439 ' HB2' ' HA ' ' A' ' 211' ' ' ASP . 96.7 p -95.27 -80.34 0.42 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-O 122.376 1.084 . . . . 1.72 110.746 -176.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -125.39 -2.27 7.49 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 105.02 -2.215 . . . . 1.04 105.02 173.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.559 HD12 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -162.1 177.72 9.45 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.187 -1.824 . . . . 1.03 109.351 -173.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.673 ' OG1' ' HA ' ' A' ' 182' ' ' ASP . 4.1 m -121.44 173.48 7.35 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.64 0.733 . . . . 1.0 111.919 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.749 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 41.2 t -82.76 130.71 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 114.941 -1.027 . . . . 1.03 109.056 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.55 15.7 81.08 Favored Glycine 0 C--N 1.303 -1.267 0 CA-C-N 114.265 -1.334 . . . . 0.14 110.52 -169.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -44.53 38.51 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.382 -0.599 . . . . 0.9 109.382 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.63 131.25 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 124.375 1.047 . . . . 1.01 111.623 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.516 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -152.08 -148.87 0.27 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 113.991 -1.459 . . . . 1.04 109.396 -174.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.506 ' HB3' HG22 ' A' ' 231' ' ' VAL . 14.7 tttt -135.96 140.9 44.33 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.129 -0.487 . . . . 4.11 109.895 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.449 HG12 ' HG ' ' A' ' 217' ' ' LEU . 8.3 p -126.12 150.38 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 121.187 0.518 . . . . 1.66 109.97 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.45 ' C ' ' HE3' ' A' ' 195' ' ' LYS . 0.1 OUTLIER -74.28 48.19 0.32 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 125.445 1.498 . . . . 4.04 112.45 -179.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' A' ' 194' ' ' VAL . . . -69.34 103.57 2.02 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 113.42 -1.718 . . . . 1.48 110.756 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 86.89 32.18 15.6 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.511 -0.768 . . . . 2.12 111.221 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 71.98 10.87 6.16 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.147 0.975 . . . . 3.89 111.194 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -132.94 131.75 41.18 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.593 -0.73 . . . . 2.05 111.081 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -63.5 116.02 5.2 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 122.19 0.995 . . . . 1.45 108.826 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.618 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 34.7 tpp -104.6 -77.59 0.58 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.47 -1.695 . . . . 1.96 110.556 -164.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 201' ' ' MET . 4.2 t70 151.52 140.79 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 113.304 -1.771 . . . . 1.86 106.587 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.683 ' HB3' ' CG2' ' A' ' 215' ' ' VAL . . . -160.87 150.95 17.6 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 120.44 -0.504 . . . . 1.03 111.169 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 17.1 m -119.79 127.52 52.87 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.638 -0.425 . . . . 1.01 111.805 -174.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.749 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 89.5 t -63.24 123.04 15.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 113.927 1.084 . . . . 1.02 113.927 -170.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.9 -38.67 7.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.814 -1.084 . . . . 1.3 109.721 175.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.578 ' O ' HG11 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -158.31 150.08 21.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 105.395 -2.076 . . . . 2.2 105.395 -178.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.656 HD13 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -114.67 161.31 13.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 112.918 0.71 . . . . 1.03 112.918 -171.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.464 ' N ' HG21 ' A' ' 208' ' ' ILE . 31.9 p -112.65 -163.07 0.83 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.806 -0.634 . . . . 0.95 110.231 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -51.77 -37.49 51.56 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.324 0.583 . . . . 4.37 111.128 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.641 ' C ' ' HB1' ' A' ' 227' ' ' ALA . 0.4 OUTLIER -156.7 -24.63 0.1 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.778 -0.823 . . . . 1.67 108.778 -173.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.476 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -94.83 -151.36 28.25 Favored Glycine 0 CA--C 1.477 -2.31 0 N-CA-C 107.619 -2.193 . . . . 0.12 107.619 176.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.606 ' CG1' HG12 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -150.52 -176.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 C-N-CA 119.811 -0.755 . . . . 1.04 111.516 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -128.9 90.77 3.1 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.608 -1.627 . . . . 3.9 106.608 158.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 222' ' ' SER . 26.5 m -86.2 -177.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 114.587 -1.188 . . . . 1.03 111.333 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 204' ' ' THR . 31.6 tp60 -102.69 106.64 17.32 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.517 -1.22 . . . . 2.31 107.976 171.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.623 ' HB2' ' H ' ' A' ' 221' ' ' MET . 10.9 mp -71.19 144.52 50.12 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.542 -0.863 . . . . 1.1 110.462 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -67.38 -27.88 67.47 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.406 -1.27 . . . . 1.28 108.685 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 41.0 m -67.21 -16.36 64.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.645 -1.161 . . . . 1.35 109.772 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.57 30.99 14.03 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 114.887 -1.051 . . . . 0.84 112.457 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.623 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 5.5 tpp -90.04 -63.63 1.25 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.548 0.573 . . . . 1.56 112.548 -175.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.79 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 18.3 m 78.29 122.46 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.282 1.033 . . . . 1.12 110.634 -172.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 222' ' ' SER . 61.4 tp 159.06 -41.99 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.257 0.973 . . . . 1.18 113.176 -166.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.721 ' O ' ' HB ' ' A' ' 225' ' ' VAL 0.293 0.2 OUTLIER 31.64 -92.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.44 1.096 . . . . 1.1 113.082 -156.466 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.721 ' HB ' ' O ' ' A' ' 224' ' ' ILE . 10.0 p 157.25 -158.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.027 0.83 . . . . 1.42 110.189 -167.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.679 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 0.1 OUTLIER -95.6 153.03 17.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.665 -1.152 . . . . 4.06 108.355 178.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.641 ' HB1' ' C ' ' A' ' 211' ' ' ASP . . . -61.57 -19.43 62.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.337 0.865 . . . . 1.08 113.337 -173.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -101.8 27.09 6.75 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.441 1.115 . . . . 2.57 109.086 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.552 ' CB ' HG21 ' A' ' 225' ' ' VAL . 0.8 OUTLIER -139.17 -22.39 0.93 Allowed 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.698 -1.592 . . . . 3.05 110.693 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.66 ' C ' HD13 ' A' ' 230' ' ' LEU . 1.2 pp -95.47 173.2 7.63 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 116.593 -0.276 . . . . 1.45 110.513 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 193' ' ' LYS . 23.9 m -137.96 72.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.686 0.755 . . . . 1.5 112.392 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.516 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.304 -0.855 . . . . 1.3 111.104 170.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.886 0.374 . . . . 6.05 110.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.9 p -113.76 17.62 17.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.166 0.508 . . . . 3.09 110.626 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.509 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 3.6 p30 -159.72 160.64 34.29 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.748 -0.66 . . . . 1.83 110.128 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 19.6 mt -88.48 -56.42 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 115.248 -0.887 . . . . 1.15 109.018 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 94.3 p -105.29 -78.29 0.57 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 122.192 0.996 . . . . 1.72 110.503 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.47 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -126.23 -2.84 6.93 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 104.95 -2.241 . . . . 1.04 104.95 172.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.544 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -161.02 -178.58 6.88 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.42 -1.718 . . . . 1.03 110.283 -173.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.631 ' C ' HD13 ' A' ' 208' ' ' ILE . 6.5 m -125.39 170.74 11.06 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.102 0.953 . . . . 1.0 112.592 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.784 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.5 t -82.81 131.2 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.957 -1.474 . . . . 1.03 109.516 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.56 13.96 80.75 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.941 -1.481 . . . . 0.14 110.958 -170.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -73.52 -47.02 44.2 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.656 -0.498 . . . . 0.9 109.656 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 70.97 123.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.75 -1.114 . . . . 1.01 111.891 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.549 HD13 ' N ' ' A' ' 192' ' ' LEU . 0.1 OUTLIER -156.62 -157.52 0.71 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.195 -1.366 . . . . 1.04 111.372 -171.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.438 ' HD2' ' CG2' ' A' ' 231' ' ' VAL . 29.8 ttmt -109.06 142.61 39.52 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.973 0.892 . . . . 4.11 111.234 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.428 HG12 ' HG ' ' A' ' 217' ' ' LEU . 1.5 p -113.06 -32.14 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 113.542 -1.663 . . . . 1.66 108.849 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 25.1 ttmt 59.19 95.36 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 111.092 -2.776 . . . . 4.04 110.555 -176.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -103.08 97.14 7.28 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.704 -1.589 . . . . 1.48 110.852 -174.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 198' ' ' GLN . . . 85.03 55.72 2.58 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.89 -0.671 . . . . 2.12 112.172 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.407 ' HB3' ' O ' ' A' ' 197' ' ' GLY . 26.7 tt0 74.01 -35.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.17 0.588 . . . . 3.89 112.522 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 197' ' ' GLY . 13.1 m120 -96.09 158.97 15.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.81 -0.441 . . . . 2.05 109.81 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -71.73 177.05 4.38 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.703 0.763 . . . . 1.45 109.436 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.736 ' SD ' ' HB3' ' A' ' 218' ' ' ASN . 37.4 tpp -146.29 -55.65 0.27 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.896 -1.047 . . . . 1.96 110.287 -168.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 201' ' ' MET . 17.6 m-20 97.03 105.27 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.472 -2.149 . . . . 1.86 109.165 174.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.725 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -128.38 147.93 50.66 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.121 -0.945 . . . . 1.03 110.664 -167.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 40.6 m -116.18 125.24 52.02 Favored 'General case' 0 C--O 1.211 -0.921 0 C-N-CA 120.378 -0.529 . . . . 1.01 112.272 -170.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.784 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 85.3 t -61.73 121.49 10.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 112.917 0.71 . . . . 1.02 112.917 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -102.63 -36.51 8.31 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.627 -0.715 . . . . 1.3 110.067 175.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.634 ' O ' HG11 ' A' ' 213' ' ' VAL . 35.1 tt0 -156.81 157.12 34.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.267 -2.123 . . . . 2.2 105.267 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.631 HD13 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.48 160.27 19.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 112.63 0.604 . . . . 1.03 112.63 -172.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 208' ' ' ILE . 34.0 p -112.11 -161.66 0.76 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.802 -0.636 . . . . 0.95 110.609 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -56.51 -30.0 62.5 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.389 0.515 . . . . 4.37 112.389 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.595 ' C ' ' HB1' ' A' ' 227' ' ' ALA . 4.3 t0 -161.88 -24.35 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.332 -0.988 . . . . 1.67 108.332 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.467 ' HA2' HD23 ' A' ' 230' ' ' LEU . . . -98.07 -149.31 24.88 Favored Glycine 0 CA--C 1.473 -2.561 0 N-CA-C 107.685 -2.166 . . . . 0.12 107.685 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.641 ' CG1' HG11 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -149.04 -175.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 C-N-CA 119.881 -0.728 . . . . 1.04 111.695 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.428 ' HA ' ' C ' ' A' ' 223' ' ' LEU . 29.6 ttt-85 -129.94 93.33 3.48 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.229 -1.397 . . . . 3.9 107.229 157.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.725 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 19.9 m -87.22 179.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 114.061 -1.427 . . . . 1.03 110.415 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -100.39 113.47 26.24 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 107.707 -1.22 . . . . 2.31 107.707 172.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.541 ' HB2' ' H ' ' A' ' 221' ' ' MET . 9.8 mp -72.87 144.58 47.37 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.86 -0.736 . . . . 1.1 109.571 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.736 ' HB3' ' SD ' ' A' ' 201' ' ' MET . 15.9 t-20 -67.57 -22.9 65.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.175 -0.92 . . . . 1.28 108.662 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 22.0 m -66.42 -18.29 65.27 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.671 -1.149 . . . . 1.35 109.768 167.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 86.27 32.89 15.48 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.887 -1.051 . . . . 0.84 111.22 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.541 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 14.5 ttt -102.08 -54.02 2.8 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 112.359 0.503 . . . . 1.56 112.359 -172.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 28.0 m 77.04 125.39 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.495 0.718 . . . . 1.12 112.092 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 222' ' ' SER . 39.1 tp 158.98 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.968 -1.015 . . . . 1.18 113.574 -168.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.647 ' CG2' ' H ' ' A' ' 225' ' ' VAL 0.297 0.1 OUTLIER 34.53 -93.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 124.635 1.174 . . . . 1.1 113.481 -157.737 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.69 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 9.7 p 162.12 -153.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 119.139 0.881 . . . . 1.42 110.416 -164.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.69 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 0.8 OUTLIER -108.06 159.59 16.45 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.833 -1.076 . . . . 4.06 108.55 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.595 ' HB1' ' C ' ' A' ' 211' ' ' ASP . . . -64.7 -16.4 62.83 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.534 0.939 . . . . 1.08 113.534 -170.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -100.52 29.97 4.16 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.603 1.192 . . . . 2.57 109.526 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.532 ' HB3' HG23 ' A' ' 225' ' ' VAL . 11.2 t60 -137.19 -31.79 0.81 Allowed 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.012 -1.449 . . . . 3.05 109.372 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.687 HD13 ' O ' ' A' ' 230' ' ' LEU . 1.2 pp -86.8 154.41 20.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.252 -0.431 . . . . 1.45 109.965 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.438 ' CG2' ' HD2' ' A' ' 193' ' ' LYS . 18.7 m -127.69 47.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 122.172 0.986 . . . . 1.5 112.488 -177.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.562 ' HD1' ' N ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-N 113.647 -1.615 . . . . 1.3 112.086 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.046 0.45 . . . . 6.05 110.012 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.1 t -101.61 13.95 33.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.415 0.626 . . . . 3.09 109.757 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.438 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 6.9 m-20 -130.07 -169.77 2.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.677 -0.86 . . . . 1.83 108.677 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 19.7 mt -84.76 -73.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.191 0.519 . . . . 1.15 110.159 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 99.9 p -97.78 -80.23 0.45 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.269 1.033 . . . . 1.72 110.48 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.448 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -121.29 -3.81 9.46 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 105.013 -2.217 . . . . 1.04 105.013 171.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.53 HD11 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -159.85 -174.95 4.85 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 113.393 -1.73 . . . . 1.03 110.706 -173.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.62 ' C ' HD13 ' A' ' 208' ' ' ILE . 7.1 m -128.51 170.85 12.69 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.024 -0.989 . . . . 1.0 112.543 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.777 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 57.7 t -81.78 133.4 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.111 -1.404 . . . . 1.03 109.366 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.95 13.66 82.83 Favored Glycine 0 C--N 1.303 -1.276 0 CA-C-N 114.031 -1.441 . . . . 0.14 110.903 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.416 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 2.6 tt0 -72.53 -49.95 29.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.606 -0.438 . . . . 0.9 109.846 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.15 127.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.573 -1.194 . . . . 1.01 112.006 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.509 HD11 ' N ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -154.95 -149.75 0.28 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.49 -1.232 . . . . 1.04 110.45 -174.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' A' ' 231' ' ' VAL . 0.0 OUTLIER -122.93 146.22 47.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.612 0.72 . . . . 4.11 111.778 -176.477 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 6.9 p -132.74 145.82 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 CA-C-N 114.134 -1.394 . . . . 1.66 107.718 163.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.566 ' HE2' ' N ' ' A' ' 200' ' ' ALA . 9.4 ttmt -102.23 95.56 6.39 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.295 -1.002 . . . . 4.04 108.295 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -96.02 73.48 3.0 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.69 -1.141 . . . . 1.48 109.671 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 119.3 -114.42 2.77 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.856 -1.065 . . . . 2.12 110.964 -175.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -99.53 -23.88 14.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.468 0.651 . . . . 3.89 110.767 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 39.2 m-80 -112.83 149.2 33.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.375 -0.83 . . . . 2.05 112.004 -170.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.566 ' N ' ' HE2' ' A' ' 195' ' ' LYS . . . -75.55 151.18 37.95 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.927 -1.509 . . . . 1.45 106.927 166.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.625 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 46.1 tpp -108.08 -59.29 1.87 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.443 -1.253 . . . . 1.96 110.375 -163.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.625 ' HB2' ' O ' ' A' ' 201' ' ' MET . 0.9 OUTLIER 95.24 109.54 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 111.815 -2.448 . . . . 1.86 108.104 -178.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.656 ' HB2' ' CG2' ' A' ' 215' ' ' VAL . . . -139.81 152.42 46.52 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.768 -1.106 . . . . 1.03 110.658 -161.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 18.3 m -117.63 129.46 55.76 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 121.088 0.47 . . . . 1.01 111.716 -171.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.777 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 86.1 t -64.7 122.25 15.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.979 0.733 . . . . 1.02 112.979 -170.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.432 HD22 ' OE1' ' A' ' 216' ' ' GLN . 0.0 OUTLIER -103.95 -39.23 6.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.699 0.762 . . . . 1.3 109.484 174.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.677 ' O ' HG12 ' A' ' 213' ' ' VAL . 18.2 mt-10 -148.75 156.19 42.02 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 104.786 -2.302 . . . . 2.2 104.786 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.62 HD13 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.54 161.73 19.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 112.42 0.526 . . . . 1.03 112.42 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 208' ' ' ILE . 31.4 p -112.45 -163.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.95 110.247 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -58.1 -27.39 63.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.875 0.694 . . . . 4.37 112.875 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.588 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 4.9 t0 -159.75 -27.77 0.07 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.154 -1.054 . . . . 1.67 108.154 -174.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.424 ' HA2' HD13 ' A' ' 230' ' ' LEU . . . -96.84 -151.08 27.62 Favored Glycine 0 CA--C 1.475 -2.456 0 N-CA-C 107.842 -2.103 . . . . 0.12 107.842 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.677 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -145.79 -174.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 C-N-CA 119.769 -0.772 . . . . 1.04 111.45 -178.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.481 ' H ' HG12 ' A' ' 213' ' ' VAL . 72.8 mtm-85 -134.26 81.69 1.93 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.973 -1.491 . . . . 3.9 106.973 164.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.698 ' O ' ' HA ' ' A' ' 222' ' ' SER . 26.5 m -80.93 -177.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 114.15 -1.386 . . . . 1.03 112.165 -173.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 204' ' ' THR . 26.4 tp60 -104.83 116.59 32.26 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.623 -1.251 . . . . 2.31 107.623 171.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.613 ' HB2' ' H ' ' A' ' 221' ' ' MET . 10.9 mp -76.57 150.34 36.52 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.39 -0.924 . . . . 1.1 111.257 -174.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.565 ' HB3' ' SD ' ' A' ' 201' ' ' MET . 21.7 t-20 -52.67 -43.54 65.62 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.734 -1.121 . . . . 1.28 109.368 174.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 58.3 m -67.12 -11.55 57.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.16 -0.927 . . . . 1.35 111.806 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.21 35.13 18.78 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.607 -0.806 . . . . 0.84 111.87 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.613 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 18.3 tpp -85.12 -56.33 3.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.45 0.643 . . . . 1.56 110.93 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.698 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 59.7 p 71.19 120.88 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.454 -1.703 . . . . 1.12 110.793 -175.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 222' ' ' SER . 51.9 tp 166.1 -42.45 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.283 1.216 . . . . 1.18 114.283 -168.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.636 HG23 ' C ' ' A' ' 213' ' ' VAL 0.341 0.1 OUTLIER 31.75 -99.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.498 1.119 . . . . 1.1 113.558 -154.433 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.758 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 12.1 p 162.51 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.45 1.023 . . . . 1.42 109.984 -160.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.758 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 0.1 OUTLIER -106.05 152.58 23.2 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.25 -0.886 . . . . 4.06 108.756 -178.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.588 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -51.5 -24.0 4.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.187 1.18 . . . . 1.08 114.187 -167.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -94.31 26.45 3.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.838 1.304 . . . . 2.57 109.224 -174.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.538 ' HB3' HG22 ' A' ' 225' ' ' VAL . 16.5 t60 -139.44 -21.1 0.93 Allowed 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 113.842 -1.526 . . . . 3.05 109.63 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.618 HD12 ' CE2' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -82.14 144.88 30.44 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.828 -0.434 . . . . 1.45 109.828 171.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 231' ' ' VAL . 25.0 m -120.67 66.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 122.422 1.106 . . . . 1.5 111.582 171.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.618 ' CE2' HD12 ' A' ' 230' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.144 0 CA-C-N 115.154 -0.93 . . . . 1.3 110.797 171.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.153 -0.314 . . . . 6.05 110.153 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 87.9 p 52.73 30.51 8.97 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.677 0.791 . . . . 3.09 110.594 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.434 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 4.5 m-20 -77.19 139.32 39.87 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.446 -0.797 . . . . 1.83 109.625 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.1 mt -70.71 -62.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.942 -1.027 . . . . 1.15 109.234 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 74.0 m -108.34 -78.78 0.58 Allowed 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.411 -0.813 . . . . 1.72 111.295 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.412 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -117.12 -0.71 12.04 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.866 -1.531 . . . . 1.04 106.866 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.535 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.31 -178.51 3.18 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.111 -1.859 . . . . 1.03 109.497 -171.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.629 ' C ' HD12 ' A' ' 208' ' ' ILE . 3.6 m -123.34 171.94 9.04 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.794 0.807 . . . . 1.0 112.587 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.758 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.4 t -84.71 135.66 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 114.477 -1.238 . . . . 1.03 108.917 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 71.89 18.66 77.74 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 114.374 -1.285 . . . . 0.14 110.186 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -72.38 -53.23 12.87 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.44 -0.948 . . . . 0.9 108.44 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 73.32 127.66 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.282 -1.781 . . . . 1.01 111.351 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -148.3 -151.58 0.4 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.662 -1.608 . . . . 1.04 108.532 -174.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.488 ' HD2' ' HB1' ' A' ' 200' ' ' ALA . 12.5 mtmt -129.32 148.15 51.21 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.547 -0.751 . . . . 4.11 109.629 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 195' ' ' LYS . 1.2 p -96.85 -32.84 4.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.857 -1.065 . . . . 1.66 112.077 -167.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 4.5 tppp? 60.5 96.43 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.447 -1.706 . . . . 4.04 109.604 -172.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -130.05 114.75 16.17 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.181 -1.372 . . . . 1.48 110.396 -173.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.0 48.04 17.16 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.621 -0.8 . . . . 2.12 111.747 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 75.3 -26.16 0.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.538 0.735 . . . . 3.89 112.478 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -106.47 150.52 26.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.96 0.41 . . . . 2.05 111.308 -177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.488 ' HB1' ' HD2' ' A' ' 193' ' ' LYS . . . -78.23 151.35 33.17 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.573 -0.899 . . . . 1.45 108.573 173.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.655 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 40.6 tpp -127.01 -80.63 0.6 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.548 -0.908 . . . . 1.96 108.548 -167.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.655 ' HB2' ' O ' ' A' ' 201' ' ' MET . 3.3 t70 151.75 146.99 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.311 -1.737 . . . . 1.86 106.311 170.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.758 ' HB2' ' CG2' ' A' ' 215' ' ' VAL . . . -158.9 148.24 18.88 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.933 -0.707 . . . . 1.03 112.095 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 22.8 m -119.24 127.19 53.02 Favored 'General case' 0 C--O 1.21 -0.975 0 C-N-CA 120.457 -0.497 . . . . 1.01 112.2 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.758 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 85.6 t -65.55 121.05 13.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 113.014 0.746 . . . . 1.02 113.014 -170.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -101.55 -37.84 8.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.201 -0.909 . . . . 1.3 109.827 175.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.637 ' O ' HG11 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -157.69 151.71 24.35 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 105.116 -2.179 . . . . 2.2 105.116 -178.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.629 HD12 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -115.92 160.98 14.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 112.372 0.508 . . . . 1.03 112.372 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.406 ' N ' HG23 ' A' ' 208' ' ' ILE . 22.4 p -112.74 -172.03 1.97 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.617 -0.882 . . . . 0.95 108.617 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.711 ' HG3' ' OD1' ' A' ' 211' ' ' ASP . 13.2 pttp -55.41 -28.04 51.61 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.654 0.613 . . . . 4.37 112.654 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.711 ' OD1' ' HG3' ' A' ' 210' ' ' LYS . 6.6 p-10 -149.66 -33.21 0.2 Allowed 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.971 -0.751 . . . . 1.67 108.971 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.436 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -98.29 -153.0 28.45 Favored Glycine 0 CA--C 1.476 -2.349 0 N-CA-C 108.009 -2.036 . . . . 0.12 108.009 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.637 HG11 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -147.08 -176.76 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.499 0 C-N-CA 119.874 -0.731 . . . . 1.04 110.81 -176.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.403 ' H ' HG11 ' A' ' 213' ' ' VAL . 18.9 ttm180 -128.5 87.7 2.63 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.549 -1.648 . . . . 3.9 106.549 158.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.758 ' CG2' ' HB2' ' A' ' 203' ' ' ALA . 22.6 m -83.2 -177.19 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.347 -1.297 . . . . 1.03 110.469 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 0.8 OUTLIER -103.84 115.49 30.56 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.888 -1.051 . . . . 2.31 108.261 168.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.578 ' HB2' ' H ' ' A' ' 221' ' ' MET . 11.0 mp -76.79 144.04 39.43 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.899 -0.721 . . . . 1.1 110.634 -175.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.538 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 12.8 t-20 -66.13 -28.17 68.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.41 -1.268 . . . . 1.28 108.802 178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.6 m -65.69 -18.52 65.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.427 -1.26 . . . . 1.35 109.587 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 92.44 26.12 18.99 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 114.809 -1.087 . . . . 0.84 112.435 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.578 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 2.5 tpp -88.53 -63.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.73 -0.388 . . . . 1.56 111.9 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 25.7 m 75.93 122.19 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.031 -0.986 . . . . 1.12 110.589 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 222' ' ' SER . 52.4 tp 156.32 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.192 0.932 . . . . 1.18 112.946 -163.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.647 ' O ' ' HB ' ' A' ' 225' ' ' VAL 0.303 0.2 OUTLIER 32.92 -94.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.573 1.149 . . . . 1.1 113.217 -156.575 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.694 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 8.8 p 159.94 -152.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 118.794 0.725 . . . . 1.42 110.417 -162.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.694 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 18.6 mtm180 -105.33 164.3 11.96 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.763 -1.108 . . . . 4.06 109.315 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.606 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -69.48 -17.54 63.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.339 -0.846 . . . . 1.08 112.329 -171.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -101.68 28.02 5.94 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.509 1.147 . . . . 2.57 109.442 -177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.51 ' HB3' HG21 ' A' ' 225' ' ' VAL . 7.9 t60 -137.03 -34.37 0.73 Allowed 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.957 -1.474 . . . . 3.05 109.309 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.657 HD13 ' O ' ' A' ' 230' ' ' LEU . 1.0 OUTLIER -83.28 157.61 22.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 116.014 -0.539 . . . . 1.45 111.221 -171.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 14.7 m -128.25 72.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.277 0.843 . . . . 1.5 113.277 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.499 ' HB3' HD21 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-N 115.438 -0.801 . . . . 1.3 110.772 165.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 121.324 0.583 . . . . 6.05 111.378 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.0 t -91.8 15.6 12.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.899 -0.778 . . . . 3.09 108.899 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -157.27 147.68 21.1 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.825 -1.08 . . . . 1.83 110.129 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.8 mt -82.36 -56.63 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.291 -0.868 . . . . 1.15 108.824 171.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.2 p -101.81 -82.76 0.47 Allowed 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 122.421 1.105 . . . . 1.72 110.312 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -122.81 -2.98 8.72 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 105.089 -2.189 . . . . 1.04 105.089 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.546 HD12 ' CG1' ' A' ' 213' ' ' VAL . 0.6 OUTLIER -159.28 -177.24 6.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.489 -1.687 . . . . 1.03 110.462 -175.036 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.662 ' C ' HD12 ' A' ' 208' ' ' ILE . 6.0 m -125.96 170.93 11.2 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.084 0.945 . . . . 1.0 112.808 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.782 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.1 t -80.75 134.44 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-N 114.151 -1.386 . . . . 1.03 109.277 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.39 81.59 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.243 -1.344 . . . . 0.14 110.641 -170.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.482 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 3.1 tt0 -73.28 -49.7 26.24 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.312 -0.555 . . . . 0.9 109.604 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 71.71 124.12 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.207 -1.361 . . . . 1.01 111.846 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.552 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.1 OUTLIER -150.13 -152.3 0.43 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.603 -1.18 . . . . 1.04 111.001 -173.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.537 ' HE3' ' HB2' ' A' ' 195' ' ' LYS . 0.5 OUTLIER -115.46 139.98 49.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.33 -0.85 . . . . 4.11 110.32 -177.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.487 HG12 ' HG ' ' A' ' 217' ' ' LEU . 1.1 p -112.27 -31.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 113.92 -1.491 . . . . 1.66 110.306 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 0.5 OUTLIER 62.42 108.36 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 111.87 -2.423 . . . . 4.04 110.228 -166.356 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.15 89.11 3.05 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.056 -0.975 . . . . 1.48 110.372 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.05 49.3 0.83 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.807 -0.633 . . . . 2.12 112.281 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 64.5 2.62 1.64 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.242 0.617 . . . . 3.89 112.416 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 42.5 m-80 -138.21 161.72 36.12 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.067 -0.716 . . . . 2.05 109.067 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -69.3 172.9 6.33 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.456 0.646 . . . . 1.45 109.643 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.634 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 35.6 tpp -147.88 -59.19 0.25 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.42 -0.809 . . . . 1.96 110.95 -166.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.711 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 2.1 m-20 104.59 115.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 112.127 -2.306 . . . . 1.86 109.269 177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.662 ' HB2' ' CG2' ' A' ' 215' ' ' VAL . . . -135.87 146.63 47.63 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.876 -0.602 . . . . 1.03 110.177 -172.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 19.0 m -112.75 130.21 56.15 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.383 -0.527 . . . . 1.01 111.475 -168.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.782 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 91.7 t -66.11 120.03 12.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 112.773 0.657 . . . . 1.02 112.773 -172.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -101.52 -40.24 7.14 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.302 -0.863 . . . . 1.3 109.489 175.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.656 ' O ' HG12 ' A' ' 213' ' ' VAL . 24.3 mt-10 -150.28 155.52 39.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.091 -2.188 . . . . 2.2 105.091 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.662 HD12 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.85 160.38 20.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 112.634 0.605 . . . . 1.03 112.634 -175.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.45 ' N ' HG23 ' A' ' 208' ' ' ILE . 37.6 p -113.27 -167.07 1.14 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.835 -0.62 . . . . 0.95 109.839 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -58.67 -27.73 65.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.83 0.347 . . . . 4.37 111.679 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.69 ' C ' ' HB1' ' A' ' 227' ' ' ALA . 9.0 t0 -150.51 -35.39 0.15 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.668 -1.234 . . . . 1.67 107.668 -173.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.481 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -96.01 -146.87 21.71 Favored Glycine 0 CA--C 1.476 -2.383 0 N-CA-C 108.682 -1.767 . . . . 0.12 108.682 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.762 ' CB ' HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -145.51 -170.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 C-N-CA 119.893 -0.723 . . . . 1.04 112.003 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 223' ' ' LEU . 18.0 mmm180 -137.5 81.89 1.89 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.15 -1.426 . . . . 3.9 107.15 162.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.662 ' CG2' ' HB2' ' A' ' 203' ' ' ALA . 34.0 m -81.87 -177.69 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.484 -0.78 . . . . 1.03 113.043 -175.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -106.52 114.53 28.7 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.986 -1.461 . . . . 2.31 108.708 173.268 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.487 ' HG ' HG12 ' A' ' 194' ' ' VAL . 9.6 mp -72.52 145.29 47.57 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.656 0.741 . . . . 1.1 112.134 -175.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.711 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 20.5 t-20 -66.13 -28.62 68.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.878 -1.51 . . . . 1.28 108.679 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.9 m -62.37 -18.48 61.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.496 -1.229 . . . . 1.35 109.775 169.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.73 21.71 12.06 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.317 -0.856 . . . . 0.84 112.153 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.496 ' HG2' ' H ' ' A' ' 222' ' ' SER . 26.4 ttp -108.71 -163.37 0.87 Allowed 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 107.509 -1.293 . . . . 1.56 107.509 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 10.0 m -157.8 129.28 6.77 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.99 -1.115 . . . . 1.12 107.99 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 214' ' ' ARG . 48.2 tp 178.22 -55.56 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.228 1.196 . . . . 1.18 114.228 -168.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.822 ' CG2' ' H ' ' A' ' 225' ' ' VAL . 0.4 OUTLIER 49.08 -99.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.376 1.07 . . . . 1.1 112.25 -161.141 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.822 ' H ' ' CG2' ' A' ' 224' ' ' ILE . 8.7 p 156.84 -159.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 118.777 0.717 . . . . 1.42 109.214 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.663 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 15.5 ptt180 -97.38 163.17 12.99 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.501 -0.772 . . . . 4.06 109.146 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.69 ' HB1' ' C ' ' A' ' 211' ' ' ASP . . . -71.19 -15.39 62.47 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.743 0.646 . . . . 1.08 112.743 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' A' ' 226' ' ' ARG . 11.6 tp10 -98.95 28.61 4.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.859 1.314 . . . . 2.57 109.011 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.604 ' CB ' HG21 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -136.56 -29.96 0.93 Allowed 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.504 -1.68 . . . . 3.05 110.575 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.703 HD11 ' O ' ' A' ' 230' ' ' LEU . 1.1 pp -90.49 155.58 18.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 116.168 -0.469 . . . . 1.45 111.316 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.482 HG21 ' HD2' ' A' ' 193' ' ' LYS . 19.3 m -129.43 88.3 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.886 0.851 . . . . 1.5 111.827 173.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.552 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.152 -0.928 . . . . 1.3 110.998 171.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 63.9 t . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 109.844 -0.428 . . . . 6.05 109.844 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.8 t 70.8 27.27 3.6 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.813 0.696 . . . . 3.09 109.382 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.441 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 16.7 m-20 -121.26 -161.17 0.89 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.256 -0.884 . . . . 1.83 108.721 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 188' ' ' VAL . 14.4 mt -87.02 -61.69 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.407 0.622 . . . . 1.15 109.964 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.8 t -117.08 -77.21 0.57 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.453 -0.794 . . . . 1.72 110.375 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.411 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -120.04 -1.05 10.44 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.889 -1.522 . . . . 1.04 106.889 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.53 HD13 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -166.36 -175.39 3.23 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 112.627 -2.079 . . . . 1.03 109.21 -171.567 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.615 ' C ' HD13 ' A' ' 208' ' ' ILE . 5.9 m -125.44 172.26 9.8 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.402 -0.817 . . . . 1.0 112.514 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.777 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 48.5 t -83.17 135.12 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.494 -1.23 . . . . 1.03 109.38 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.71 14.79 81.07 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.176 -1.375 . . . . 0.14 110.45 -170.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -69.85 -50.46 42.42 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.926 -0.768 . . . . 0.9 108.926 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 73.71 127.27 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.42 -1.718 . . . . 1.01 111.68 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.569 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -148.97 -149.42 0.3 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.929 -1.487 . . . . 1.04 108.845 -174.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.435 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 11.3 mttp -135.79 148.27 48.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.87 0.843 . . . . 4.11 111.71 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 7.9 p -121.3 151.54 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 114.121 -1.4 . . . . 1.66 108.414 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 1.2 ttmt -92.87 85.16 5.09 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.194 -0.669 . . . . 4.04 109.194 -178.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.5 82.59 2.18 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.699 -0.682 . . . . 1.48 110.396 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 199' ' ' ASN . . . 104.74 47.75 1.16 Allowed Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.427 -0.806 . . . . 2.12 111.61 -177.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 75.19 -19.85 0.37 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.564 0.746 . . . . 3.89 112.305 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 197' ' ' GLY . 41.7 m-80 -117.56 142.35 47.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.201 -0.454 . . . . 2.05 110.986 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -68.89 132.89 47.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.472 -0.936 . . . . 1.45 108.472 172.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.624 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 12.3 ttm -106.16 -79.16 0.57 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.566 -1.197 . . . . 1.96 109.33 -168.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.624 ' HB2' ' O ' ' A' ' 201' ' ' MET . 4.0 t70 161.73 149.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.275 -1.38 . . . . 1.86 107.275 171.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.723 ' HB3' ' CG2' ' A' ' 215' ' ' VAL . . . -162.92 149.67 12.76 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.393 -0.523 . . . . 1.03 111.742 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 20.7 m -118.79 126.65 52.33 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 120.558 -0.457 . . . . 1.01 112.009 -174.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.777 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 96.0 t -62.84 123.41 15.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 113.373 0.879 . . . . 1.02 113.373 -170.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -104.89 -34.43 8.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.408 -0.815 . . . . 1.3 110.092 175.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.572 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.3 OUTLIER -161.53 149.21 14.95 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.477 -2.046 . . . . 2.2 105.477 -178.058 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.615 HD13 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -114.71 156.43 15.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 112.837 0.68 . . . . 1.03 112.837 -172.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.428 ' N ' HG21 ' A' ' 208' ' ' ILE . 43.4 p -111.98 -161.0 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.569 0.581 . . . . 0.95 112.569 -174.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -44.46 -37.99 3.8 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 114.902 -1.045 . . . . 4.37 111.582 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.638 ' C ' ' HB1' ' A' ' 227' ' ' ALA . 2.1 t70 -162.84 -25.71 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.614 -1.254 . . . . 1.67 107.614 -175.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.503 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.45 -149.75 25.65 Favored Glycine 0 CA--C 1.474 -2.501 0 N-CA-C 108.165 -1.974 . . . . 0.12 108.165 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.647 ' CG1' HG11 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -145.41 -177.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.638 0 C-N-CA 119.826 -0.75 . . . . 1.04 111.052 -177.038 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 223' ' ' LEU . 98.5 mtt180 -128.76 82.1 2.06 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.935 -1.505 . . . . 3.9 106.935 162.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.723 ' CG2' ' HB3' ' A' ' 203' ' ' ALA . 26.9 m -80.65 -176.57 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.761 -1.109 . . . . 1.03 111.599 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 204' ' ' THR . 11.0 tm0? -104.84 109.84 21.96 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.332 -1.304 . . . . 2.31 108.193 170.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.573 ' HB2' ' H ' ' A' ' 221' ' ' MET . 11.0 mp -74.07 140.19 45.16 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 119.571 -0.852 . . . . 1.1 110.918 -172.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 66.2 t30 -73.9 -18.82 60.86 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.915 -1.493 . . . . 1.28 107.168 173.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.31 -22.33 63.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.232 -1.804 . . . . 1.35 109.06 165.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.2 31.05 15.03 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.001 -1.454 . . . . 0.84 111.876 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.573 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 1.5 tpp -107.73 -63.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.452 0.538 . . . . 1.56 112.452 -173.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 26.7 m 79.73 122.07 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.897 -1.047 . . . . 1.12 110.577 -172.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 222' ' ' SER . 56.9 tp 161.98 -41.32 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.842 1.053 . . . . 1.18 113.842 -166.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.662 ' CG2' ' H ' ' A' ' 225' ' ' VAL 0.333 0.1 OUTLIER 33.85 -97.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.985 1.314 . . . . 1.1 114.098 -157.568 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.662 ' H ' ' CG2' ' A' ' 224' ' ' ILE . 9.9 p 159.61 -156.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 119.308 0.958 . . . . 1.42 109.833 -165.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.647 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 5.2 ptp180 -101.89 159.88 14.96 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.577 -0.738 . . . . 4.06 109.135 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.638 ' HB1' ' C ' ' A' ' 211' ' ' ASP . . . -68.03 -19.58 64.92 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.082 0.771 . . . . 1.08 113.082 -164.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.485 ' HG2' ' CD ' ' A' ' 226' ' ' ARG . 13.8 pt-20 -99.83 24.41 8.46 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 122.198 0.999 . . . . 2.57 109.802 -177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.513 ' HB3' HG22 ' A' ' 225' ' ' VAL . 8.6 t60 -138.18 -24.5 0.98 Allowed 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.053 -1.43 . . . . 3.05 109.178 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.651 ' C ' HD12 ' A' ' 230' ' ' LEU . 1.4 pp -92.82 166.78 12.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.17 -0.468 . . . . 1.45 110.709 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.9 m -130.33 83.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 113.242 0.83 . . . . 1.5 113.242 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.569 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.69 -0.672 . . . . 1.3 109.778 161.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.355 -0.239 . . . . 6.05 110.355 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.0 t 71.16 29.49 2.86 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.956 0.785 . . . . 3.09 109.693 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.504 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 37.9 m-20 -121.75 -170.61 2.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.357 -0.838 . . . . 1.83 109.395 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.8 mt -79.22 -80.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 120.758 0.314 . . . . 1.15 110.458 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.3 m -95.95 -68.78 0.78 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.318 0.58 . . . . 1.72 110.939 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -128.39 0.36 5.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.911 -1.515 . . . . 1.04 106.911 173.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.532 HD12 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.13 -176.72 2.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.347 -1.751 . . . . 1.03 109.42 -171.336 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.597 ' C ' HD13 ' A' ' 208' ' ' ILE . 8.2 m -126.28 170.81 11.5 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.965 0.888 . . . . 1.0 112.435 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.758 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 47.7 t -82.15 133.89 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 113.992 -1.458 . . . . 1.03 109.077 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.68 18.97 80.05 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 113.965 -1.47 . . . . 0.14 110.434 -170.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.418 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 3.8 tt0 -70.42 -48.94 53.67 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.81 -0.811 . . . . 0.9 108.81 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 67.86 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.806 -1.543 . . . . 1.01 111.689 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 192' ' ' LEU . 0.1 OUTLIER -149.98 -147.8 0.24 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.289 -1.778 . . . . 1.04 109.516 -174.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 202' ' ' ASP . 0.8 OUTLIER -122.4 157.66 31.38 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.506 0.669 . . . . 4.11 110.621 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 9.9 p -134.11 150.96 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.462 -1.31 . . . . 1.66 107.462 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -91.14 87.59 6.61 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.77 -0.826 . . . . 4.04 108.77 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.57 95.92 5.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.668 -0.696 . . . . 1.48 109.981 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.8 37.01 4.06 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.259 -0.737 . . . . 2.12 111.259 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 72.49 0.01 3.46 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.711 0.767 . . . . 3.89 111.938 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -132.89 141.24 48.29 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.076 -0.511 . . . . 2.05 111.036 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -67.34 127.41 32.58 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.31 -0.996 . . . . 1.45 108.31 175.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.524 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 6.0 ttm -108.06 -76.33 0.61 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.053 -1.431 . . . . 1.96 109.412 -166.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 14.1 t70 160.89 149.81 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 106.311 -1.737 . . . . 1.86 106.311 173.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.66 ' HB3' ' CG2' ' A' ' 215' ' ' VAL . . . -165.08 149.9 9.19 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 120.336 -0.545 . . . . 1.03 111.676 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 22.1 m -117.54 127.57 54.12 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 120.897 0.38 . . . . 1.01 111.617 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.758 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 91.9 t -67.03 116.3 6.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.929 0.715 . . . . 1.02 112.929 -172.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.674 ' CD2' ' HB2' ' A' ' 216' ' ' GLN . 0.2 OUTLIER -96.56 -38.56 9.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.544 -0.753 . . . . 1.3 110.839 172.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.631 ' O ' HG13 ' A' ' 213' ' ' VAL . 29.0 tt0 -153.69 156.03 37.08 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.472 -2.047 . . . . 2.2 105.472 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.597 HD13 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -118.84 161.87 17.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 111.873 0.323 . . . . 1.03 111.873 -174.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.442 ' N ' HG23 ' A' ' 208' ' ' ILE . 44.2 p -113.83 -164.09 0.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.281 -0.418 . . . . 0.95 110.487 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -49.45 -34.7 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.476 0.485 . . . . 4.37 111.834 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.618 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 0.4 OUTLIER -159.82 -25.82 0.07 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.447 -0.946 . . . . 1.67 108.447 -174.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.46 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.57 -151.82 28.52 Favored Glycine 0 CA--C 1.474 -2.471 0 N-CA-C 107.672 -2.171 . . . . 0.12 107.672 176.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.651 ' CG1' HG11 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -145.08 -176.78 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.65 0 C-N-CA 119.677 -0.809 . . . . 1.04 110.757 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.452 ' H ' HG13 ' A' ' 213' ' ' VAL . 24.0 ttp180 -130.4 85.44 2.29 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.614 -1.625 . . . . 3.9 106.614 159.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.66 ' CG2' ' HB3' ' A' ' 203' ' ' ALA . 26.1 m -80.48 177.16 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 114.018 -1.446 . . . . 1.03 109.315 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.674 ' HB2' ' CD2' ' A' ' 206' ' ' LEU . 0.9 OUTLIER -107.05 113.14 26.43 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 107.263 -1.384 . . . . 2.31 107.263 171.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.547 ' HB2' ' H ' ' A' ' 221' ' ' MET . 9.5 mp -70.65 147.3 49.3 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.52 -0.764 . . . . 1.1 112.288 -171.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.591 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 5.9 t-20 -71.55 -20.35 62.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.117 -1.401 . . . . 1.28 107.904 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.53 -21.19 65.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.982 -1.463 . . . . 1.35 108.929 166.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 95.68 22.43 21.22 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.477 -1.238 . . . . 0.84 112.01 -177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.547 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 19.8 ttp -109.08 -162.06 0.79 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.949 -1.13 . . . . 1.56 107.949 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.647 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 9.7 m -162.15 128.98 3.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.798 -1.186 . . . . 1.12 107.798 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 222' ' ' SER . 43.1 tp 166.38 -41.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.909 1.077 . . . . 1.18 113.909 -165.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.64 HG23 ' N ' ' A' ' 225' ' ' VAL 0.276 0.4 OUTLIER 33.74 -89.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.369 1.068 . . . . 1.1 113.158 -156.806 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.671 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 8.5 p 159.7 -156.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.549 -0.538 . . . . 1.42 109.549 -164.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.671 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 18.1 ttm180 -106.59 165.82 11.01 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.482 -0.933 . . . . 4.06 108.482 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.618 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -68.78 -16.87 63.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.754 0.65 . . . . 1.08 112.754 -167.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -100.26 25.02 7.99 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.581 1.181 . . . . 2.57 109.441 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.607 ' CB ' HG22 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -139.17 -24.06 0.89 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 113.994 -1.457 . . . . 3.05 111.238 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.622 HD13 ' O ' ' A' ' 230' ' ' LEU . 0.9 OUTLIER -92.9 161.21 14.57 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.072 0.463 . . . . 1.45 111.094 -175.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.23 73.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.202 0.815 . . . . 1.5 113.202 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 232' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.448 -0.787 . . . . 1.3 110.475 166.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 121.029 0.443 . . . . 6.05 110.079 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.3 t -116.37 14.62 15.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.569 0.7 . . . . 3.09 109.902 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.491 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 28.4 m-20 -136.45 158.36 44.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.972 -0.751 . . . . 1.83 108.972 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 33.3 mt -81.91 -68.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.189 0.518 . . . . 1.15 110.048 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 92.9 p -92.89 -79.31 0.4 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.074 0.94 . . . . 1.72 110.304 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.446 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -124.68 -2.37 7.87 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 105.035 -2.209 . . . . 1.04 105.035 171.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.519 HD11 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -161.36 -176.1 5.19 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.586 -1.643 . . . . 1.03 110.328 -174.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.662 ' C ' HD12 ' A' ' 208' ' ' ILE . 6.7 m -126.75 170.89 11.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.936 0.874 . . . . 1.0 112.636 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.771 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.9 t -81.89 133.46 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 114.125 -1.398 . . . . 1.03 109.338 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.26 18.84 79.87 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 114.254 -1.339 . . . . 0.14 110.359 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -73.62 -49.25 27.03 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.638 -0.875 . . . . 0.9 108.638 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 71.85 127.78 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.839 -1.528 . . . . 1.01 111.337 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -149.4 -150.87 0.37 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 113.824 -1.535 . . . . 1.04 108.99 -175.091 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 202' ' ' ASP . 13.8 mttt -131.06 146.51 52.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.489 0.661 . . . . 4.11 110.492 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 10.0 p -121.9 150.54 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.717 -1.129 . . . . 1.66 108.051 175.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -91.9 81.63 5.16 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.482 -0.562 . . . . 4.04 109.482 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -98.95 99.47 10.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.472 -0.786 . . . . 1.48 110.099 -174.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.15 34.08 6.61 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.125 -0.79 . . . . 2.12 111.125 -173.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.408 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 0.0 OUTLIER 70.34 9.1 6.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.316 0.646 . . . . 3.89 111.867 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -134.72 131.07 37.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.517 -0.31 . . . . 2.05 110.871 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -64.13 122.62 17.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.974 0.892 . . . . 1.45 109.195 176.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.451 ' HG2' ' HB3' ' A' ' 218' ' ' ASN . 15.3 ttm -107.1 -75.24 0.64 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.926 -1.488 . . . . 1.96 110.028 -164.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 2.9 t70 159.39 150.29 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 113.623 -1.626 . . . . 1.86 107.989 174.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.691 ' HB3' ' CG2' ' A' ' 215' ' ' VAL . . . -165.23 150.35 9.25 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.642 -0.423 . . . . 1.03 111.655 178.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 17.9 m -119.34 130.44 55.36 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 120.629 -0.428 . . . . 1.01 111.554 -175.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.771 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 86.0 t -66.99 121.59 16.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 112.883 0.697 . . . . 1.02 112.883 -171.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -38.96 7.34 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.384 -0.826 . . . . 1.3 109.479 175.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.633 ' O ' HG13 ' A' ' 213' ' ' VAL . 24.5 mt-10 -152.47 157.25 40.89 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.192 -2.151 . . . . 2.2 105.192 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.662 HD12 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -122.23 159.68 25.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 112.595 0.591 . . . . 1.03 112.595 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.485 ' N ' HG21 ' A' ' 208' ' ' ILE . 32.9 p -111.72 -164.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.605 . . . . 0.95 110.78 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -53.7 -31.31 47.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.286 0.476 . . . . 4.37 112.286 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.657 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 0.6 OUTLIER -158.35 -27.24 0.08 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.263 -1.014 . . . . 1.67 108.263 -174.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.466 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -95.76 -150.45 27.02 Favored Glycine 0 CA--C 1.474 -2.502 0 N-CA-C 108.032 -2.027 . . . . 0.12 108.032 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.647 ' CG1' HG12 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -146.01 -176.5 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.526 0 C-N-CA 119.867 -0.733 . . . . 1.04 111.08 -177.691 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.462 ' H ' HG13 ' A' ' 213' ' ' VAL . 62.3 mtp180 -132.51 80.83 1.92 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.068 -1.456 . . . . 3.9 107.068 164.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.691 ' CG2' ' HB3' ' A' ' 203' ' ' ALA . 27.0 m -82.48 -178.0 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 114.524 -1.217 . . . . 1.03 111.88 -173.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 0.3 OUTLIER -106.56 109.34 21.23 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.839 -1.073 . . . . 2.31 108.733 170.253 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' A' ' 221' ' ' MET . 8.8 mp -69.08 143.83 54.12 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.847 0.832 . . . . 1.1 111.515 -174.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.451 ' HB3' ' HG2' ' A' ' 201' ' ' MET . 17.5 t-20 -70.12 -23.94 63.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.788 -1.551 . . . . 1.28 107.792 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.66 -26.66 45.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.917 -1.492 . . . . 1.35 109.005 166.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.84 21.84 11.72 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 114.025 -1.443 . . . . 0.84 111.262 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.543 ' HB3' HD23 ' A' ' 217' ' ' LEU . 32.1 ttm -105.95 -167.01 1.26 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.467 -1.308 . . . . 1.56 107.467 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 18.2 m -159.51 124.16 3.98 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.387 -0.968 . . . . 1.12 108.387 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 214' ' ' ARG . 62.5 tp 172.18 -43.18 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.324 1.231 . . . . 1.18 114.324 -167.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.673 ' O ' ' HB ' ' A' ' 225' ' ' VAL 0.302 0.1 OUTLIER 36.09 -93.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.358 1.063 . . . . 1.1 113.089 -155.728 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.684 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 7.1 p 158.89 -152.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 118.884 0.765 . . . . 1.42 109.654 -166.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.684 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 10.3 ttt180 -107.69 162.13 14.25 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.313 -0.995 . . . . 4.06 108.313 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.657 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -66.84 -17.85 65.09 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.803 0.668 . . . . 1.08 112.803 -167.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.62 20.48 11.79 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 122.064 0.935 . . . . 2.57 110.518 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.538 ' HB3' HG21 ' A' ' 225' ' ' VAL . 7.4 t60 -139.94 -25.83 0.8 Allowed 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 114.217 -1.356 . . . . 3.05 109.444 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.613 ' C ' HD13 ' A' ' 230' ' ' LEU . 1.0 OUTLIER -88.47 163.2 16.05 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.291 0.567 . . . . 1.45 111.271 -176.101 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.28 78.01 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 113.175 0.805 . . . . 1.5 113.175 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.543 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.504 -0.76 . . . . 1.3 110.041 164.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.341 -0.244 . . . . 6.05 110.341 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.1 p 50.58 36.78 14.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.639 0.733 . . . . 3.09 110.377 -170.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.512 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 27.4 m-20 -113.15 -168.01 1.27 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.885 -1.052 . . . . 1.83 109.436 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.3 mt -87.04 -75.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-O 120.866 0.365 . . . . 1.15 110.266 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -100.54 -73.85 0.63 Allowed 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 116.206 -0.452 . . . . 1.72 111.341 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -122.75 0.34 9.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 107.167 -1.419 . . . . 1.04 107.167 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.563 HD11 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.76 -176.15 2.3 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 113.081 -1.872 . . . . 1.03 109.223 -171.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.603 ' C ' HD12 ' A' ' 208' ' ' ILE . 7.3 m -126.58 171.49 11.05 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.832 0.825 . . . . 1.0 112.516 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.766 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 58.4 t -82.53 134.86 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 114.073 -1.422 . . . . 1.03 109.218 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.65 16.86 80.38 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 113.914 -1.494 . . . . 0.14 110.539 -170.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -74.66 -51.16 15.14 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.008 -0.738 . . . . 0.9 109.008 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.57 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 113.667 -1.606 . . . . 1.01 111.582 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -149.42 -149.53 0.3 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.106 -1.406 . . . . 1.04 109.054 -175.064 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 4.8 mttp -134.96 148.5 50.03 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.381 0.61 . . . . 4.11 110.515 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.439 ' HB ' HG12 ' A' ' 224' ' ' ILE . 9.3 p -134.87 151.16 30.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.732 -1.122 . . . . 1.66 108.439 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.639 ' HE3' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -100.41 111.18 23.41 Favored 'General case' 0 N--CA 1.397 -3.087 0 CA-C-O 123.256 1.503 . . . . 4.04 108.181 173.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.427 ' HB3' ' CE ' ' A' ' 201' ' ' MET . . . -121.86 100.95 7.27 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.131 -1.85 . . . . 1.48 109.492 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 198' ' ' GLN . . . 99.04 32.23 5.94 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.168 -1.173 . . . . 2.12 110.168 -169.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' A' ' 197' ' ' GLY . 42.5 tt0 77.95 -18.15 0.52 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.578 0.751 . . . . 3.89 112.237 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 10.8 m120 -112.97 138.28 50.08 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.29 -0.256 . . . . 2.05 111.064 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -69.21 146.26 52.53 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.958 0.885 . . . . 1.45 109.913 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.65 ' SD ' ' HB3' ' A' ' 217' ' ' LEU . 51.0 ttm -115.28 -83.7 0.62 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.888 -1.506 . . . . 1.96 110.046 -167.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 1.1 m-20 142.73 122.58 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 126.181 1.793 . . . . 1.86 106.378 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.695 ' HB2' ' CG2' ' A' ' 215' ' ' VAL . . . -148.43 150.36 33.35 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 119.185 -1.006 . . . . 1.03 112.37 -172.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 26.9 m -113.55 129.1 56.62 Favored 'General case' 0 C--O 1.21 -1.015 0 C-N-CA 120.69 -0.404 . . . . 1.01 111.909 -173.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.766 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 88.1 t -66.92 122.12 17.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 112.602 0.593 . . . . 1.02 112.602 -172.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -106.65 -34.25 7.38 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.701 0.762 . . . . 1.3 109.564 176.455 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.653 ' O ' HG11 ' A' ' 213' ' ' VAL . 24.3 tt0 -153.44 155.19 35.85 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 104.81 -2.293 . . . . 2.2 104.81 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.603 HD12 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.89 159.87 20.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 120.739 0.304 . . . . 1.03 111.543 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.435 ' N ' HG23 ' A' ' 208' ' ' ILE . 58.2 p -112.59 -166.99 1.13 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.303 -0.408 . . . . 0.95 110.174 -177.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -52.21 -28.74 19.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.548 0.573 . . . . 4.37 112.548 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.635 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 8.9 t0 -158.42 -28.6 0.08 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.98 -1.119 . . . . 1.67 107.98 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.456 ' HA2' HD23 ' A' ' 230' ' ' LEU . . . -91.51 -149.72 24.21 Favored Glycine 0 CA--C 1.473 -2.538 0 N-CA-C 108.025 -2.03 . . . . 0.12 108.025 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.662 ' CG1' HG12 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -144.37 -174.32 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 C-N-CA 119.56 -0.856 . . . . 1.04 111.218 -178.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.483 ' H ' HG11 ' A' ' 213' ' ' VAL . 40.4 ttt180 -133.9 90.71 2.73 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.904 -1.517 . . . . 3.9 106.904 162.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.695 ' CG2' ' HB2' ' A' ' 203' ' ' ALA . 23.3 m -90.14 179.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 114.041 -1.436 . . . . 1.03 110.718 -174.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -106.22 109.46 21.41 Favored 'General case' 0 N--CA 1.422 -1.846 0 O-C-N 124.118 0.886 . . . . 2.31 108.743 173.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.65 ' HB3' ' SD ' ' A' ' 201' ' ' MET . 9.5 mp -70.46 144.39 51.47 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.952 0.882 . . . . 1.1 112.12 -173.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 13.4 t-20 -66.5 -30.6 70.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.012 -1.449 . . . . 1.28 109.782 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 23.7 m -65.59 -14.32 60.87 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.643 -0.708 . . . . 1.35 109.859 169.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 96.32 33.27 6.3 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.323 -0.942 . . . . 0.84 112.268 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.536 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 27.8 ttp -110.55 -164.9 0.95 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.465 -1.309 . . . . 1.56 107.465 174.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 80.6 p -165.48 128.31 2.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.719 -0.845 . . . . 1.12 108.719 176.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 222' ' ' SER . 64.6 tp 167.47 -44.48 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.297 1.221 . . . . 1.18 114.297 -162.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.64 ' CG2' ' H ' ' A' ' 225' ' ' VAL 0.288 0.2 OUTLIER 35.07 -93.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.246 1.018 . . . . 1.1 113.245 -157.267 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.704 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 7.2 p 159.7 -156.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 119.053 0.842 . . . . 1.42 110.086 -164.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.704 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 28.9 ttt180 -97.64 164.52 12.38 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.201 -1.037 . . . . 4.06 108.201 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.635 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -71.55 -15.58 62.29 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.552 -0.749 . . . . 1.08 112.63 -170.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -103.0 26.85 7.68 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.659 1.218 . . . . 2.57 109.185 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.639 ' O ' ' HE3' ' A' ' 195' ' ' LYS . 0.3 OUTLIER -138.25 -24.96 0.96 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.618 -1.628 . . . . 3.05 110.306 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.638 ' C ' HD12 ' A' ' 230' ' ' LEU . 1.3 pp -94.1 163.86 13.3 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.151 0.501 . . . . 1.45 110.9 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.79 76.63 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 113.033 0.753 . . . . 1.5 113.033 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.543 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.388 -0.815 . . . . 1.3 110.296 165.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.856 -0.424 . . . . 6.05 109.856 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.9 t 71.6 28.25 2.83 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.845 0.715 . . . . 3.09 109.262 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.424 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 12.7 m-20 -130.02 167.57 18.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.57 -0.9 . . . . 1.83 108.57 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.0 mt -78.49 -72.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 109.221 -0.659 . . . . 1.15 109.221 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.2 m -102.79 -74.44 0.63 Allowed 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.617 -0.719 . . . . 1.72 111.451 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -120.99 0.28 10.2 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.219 -1.4 . . . . 1.04 107.219 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.531 HD13 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -170.85 -176.82 2.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.017 -1.902 . . . . 1.03 109.356 -172.043 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.611 ' C ' HD13 ' A' ' 208' ' ' ILE . 7.4 m -125.98 171.73 10.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.845 0.831 . . . . 1.0 112.207 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.775 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 61.3 t -81.01 137.15 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.187 -1.369 . . . . 1.03 109.449 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 72.8 15.93 78.06 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 113.994 -1.457 . . . . 0.14 110.488 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -71.43 -51.71 22.48 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.855 -0.795 . . . . 0.9 108.855 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 73.46 128.69 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.678 -1.601 . . . . 1.01 111.602 178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -152.35 -147.2 0.22 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.772 -1.558 . . . . 1.04 108.669 -174.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.461 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 1.1 mppt? -118.39 160.34 21.85 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.537 -0.912 . . . . 4.11 108.537 170.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.466 HG22 ' CD2' ' A' ' 217' ' ' LEU . 1.2 p -105.42 -33.66 2.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 122.43 1.109 . . . . 1.66 110.757 -173.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 23.4 ttmt 57.28 89.1 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 112.187 -2.279 . . . . 4.04 109.742 -170.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -90.02 71.18 7.44 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 112.721 -2.036 . . . . 1.48 109.757 -170.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.21 -105.49 1.77 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.135 -0.939 . . . . 2.12 111.716 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -100.59 -22.89 14.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.456 0.646 . . . . 3.89 110.998 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 88.4 m-20 -120.3 159.95 23.99 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.424 -0.807 . . . . 2.05 111.636 -170.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -84.09 166.69 17.46 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.944 -0.571 . . . . 1.45 109.583 176.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.721 ' HG2' ' OG ' ' A' ' 219' ' ' SER . 39.8 tpp -141.86 -91.66 0.14 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.611 -1.255 . . . . 1.96 107.611 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.546 ' C ' HD21 ' A' ' 218' ' ' ASN . 9.0 p-10 162.54 141.26 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.327 -1.36 . . . . 1.86 107.327 172.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.677 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -158.15 152.06 23.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 120.275 -0.57 . . . . 1.03 111.852 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 16.6 m -117.47 129.83 56.07 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 121.06 0.457 . . . . 1.01 112.163 -174.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.775 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 94.9 t -65.33 121.32 14.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.763 0.653 . . . . 1.02 112.763 -171.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -102.86 -36.89 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 1.3 109.675 176.004 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.655 ' O ' HG12 ' A' ' 213' ' ' VAL . 28.3 tt0 -156.69 155.98 32.63 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 105.469 -2.048 . . . . 2.2 105.469 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.611 HD13 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.24 160.63 19.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 112.037 0.384 . . . . 1.03 112.037 -173.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.445 ' N ' HG21 ' A' ' 208' ' ' ILE . 26.9 p -110.82 -162.29 0.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.35 -0.611 . . . . 0.95 109.35 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.471 ' HG3' ' OD1' ' A' ' 211' ' ' ASP . 40.8 pttt -59.82 -30.72 69.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.073 0.463 . . . . 4.37 110.674 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.665 ' C ' ' HB3' ' A' ' 227' ' ' ALA . 1.7 m-20 -151.27 -35.08 0.14 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.272 -1.01 . . . . 1.67 108.272 -173.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.432 ' HA2' HD22 ' A' ' 230' ' ' LEU . . . -93.7 -153.07 29.96 Favored Glycine 0 CA--C 1.474 -2.49 0 N-CA-C 107.804 -2.119 . . . . 0.12 107.804 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -146.04 -177.11 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.486 0 C-N-CA 119.861 -0.736 . . . . 1.04 110.678 -176.213 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.415 ' H ' HG12 ' A' ' 213' ' ' VAL . 71.1 ttt180 -129.01 91.05 3.13 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.034 -1.469 . . . . 3.9 107.034 157.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.677 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 20.7 m -86.89 177.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.052 -1.431 . . . . 1.03 110.31 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.7 OUTLIER -102.77 107.66 18.61 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.432 -0.951 . . . . 2.31 108.432 173.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.573 HD13 ' N ' ' A' ' 217' ' ' LEU . 6.8 mp -70.3 133.49 47.02 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.312 0.577 . . . . 1.1 109.827 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.546 HD21 ' C ' ' A' ' 202' ' ' ASP . 59.0 m-80 -76.86 -14.15 59.92 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.772 -1.104 . . . . 1.28 108.699 176.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.721 ' OG ' ' HG2' ' A' ' 201' ' ' MET . 59.4 m -57.31 -24.84 57.63 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 114.973 -1.012 . . . . 1.35 108.31 162.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.44 23.56 6.25 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 113.983 -1.462 . . . . 0.84 112.879 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.541 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 20.3 ttp -118.32 -162.15 0.87 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.018 -0.734 . . . . 1.56 109.018 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 85.5 p -164.91 126.49 2.11 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.992 -1.114 . . . . 1.12 107.992 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 222' ' ' SER . 49.6 tp 166.77 -38.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.68 0.993 . . . . 1.18 113.68 -163.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.661 ' O ' ' HB ' ' A' ' 225' ' ' VAL 0.265 0.5 OUTLIER 36.29 -89.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 124.213 1.005 . . . . 1.1 112.717 -157.778 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.699 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 8.2 p 159.07 -155.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.454 0.645 . . . . 1.42 110.358 -164.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.699 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 8.5 tpp180 -102.78 159.37 15.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.904 -1.147 . . . . 4.06 107.904 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.665 ' HB3' ' C ' ' A' ' 211' ' ' ASP . . . -68.15 -13.87 62.55 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.443 0.535 . . . . 1.08 112.443 -171.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.07 17.2 16.03 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.994 0.902 . . . . 2.57 110.691 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.609 ' CB ' HG22 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -131.68 -25.6 2.1 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.402 -1.272 . . . . 3.05 111.008 -178.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 230' ' ' LEU . 0.9 OUTLIER -90.35 155.27 19.08 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.373 0.606 . . . . 1.45 111.222 -173.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.67 73.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.198 -0.91 . . . . 1.5 112.787 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.374 -0.83 . . . . 1.3 111.151 167.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 121.516 0.674 . . . . 6.05 111.07 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.3 m -90.35 25.15 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.669 -0.696 . . . . 3.09 110.184 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.599 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 13.7 m-20 71.78 137.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.83 -1.077 . . . . 1.83 111.696 175.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 26.7 mt -76.8 -51.55 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 114.984 -1.007 . . . . 1.15 109.829 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.1 t -118.89 -73.21 0.65 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.459 -0.791 . . . . 1.72 110.732 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -123.86 0.3 8.59 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.131 -1.433 . . . . 1.04 107.131 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.568 HD13 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.8 -178.38 2.94 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 112.881 -1.963 . . . . 1.03 108.984 -171.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.648 ' C ' HD11 ' A' ' 208' ' ' ILE . 5.7 m -123.35 171.18 9.62 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.868 0.842 . . . . 1.0 112.331 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.766 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 50.4 t -81.51 134.52 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.244 -1.343 . . . . 1.03 109.081 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.97 16.87 80.33 Favored Glycine 0 C--N 1.303 -1.254 0 CA-C-N 114.245 -1.343 . . . . 0.14 110.428 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.526 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -71.28 -53.32 14.68 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.816 -0.809 . . . . 0.9 108.816 179.39 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.53 128.49 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.419 -1.718 . . . . 1.01 111.815 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -151.45 -149.08 0.29 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 113.808 -1.542 . . . . 1.04 109.255 -174.285 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.455 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 14.3 mptt -121.41 154.12 36.94 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.591 -0.892 . . . . 4.11 108.591 173.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 217' ' ' LEU . 1.4 p -100.47 -33.69 3.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 122.431 1.11 . . . . 1.66 110.463 -173.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 23.1 ttmt 55.59 87.93 0.05 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 112.214 -2.267 . . . . 4.04 110.493 -174.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.97 104.45 14.66 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 112.388 -2.187 . . . . 1.48 109.79 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 199' ' ' ASN . . . 74.16 50.07 11.23 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.696 -0.764 . . . . 2.12 111.571 -175.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 72.28 -38.1 0.41 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.471 0.708 . . . . 3.89 112.375 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 197' ' ' GLY . 28.4 m-80 -79.26 135.35 36.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.111 0.482 . . . . 2.05 110.744 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -78.58 155.07 29.84 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.187 -0.671 . . . . 1.45 109.187 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.56 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 45.5 tpp -136.04 -82.19 0.39 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.463 -0.94 . . . . 1.96 108.463 -172.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.595 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 10.3 t70 159.6 153.99 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 105.954 -1.869 . . . . 1.86 105.954 171.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.676 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -165.54 149.25 8.17 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 118.624 0.647 . . . . 1.03 111.396 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 16.9 m -118.22 129.46 55.5 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-O 121.181 0.515 . . . . 1.01 111.771 -174.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.766 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 95.2 t -66.21 122.45 17.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 113.192 0.812 . . . . 1.02 113.192 -170.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.69 -36.0 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.207 -0.906 . . . . 1.3 110.0 175.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.662 ' O ' HG11 ' A' ' 213' ' ' VAL . 27.1 tt0 -155.14 158.24 38.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.405 -2.072 . . . . 2.2 105.405 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.648 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.96 158.37 23.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 111.937 0.347 . . . . 1.03 111.937 -175.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.426 ' N ' HG21 ' A' ' 208' ' ' ILE . 32.6 p -114.62 -164.08 0.91 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.437 -0.505 . . . . 0.95 112.124 -174.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -48.09 -29.67 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.325 -0.852 . . . . 4.37 112.572 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.592 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 9.2 t0 -168.35 -22.54 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.159 -1.052 . . . . 1.67 108.159 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.469 ' HA2' HD22 ' A' ' 230' ' ' LEU . . . -93.39 -149.43 25.15 Favored Glycine 0 CA--C 1.475 -2.462 0 N-CA-C 107.873 -2.091 . . . . 0.12 107.873 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.662 HG11 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -145.92 -176.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 C-N-CA 119.893 -0.723 . . . . 1.04 111.065 -177.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.452 ' H ' HG11 ' A' ' 213' ' ' VAL . 65.9 ttt180 -131.33 94.73 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.997 -1.483 . . . . 3.9 106.997 161.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.709 ' O ' ' HA ' ' A' ' 222' ' ' SER . 28.5 m -95.02 -179.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 114.15 -1.386 . . . . 1.03 110.932 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 204' ' ' THR . 32.2 tp60 -103.09 101.74 11.72 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.553 -1.277 . . . . 2.31 107.553 172.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.567 ' HB2' ' H ' ' A' ' 221' ' ' MET . 9.9 mp -64.18 139.12 58.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.099 0.952 . . . . 1.1 111.604 -174.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.595 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 19.2 t-20 -72.6 -21.1 61.18 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.352 -1.749 . . . . 1.28 107.549 172.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 6.5 m -58.99 -20.19 50.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.351 -1.749 . . . . 1.35 109.172 165.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 99.19 25.68 9.34 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.868 -1.06 . . . . 0.84 112.415 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.567 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 19.1 ttp -126.34 -159.22 0.9 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.13 -0.693 . . . . 1.56 109.13 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.709 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 14.5 m -162.31 129.25 3.72 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.609 -1.256 . . . . 1.12 107.609 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 222' ' ' SER . 62.4 tp 164.4 -43.61 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.893 1.071 . . . . 1.18 113.893 -164.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.679 ' O ' ' HB ' ' A' ' 225' ' ' VAL 0.285 0.2 OUTLIER 33.29 -90.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.387 1.075 . . . . 1.1 113.058 -155.925 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.682 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 8.3 p 158.52 -156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 118.888 0.767 . . . . 1.42 109.995 -166.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.682 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 30.6 ttt180 -102.6 163.24 12.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.194 -1.039 . . . . 4.06 108.194 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.592 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -67.73 -16.82 64.32 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.174 0.805 . . . . 1.08 113.174 -168.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 228' ' ' GLU . 31.5 tt0 -99.64 16.55 23.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.689 1.233 . . . . 2.57 110.002 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.58 ' CB ' HG21 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -126.49 -28.03 3.09 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.838 -1.528 . . . . 3.05 111.166 178.105 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.61 ' C ' HD11 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -90.78 166.77 12.93 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 121.35 0.595 . . . . 1.45 111.244 -172.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 193' ' ' LYS . 16.8 m -135.92 76.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.14 -0.936 . . . . 1.5 112.654 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.577 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.448 -0.787 . . . . 1.3 110.038 165.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.125 0.488 . . . . 6.05 110.218 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.8 t -106.8 16.04 24.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.605 0.717 . . . . 3.09 109.512 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.573 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 9.3 m-20 -125.71 -168.42 1.84 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.381 -0.827 . . . . 1.83 109.367 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.2 mt -92.06 -72.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.267 0.556 . . . . 1.15 110.432 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 96.5 p -90.79 -82.67 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.134 0.968 . . . . 1.72 110.38 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -122.12 -2.81 9.09 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.149 -2.167 . . . . 1.04 105.149 171.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.573 ' C ' ' HB3' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -158.09 -177.23 6.4 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 113.484 -1.689 . . . . 1.03 110.613 -175.036 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.694 ' C ' HD13 ' A' ' 208' ' ' ILE . 6.7 m -125.65 171.13 10.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.785 0.802 . . . . 1.0 112.675 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.765 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 48.9 t -82.65 134.22 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.354 -1.294 . . . . 1.03 109.563 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.9 79.32 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.05 -1.432 . . . . 0.14 110.406 -170.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -73.03 -52.33 14.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.335 -0.617 . . . . 0.9 109.335 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 77.09 129.64 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.058 -1.428 . . . . 1.01 111.703 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.55 HD13 ' N ' ' A' ' 192' ' ' LEU . 0.0 OUTLIER -153.56 -149.71 0.3 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.844 -1.525 . . . . 1.04 109.338 -173.171 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.511 ' HB3' HG22 ' A' ' 231' ' ' VAL . 12.2 tttt -137.29 144.21 42.55 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.081 -0.509 . . . . 4.11 110.492 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 12.9 p -123.13 155.33 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.717 -0.674 . . . . 1.66 109.428 176.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.707 ' HA ' ' H ' ' A' ' 200' ' ' ALA . 0.0 OUTLIER -80.39 96.57 6.74 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.749 0.785 . . . . 4.04 110.79 -178.394 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.06 152.31 29.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.952 -1.476 . . . . 1.48 110.344 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.52 -105.43 1.86 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.038 -0.601 . . . . 2.12 112.627 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -93.68 28.16 2.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.126 0.965 . . . . 3.89 109.179 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 59.96 132.17 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 114.53 -1.214 . . . . 2.05 112.395 -171.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.707 ' H ' ' HA ' ' A' ' 195' ' ' LYS . . . 46.69 111.74 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.108 -1.86 . . . . 1.45 111.804 -164.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.511 ' HG3' ' HB3' ' A' ' 218' ' ' ASN . 38.6 tpp -107.08 -73.24 0.69 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.857 -1.52 . . . . 1.96 109.896 -166.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 19.0 t70 147.84 145.16 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 112.819 -1.991 . . . . 1.86 105.936 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.746 ' HB2' ' CG2' ' A' ' 215' ' ' VAL . . . -164.31 151.76 11.97 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 120.224 -0.59 . . . . 1.03 112.154 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 15.6 m -120.9 128.9 53.21 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 120.822 0.344 . . . . 1.01 111.423 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.765 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 95.7 t -64.76 122.53 15.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.46 0.911 . . . . 1.02 113.46 -171.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -103.21 -40.05 6.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.15 -0.932 . . . . 1.3 109.697 174.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.695 ' O ' HG11 ' A' ' 213' ' ' VAL . 23.6 mt-10 -149.37 157.06 43.0 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 104.833 -2.284 . . . . 2.2 104.833 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.694 HD13 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -121.23 160.86 21.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 112.4 0.519 . . . . 1.03 112.4 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.492 ' N ' HG23 ' A' ' 208' ' ' ILE . 30.0 p -110.98 -160.13 0.7 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.947 -0.57 . . . . 0.95 109.943 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -64.32 -27.51 69.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.134 0.42 . . . . 4.37 112.134 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.672 ' C ' ' HB3' ' A' ' 227' ' ' ALA . 9.7 t0 -153.89 -31.43 0.12 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.767 -1.198 . . . . 1.67 107.767 -174.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.445 ' HA2' HD22 ' A' ' 230' ' ' LEU . . . -98.11 -148.81 24.21 Favored Glycine 0 CA--C 1.476 -2.383 0 N-CA-C 108.302 -1.919 . . . . 0.12 108.302 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.695 HG11 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -148.47 -177.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 CA-C-O 121.74 0.781 . . . . 1.04 111.837 -176.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 214' ' ' ARG . 25.4 ttt85 -127.63 94.86 4.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.841 -1.541 . . . . 3.9 106.841 156.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.746 ' CG2' ' HB2' ' A' ' 203' ' ' ALA . 25.8 m -88.64 -177.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 114.319 -1.31 . . . . 1.03 110.526 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -105.11 113.21 26.67 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.868 -1.16 . . . . 2.31 107.868 169.405 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.619 ' HB2' ' H ' ' A' ' 221' ' ' MET . 11.2 mp -73.41 147.07 44.6 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.891 -0.724 . . . . 1.1 110.725 -174.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 45.2 t-20 -64.28 -30.91 71.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.978 -1.01 . . . . 1.28 108.4 175.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.9 m -63.67 -17.42 62.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.693 -1.14 . . . . 1.35 109.702 169.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 86.5 29.35 24.66 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 114.983 -1.008 . . . . 0.84 112.178 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.619 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 33.6 ttm -92.64 -58.89 2.21 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.549 -0.461 . . . . 1.56 111.675 -174.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 40.2 m 76.94 123.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.212 -0.904 . . . . 1.12 110.707 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 222' ' ' SER . 46.1 tp 159.31 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.07 -0.968 . . . . 1.18 113.452 -163.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.667 ' CG2' ' H ' ' A' ' 225' ' ' VAL 0.314 0.1 OUTLIER 31.75 -96.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.61 1.164 . . . . 1.1 113.396 -156.733 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.667 ' H ' ' CG2' ' A' ' 224' ' ' ILE . 9.9 p 158.63 -157.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 119.323 0.965 . . . . 1.42 109.842 -165.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.661 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 1.1 ptp180 -98.77 161.82 13.44 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.28 -0.873 . . . . 4.06 108.884 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.672 ' HB3' ' C ' ' A' ' 211' ' ' ASP . . . -73.0 -15.05 61.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.626 0.602 . . . . 1.08 112.626 -167.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.446 ' H ' ' HG3' ' A' ' 226' ' ' ARG . 31.1 tt0 -105.08 31.6 4.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.532 1.158 . . . . 2.57 108.773 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.513 ' HB3' HG22 ' A' ' 225' ' ' VAL . 7.7 t60 -144.99 -25.77 0.49 Allowed 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 113.797 -1.547 . . . . 3.05 109.137 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.601 ' C ' HD11 ' A' ' 230' ' ' LEU . 1.3 pp -88.82 164.25 15.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 120.72 0.295 . . . . 1.45 110.316 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 193' ' ' LYS . 19.6 m -127.34 63.71 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 122.192 0.996 . . . . 1.5 112.105 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.518 ' HB3' HD21 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 114.523 -1.217 . . . . 1.3 110.828 170.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 121.495 0.664 . . . . 6.05 110.752 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 12.2 p -141.39 17.2 2.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.267 -0.879 . . . . 3.09 109.636 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.561 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 44.1 m-20 74.15 159.62 0.22 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.469 -1.241 . . . . 1.83 111.132 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.4 mt -73.98 -72.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 115.952 -0.567 . . . . 1.15 110.438 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 53.9 p -95.38 -76.27 0.5 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.003 0.906 . . . . 1.72 110.504 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.464 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -126.14 -2.6 7.0 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 104.843 -2.28 . . . . 1.04 104.843 172.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.55 HD13 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -162.63 -177.32 5.51 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.31 -1.768 . . . . 1.03 109.863 -174.247 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.624 ' C ' HD13 ' A' ' 208' ' ' ILE . 6.5 m -124.76 170.99 10.48 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.951 0.881 . . . . 1.0 112.552 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.763 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 47.6 t -81.49 134.06 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 114.176 -1.375 . . . . 1.03 108.916 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.39 17.76 79.79 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.177 -1.374 . . . . 0.14 110.614 -170.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 2.0 tt0 -73.39 -48.97 29.72 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.914 -0.773 . . . . 0.9 108.914 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.58 128.74 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.119 -1.4 . . . . 1.01 111.091 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.539 ' CD2' ' HB3' ' A' ' 232' ' ' PHE . 0.1 OUTLIER -151.55 -149.23 0.29 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.121 -1.4 . . . . 1.04 109.587 -174.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.525 ' HB3' HG21 ' A' ' 231' ' ' VAL . 0.0 OUTLIER -128.06 150.56 49.89 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.25 0.548 . . . . 4.11 110.164 179.386 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 6.3 p -127.08 148.82 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 115.046 -0.979 . . . . 1.66 109.307 174.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.596 ' HD3' ' N ' ' A' ' 200' ' ' ALA . 0.2 OUTLIER -89.48 88.11 7.33 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.809 -0.811 . . . . 4.04 108.809 178.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -110.8 99.62 8.52 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.895 -1.048 . . . . 1.48 110.097 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 82.71 48.25 5.6 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.796 -0.922 . . . . 2.12 110.796 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 74.76 -20.25 0.34 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.364 0.666 . . . . 3.89 112.438 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -114.64 138.79 50.25 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.255 0.465 . . . . 2.05 112.255 -174.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -70.16 123.93 22.85 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.095 -1.076 . . . . 1.45 108.095 173.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' MET . . . . . 0.587 ' HG2' ' OG ' ' A' ' 219' ' ' SER . 43.8 tpp -101.88 -76.0 0.58 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.528 -1.214 . . . . 1.96 109.579 -166.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.586 ' HB2' ' O ' ' A' ' 201' ' ' MET . 9.5 t70 155.84 147.38 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.245 -1.798 . . . . 1.86 106.312 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . 0.661 ' HB3' ' CG2' ' A' ' 215' ' ' VAL . . . -164.57 151.47 11.2 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 120.245 -0.582 . . . . 1.03 111.512 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 19.8 m -119.72 127.35 52.77 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.523 -0.471 . . . . 1.01 112.148 -174.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.763 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 81.1 t -64.27 123.22 16.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 113.208 0.818 . . . . 1.02 113.208 -170.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -35.17 7.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.782 -0.644 . . . . 1.3 109.493 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.626 ' O ' HG11 ' A' ' 213' ' ' VAL . 26.2 tt0 -153.3 154.23 34.18 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 105.261 -2.126 . . . . 2.2 105.261 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.624 HD13 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.33 160.0 21.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 112.148 0.425 . . . . 1.03 112.148 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.502 ' N ' HG23 ' A' ' 208' ' ' ILE . 31.0 p -112.65 -162.95 0.82 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.001 -0.545 . . . . 0.95 110.917 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -48.72 -35.28 13.73 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.652 0.595 . . . . 4.37 112.189 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 227' ' ' ALA . 0.9 OUTLIER -168.22 -13.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.692 0.758 . . . . 1.67 109.541 -175.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.484 ' HA2' HD13 ' A' ' 230' ' ' LEU . . . -96.63 -152.38 28.83 Favored Glycine 0 CA--C 1.48 -2.152 0 N-CA-C 107.437 -2.265 . . . . 0.12 107.437 171.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.626 HG11 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -147.11 -176.77 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 C-N-CA 120.037 -0.665 . . . . 1.04 111.334 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.457 ' H ' HG11 ' A' ' 213' ' ' VAL . 25.4 ttt180 -131.16 91.63 3.07 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.326 -1.361 . . . . 3.9 107.326 159.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.661 ' CG2' ' HB3' ' A' ' 203' ' ' ALA . 20.6 m -91.31 179.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 113.712 -1.585 . . . . 1.03 110.515 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 7.0 tm0? -104.31 107.55 18.52 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.751 -0.833 . . . . 2.31 108.751 173.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.54 ' HB2' ' H ' ' A' ' 221' ' ' MET . 8.4 mp -70.42 134.52 47.9 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.861 0.839 . . . . 1.1 111.165 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.46 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 41.9 t30 -71.45 -20.48 62.09 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.574 -1.648 . . . . 1.28 108.823 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.587 ' OG ' ' HG2' ' A' ' 201' ' ' MET . 67.1 m -62.37 -24.04 67.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.551 -1.204 . . . . 1.35 109.442 166.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 112.31 21.88 6.05 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.741 -1.118 . . . . 0.84 113.358 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' MET . . . . . 0.54 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 25.0 ttp -116.25 -162.95 0.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.029 -0.73 . . . . 1.56 109.029 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 40.6 m -161.16 127.21 3.84 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.662 -1.236 . . . . 1.12 107.662 175.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 222' ' ' SER . 49.4 tp 165.64 -40.16 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.424 1.268 . . . . 1.18 114.424 -164.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.664 ' O ' ' HB ' ' A' ' 225' ' ' VAL 0.283 0.2 OUTLIER 34.48 -89.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.225 1.01 . . . . 1.1 112.511 -156.295 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.715 ' CG2' ' H ' ' A' ' 226' ' ' ARG . 11.5 p 157.85 -155.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.976 -0.749 . . . . 1.42 108.976 -169.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.715 ' H ' ' CG2' ' A' ' 225' ' ' VAL . 13.4 ttm180 -103.3 160.04 15.03 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.026 -0.731 . . . . 4.06 109.026 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 211' ' ' ASP . . . -50.43 -31.7 15.75 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.122 0.786 . . . . 1.08 113.122 -171.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -93.09 29.47 1.85 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.528 1.156 . . . . 2.57 109.183 -169.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.584 ' HB3' HG21 ' A' ' 225' ' ' VAL . 15.4 t60 -146.73 -18.86 0.42 Allowed 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 113.818 -1.537 . . . . 3.05 110.398 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.518 HD23 HD11 ' A' ' 224' ' ' ILE . 0.7 OUTLIER -62.58 151.55 37.51 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.59 -0.522 . . . . 1.45 109.59 174.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 193' ' ' LYS . 24.7 m -128.03 49.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.577 1.18 . . . . 1.5 110.7 172.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.539 ' HB3' ' CD2' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 113.365 -1.743 . . . . 1.3 111.197 173.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.608 0.242 . . . . 5.6100000000000003 110.538 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.3 t 64.27 19.29 11.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.836 -0.62 . . . . 2.7599999999999998 109.487 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.684 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 36.7 m-20 69.25 147.71 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.644 -1.162 . . . . 1.8300000000000001 110.921 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -67.23 -66.45 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.03 0.443 . . . . 0.5 110.237 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.8 m -108.17 -72.35 0.73 Allowed 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.891 -0.595 . . . . 1.55 111.436 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.607 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -124.41 0.47 8.29 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.898 -1.519 . . . . 0.22 106.898 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 185' ' ' ALA . 0.5 OUTLIER -171.21 -179.18 2.6 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 112.81 -1.995 . . . . 0.14000000000000001 108.985 -172.227 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.8 m -122.33 171.71 8.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.861 0.839 . . . . 0.20000000000000001 112.09 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.766 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 58.2 t -81.08 133.74 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 114.247 -1.342 . . . . 0.10000000000000001 108.805 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.17 19.26 79.84 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.322 -1.308 . . . . 0.14000000000000001 110.527 -170.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.6 ' HB2' ' O ' ' A' ' 187' ' ' THR . 3.0 tt0 -74.29 -51.52 15.0 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.47 -0.567 . . . . 0.90000000000000002 109.47 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.3 126.11 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.991 -1.459 . . . . 0.22 111.718 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 192' ' ' LEU . 0.1 OUTLIER -159.33 -149.02 0.19 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.512 -1.222 . . . . 0.34999999999999998 111.178 -173.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.658 ' HG3' ' HB1' ' A' ' 200' ' ' ALA . 6.7 ttpt -114.69 146.15 41.23 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.651 0.739 . . . . 3.77 111.019 -173.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.542 HG21 HD21 ' A' ' 217' ' ' LEU . 1.5 p -113.94 -34.13 2.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.129 -1.396 . . . . 1.6599999999999999 109.64 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 19.1 ttmt 60.37 99.21 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 111.692 -2.504 . . . . 3.46 110.68 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.66 88.91 2.84 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.749 -1.569 . . . . 1.3200000000000001 110.755 -173.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.32 54.85 1.53 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.866 -0.683 . . . . 2.1200000000000001 111.903 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 73.76 -27.88 0.19 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.395 0.678 . . . . 3.46 112.703 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -106.09 153.63 21.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.819 -0.437 . . . . 2.0299999999999998 109.819 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.658 ' HB1' ' HG3' ' A' ' 193' ' ' LYS . . . -69.89 170.75 10.54 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.723 0.773 . . . . 0.96999999999999997 109.168 174.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.635 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 30.7 tpp -146.91 -57.79 0.27 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.679 -1.146 . . . . 1.6499999999999999 110.634 -165.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.635 ' HB2' ' O ' ' A' ' 201' ' ' MET . 3.2 m-20 108.39 136.22 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 111.51 -2.586 . . . . 1.8600000000000001 107.939 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.702 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -151.41 148.61 28.31 Favored 'General case' 0 N--CA 1.422 -1.828 0 C-N-CA 120.673 -0.411 . . . . 0.14999999999999999 110.459 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 22.7 m -114.45 127.79 56.01 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.132 0.491 . . . . 0.13 111.525 -170.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.766 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 87.2 t -65.32 121.76 14.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 112.8 0.667 . . . . 0.070000000000000007 112.8 -170.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -104.06 -35.96 7.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.867 0.841 . . . . 0.59999999999999998 109.643 175.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.706 ' O ' HG12 ' A' ' 213' ' ' VAL . 37.3 mt-10 -151.1 158.84 44.55 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.601 -2.0 . . . . 2.2000000000000002 105.601 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.59 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -123.35 155.43 29.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 O-C-N 123.558 0.536 . . . . 0.14999999999999999 111.767 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.7 p -108.14 -160.78 0.74 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.627 -0.715 . . . . 0.17999999999999999 110.536 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -51.04 -37.8 47.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.298 0.571 . . . . 3.8199999999999998 110.899 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.586 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 3.5 t0 -161.17 -19.75 0.05 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.991 -1.004 . . . . 1.6699999999999999 109.315 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.603 ' HA2' HD11 ' A' ' 230' ' ' LEU . . . -94.36 -153.1 30.0 Favored Glycine 0 CA--C 1.478 -2.227 0 N-CA-C 107.936 -2.066 . . . . 0.10000000000000001 107.936 173.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -145.65 -178.83 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 C-N-CA 119.905 -0.718 . . . . 0.089999999999999997 111.149 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.426 ' H ' HG12 ' A' ' 213' ' ' VAL . 85.3 mtt180 -130.18 86.57 2.41 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.873 -1.528 . . . . 3.3900000000000001 106.873 163.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.714 HG22 ' HB ' ' A' ' 224' ' ' ILE . 25.5 m -87.51 178.65 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 114.838 -1.074 . . . . 0.12 111.859 -174.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 20.3 tm0? -105.2 112.12 25.13 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.216 -0.902 . . . . 1.6899999999999999 108.969 173.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 221' ' ' MET . 8.4 mp -71.34 138.75 49.5 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.688 0.756 . . . . 0.32000000000000001 111.752 -174.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -71.2 -16.78 62.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.608 -1.633 . . . . 1.28 109.249 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 71.8 m -67.97 -24.96 65.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.897 -1.047 . . . . 1.1100000000000001 109.562 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.16 25.25 5.39 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.258 -0.883 . . . . 0.68000000000000005 112.308 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.611 ' HB3' HD22 ' A' ' 217' ' ' LEU . 27.7 ttp -115.12 -163.12 0.86 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.315 -0.995 . . . . 1.5600000000000001 108.315 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 17.9 m -160.84 126.43 3.84 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.407 -0.96 . . . . 0.90000000000000002 108.407 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 214' ' ' ARG . 37.9 tp 176.2 -44.99 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.826 1.417 . . . . 0.38 114.826 -168.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.973 HD13 HD22 ' A' ' 230' ' ' LEU 0.329 0.1 OUTLIER 34.28 -97.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.188 0.995 . . . . 0.23000000000000001 113.446 -154.547 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.032 HG22 ' H ' ' A' ' 226' ' ' ARG . 14.9 p 160.42 -158.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 118.994 0.815 . . . . 0.80000000000000004 109.581 -160.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 1.032 ' H ' HG22 ' A' ' 225' ' ' VAL . 20.2 ttm180 -105.89 161.24 14.62 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.333 -0.988 . . . . 3.5299999999999998 108.333 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.586 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -55.51 -20.86 14.3 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 113.695 0.998 . . . . 0.29999999999999999 113.695 -166.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -92.24 19.1 7.33 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.385 1.088 . . . . 2.5699999999999998 110.181 -173.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.648 ' HB3' HG11 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -136.5 -19.24 1.42 Allowed 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 113.741 -1.572 . . . . 2.2400000000000002 111.082 -178.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.973 HD22 HD13 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -82.0 141.07 33.57 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 120.817 0.342 . . . . 0.80000000000000004 110.218 175.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' CG2' ' HD3' ' A' ' 193' ' ' LYS . 20.6 m -123.52 69.01 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 122.005 0.907 . . . . 0.88 111.221 170.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.57 ' CB ' HE22 ' A' ' 190' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.439 -0.997 0 CA-C-N 114.859 -1.064 . . . . 1.3 111.177 172.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.326 0.584 . . . . 5.6100000000000003 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.0 p -99.8 14.88 28.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.703 -0.681 . . . . 2.7599999999999998 109.23 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.571 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 27.0 m-20 72.58 142.83 0.06 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.292 -1.322 . . . . 1.8300000000000001 111.146 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.622 ' HB ' HD12 ' A' ' 208' ' ' ILE . 4.0 mm -73.62 -50.86 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 108.768 -0.827 . . . . 0.5 108.768 172.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.5 t -125.44 -78.23 0.59 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.816 -1.084 . . . . 1.55 110.737 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.566 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -116.93 0.37 12.43 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.006 -1.479 . . . . 0.22 107.006 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.603 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.24 -179.25 3.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 112.664 -2.062 . . . . 0.14000000000000001 108.563 -171.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.723 HG22 ' H ' ' A' ' 188' ' ' VAL . 5.3 m -122.62 170.99 9.46 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.909 0.861 . . . . 0.20000000000000001 112.806 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.783 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.4 t -84.54 131.52 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.173 -1.376 . . . . 0.10000000000000001 109.162 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.83 18.23 79.06 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 113.975 -1.466 . . . . 0.14000000000000001 110.471 -169.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 187' ' ' THR . 2.1 tt0 -73.46 -53.15 11.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.092 -0.707 . . . . 0.90000000000000002 109.092 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.47 128.71 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.487 -1.688 . . . . 0.22 111.698 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.616 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -150.42 -151.03 0.37 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 113.842 -1.526 . . . . 0.34999999999999998 108.839 -174.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.419 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 15.5 mttt -136.71 146.54 45.98 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.678 -0.692 . . . . 3.77 109.928 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 9.1 p -127.33 148.14 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.901 -0.59 . . . . 1.6599999999999999 110.278 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 199' ' ' ASN . 3.6 ttmt -95.68 91.58 6.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.724 -0.843 . . . . 3.46 108.724 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.486 ' HB3' ' HE3' ' A' ' 201' ' ' MET . . . -116.51 89.32 3.08 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.47 -0.786 . . . . 1.3200000000000001 110.57 -176.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 198' ' ' GLN . . . 104.05 44.54 1.61 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.291 -0.868 . . . . 2.1200000000000001 111.301 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.434 ' HB3' ' O ' ' A' ' 197' ' ' GLY . 59.1 tt0 77.89 -23.92 0.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.622 0.769 . . . . 3.46 112.287 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 16.6 m120 -115.64 143.63 45.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.907 0.385 . . . . 2.0299999999999998 111.888 -173.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -74.13 131.8 41.64 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.645 -0.872 . . . . 0.96999999999999997 108.645 173.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 217' ' ' LEU . 54.4 ttm -91.67 -85.16 0.25 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.198 -1.364 . . . . 1.6499999999999999 110.964 -166.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 146.75 110.21 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 125.891 1.676 . . . . 1.8600000000000001 106.915 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.818 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -143.69 147.99 35.08 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.975 -0.69 . . . . 0.14999999999999999 111.988 -169.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 21.9 m -116.49 128.37 55.4 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 120.974 0.416 . . . . 0.13 112.052 -172.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.783 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 94.3 t -64.89 120.92 12.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 113.252 0.834 . . . . 0.070000000000000007 113.252 -171.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -101.72 -36.33 8.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.456 -0.793 . . . . 0.59999999999999998 109.999 175.219 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.649 ' O ' HG12 ' A' ' 213' ' ' VAL . 28.8 tt0 -157.47 157.68 34.33 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 105.316 -2.105 . . . . 2.2000000000000002 105.316 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.622 HD12 ' HB ' ' A' ' 183' ' ' ILE . 1.4 mt -119.01 158.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 112.104 0.409 . . . . 0.14999999999999999 112.104 -173.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 61.8 p -111.86 -160.78 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.159 -0.473 . . . . 0.17999999999999999 111.387 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -53.68 -30.46 43.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 3.8199999999999998 111.985 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.677 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 8.9 t0 -163.57 -25.84 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.022 -1.103 . . . . 1.6699999999999999 108.022 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.586 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.53 -148.56 23.83 Favored Glycine 0 CA--C 1.475 -2.443 0 N-CA-C 107.836 -2.106 . . . . 0.10000000000000001 107.836 177.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -146.29 -177.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 C-N-CA 119.886 -0.726 . . . . 0.089999999999999997 111.011 -178.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.412 ' H ' HG12 ' A' ' 213' ' ' VAL . 58.4 ttt180 -130.14 90.83 3.01 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.066 -1.457 . . . . 3.3900000000000001 107.066 158.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.818 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 22.1 m -87.35 -176.95 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 113.966 -1.47 . . . . 0.12 109.969 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 204' ' ' THR . 1.1 tt0 -105.24 112.41 25.51 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 108.024 -1.102 . . . . 1.6899999999999999 108.024 169.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.742 ' HB2' ' H ' ' A' ' 221' ' ' MET . 10.2 mp -70.96 155.5 40.74 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.632 -0.827 . . . . 0.32000000000000001 110.889 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.48 ' HB3' ' HG2' ' A' ' 201' ' ' MET . 15.6 t-20 -60.46 -36.46 78.3 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.724 -0.671 . . . . 1.28 109.418 173.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 66.4 m -70.62 -7.98 48.28 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.477 -0.783 . . . . 1.1100000000000001 110.253 170.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 74.51 37.1 47.52 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 114.968 -1.015 . . . . 0.68000000000000005 112.902 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.742 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 4.4 mtp -84.55 -50.48 7.67 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 122.018 0.914 . . . . 1.5600000000000001 109.732 -176.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.784 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 19.4 m 70.89 117.75 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 112.82 -1.991 . . . . 0.90000000000000002 111.186 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 222' ' ' SER . 57.8 tp 162.77 -40.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.819 -1.082 . . . . 0.38 113.533 -161.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.764 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.288 0.2 OUTLIER 32.99 -92.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.522 1.129 . . . . 0.23000000000000001 113.249 -157.666 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.992 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.8 p 160.71 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 118.925 0.784 . . . . 0.80000000000000004 110.341 -165.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.992 ' H ' HG22 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -99.66 154.1 18.55 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.636 -1.166 . . . . 3.5299999999999998 108.293 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -61.56 -18.14 58.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.042 1.127 . . . . 0.29999999999999999 114.042 -170.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -102.76 31.47 4.13 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 122.787 1.28 . . . . 2.5699999999999998 108.936 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.443 ' HB3' HG21 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -140.59 -25.02 0.77 Allowed 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 113.747 -1.57 . . . . 2.2400000000000002 110.549 178.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.586 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.2 pp -93.29 163.84 13.45 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 116.056 -0.52 . . . . 0.80000000000000004 110.994 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.86 72.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 113.439 0.903 . . . . 0.88 113.439 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.582 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.896 0 CA-C-N 115.115 -0.948 . . . . 1.3 110.697 164.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 121.153 0.501 . . . . 5.6100000000000003 110.367 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.0 t -118.95 20.63 12.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.683 -0.69 . . . . 2.7599999999999998 109.234 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.719 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 51.2 m-20 73.1 143.7 0.07 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.704 -1.135 . . . . 1.8300000000000001 110.944 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.8 mt -73.48 -49.89 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.547 -0.751 . . . . 0.5 110.325 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 t -124.36 -74.44 0.61 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.527 -0.76 . . . . 1.55 111.276 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.559 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -121.88 0.55 9.76 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.383 -1.71 . . . . 0.22 106.383 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD11 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -170.12 179.68 3.44 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.851 -1.977 . . . . 0.14000000000000001 109.342 -171.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.725 HG22 ' H ' ' A' ' 188' ' ' VAL . 4.5 m -121.18 170.91 9.11 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.808 0.813 . . . . 0.20000000000000001 112.353 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.783 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 50.5 t -83.49 131.5 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.183 -1.371 . . . . 0.10000000000000001 109.017 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.04 16.83 79.29 Favored Glycine 0 C--N 1.301 -1.366 0 CA-C-N 114.159 -1.382 . . . . 0.14000000000000001 110.691 -169.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -72.85 -50.26 25.05 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.927 -0.768 . . . . 0.90000000000000002 108.927 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 71.99 124.94 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.089 -1.414 . . . . 0.22 111.794 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.61 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -145.86 -149.99 0.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.687 -1.597 . . . . 0.34999999999999998 108.779 -174.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.46 ' HB2' HG22 ' A' ' 231' ' ' VAL . 0.0 OUTLIER -127.13 145.96 50.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.33 0.586 . . . . 3.77 110.547 177.247 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 5.0 p -115.88 146.92 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.841 -1.072 . . . . 1.6599999999999999 109.357 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.551 ' HD3' ' N ' ' A' ' 200' ' ' ALA . 0.0 OUTLIER -89.75 91.58 8.7 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.38 -0.97 . . . . 3.46 108.38 177.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -115.51 96.28 5.56 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.962 -1.017 . . . . 1.3200000000000001 109.967 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 199' ' ' ASN . . . 94.84 38.71 4.83 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.034 -0.827 . . . . 2.1200000000000001 111.034 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 73.82 -18.3 0.4 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.649 0.78 . . . . 3.46 111.974 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 197' ' ' GLY . 39.4 m-80 -111.39 142.06 44.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.033 -0.531 . . . . 2.0299999999999998 111.059 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -71.5 132.79 45.22 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.241 -1.022 . . . . 0.96999999999999997 108.241 173.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.544 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 37.6 tpp -107.02 -76.99 0.6 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.726 -1.125 . . . . 1.6499999999999999 109.61 -169.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 4.2 t70 162.04 149.71 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 105.384 -2.08 . . . . 1.8600000000000001 105.384 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.833 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -165.21 149.68 8.87 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 118.974 0.806 . . . . 0.14999999999999999 111.774 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 21.1 m -117.96 126.93 53.28 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.454 -0.498 . . . . 0.13 112.143 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.783 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 99.9 t -64.39 121.5 13.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 113.248 0.833 . . . . 0.070000000000000007 113.248 -169.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -104.94 -35.07 7.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.629 -0.714 . . . . 0.59999999999999998 110.059 175.138 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.712 ' O ' HG12 ' A' ' 213' ' ' VAL . 29.0 tt0 -153.6 156.81 38.66 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.128 -2.175 . . . . 2.2000000000000002 105.128 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.575 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.13 160.68 20.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 112.135 0.42 . . . . 0.14999999999999999 112.135 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.5 p -115.39 -160.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.17999999999999999 111.571 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -53.44 -31.58 46.02 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.824 -0.626 . . . . 3.8199999999999998 111.727 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 2.0 t70 -164.61 -22.04 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.61 -0.885 . . . . 1.6699999999999999 108.61 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.523 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -94.39 -150.91 27.64 Favored Glycine 0 CA--C 1.475 -2.437 0 N-CA-C 107.784 -2.126 . . . . 0.10000000000000001 107.784 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -146.83 -177.08 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.64 0 C-N-CA 119.797 -0.761 . . . . 0.089999999999999997 111.077 -176.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 42.2 ttt-85 -129.78 92.25 3.29 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.085 -1.45 . . . . 3.3900000000000001 107.085 159.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.833 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 23.3 m -90.58 -176.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 114.325 -1.307 . . . . 0.12 110.612 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 204' ' ' THR . 17.0 tm0? -105.43 106.65 17.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.339 -0.846 . . . . 1.6899999999999999 108.718 170.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.621 ' HB2' ' H ' ' A' ' 221' ' ' MET . 8.9 mp -66.28 140.97 58.16 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.943 0.878 . . . . 0.32000000000000001 111.555 -174.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.616 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 23.6 t-20 -75.75 -18.94 59.38 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.612 -1.631 . . . . 1.28 108.378 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 37.4 m -63.98 -17.17 63.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.35 -1.295 . . . . 1.1100000000000001 108.914 164.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.05 17.16 16.9 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 114.695 -1.138 . . . . 0.68000000000000005 113.303 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.621 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 18.4 ttp -111.39 -159.25 0.67 Allowed 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.069 -0.715 . . . . 1.5600000000000001 109.069 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 20.0 m -161.77 128.98 3.94 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.586 -1.264 . . . . 0.90000000000000002 107.586 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 222' ' ' SER . 39.6 tp 162.97 -38.66 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.815 1.043 . . . . 0.38 113.815 -165.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.76 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.279 0.2 OUTLIER 34.22 -91.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.525 1.13 . . . . 0.23000000000000001 112.973 -157.258 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.947 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.3 p 160.09 -156.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 118.548 0.613 . . . . 0.80000000000000004 109.584 -164.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.947 ' H ' HG22 ' A' ' 225' ' ' VAL . 14.3 ttm180 -104.34 163.46 12.41 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.442 -0.948 . . . . 3.5299999999999998 108.442 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -66.93 -17.27 64.83 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.275 0.843 . . . . 0.29999999999999999 113.275 -170.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.57 25.11 8.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 122.575 1.179 . . . . 2.5699999999999998 109.315 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.492 ' HB3' HG21 ' A' ' 225' ' ' VAL . 0.9 OUTLIER -140.02 -22.24 0.86 Allowed 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 113.769 -1.56 . . . . 2.2400000000000002 111.238 -179.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.523 HD21 ' HA2' ' A' ' 212' ' ' GLY . 0.8 OUTLIER -92.28 171.38 9.1 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.179 0.514 . . . . 0.80000000000000004 111.414 -176.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 231' ' ' VAL . 0.2 OUTLIER -136.98 93.81 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 CA-C-O 122.455 1.121 . . . . 0.88 109.857 176.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.833 -1.076 . . . . 1.3 110.173 161.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.58 -0.155 . . . . 5.6100000000000003 110.58 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.9 t 70.4 13.95 7.47 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.803 0.689 . . . . 2.7599999999999998 110.701 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.594 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 23.2 m-20 69.43 157.47 0.15 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.195 -0.911 . . . . 1.8300000000000001 111.545 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.4 mt -77.67 -66.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.887 -0.597 . . . . 0.5 110.529 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 93.9 p -94.94 -79.48 0.43 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.414 1.102 . . . . 1.55 110.717 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -126.15 -1.73 7.05 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 105.059 -2.2 . . . . 0.22 105.059 171.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.617 HD21 HG22 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -160.22 -178.0 6.66 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 113.658 -1.61 . . . . 0.14000000000000001 110.575 -175.402 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.2 m -124.18 172.01 9.38 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.189 -0.914 . . . . 0.20000000000000001 112.58 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.799 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 48.6 t -84.19 132.92 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.267 -1.333 . . . . 0.10000000000000001 109.762 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.89 14.92 82.09 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.027 -1.442 . . . . 0.14000000000000001 110.68 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.536 HE22 ' HB3' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -72.71 -51.24 20.07 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.076 0.465 . . . . 0.90000000000000002 109.752 -178.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 77.68 128.46 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.26 -1.336 . . . . 0.22 112.051 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.646 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -156.22 -150.02 0.27 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.194 -1.366 . . . . 0.34999999999999998 110.464 -173.301 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 22.5 ttpt -111.33 144.41 40.56 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.526 -0.761 . . . . 3.77 110.467 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.61 HG21 HD21 ' A' ' 217' ' ' LEU . 1.5 p -106.07 -32.74 2.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 122.615 1.198 . . . . 1.6599999999999999 109.295 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 1.2 ttpp 62.2 97.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 111.708 -2.496 . . . . 3.46 110.309 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -111.23 116.78 31.62 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.964 -1.471 . . . . 1.3200000000000001 110.066 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 76.29 48.54 9.34 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.729 -0.748 . . . . 2.1200000000000001 111.791 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 73.88 -31.58 0.22 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.355 0.662 . . . . 3.46 112.67 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 71.7 m-20 -99.56 168.25 10.08 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.265 -0.272 . . . . 2.0299999999999998 110.265 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -71.19 177.39 3.85 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.502 0.668 . . . . 0.96999999999999997 109.706 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.535 ' O ' ' HB3' ' A' ' 202' ' ' ASP . 38.5 tpp -154.03 -66.12 0.14 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.195 -0.911 . . . . 1.6499999999999999 109.796 -170.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.535 ' HB3' ' O ' ' A' ' 201' ' ' MET . 0.7 OUTLIER 122.79 141.37 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 126.597 2.436 . . . . 1.8600000000000001 108.071 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.787 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -160.67 148.34 15.95 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 116.106 -0.497 . . . . 0.14999999999999999 111.299 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 20.9 m -119.27 127.38 53.18 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 112.441 0.534 . . . . 0.13 112.441 -170.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.799 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 98.4 t -61.86 122.81 13.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.405 0.891 . . . . 0.070000000000000007 113.405 -170.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -105.58 -37.57 6.73 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.461 -0.791 . . . . 0.59999999999999998 109.873 174.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.674 ' O ' HG12 ' A' ' 213' ' ' VAL . 6.5 tp10 -152.09 154.21 35.46 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.118 -2.178 . . . . 2.2000000000000002 105.118 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.625 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -117.17 162.21 15.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 112.653 0.612 . . . . 0.14999999999999999 112.653 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.426 ' N ' HG22 ' A' ' 208' ' ' ILE . 30.3 p -112.41 -161.49 0.76 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.17999999999999999 109.938 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 210' ' ' LYS . 12.6 mptt -63.31 -29.45 70.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.766 0.317 . . . . 3.8199999999999998 111.567 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.659 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 8.1 p-10 -151.01 -33.7 0.15 Allowed 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.589 -0.893 . . . . 1.6699999999999999 108.589 -172.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.564 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -98.49 -146.78 21.15 Favored Glycine 0 CA--C 1.47 -2.75 0 N-CA-C 107.981 -2.048 . . . . 0.10000000000000001 107.981 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.715 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -149.29 -175.11 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.667 0 C-N-CA 119.846 -0.742 . . . . 0.089999999999999997 111.725 -177.342 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.425 ' H ' HG12 ' A' ' 213' ' ' VAL . 16.1 ttt180 -130.06 94.18 3.65 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.985 -1.487 . . . . 3.3900000000000001 106.985 158.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.787 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 23.9 m -90.91 -179.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 114.274 -1.33 . . . . 0.12 110.748 -176.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 19.8 tm0? -104.09 110.8 23.12 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.538 -0.912 . . . . 1.6899999999999999 108.538 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.643 HD22 ' HB3' ' A' ' 221' ' ' MET . 8.8 mp -68.7 143.67 54.66 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.597 0.713 . . . . 0.32000000000000001 111.571 -175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.512 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 11.0 t-20 -65.3 -30.78 71.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.116 -1.402 . . . . 1.28 108.569 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.8 m -57.59 -22.53 45.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.265 -1.334 . . . . 1.1100000000000001 109.651 169.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.81 19.97 10.44 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.935 -1.03 . . . . 0.68000000000000005 112.426 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.643 ' HB3' HD22 ' A' ' 217' ' ' LEU . 19.7 ttp -108.63 -161.2 0.75 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.283 -1.006 . . . . 1.5600000000000001 108.283 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.702 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 13.6 m -163.11 128.55 3.16 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.692 -0.855 . . . . 0.90000000000000002 108.692 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 222' ' ' SER . 61.4 tp 167.36 -42.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.224 1.194 . . . . 0.38 114.224 -166.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.75 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.274 0.1 OUTLIER 35.25 -93.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.487 1.115 . . . . 0.23000000000000001 113.938 -158.869 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.994 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.7 p 160.91 -158.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 118.636 0.653 . . . . 0.80000000000000004 110.494 -162.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.994 ' H ' HG22 ' A' ' 225' ' ' VAL . 7.0 ptp180 -105.27 165.17 11.3 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.96 -1.018 . . . . 3.5299999999999998 109.484 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -69.23 -17.76 63.81 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.307 -0.86 . . . . 0.29999999999999999 112.806 -166.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.459 ' H ' ' HG3' ' A' ' 226' ' ' ARG . 36.4 tt0 -101.2 25.65 7.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.749 1.262 . . . . 2.5699999999999998 109.201 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.419 ' HB3' HG21 ' A' ' 225' ' ' VAL . 1.2 m-70 -135.76 -25.25 1.28 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.721 -1.581 . . . . 2.2400000000000002 110.809 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.564 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.0 OUTLIER -93.91 160.58 14.67 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.048 0.452 . . . . 0.80000000000000004 111.084 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 231' ' ' VAL . 30.3 m -131.62 82.5 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.939 0.876 . . . . 0.88 111.814 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.536 ' HB3' HE22 ' A' ' 190' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.557 -0.747 . . . . 1.3 111.561 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 121.648 0.737 . . . . 5.6100000000000003 110.293 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.0 p -130.19 26.55 5.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.129 -0.941 . . . . 2.7599999999999998 109.666 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -47.5 126.82 10.39 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.342 1.068 . . . . 1.8300000000000001 112.501 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 22.5 mt -78.29 -51.55 17.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 113.23 -1.805 . . . . 0.5 109.042 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' A' ' 211' ' ' ASP . 47.3 t -112.75 -80.97 0.59 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.816 -1.084 . . . . 1.55 110.187 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.542 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -116.85 -0.34 12.29 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.915 -1.513 . . . . 0.22 106.915 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.573 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -168.02 -178.59 3.79 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 113.29 -1.777 . . . . 0.14000000000000001 109.797 -170.231 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 188' ' ' VAL . 2.2 m -119.37 170.4 9.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.798 0.809 . . . . 0.20000000000000001 112.836 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.79 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 43.4 t -86.18 132.61 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 114.124 -1.398 . . . . 0.10000000000000001 108.67 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.98 19.64 79.76 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.466 -1.243 . . . . 0.14000000000000001 110.248 -169.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -74.44 -47.03 36.13 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.739 -0.837 . . . . 0.90000000000000002 108.739 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 69.94 125.86 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.16 -1.382 . . . . 0.22 111.574 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -146.8 -149.51 0.29 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.885 -1.507 . . . . 0.34999999999999998 108.904 -175.126 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 202' ' ' ASP . 13.5 mttt -127.92 140.8 51.79 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.934 -0.575 . . . . 3.77 110.307 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.714 HG11 ' HG ' ' A' ' 217' ' ' LEU . 6.3 p -110.16 141.53 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-O 121.607 0.717 . . . . 1.6599999999999999 109.493 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.529 ' H ' ' HG3' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -76.98 50.99 0.76 Allowed 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 124.615 1.166 . . . . 3.46 111.578 177.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -61.72 102.93 0.29 Allowed 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 113.496 -1.684 . . . . 1.3200000000000001 110.374 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 79.78 27.34 54.09 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.14 -0.784 . . . . 2.1200000000000001 111.14 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 71.78 2.04 4.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.934 0.894 . . . . 3.46 111.112 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -106.09 129.9 54.09 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.373 -0.83 . . . . 2.0299999999999998 109.629 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.421 ' HB1' ' HD3' ' A' ' 193' ' ' LYS . . . -70.74 118.45 13.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 122.364 1.078 . . . . 0.96999999999999997 109.464 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.584 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 30.0 tpp -102.3 -79.15 0.53 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.335 -1.757 . . . . 1.6499999999999999 110.253 -166.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 201' ' ' MET . 3.7 t70 158.29 142.46 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 113.714 -1.584 . . . . 1.8600000000000001 106.979 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.796 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -163.56 150.54 12.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 120.315 -0.554 . . . . 0.14999999999999999 112.151 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 18.9 m -117.49 127.12 53.69 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.67 -0.412 . . . . 0.13 112.032 -175.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.79 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 91.0 t -63.85 122.25 14.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 113.025 0.75 . . . . 0.070000000000000007 113.025 -171.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -103.16 -35.17 8.58 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.473 -0.785 . . . . 0.59999999999999998 109.76 175.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.676 ' O ' HG12 ' A' ' 213' ' ' VAL . 8.1 tp10 -159.03 157.57 31.46 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.904 -1.887 . . . . 2.2000000000000002 105.904 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.625 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -118.66 157.37 20.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 112.426 0.528 . . . . 0.14999999999999999 112.426 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 39.5 p -111.43 -158.51 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.77 -0.65 . . . . 0.17999999999999999 111.476 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -59.96 -25.81 65.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 3.8199999999999998 112.015 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.727 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 5.4 t0 -163.2 -29.44 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.292 -1.373 . . . . 1.6699999999999999 107.292 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.598 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -95.56 -149.36 25.57 Favored Glycine 0 CA--C 1.474 -2.48 0 N-CA-C 108.134 -1.986 . . . . 0.10000000000000001 108.134 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -146.47 -177.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.601 0 C-N-CA 119.903 -0.719 . . . . 0.089999999999999997 111.211 -177.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -128.96 93.17 3.54 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.833 -1.543 . . . . 3.3900000000000001 106.833 158.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.796 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 23.8 m -88.8 -177.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 114.089 -1.414 . . . . 0.12 110.108 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.463 ' HA ' ' OG ' ' A' ' 222' ' ' SER . 21.5 tm0? -104.07 113.23 26.62 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 108.093 -1.077 . . . . 1.6899999999999999 108.093 170.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 221' ' ' MET . 11.1 mp -75.95 142.89 41.87 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 119.744 -0.782 . . . . 0.32000000000000001 110.823 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -66.01 -31.57 72.54 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.537 -1.21 . . . . 1.28 108.334 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.5 m -60.85 -20.12 61.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.48 -1.236 . . . . 1.1100000000000001 109.902 169.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 91.82 29.97 11.09 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 114.654 -1.157 . . . . 0.68000000000000005 112.117 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.856 ' HB3' HD22 ' A' ' 217' ' ' LEU . 36.6 ttm -94.87 -62.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.451 -0.5 . . . . 1.5600000000000001 111.941 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 23.8 m 76.72 123.15 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.085 0.865 . . . . 0.90000000000000002 110.675 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 222' ' ' SER . 57.2 tp 157.01 -38.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.333 -0.849 . . . . 0.38 113.049 -162.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.778 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.3 0.2 OUTLIER 33.47 -93.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.864 1.266 . . . . 0.23000000000000001 113.307 -157.23 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.953 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.5 p 160.51 -156.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 118.887 0.767 . . . . 0.80000000000000004 109.656 -165.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.953 ' H ' HG22 ' A' ' 225' ' ' VAL . 35.5 ttt180 -103.05 164.01 11.87 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.14 -1.059 . . . . 3.5299999999999998 108.14 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -72.05 -14.72 61.94 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.719 0.637 . . . . 0.29999999999999999 112.719 -166.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -101.02 25.05 8.5 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.666 1.222 . . . . 2.5699999999999998 109.215 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.422 ' HB3' HG21 ' A' ' 225' ' ' VAL . 0.7 OUTLIER -137.67 -24.02 1.05 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.775 -1.557 . . . . 2.2400000000000002 110.818 178.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.598 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.2 pp -94.16 164.99 12.83 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 116.163 -0.471 . . . . 0.80000000000000004 110.79 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 18.5 m -134.16 73.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 113.356 0.873 . . . . 0.88 113.356 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.583 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.039 0 CA-C-N 115.689 -0.687 . . . . 1.3 110.301 165.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.562 0.696 . . . . 5.6100000000000003 110.787 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.0 m -89.69 27.71 1.47 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.333 -0.849 . . . . 2.7599999999999998 110.302 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.578 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 11.0 m-20 72.4 141.88 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.092 -0.958 . . . . 1.8300000000000001 111.337 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.6 mt -76.42 -49.31 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 115.738 -0.665 . . . . 0.5 109.305 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 211' ' ' ASP . 35.5 t -124.95 -77.04 0.59 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.344 -0.844 . . . . 1.55 111.132 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.588 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -117.41 -0.08 12.05 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.107 -1.442 . . . . 0.22 107.107 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.591 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.78 -178.8 3.08 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 112.791 -2.004 . . . . 0.14000000000000001 109.07 -171.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.1 m -124.38 171.13 10.16 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.881 0.848 . . . . 0.20000000000000001 112.243 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.771 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 61.7 t -82.92 131.84 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.139 -1.391 . . . . 0.10000000000000001 109.411 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.1 14.3 80.77 Favored Glycine 0 C--N 1.302 -1.342 0 CA-C-N 113.955 -1.475 . . . . 0.14000000000000001 110.725 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.584 ' HB2' ' O ' ' A' ' 187' ' ' THR . 1.9 tt0 -70.7 -51.8 25.19 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.847 -0.798 . . . . 0.90000000000000002 108.847 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.83 125.82 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.377 -1.738 . . . . 0.22 111.593 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 192' ' ' LEU . 0.1 OUTLIER -152.4 -146.98 0.21 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 113.687 -1.597 . . . . 0.34999999999999998 109.209 -174.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.495 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 10.3 mtmt -130.26 149.33 52.01 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.541 0.686 . . . . 3.77 111.065 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 8.1 p -116.63 149.01 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.633 -1.167 . . . . 1.6599999999999999 108.191 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 4.3 ttmt -101.06 89.27 3.76 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.265 -1.013 . . . . 3.46 108.265 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -85.3 73.06 10.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.681 -1.145 . . . . 1.3200000000000001 109.584 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 113.2 -103.46 1.39 Allowed Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.911 -1.04 . . . . 2.1200000000000001 111.188 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -110.15 -18.0 13.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.515 0.674 . . . . 3.46 110.765 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -117.75 142.3 47.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.779 -0.646 . . . . 2.0299999999999998 112.312 -171.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -74.71 144.07 43.87 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.976 -1.12 . . . . 0.96999999999999997 107.976 170.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.495 ' HG3' ' HB3' ' A' ' 218' ' ' ASN . 34.7 tpp -117.28 -79.03 0.58 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.959 -1.019 . . . . 1.6499999999999999 109.347 -171.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.9 OUTLIER 162.95 151.32 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.707 -1.59 . . . . 1.8600000000000001 106.707 173.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.791 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -165.82 151.66 9.15 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 118.814 0.734 . . . . 0.14999999999999999 112.141 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 17.4 m -115.67 129.78 56.61 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 120.979 0.418 . . . . 0.13 111.635 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.771 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 86.3 t -69.0 118.97 14.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 112.911 0.708 . . . . 0.070000000000000007 112.911 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 216' ' ' GLN . 8.3 mt -101.94 -36.14 8.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.274 0.559 . . . . 0.59999999999999998 110.771 174.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.702 ' O ' HG12 ' A' ' 213' ' ' VAL . 40.1 mt-10 -150.35 162.17 41.05 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 105.501 -2.037 . . . . 2.2000000000000002 105.501 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.589 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -126.16 155.28 36.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 123.373 0.421 . . . . 0.14999999999999999 111.987 -175.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.6 p -111.05 -160.95 0.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.949 -0.569 . . . . 0.17999999999999999 111.422 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -49.8 -35.47 22.83 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.385 -0.825 . . . . 3.8199999999999998 111.626 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.694 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 5.3 t70 -162.1 -24.19 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.02 -1.104 . . . . 1.6699999999999999 108.02 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.619 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.43 -150.14 26.24 Favored Glycine 0 CA--C 1.473 -2.574 0 N-CA-C 108.085 -2.006 . . . . 0.10000000000000001 108.085 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -144.37 -178.33 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 C-N-CA 119.787 -0.765 . . . . 0.089999999999999997 111.139 -177.464 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.418 ' H ' HG12 ' A' ' 213' ' ' VAL . 23.7 ttt85 -129.6 91.79 3.22 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.119 -1.438 . . . . 3.3900000000000001 107.119 159.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.791 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 25.8 m -89.11 -176.45 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.881 -1.509 . . . . 0.12 110.297 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.499 ' HB2' HD21 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -104.06 108.71 20.19 Favored 'General case' 0 N--CA 1.425 -1.703 0 O-C-N 124.196 0.935 . . . . 1.6899999999999999 108.549 168.139 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.603 ' HB2' ' H ' ' A' ' 221' ' ' MET . 8.5 mp -67.74 138.1 55.97 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.805 0.812 . . . . 0.32000000000000001 111.593 -175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.495 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 24.8 t-20 -72.37 -21.66 61.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.758 -1.565 . . . . 1.28 108.642 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.453 ' OG ' ' HG2' ' A' ' 201' ' ' MET . 17.8 m -60.84 -19.03 59.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.646 -1.161 . . . . 1.1100000000000001 109.036 166.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 108.01 14.86 15.85 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.729 -1.123 . . . . 0.68000000000000005 112.633 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.603 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 26.9 ttm -103.59 -146.24 0.37 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.39 0.614 . . . . 1.5600000000000001 109.759 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 69.0 m 176.61 123.4 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 126.171 1.788 . . . . 0.90000000000000002 107.134 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 222' ' ' SER . 33.2 tp 160.89 -40.93 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.402 0.89 . . . . 0.38 113.402 -161.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.739 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.289 0.2 OUTLIER 32.54 -91.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.523 1.129 . . . . 0.23000000000000001 112.924 -155.814 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.959 HG22 ' H ' ' A' ' 226' ' ' ARG . 7.3 p 159.03 -153.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 118.788 0.722 . . . . 0.80000000000000004 109.16 -167.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.959 ' H ' HG22 ' A' ' 225' ' ' VAL . 8.4 mtt180 -104.32 162.15 13.46 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.496 -0.774 . . . . 3.5299999999999998 109.023 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -67.91 -16.29 64.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.61 -0.723 . . . . 0.29999999999999999 112.597 -169.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -101.18 28.1 5.63 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 122.254 1.026 . . . . 2.5699999999999998 109.745 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.489 ' CG ' HG21 ' A' ' 225' ' ' VAL . 43.2 t-80 -143.85 -25.41 0.56 Allowed 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 114.231 -1.349 . . . . 2.2400000000000002 109.635 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.619 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.1 pp -89.93 170.38 10.42 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.042 0.448 . . . . 0.80000000000000004 111.319 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.76 77.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 113.406 0.891 . . . . 0.88 113.406 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 232' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.714 -0.66 . . . . 1.3 109.834 163.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.63 0.728 . . . . 5.6100000000000003 109.939 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.5 m -130.41 30.33 4.74 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.39 -0.823 . . . . 2.7599999999999998 109.429 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.614 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 9.5 m-20 -111.19 -159.46 0.68 Allowed 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.99 -1.004 . . . . 1.8300000000000001 109.281 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 188' ' ' VAL . 6.0 mt -84.68 -62.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 120.999 0.428 . . . . 0.5 110.107 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.6 t -118.37 -73.66 0.64 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.76 -0.655 . . . . 1.55 110.677 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.638 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -120.4 0.81 10.63 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.079 -1.452 . . . . 0.22 107.079 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 185' ' ' ALA . 0.5 OUTLIER -170.35 -179.91 3.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.968 -1.924 . . . . 0.14000000000000001 109.382 -170.071 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.707 HG22 ' H ' ' A' ' 188' ' ' VAL . 7.6 m -123.99 170.84 10.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.892 0.853 . . . . 0.20000000000000001 111.994 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.784 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 61.0 t -80.76 132.85 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 114.256 -1.338 . . . . 0.10000000000000001 109.384 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.24 15.46 80.98 Favored Glycine 0 C--N 1.302 -1.331 0 CA-C-N 113.806 -1.543 . . . . 0.14000000000000001 110.815 -170.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 187' ' ' THR . 24.0 tt0 -70.11 -49.13 53.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.603 -0.518 . . . . 0.90000000000000002 109.603 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 74.76 125.28 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.576 -1.193 . . . . 0.22 112.092 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.602 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -161.24 -150.97 0.21 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.147 -1.388 . . . . 0.34999999999999998 111.199 -172.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' A' ' 231' ' ' VAL . 0.0 OUTLIER -114.87 144.36 43.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.33 0.586 . . . . 3.77 110.808 -173.6 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.539 HG11 ' HG ' ' A' ' 217' ' ' LEU . 2.2 p -111.6 -37.6 2.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.633 1.206 . . . . 1.6599999999999999 110.097 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 21.1 ttmt 54.52 99.86 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 112.047 -2.342 . . . . 3.46 111.074 -171.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.524 ' HB3' ' HE3' ' A' ' 201' ' ' MET . . . -134.78 109.17 8.39 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.634 -1.621 . . . . 1.3200000000000001 110.246 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.33 41.06 2.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.917 -0.659 . . . . 2.1200000000000001 111.687 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 62.35 12.67 5.42 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.277 0.631 . . . . 3.46 111.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 36.0 m-80 -145.56 151.53 38.27 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.957 -0.565 . . . . 2.0299999999999998 110.401 -174.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -76.56 156.13 33.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.521 -0.918 . . . . 0.96999999999999997 108.521 173.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.547 ' O ' ' HB3' ' A' ' 202' ' ' ASP . 51.8 ttm -129.15 -58.01 1.14 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.759 -1.11 . . . . 1.6499999999999999 110.116 -164.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 3.0 t70 101.16 126.35 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 111.209 -2.723 . . . . 1.8600000000000001 109.153 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.721 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -145.94 148.78 33.14 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.112 -1.404 . . . . 0.14999999999999999 111.086 -168.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 25.9 m -115.56 124.98 52.37 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-O 120.92 0.391 . . . . 0.13 112.001 -169.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.784 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 87.8 t -59.22 122.93 10.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 113.046 0.758 . . . . 0.070000000000000007 113.046 -171.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.415 HD21 ' OE1' ' A' ' 216' ' ' GLN . 0.0 OUTLIER -104.89 -39.96 6.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.569 -0.741 . . . . 0.59999999999999998 109.877 173.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.716 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.3 mt-10 -148.19 153.58 38.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.268 -2.123 . . . . 2.2000000000000002 105.268 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.57 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -117.31 157.27 18.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 O-C-N 123.313 0.383 . . . . 0.14999999999999999 111.924 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 p -112.57 -164.34 0.91 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.585 . . . . 0.17999999999999999 111.365 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' A' ' 210' ' ' LYS . 14.3 pttt -53.43 -25.17 14.86 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.868 0.692 . . . . 3.8199999999999998 112.868 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.716 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 19.6 t0 -166.23 -26.0 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.784 -1.191 . . . . 1.6699999999999999 107.784 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.56 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -94.16 -148.88 24.6 Favored Glycine 0 CA--C 1.475 -2.423 0 N-CA-C 107.86 -2.096 . . . . 0.10000000000000001 107.86 177.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -147.8 -176.15 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 C-N-CA 119.897 -0.721 . . . . 0.089999999999999997 111.198 -178.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 223' ' ' LEU . 26.6 ttp180 -131.14 94.04 3.5 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.331 -1.359 . . . . 3.3900000000000001 107.331 159.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.833 ' O ' ' HA ' ' A' ' 222' ' ' SER . 28.1 m -89.58 178.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 114.46 -1.246 . . . . 0.12 111.783 -175.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 204' ' ' THR . 22.3 tp60 -101.84 104.44 15.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.189 -1.041 . . . . 1.6899999999999999 108.189 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.645 ' HB2' ' H ' ' A' ' 221' ' ' MET . 9.2 mp -62.86 146.91 51.68 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.575 0.702 . . . . 0.32000000000000001 111.82 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 1.7 t-20 -63.04 -30.33 71.51 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.117 -1.402 . . . . 1.28 109.562 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 39.7 m -68.53 -15.28 63.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.449 -0.796 . . . . 1.1100000000000001 110.056 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.52 24.1 9.67 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.453 -0.794 . . . . 0.68000000000000005 112.776 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.645 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 28.7 ttp -104.84 -166.1 1.2 Allowed 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.763 -1.199 . . . . 1.5600000000000001 107.763 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.833 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 1.5 m -157.26 131.38 8.32 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.007 -0.738 . . . . 0.90000000000000002 109.007 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.504 ' N ' ' HG3' ' A' ' 214' ' ' ARG . 57.5 tp 170.39 -44.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.995 1.109 . . . . 0.38 113.995 -168.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.726 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.281 0.2 OUTLIER 33.67 -98.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.105 0.962 . . . . 0.23000000000000001 113.553 -158.185 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.725 ' N ' HG23 ' A' ' 224' ' ' ILE . 12.8 m 178.94 -164.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.877 0.846 . . . . 0.80000000000000004 111.176 -158.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.442 ' H ' ' HB ' ' A' ' 225' ' ' VAL . 8.6 tpt85 -97.16 165.96 11.8 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.867 -1.901 . . . . 3.5299999999999998 105.867 166.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -69.64 -14.38 62.79 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.216 0.531 . . . . 0.29999999999999999 112.392 -172.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.77 24.99 5.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.047 0.927 . . . . 2.5699999999999998 110.278 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.442 ' HB3' HG11 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -135.03 -23.84 1.49 Allowed 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.33 -1.305 . . . . 2.2400000000000002 111.062 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.56 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.1 pp -94.78 153.35 17.8 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 122.995 0.518 . . . . 0.80000000000000004 111.114 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.537 HG22 ' HE3' ' A' ' 193' ' ' LYS . 21.5 m -126.62 65.02 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.765 0.793 . . . . 0.88 112.402 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 232' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.17 -0.923 . . . . 1.3 111.806 172.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.489 0.661 . . . . 5.6100000000000003 111.158 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.0 m -119.12 17.98 13.14 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.902 -0.59 . . . . 2.7599999999999998 109.865 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.686 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 39.7 m-20 73.95 153.11 0.14 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 114.986 -1.007 . . . . 1.8300000000000001 111.101 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.93 -68.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.543 0.687 . . . . 0.5 109.962 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 211' ' ' ASP . 96.7 p -95.27 -80.34 0.42 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-O 122.376 1.084 . . . . 1.55 110.746 -176.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.516 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -125.39 -2.27 7.49 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 105.02 -2.215 . . . . 0.22 105.02 173.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.719 HD13 HD21 ' A' ' 192' ' ' LEU . 0.5 OUTLIER -162.1 177.72 9.45 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.187 -1.824 . . . . 0.14000000000000001 109.351 -173.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 188' ' ' VAL . 4.1 m -121.44 173.48 7.35 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.64 0.733 . . . . 0.20000000000000001 111.919 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.768 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 41.2 t -82.76 130.71 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 114.941 -1.027 . . . . 0.10000000000000001 109.056 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.55 15.7 81.08 Favored Glycine 0 C--N 1.303 -1.267 0 CA-C-N 114.265 -1.334 . . . . 0.14000000000000001 110.52 -169.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -76.07 -44.53 38.51 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.382 -0.599 . . . . 0.90000000000000002 109.382 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.63 131.25 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 124.375 1.047 . . . . 0.22 111.623 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.719 HD21 HD13 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -152.08 -148.87 0.27 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 113.991 -1.459 . . . . 0.34999999999999998 109.396 -174.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.584 ' HB3' HG23 ' A' ' 231' ' ' VAL . 14.7 tttt -135.96 140.9 44.33 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.129 -0.487 . . . . 3.77 109.895 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.526 HG11 ' HG ' ' A' ' 217' ' ' LEU . 8.3 p -126.12 150.38 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 121.187 0.518 . . . . 1.6599999999999999 109.97 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.462 ' H ' ' HG3' ' A' ' 195' ' ' LYS . 0.1 OUTLIER -74.28 48.19 0.32 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 125.445 1.498 . . . . 3.46 112.45 -179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.513 ' HB2' HG13 ' A' ' 194' ' ' VAL . . . -69.34 103.57 2.02 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 113.42 -1.718 . . . . 1.3200000000000001 110.756 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 86.89 32.18 15.6 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.511 -0.768 . . . . 2.1200000000000001 111.221 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 71.98 10.87 6.16 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.147 0.975 . . . . 3.46 111.194 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.413 ' C ' ' HA ' ' A' ' 195' ' ' LYS . 39.2 m-80 -132.94 131.75 41.18 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.593 -0.73 . . . . 2.0299999999999998 111.081 -176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -63.5 116.02 5.2 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 122.19 0.995 . . . . 0.96999999999999997 108.826 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.629 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 34.7 tpp -104.6 -77.59 0.58 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.47 -1.695 . . . . 1.6499999999999999 110.556 -164.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.629 ' HB2' ' O ' ' A' ' 201' ' ' MET . 4.2 t70 151.52 140.79 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 113.304 -1.771 . . . . 1.8600000000000001 106.587 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.77 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -160.87 150.95 17.6 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 120.44 -0.504 . . . . 0.14999999999999999 111.169 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 17.1 m -119.79 127.52 52.87 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.638 -0.425 . . . . 0.13 111.805 -174.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.768 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 89.5 t -63.24 123.04 15.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 113.927 1.084 . . . . 0.070000000000000007 113.927 -170.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -101.9 -38.67 7.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.814 -1.084 . . . . 0.59999999999999998 109.721 175.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.576 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -158.31 150.08 21.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 105.395 -2.076 . . . . 2.2000000000000002 105.395 -178.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.622 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -114.67 161.31 13.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 112.918 0.71 . . . . 0.14999999999999999 112.918 -171.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.434 ' N ' HG22 ' A' ' 208' ' ' ILE . 31.9 p -112.65 -163.07 0.83 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.806 -0.634 . . . . 0.17999999999999999 110.231 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -51.77 -37.49 51.56 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.324 0.583 . . . . 3.8199999999999998 111.128 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.638 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 0.4 OUTLIER -156.7 -24.63 0.1 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.778 -0.823 . . . . 1.6699999999999999 108.778 -173.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.558 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -94.83 -151.36 28.25 Favored Glycine 0 CA--C 1.477 -2.31 0 N-CA-C 107.619 -2.193 . . . . 0.10000000000000001 107.619 176.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.743 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -150.52 -176.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 C-N-CA 119.811 -0.755 . . . . 0.089999999999999997 111.516 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -128.9 90.77 3.1 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.608 -1.627 . . . . 3.3900000000000001 106.608 158.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 222' ' ' SER . 26.5 m -86.2 -177.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 114.587 -1.188 . . . . 0.12 111.333 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 204' ' ' THR . 31.6 tp60 -102.69 106.64 17.32 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.517 -1.22 . . . . 1.6899999999999999 107.976 171.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.883 HD22 ' HB3' ' A' ' 221' ' ' MET . 10.9 mp -71.19 144.52 50.12 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.542 -0.863 . . . . 0.32000000000000001 110.462 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -27.88 67.47 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.406 -1.27 . . . . 1.28 108.685 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 41.0 m -67.21 -16.36 64.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.645 -1.161 . . . . 1.1100000000000001 109.772 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 88.57 30.99 14.03 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 114.887 -1.051 . . . . 0.68000000000000005 112.457 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.883 ' HB3' HD22 ' A' ' 217' ' ' LEU . 5.5 tpp -90.04 -63.63 1.25 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.548 0.573 . . . . 1.5600000000000001 112.548 -175.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.79 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 18.3 m 78.29 122.46 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.282 1.033 . . . . 0.90000000000000002 110.634 -172.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 222' ' ' SER . 61.4 tp 159.06 -41.99 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.257 0.973 . . . . 0.38 113.176 -166.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.773 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.293 0.2 OUTLIER 31.64 -92.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.44 1.096 . . . . 0.23000000000000001 113.082 -156.466 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.94 HG22 ' H ' ' A' ' 226' ' ' ARG . 10.0 p 157.25 -158.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.027 0.83 . . . . 0.80000000000000004 110.189 -167.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.94 ' H ' HG22 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -95.6 153.03 17.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.665 -1.152 . . . . 3.5299999999999998 108.355 178.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -61.57 -19.43 62.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.337 0.865 . . . . 0.29999999999999999 113.337 -173.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -101.8 27.09 6.75 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.441 1.115 . . . . 2.5699999999999998 109.086 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.434 ' HB3' HG21 ' A' ' 225' ' ' VAL . 0.8 OUTLIER -139.17 -22.39 0.93 Allowed 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.698 -1.592 . . . . 2.2400000000000002 110.693 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.558 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.2 pp -95.47 173.2 7.63 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 116.593 -0.276 . . . . 0.80000000000000004 110.513 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 193' ' ' LYS . 23.9 m -137.96 72.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.686 0.755 . . . . 0.88 112.392 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.695 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.304 -0.855 . . . . 1.3 111.104 170.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.886 0.374 . . . . 5.6100000000000003 110.47 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.9 p -113.76 17.62 17.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.166 0.508 . . . . 2.7599999999999998 110.626 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.516 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 3.6 p30 -159.72 160.64 34.29 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.748 -0.66 . . . . 1.8300000000000001 110.128 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 19.6 mt -88.48 -56.42 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 115.248 -0.887 . . . . 0.5 109.018 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 94.3 p -105.29 -78.29 0.57 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 122.192 0.996 . . . . 1.55 110.503 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.47 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -126.23 -2.84 6.93 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 104.95 -2.241 . . . . 0.22 104.95 172.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.622 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -161.02 -178.58 6.88 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.42 -1.718 . . . . 0.14000000000000001 110.283 -173.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.5 m -125.39 170.74 11.06 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.102 0.953 . . . . 0.20000000000000001 112.592 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.805 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.5 t -82.81 131.2 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.957 -1.474 . . . . 0.10000000000000001 109.516 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.56 13.96 80.75 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.941 -1.481 . . . . 0.14000000000000001 110.958 -170.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -73.52 -47.02 44.2 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.656 -0.498 . . . . 0.90000000000000002 109.656 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 70.97 123.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.75 -1.114 . . . . 0.22 111.891 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.649 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -156.62 -157.52 0.71 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.195 -1.366 . . . . 0.34999999999999998 111.372 -171.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.461 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 29.8 ttmt -109.06 142.61 39.52 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.973 0.892 . . . . 3.77 111.234 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.473 HG11 ' HG ' ' A' ' 217' ' ' LEU . 1.5 p -113.06 -32.14 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 113.542 -1.663 . . . . 1.6599999999999999 108.849 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 25.1 ttmt 59.19 95.36 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 111.092 -2.776 . . . . 3.46 110.555 -176.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.401 ' HB3' ' HE3' ' A' ' 201' ' ' MET . . . -103.08 97.14 7.28 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.704 -1.589 . . . . 1.3200000000000001 110.852 -174.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 198' ' ' GLN . . . 85.03 55.72 2.58 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.89 -0.671 . . . . 2.1200000000000001 112.172 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 197' ' ' GLY . 26.7 tt0 74.01 -35.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.17 0.588 . . . . 3.46 112.522 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -96.09 158.97 15.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.81 -0.441 . . . . 2.0299999999999998 109.81 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -71.73 177.05 4.38 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.703 0.763 . . . . 0.96999999999999997 109.436 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.753 ' SD ' ' HB3' ' A' ' 218' ' ' ASN . 37.4 tpp -146.29 -55.65 0.27 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.896 -1.047 . . . . 1.6499999999999999 110.287 -168.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 201' ' ' MET . 17.6 m-20 97.03 105.27 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.472 -2.149 . . . . 1.8600000000000001 109.165 174.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.777 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -128.38 147.93 50.66 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.121 -0.945 . . . . 0.14999999999999999 110.664 -167.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 40.6 m -116.18 125.24 52.02 Favored 'General case' 0 C--O 1.211 -0.921 0 C-N-CA 120.378 -0.529 . . . . 0.13 112.272 -170.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.805 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 85.3 t -61.73 121.49 10.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 112.917 0.71 . . . . 0.070000000000000007 112.917 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -102.63 -36.51 8.31 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.627 -0.715 . . . . 0.59999999999999998 110.067 175.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.646 ' O ' HG12 ' A' ' 213' ' ' VAL . 35.1 tt0 -156.81 157.12 34.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.267 -2.123 . . . . 2.2000000000000002 105.267 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.624 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.48 160.27 19.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 112.63 0.604 . . . . 0.14999999999999999 112.63 -172.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 34.0 p -112.11 -161.66 0.76 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.802 -0.636 . . . . 0.17999999999999999 110.609 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -56.51 -30.0 62.5 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.389 0.515 . . . . 3.8199999999999998 112.389 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.651 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 4.3 t0 -161.88 -24.35 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.332 -0.988 . . . . 1.6699999999999999 108.332 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.608 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -98.07 -149.31 24.88 Favored Glycine 0 CA--C 1.473 -2.561 0 N-CA-C 107.685 -2.166 . . . . 0.10000000000000001 107.685 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.659 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -149.04 -175.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 C-N-CA 119.881 -0.728 . . . . 0.089999999999999997 111.695 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 223' ' ' LEU . 29.6 ttt-85 -129.94 93.33 3.48 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.229 -1.397 . . . . 3.3900000000000001 107.229 157.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.778 HG22 ' HB ' ' A' ' 224' ' ' ILE . 19.9 m -87.22 179.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 114.061 -1.427 . . . . 0.12 110.415 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 204' ' ' THR . 1.3 tm0? -100.39 113.47 26.24 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 107.707 -1.22 . . . . 1.6899999999999999 107.707 172.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.716 HD12 HG23 ' A' ' 215' ' ' VAL . 9.8 mp -72.87 144.58 47.37 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.86 -0.736 . . . . 0.32000000000000001 109.571 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.753 ' HB3' ' SD ' ' A' ' 201' ' ' MET . 15.9 t-20 -67.57 -22.9 65.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.175 -0.92 . . . . 1.28 108.662 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 22.0 m -66.42 -18.29 65.27 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.671 -1.149 . . . . 1.1100000000000001 109.768 167.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 86.27 32.89 15.48 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.887 -1.051 . . . . 0.68000000000000005 111.22 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.627 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 14.5 ttt -102.08 -54.02 2.8 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 112.359 0.503 . . . . 1.5600000000000001 112.359 -172.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 28.0 m 77.04 125.39 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.495 0.718 . . . . 0.90000000000000002 112.092 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 222' ' ' SER . 39.1 tp 158.98 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.968 -1.015 . . . . 0.38 113.574 -168.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.778 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.297 0.1 OUTLIER 34.53 -93.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 124.635 1.174 . . . . 0.23000000000000001 113.481 -157.737 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.95 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.7 p 162.12 -153.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 119.139 0.881 . . . . 0.80000000000000004 110.416 -164.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.95 ' H ' HG22 ' A' ' 225' ' ' VAL . 0.8 OUTLIER -108.06 159.59 16.45 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.833 -1.076 . . . . 3.5299999999999998 108.55 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -64.7 -16.4 62.83 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.534 0.939 . . . . 0.29999999999999999 113.534 -170.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -100.52 29.97 4.16 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.603 1.192 . . . . 2.5699999999999998 109.526 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.641 ' CG ' HG21 ' A' ' 225' ' ' VAL . 11.2 t60 -137.19 -31.79 0.81 Allowed 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.012 -1.449 . . . . 2.2400000000000002 109.372 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 230' ' ' LEU . 1.2 pp -86.8 154.41 20.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.252 -0.431 . . . . 0.80000000000000004 109.965 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.432 ' CG2' ' HD2' ' A' ' 193' ' ' LYS . 18.7 m -127.69 47.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 122.172 0.986 . . . . 0.88 112.488 -177.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.62 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-N 113.647 -1.615 . . . . 1.3 112.086 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.046 0.45 . . . . 5.6100000000000003 110.012 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.1 t -101.61 13.95 33.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.415 0.626 . . . . 2.7599999999999998 109.757 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.445 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 6.9 m-20 -130.07 -169.77 2.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.677 -0.86 . . . . 1.8300000000000001 108.677 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 19.7 mt -84.76 -73.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.191 0.519 . . . . 0.5 110.159 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.455 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 99.9 p -97.78 -80.23 0.45 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.269 1.033 . . . . 1.55 110.48 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.466 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -121.29 -3.81 9.46 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 105.013 -2.217 . . . . 0.22 105.013 171.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.541 HD11 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -159.85 -174.95 4.85 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 113.393 -1.73 . . . . 0.14000000000000001 110.706 -173.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 188' ' ' VAL . 7.1 m -128.51 170.85 12.69 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.024 -0.989 . . . . 0.20000000000000001 112.543 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.794 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 57.7 t -81.78 133.4 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.111 -1.404 . . . . 0.10000000000000001 109.366 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.95 13.66 82.83 Favored Glycine 0 C--N 1.303 -1.276 0 CA-C-N 114.031 -1.441 . . . . 0.14000000000000001 110.903 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -72.53 -49.95 29.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.606 -0.438 . . . . 0.90000000000000002 109.846 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.15 127.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.573 -1.194 . . . . 0.22 112.006 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.618 HD13 HD12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.95 -149.75 0.28 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.49 -1.232 . . . . 0.34999999999999998 110.45 -174.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.602 ' HB3' HG22 ' A' ' 231' ' ' VAL . 0.0 OUTLIER -122.93 146.22 47.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.612 0.72 . . . . 3.77 111.778 -176.477 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.436 ' HB ' HG12 ' A' ' 224' ' ' ILE . 6.9 p -132.74 145.82 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 CA-C-N 114.134 -1.394 . . . . 1.6599999999999999 107.718 163.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.578 ' HE2' ' N ' ' A' ' 200' ' ' ALA . 9.4 ttmt -102.23 95.56 6.39 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.295 -1.002 . . . . 3.46 108.295 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -96.02 73.48 3.0 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.69 -1.141 . . . . 1.3200000000000001 109.671 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 119.3 -114.42 2.77 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.856 -1.065 . . . . 2.1200000000000001 110.964 -175.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -99.53 -23.88 14.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.468 0.651 . . . . 3.46 110.767 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 39.2 m-80 -112.83 149.2 33.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.375 -0.83 . . . . 2.0299999999999998 112.004 -170.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.578 ' N ' ' HE2' ' A' ' 195' ' ' LYS . . . -75.55 151.18 37.95 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.927 -1.509 . . . . 0.96999999999999997 106.927 166.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.633 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 46.1 tpp -108.08 -59.29 1.87 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.443 -1.253 . . . . 1.6499999999999999 110.375 -163.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 201' ' ' MET . 0.9 OUTLIER 95.24 109.54 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 111.815 -2.448 . . . . 1.8600000000000001 108.104 -178.626 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.707 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -139.81 152.42 46.52 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.768 -1.106 . . . . 0.14999999999999999 110.658 -161.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 18.3 m -117.63 129.46 55.76 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 121.088 0.47 . . . . 0.13 111.716 -171.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.794 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 86.1 t -64.7 122.25 15.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.979 0.733 . . . . 0.070000000000000007 112.979 -170.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.44 HD21 ' OE1' ' A' ' 216' ' ' GLN . 0.0 OUTLIER -103.95 -39.23 6.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.699 0.762 . . . . 0.59999999999999998 109.484 174.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.704 ' O ' HG12 ' A' ' 213' ' ' VAL . 18.2 mt-10 -148.75 156.19 42.02 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 104.786 -2.302 . . . . 2.2000000000000002 104.786 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.612 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.54 161.73 19.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 112.42 0.526 . . . . 0.14999999999999999 112.42 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.434 ' N ' HG22 ' A' ' 208' ' ' ILE . 31.4 p -112.45 -163.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.17999999999999999 110.247 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -58.1 -27.39 63.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.875 0.694 . . . . 3.8199999999999998 112.875 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.634 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 4.9 t0 -159.75 -27.77 0.07 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.154 -1.054 . . . . 1.6699999999999999 108.154 -174.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.516 ' HA2' HD11 ' A' ' 230' ' ' LEU . . . -96.84 -151.08 27.62 Favored Glycine 0 CA--C 1.475 -2.456 0 N-CA-C 107.842 -2.103 . . . . 0.10000000000000001 107.842 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -145.79 -174.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 C-N-CA 119.769 -0.772 . . . . 0.089999999999999997 111.45 -178.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.496 ' H ' HG12 ' A' ' 213' ' ' VAL . 72.8 mtm-85 -134.26 81.69 1.93 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.973 -1.491 . . . . 3.3900000000000001 106.973 164.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.742 HG22 ' HB ' ' A' ' 224' ' ' ILE . 26.5 m -80.93 -177.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 114.15 -1.386 . . . . 0.12 112.165 -173.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 204' ' ' THR . 26.4 tp60 -104.83 116.59 32.26 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.623 -1.251 . . . . 1.6899999999999999 107.623 171.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.802 HD22 ' HB3' ' A' ' 221' ' ' MET . 10.9 mp -76.57 150.34 36.52 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.39 -0.924 . . . . 0.32000000000000001 111.257 -174.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.583 ' HB3' ' SD ' ' A' ' 201' ' ' MET . 21.7 t-20 -52.67 -43.54 65.62 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.734 -1.121 . . . . 1.28 109.368 174.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 58.3 m -67.12 -11.55 57.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.16 -0.927 . . . . 1.1100000000000001 111.806 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.21 35.13 18.78 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.607 -0.806 . . . . 0.68000000000000005 111.87 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.802 ' HB3' HD22 ' A' ' 217' ' ' LEU . 18.3 tpp -85.12 -56.33 3.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.45 0.643 . . . . 1.5600000000000001 110.93 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 59.7 p 71.19 120.88 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.454 -1.703 . . . . 0.90000000000000002 110.793 -175.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 222' ' ' SER . 51.9 tp 166.1 -42.45 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.283 1.216 . . . . 0.38 114.283 -168.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.965 HD13 HD22 ' A' ' 230' ' ' LEU 0.341 0.1 OUTLIER 31.75 -99.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.498 1.119 . . . . 0.23000000000000001 113.558 -154.433 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.072 HG22 ' H ' ' A' ' 226' ' ' ARG . 12.1 p 162.51 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.45 1.023 . . . . 0.80000000000000004 109.984 -160.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 1.072 ' H ' HG22 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -106.05 152.58 23.2 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.25 -0.886 . . . . 3.5299999999999998 108.756 -178.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.634 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -51.5 -24.0 4.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.187 1.18 . . . . 0.29999999999999999 114.187 -167.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -94.31 26.45 3.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.838 1.304 . . . . 2.5699999999999998 109.224 -174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.549 ' CG ' HG21 ' A' ' 225' ' ' VAL . 16.5 t60 -139.44 -21.1 0.93 Allowed 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 113.842 -1.526 . . . . 2.2400000000000002 109.63 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.965 HD22 HD13 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -82.14 144.88 30.44 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.828 -0.434 . . . . 0.80000000000000004 109.828 171.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 193' ' ' LYS . 25.0 m -120.67 66.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 122.422 1.106 . . . . 0.88 111.582 171.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.64 ' CE2' HD12 ' A' ' 230' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.144 0 CA-C-N 115.154 -0.93 . . . . 1.3 110.797 171.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.153 -0.314 . . . . 5.6100000000000003 110.153 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 87.9 p 52.73 30.51 8.97 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.677 0.791 . . . . 2.7599999999999998 110.594 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 4.5 m-20 -77.19 139.32 39.87 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.446 -0.797 . . . . 1.8300000000000001 109.625 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.1 mt -70.71 -62.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.942 -1.027 . . . . 0.5 109.234 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 74.0 m -108.34 -78.78 0.58 Allowed 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.411 -0.813 . . . . 1.55 111.295 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.618 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -117.12 -0.71 12.04 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.866 -1.531 . . . . 0.22 106.866 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.618 HD23 ' HB3' ' A' ' 185' ' ' ALA . 0.5 OUTLIER -169.31 -178.51 3.18 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.111 -1.859 . . . . 0.14000000000000001 109.497 -171.199 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.724 HG22 ' H ' ' A' ' 188' ' ' VAL . 3.6 m -123.34 171.94 9.04 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.794 0.807 . . . . 0.20000000000000001 112.587 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.775 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.4 t -84.71 135.66 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 114.477 -1.238 . . . . 0.10000000000000001 108.917 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 71.89 18.66 77.74 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 114.374 -1.285 . . . . 0.14000000000000001 110.186 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 187' ' ' THR . 2.1 tt0 -72.38 -53.23 12.87 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.44 -0.948 . . . . 0.90000000000000002 108.44 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 73.32 127.66 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.282 -1.781 . . . . 0.22 111.351 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 192' ' ' LEU . 0.0 OUTLIER -148.3 -151.58 0.4 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.662 -1.608 . . . . 0.34999999999999998 108.532 -174.321 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.545 ' HD2' ' HB1' ' A' ' 200' ' ' ALA . 12.5 mtmt -129.32 148.15 51.21 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.547 -0.751 . . . . 3.77 109.629 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 195' ' ' LYS . 1.2 p -96.85 -32.84 4.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.857 -1.065 . . . . 1.6599999999999999 112.077 -167.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 4.5 tppp? 60.5 96.43 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.447 -1.706 . . . . 3.46 109.604 -172.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -130.05 114.75 16.17 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.181 -1.372 . . . . 1.3200000000000001 110.396 -173.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.0 48.04 17.16 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.621 -0.8 . . . . 2.1200000000000001 111.747 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 75.3 -26.16 0.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.538 0.735 . . . . 3.46 112.478 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -106.47 150.52 26.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.96 0.41 . . . . 2.0299999999999998 111.308 -177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 193' ' ' LYS . . . -78.23 151.35 33.17 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.573 -0.899 . . . . 0.96999999999999997 108.573 173.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.67 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 40.6 tpp -127.01 -80.63 0.6 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.548 -0.908 . . . . 1.6499999999999999 108.548 -167.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 201' ' ' MET . 3.3 t70 151.75 146.99 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.311 -1.737 . . . . 1.8600000000000001 106.311 170.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.852 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -158.9 148.24 18.88 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.933 -0.707 . . . . 0.14999999999999999 112.095 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 22.8 m -119.24 127.19 53.02 Favored 'General case' 0 C--O 1.21 -0.975 0 C-N-CA 120.457 -0.497 . . . . 0.13 112.2 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.775 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 85.6 t -65.55 121.05 13.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 113.014 0.746 . . . . 0.070000000000000007 113.014 -170.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -101.55 -37.84 8.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.201 -0.909 . . . . 0.59999999999999998 109.827 175.554 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.624 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -157.69 151.71 24.35 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 105.116 -2.179 . . . . 2.2000000000000002 105.116 -178.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.61 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -115.92 160.98 14.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 112.372 0.508 . . . . 0.14999999999999999 112.372 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.4 p -112.74 -172.03 1.97 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.617 -0.882 . . . . 0.17999999999999999 108.617 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.72 ' HG3' ' OD1' ' A' ' 211' ' ' ASP . 13.2 pttp -55.41 -28.04 51.61 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.654 0.613 . . . . 3.8199999999999998 112.654 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.72 ' OD1' ' HG3' ' A' ' 210' ' ' LYS . 6.6 p-10 -149.66 -33.21 0.2 Allowed 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.971 -0.751 . . . . 1.6699999999999999 108.971 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.563 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -98.29 -153.0 28.45 Favored Glycine 0 CA--C 1.476 -2.349 0 N-CA-C 108.009 -2.036 . . . . 0.10000000000000001 108.009 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.636 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -147.08 -176.76 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.499 0 C-N-CA 119.874 -0.731 . . . . 0.089999999999999997 110.81 -176.627 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -128.5 87.7 2.63 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.549 -1.648 . . . . 3.3900000000000001 106.549 158.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.852 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 22.6 m -83.2 -177.19 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.347 -1.297 . . . . 0.12 110.469 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 20.3 tm0? -103.84 115.49 30.56 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.888 -1.051 . . . . 1.6899999999999999 108.261 168.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 221' ' ' MET . 11.0 mp -76.79 144.04 39.43 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.899 -0.721 . . . . 0.32000000000000001 110.634 -175.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.584 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 12.8 t-20 -66.13 -28.17 68.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.41 -1.268 . . . . 1.28 108.802 178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.6 m -65.69 -18.52 65.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.427 -1.26 . . . . 1.1100000000000001 109.587 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 92.44 26.12 18.99 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 114.809 -1.087 . . . . 0.68000000000000005 112.435 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.785 ' HB3' HD22 ' A' ' 217' ' ' LEU . 2.5 tpp -88.53 -63.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.73 -0.388 . . . . 1.5600000000000001 111.9 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 25.7 m 75.93 122.19 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.031 -0.986 . . . . 0.90000000000000002 110.589 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 222' ' ' SER . 52.4 tp 156.32 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.192 0.932 . . . . 0.38 112.946 -163.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.793 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.303 0.2 OUTLIER 32.92 -94.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.573 1.149 . . . . 0.23000000000000001 113.217 -156.575 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.969 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.8 p 159.94 -152.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 118.794 0.725 . . . . 0.80000000000000004 110.417 -162.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.969 ' H ' HG22 ' A' ' 225' ' ' VAL . 18.6 mtm180 -105.33 164.3 11.96 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.763 -1.108 . . . . 3.5299999999999998 109.315 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -69.48 -17.54 63.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.339 -0.846 . . . . 0.29999999999999999 112.329 -171.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -101.68 28.02 5.94 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.509 1.147 . . . . 2.5699999999999998 109.442 -177.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.62 ' CG ' HG21 ' A' ' 225' ' ' VAL . 7.9 t60 -137.03 -34.37 0.73 Allowed 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.957 -1.474 . . . . 2.2400000000000002 109.309 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 226' ' ' ARG . 1.0 OUTLIER -83.28 157.61 22.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 116.014 -0.539 . . . . 0.80000000000000004 111.221 -171.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 14.7 m -128.25 72.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.277 0.843 . . . . 0.88 113.277 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-N 115.438 -0.801 . . . . 1.3 110.772 165.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 121.324 0.583 . . . . 5.6100000000000003 111.378 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.0 t -91.8 15.6 12.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.899 -0.778 . . . . 2.7599999999999998 108.899 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.409 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 1.6 p30 -157.27 147.68 21.1 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.825 -1.08 . . . . 1.8300000000000001 110.129 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.8 mt -82.36 -56.63 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.291 -0.868 . . . . 0.5 108.824 171.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 80.2 p -101.81 -82.76 0.47 Allowed 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 122.421 1.105 . . . . 1.55 110.312 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.433 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -122.81 -2.98 8.72 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 105.089 -2.189 . . . . 0.22 105.089 170.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.581 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.6 OUTLIER -159.28 -177.24 6.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.489 -1.687 . . . . 0.14000000000000001 110.462 -175.036 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.0 m -125.96 170.93 11.2 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.084 0.945 . . . . 0.20000000000000001 112.808 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.798 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.1 t -80.75 134.44 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-N 114.151 -1.386 . . . . 0.10000000000000001 109.277 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.39 81.59 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.243 -1.344 . . . . 0.14000000000000001 110.641 -170.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -73.28 -49.7 26.24 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.312 -0.555 . . . . 0.90000000000000002 109.604 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 71.71 124.12 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.207 -1.361 . . . . 0.22 111.846 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.663 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -150.13 -152.3 0.43 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.603 -1.18 . . . . 0.34999999999999998 111.001 -173.602 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.596 ' HE3' ' HB2' ' A' ' 195' ' ' LYS . 0.5 OUTLIER -115.46 139.98 49.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.33 -0.85 . . . . 3.77 110.32 -177.565 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 217' ' ' LEU . 1.1 p -112.27 -31.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 113.92 -1.491 . . . . 1.6599999999999999 110.306 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.596 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 0.5 OUTLIER 62.42 108.36 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 111.87 -2.423 . . . . 3.46 110.228 -166.356 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.15 89.11 3.05 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.056 -0.975 . . . . 1.3200000000000001 110.372 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.05 49.3 0.83 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.807 -0.633 . . . . 2.1200000000000001 112.281 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 64.5 2.62 1.64 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.242 0.617 . . . . 3.46 112.416 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 42.5 m-80 -138.21 161.72 36.12 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.067 -0.716 . . . . 2.0299999999999998 109.067 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -69.3 172.9 6.33 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.456 0.646 . . . . 0.96999999999999997 109.643 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.631 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 35.6 tpp -147.88 -59.19 0.25 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.42 -0.809 . . . . 1.6499999999999999 110.95 -166.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 2.1 m-20 104.59 115.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 112.127 -2.306 . . . . 1.8600000000000001 109.269 177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.691 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -135.87 146.63 47.63 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.876 -0.602 . . . . 0.14999999999999999 110.177 -172.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 19.0 m -112.75 130.21 56.15 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.383 -0.527 . . . . 0.13 111.475 -168.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.798 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 91.7 t -66.11 120.03 12.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 112.773 0.657 . . . . 0.070000000000000007 112.773 -172.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -101.52 -40.24 7.14 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.302 -0.863 . . . . 0.59999999999999998 109.489 175.605 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.688 ' O ' HG12 ' A' ' 213' ' ' VAL . 24.3 mt-10 -150.28 155.52 39.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.091 -2.188 . . . . 2.2000000000000002 105.091 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.646 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.85 160.38 20.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 112.634 0.605 . . . . 0.14999999999999999 112.634 -175.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.418 ' N ' HG22 ' A' ' 208' ' ' ILE . 37.6 p -113.27 -167.07 1.14 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.835 -0.62 . . . . 0.17999999999999999 109.839 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -58.67 -27.73 65.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.83 0.347 . . . . 3.8199999999999998 111.679 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 9.0 t0 -150.51 -35.39 0.15 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.668 -1.234 . . . . 1.6699999999999999 107.668 -173.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.61 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -96.01 -146.87 21.71 Favored Glycine 0 CA--C 1.476 -2.383 0 N-CA-C 108.682 -1.767 . . . . 0.10000000000000001 108.682 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.772 ' CB ' HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -145.51 -170.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 C-N-CA 119.893 -0.723 . . . . 0.089999999999999997 112.003 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.463 ' H ' HG12 ' A' ' 213' ' ' VAL . 18.0 mmm180 -137.5 81.89 1.89 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.15 -1.426 . . . . 3.3900000000000001 107.15 162.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.792 HG22 ' HB ' ' A' ' 224' ' ' ILE . 34.0 m -81.87 -177.69 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.484 -0.78 . . . . 0.12 113.043 -175.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 204' ' ' THR . 1.1 tm0? -106.52 114.53 28.7 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.986 -1.461 . . . . 1.6899999999999999 108.708 173.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.557 ' HB2' ' H ' ' A' ' 221' ' ' MET . 9.6 mp -72.52 145.29 47.57 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.656 0.741 . . . . 0.32000000000000001 112.134 -175.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.724 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 20.5 t-20 -66.13 -28.62 68.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.878 -1.51 . . . . 1.28 108.679 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.9 m -62.37 -18.48 61.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.496 -1.229 . . . . 1.1100000000000001 109.775 169.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.73 21.71 12.06 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.317 -0.856 . . . . 0.68000000000000005 112.153 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.557 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 26.4 ttp -108.71 -163.37 0.87 Allowed 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 107.509 -1.293 . . . . 1.5600000000000001 107.509 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 10.0 m -157.8 129.28 6.77 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.99 -1.115 . . . . 0.90000000000000002 107.99 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 214' ' ' ARG . 48.2 tp 178.22 -55.56 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.228 1.196 . . . . 0.38 114.228 -168.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.792 ' HB ' HG22 ' A' ' 215' ' ' VAL . 0.4 OUTLIER 49.08 -99.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.376 1.07 . . . . 0.23000000000000001 112.25 -161.141 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.991 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.7 p 156.84 -159.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 118.777 0.717 . . . . 0.80000000000000004 109.214 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.991 ' H ' HG22 ' A' ' 225' ' ' VAL . 15.5 ptt180 -97.38 163.17 12.99 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.501 -0.772 . . . . 3.5299999999999998 109.146 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -71.19 -15.39 62.47 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.743 0.646 . . . . 0.29999999999999999 112.743 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.482 ' H ' ' HG3' ' A' ' 226' ' ' ARG . 11.6 tp10 -98.95 28.61 4.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.859 1.314 . . . . 2.5699999999999998 109.011 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.57 ' HB3' HG11 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -136.56 -29.96 0.93 Allowed 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.504 -1.68 . . . . 2.2400000000000002 110.575 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.61 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.1 pp -90.49 155.58 18.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 116.168 -0.469 . . . . 0.80000000000000004 111.316 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.501 HG22 ' HD2' ' A' ' 193' ' ' LYS . 19.3 m -129.43 88.3 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.886 0.851 . . . . 0.88 111.827 173.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.557 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.152 -0.928 . . . . 1.3 110.998 171.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 63.9 t . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 109.844 -0.428 . . . . 5.6100000000000003 109.844 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.8 t 70.8 27.27 3.6 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.813 0.696 . . . . 2.7599999999999998 109.382 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.451 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 16.7 m-20 -121.26 -161.17 0.89 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.256 -0.884 . . . . 1.8300000000000001 108.721 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.584 HD12 HG23 ' A' ' 188' ' ' VAL . 14.4 mt -87.02 -61.69 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.407 0.622 . . . . 0.5 109.964 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.8 t -117.08 -77.21 0.57 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.453 -0.794 . . . . 1.55 110.375 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.59 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -120.04 -1.05 10.44 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.889 -1.522 . . . . 0.22 106.889 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.607 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -166.36 -175.39 3.23 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 112.627 -2.079 . . . . 0.14000000000000001 109.21 -171.567 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 188' ' ' VAL . 5.9 m -125.44 172.26 9.8 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.402 -0.817 . . . . 0.20000000000000001 112.514 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.796 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 48.5 t -83.17 135.12 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.494 -1.23 . . . . 0.10000000000000001 109.38 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.71 14.79 81.07 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.176 -1.375 . . . . 0.14000000000000001 110.45 -170.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 187' ' ' THR . 2.5 tt0 -69.85 -50.46 42.42 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.926 -0.768 . . . . 0.90000000000000002 108.926 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 73.71 127.27 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.42 -1.718 . . . . 0.22 111.68 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.618 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -148.97 -149.42 0.3 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.929 -1.487 . . . . 0.34999999999999998 108.845 -174.512 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 200' ' ' ALA . 11.3 mttp -135.79 148.27 48.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.87 0.843 . . . . 3.77 111.71 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 7.9 p -121.3 151.54 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 114.121 -1.4 . . . . 1.6599999999999999 108.414 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 1.2 ttmt -92.87 85.16 5.09 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.194 -0.669 . . . . 3.46 109.194 -178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.5 82.59 2.18 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.699 -0.682 . . . . 1.3200000000000001 110.396 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.74 47.75 1.16 Allowed Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.427 -0.806 . . . . 2.1200000000000001 111.61 -177.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 75.19 -19.85 0.37 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.564 0.746 . . . . 3.46 112.305 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -117.56 142.35 47.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.201 -0.454 . . . . 2.0299999999999998 110.986 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -68.89 132.89 47.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.472 -0.936 . . . . 0.96999999999999997 108.472 172.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.636 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 12.3 ttm -106.16 -79.16 0.57 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.566 -1.197 . . . . 1.6499999999999999 109.33 -168.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.636 ' HB2' ' O ' ' A' ' 201' ' ' MET . 4.0 t70 161.73 149.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.275 -1.38 . . . . 1.8600000000000001 107.275 171.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.805 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -162.92 149.67 12.76 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.393 -0.523 . . . . 0.14999999999999999 111.742 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 20.7 m -118.79 126.65 52.33 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 120.558 -0.457 . . . . 0.13 112.009 -174.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.796 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 96.0 t -62.84 123.41 15.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 113.373 0.879 . . . . 0.070000000000000007 113.373 -170.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -104.89 -34.43 8.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.408 -0.815 . . . . 0.59999999999999998 110.092 175.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.562 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.3 OUTLIER -161.53 149.21 14.95 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.477 -2.046 . . . . 2.2000000000000002 105.477 -178.058 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.59 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -114.71 156.43 15.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 112.837 0.68 . . . . 0.14999999999999999 112.837 -172.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.4 p -111.98 -161.0 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.569 0.581 . . . . 0.17999999999999999 112.569 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -44.46 -37.99 3.8 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 114.902 -1.045 . . . . 3.8199999999999998 111.582 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.666 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 2.1 t70 -162.84 -25.71 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.614 -1.254 . . . . 1.6699999999999999 107.614 -175.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.45 -149.75 25.65 Favored Glycine 0 CA--C 1.474 -2.501 0 N-CA-C 108.165 -1.974 . . . . 0.10000000000000001 108.165 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.659 ' CG1' HG13 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -145.41 -177.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.638 0 C-N-CA 119.826 -0.75 . . . . 0.089999999999999997 111.052 -177.038 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 223' ' ' LEU . 98.5 mtt180 -128.76 82.1 2.06 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.935 -1.505 . . . . 3.3900000000000001 106.935 162.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.805 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 26.9 m -80.65 -176.57 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.761 -1.109 . . . . 0.12 111.599 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 204' ' ' THR . 11.0 tm0? -104.84 109.84 21.96 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.332 -1.304 . . . . 1.6899999999999999 108.193 170.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.771 HD22 ' HB3' ' A' ' 221' ' ' MET . 11.0 mp -74.07 140.19 45.16 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 119.571 -0.852 . . . . 0.32000000000000001 110.918 -172.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 66.2 t30 -73.9 -18.82 60.86 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.915 -1.493 . . . . 1.28 107.168 173.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.31 -22.33 63.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.232 -1.804 . . . . 1.1100000000000001 109.06 165.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 88.2 31.05 15.03 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.001 -1.454 . . . . 0.68000000000000005 111.876 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.771 ' HB3' HD22 ' A' ' 217' ' ' LEU . 1.5 tpp -107.73 -63.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.452 0.538 . . . . 1.5600000000000001 112.452 -173.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.561 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 26.7 m 79.73 122.07 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.897 -1.047 . . . . 0.90000000000000002 110.577 -172.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 222' ' ' SER . 56.9 tp 161.98 -41.32 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.842 1.053 . . . . 0.38 113.842 -166.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.799 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.333 0.1 OUTLIER 33.85 -97.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.985 1.314 . . . . 0.23000000000000001 114.098 -157.568 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.931 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.9 p 159.61 -156.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 119.308 0.958 . . . . 0.80000000000000004 109.833 -165.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.931 ' H ' HG22 ' A' ' 225' ' ' VAL . 5.2 ptp180 -101.89 159.88 14.96 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.577 -0.738 . . . . 3.5299999999999998 109.135 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -68.03 -19.58 64.92 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.082 0.771 . . . . 0.29999999999999999 113.082 -164.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.505 ' HG2' ' CD ' ' A' ' 226' ' ' ARG . 13.8 pt-20 -99.83 24.41 8.46 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 122.198 0.999 . . . . 2.5699999999999998 109.802 -177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.487 ' CG ' HG21 ' A' ' 225' ' ' VAL . 46.5 t-80 -138.18 -24.5 0.98 Allowed 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.053 -1.43 . . . . 2.2400000000000002 109.178 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.4 pp -92.82 166.78 12.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.17 -0.468 . . . . 0.80000000000000004 110.709 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.9 m -130.33 83.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 113.242 0.83 . . . . 0.88 113.242 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.618 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.69 -0.672 . . . . 1.3 109.778 161.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.355 -0.239 . . . . 5.6100000000000003 110.355 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.0 t 71.16 29.49 2.86 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.956 0.785 . . . . 2.7599999999999998 109.693 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.513 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 37.9 m-20 -121.75 -170.61 2.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.357 -0.838 . . . . 1.8300000000000001 109.395 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.8 mt -79.22 -80.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 120.758 0.314 . . . . 0.5 110.458 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.3 m -95.95 -68.78 0.78 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.318 0.58 . . . . 1.55 110.939 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.535 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -128.39 0.36 5.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.911 -1.515 . . . . 0.22 106.911 173.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.13 -176.72 2.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.347 -1.751 . . . . 0.14000000000000001 109.42 -171.336 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 188' ' ' VAL . 8.2 m -126.28 170.81 11.5 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.965 0.888 . . . . 0.20000000000000001 112.435 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.774 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 47.7 t -82.15 133.89 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 113.992 -1.458 . . . . 0.10000000000000001 109.077 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.68 18.97 80.05 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 113.965 -1.47 . . . . 0.14000000000000001 110.434 -170.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -70.42 -48.94 53.67 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.81 -0.811 . . . . 0.90000000000000002 108.81 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 67.86 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.806 -1.543 . . . . 0.22 111.689 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.627 HD11 HG11 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -149.98 -147.8 0.24 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.289 -1.778 . . . . 0.34999999999999998 109.516 -174.022 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 0.8 OUTLIER -122.4 157.66 31.38 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.506 0.669 . . . . 3.77 110.621 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.717 HG11 ' HG ' ' A' ' 217' ' ' LEU . 9.9 p -134.11 150.96 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.462 -1.31 . . . . 1.6599999999999999 107.462 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -91.14 87.59 6.61 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.77 -0.826 . . . . 3.46 108.77 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.57 95.92 5.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.668 -0.696 . . . . 1.3200000000000001 109.981 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.8 37.01 4.06 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.259 -0.737 . . . . 2.1200000000000001 111.259 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 72.49 0.01 3.46 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.711 0.767 . . . . 3.46 111.938 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -132.89 141.24 48.29 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.076 -0.511 . . . . 2.0299999999999998 111.036 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -67.34 127.41 32.58 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.31 -0.996 . . . . 0.96999999999999997 108.31 175.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.566 ' HG2' ' HB3' ' A' ' 218' ' ' ASN . 6.0 ttm -108.06 -76.33 0.61 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.053 -1.431 . . . . 1.6499999999999999 109.412 -166.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 14.1 t70 160.89 149.81 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 106.311 -1.737 . . . . 1.8600000000000001 106.311 173.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.793 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -165.08 149.9 9.19 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 120.336 -0.545 . . . . 0.14999999999999999 111.676 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 22.1 m -117.54 127.57 54.12 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 120.897 0.38 . . . . 0.13 111.617 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.774 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 91.9 t -67.03 116.3 6.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.929 0.715 . . . . 0.070000000000000007 112.929 -172.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.681 ' CD2' ' HB2' ' A' ' 216' ' ' GLN . 0.2 OUTLIER -96.56 -38.56 9.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.544 -0.753 . . . . 0.59999999999999998 110.839 172.467 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.635 ' O ' HG12 ' A' ' 213' ' ' VAL . 29.0 tt0 -153.69 156.03 37.08 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.472 -2.047 . . . . 2.2000000000000002 105.472 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.577 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -118.84 161.87 17.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 111.873 0.323 . . . . 0.14999999999999999 111.873 -174.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.2 p -113.83 -164.09 0.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.281 -0.418 . . . . 0.17999999999999999 110.487 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -49.45 -34.7 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.476 0.485 . . . . 3.8199999999999998 111.834 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.639 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 0.4 OUTLIER -159.82 -25.82 0.07 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.447 -0.946 . . . . 1.6699999999999999 108.447 -174.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.619 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.57 -151.82 28.52 Favored Glycine 0 CA--C 1.474 -2.471 0 N-CA-C 107.672 -2.171 . . . . 0.10000000000000001 107.672 176.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.652 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -145.08 -176.78 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.65 0 C-N-CA 119.677 -0.809 . . . . 0.089999999999999997 110.757 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.449 ' H ' HG12 ' A' ' 213' ' ' VAL . 24.0 ttp180 -130.4 85.44 2.29 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.614 -1.625 . . . . 3.3900000000000001 106.614 159.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.793 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 26.1 m -80.48 177.16 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 114.018 -1.446 . . . . 0.12 109.315 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.681 ' HB2' ' CD2' ' A' ' 206' ' ' LEU . 18.6 tm0? -107.05 113.14 26.43 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 107.263 -1.384 . . . . 1.6899999999999999 107.263 171.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.717 ' HG ' HG11 ' A' ' 194' ' ' VAL . 9.5 mp -70.65 147.3 49.3 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.52 -0.764 . . . . 0.32000000000000001 112.288 -171.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.605 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 5.9 t-20 -71.55 -20.35 62.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.117 -1.401 . . . . 1.28 107.904 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.53 -21.19 65.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.982 -1.463 . . . . 1.1100000000000001 108.929 166.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 95.68 22.43 21.22 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.477 -1.238 . . . . 0.68000000000000005 112.01 -177.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.629 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 19.8 ttp -109.08 -162.06 0.79 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.949 -1.13 . . . . 1.5600000000000001 107.949 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 9.7 m -162.15 128.98 3.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.798 -1.186 . . . . 0.90000000000000002 107.798 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 222' ' ' SER . 43.1 tp 166.38 -41.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.909 1.077 . . . . 0.38 113.909 -165.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.771 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.276 0.4 OUTLIER 33.74 -89.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.369 1.068 . . . . 0.23000000000000001 113.158 -156.806 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.961 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.5 p 159.7 -156.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.549 -0.538 . . . . 0.80000000000000004 109.549 -164.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.961 ' H ' HG22 ' A' ' 225' ' ' VAL . 18.1 ttm180 -106.59 165.82 11.01 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.482 -0.933 . . . . 3.5299999999999998 108.482 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -68.78 -16.87 63.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.754 0.65 . . . . 0.29999999999999999 112.754 -167.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -100.26 25.02 7.99 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.581 1.181 . . . . 2.5699999999999998 109.441 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.472 ' HB3' HG21 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -139.17 -24.06 0.89 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 113.994 -1.457 . . . . 2.2400000000000002 111.238 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.619 HD21 ' HA2' ' A' ' 212' ' ' GLY . 0.9 OUTLIER -92.9 161.21 14.57 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.072 0.463 . . . . 0.80000000000000004 111.094 -175.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.23 73.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.202 0.815 . . . . 0.88 113.202 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 232' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.448 -0.787 . . . . 1.3 110.475 166.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 121.029 0.443 . . . . 5.6100000000000003 110.079 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.3 t -116.37 14.62 15.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.569 0.7 . . . . 2.7599999999999998 109.902 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.5 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 28.4 m-20 -136.45 158.36 44.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.972 -0.751 . . . . 1.8300000000000001 108.972 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 33.3 mt -81.91 -68.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.189 0.518 . . . . 0.5 110.048 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 92.9 p -92.89 -79.31 0.4 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.074 0.94 . . . . 1.55 110.304 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -124.68 -2.37 7.87 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 105.035 -2.209 . . . . 0.22 105.035 171.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.608 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -161.36 -176.1 5.19 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.586 -1.643 . . . . 0.14000000000000001 110.328 -174.412 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.7 m -126.75 170.89 11.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.936 0.874 . . . . 0.20000000000000001 112.636 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.792 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.9 t -81.89 133.46 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 114.125 -1.398 . . . . 0.10000000000000001 109.338 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.26 18.84 79.87 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 114.254 -1.339 . . . . 0.14000000000000001 110.359 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -73.62 -49.25 27.03 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.638 -0.875 . . . . 0.90000000000000002 108.638 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 71.85 127.78 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.839 -1.528 . . . . 0.22 111.337 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.586 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -149.4 -150.87 0.37 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 113.824 -1.535 . . . . 0.34999999999999998 108.99 -175.091 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 202' ' ' ASP . 13.8 mttt -131.06 146.51 52.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.489 0.661 . . . . 3.77 110.492 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' A' ' 217' ' ' LEU . 10.0 p -121.9 150.54 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.717 -1.129 . . . . 1.6599999999999999 108.051 175.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 200' ' ' ALA . 3.1 ttmt -91.9 81.63 5.16 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.482 -0.562 . . . . 3.46 109.482 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -98.95 99.47 10.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.472 -0.786 . . . . 1.3200000000000001 110.099 -174.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.15 34.08 6.61 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.125 -0.79 . . . . 2.1200000000000001 111.125 -173.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 70.34 9.1 6.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.316 0.646 . . . . 3.46 111.867 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -134.72 131.07 37.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.517 -0.31 . . . . 2.0299999999999998 110.871 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -64.13 122.62 17.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.974 0.892 . . . . 0.96999999999999997 109.195 176.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.494 ' HG2' ' HB3' ' A' ' 218' ' ' ASN . 15.3 ttm -107.1 -75.24 0.64 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.926 -1.488 . . . . 1.6499999999999999 110.028 -164.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 2.9 t70 159.39 150.29 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 113.623 -1.626 . . . . 1.8600000000000001 107.989 174.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.793 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -165.23 150.35 9.25 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.642 -0.423 . . . . 0.14999999999999999 111.655 178.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 17.9 m -119.34 130.44 55.36 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 120.629 -0.428 . . . . 0.13 111.554 -175.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.792 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 86.0 t -66.99 121.59 16.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 112.883 0.697 . . . . 0.070000000000000007 112.883 -171.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -102.46 -38.96 7.34 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.384 -0.826 . . . . 0.59999999999999998 109.479 175.055 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.643 ' O ' HG12 ' A' ' 213' ' ' VAL . 24.5 mt-10 -152.47 157.25 40.89 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.192 -2.151 . . . . 2.2000000000000002 105.192 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.632 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -122.23 159.68 25.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 112.595 0.591 . . . . 0.14999999999999999 112.595 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 208' ' ' ILE . 32.9 p -111.72 -164.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.605 . . . . 0.17999999999999999 110.78 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -53.7 -31.31 47.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.286 0.476 . . . . 3.8199999999999998 112.286 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.675 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 0.6 OUTLIER -158.35 -27.24 0.08 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.263 -1.014 . . . . 1.6699999999999999 108.263 -174.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.614 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -95.76 -150.45 27.02 Favored Glycine 0 CA--C 1.474 -2.502 0 N-CA-C 108.032 -2.027 . . . . 0.10000000000000001 108.032 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.678 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -146.01 -176.5 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.526 0 C-N-CA 119.867 -0.733 . . . . 0.089999999999999997 111.08 -177.691 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.466 ' H ' HG12 ' A' ' 213' ' ' VAL . 62.3 mtp180 -132.51 80.83 1.92 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.068 -1.456 . . . . 3.3900000000000001 107.068 164.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.793 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 27.0 m -82.48 -178.0 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 114.524 -1.217 . . . . 0.12 111.88 -173.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 16.9 tm0? -106.56 109.34 21.23 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.839 -1.073 . . . . 1.6899999999999999 108.733 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.716 HD22 ' HB3' ' A' ' 221' ' ' MET . 8.8 mp -69.08 143.83 54.12 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.847 0.832 . . . . 0.32000000000000001 111.515 -174.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.494 ' HB3' ' HG2' ' A' ' 201' ' ' MET . 17.5 t-20 -70.12 -23.94 63.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.788 -1.551 . . . . 1.28 107.792 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.66 -26.66 45.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.917 -1.492 . . . . 1.1100000000000001 109.005 166.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.84 21.84 11.72 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 114.025 -1.443 . . . . 0.68000000000000005 111.262 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.716 ' HB3' HD22 ' A' ' 217' ' ' LEU . 32.1 ttm -105.95 -167.01 1.26 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.467 -1.308 . . . . 1.5600000000000001 107.467 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 18.2 m -159.51 124.16 3.98 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.387 -0.968 . . . . 0.90000000000000002 108.387 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 214' ' ' ARG . 62.5 tp 172.18 -43.18 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.324 1.231 . . . . 0.38 114.324 -167.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.755 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.302 0.1 OUTLIER 36.09 -93.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.358 1.063 . . . . 0.23000000000000001 113.089 -155.728 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.969 HG22 ' H ' ' A' ' 226' ' ' ARG . 7.1 p 158.89 -152.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 118.884 0.765 . . . . 0.80000000000000004 109.654 -166.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.969 ' H ' HG22 ' A' ' 225' ' ' VAL . 10.3 ttt180 -107.69 162.13 14.25 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.313 -0.995 . . . . 3.5299999999999998 108.313 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -66.84 -17.85 65.09 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.803 0.668 . . . . 0.29999999999999999 112.803 -167.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.62 20.48 11.79 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 122.064 0.935 . . . . 2.5699999999999998 110.518 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.545 ' CG ' HG21 ' A' ' 225' ' ' VAL . 28.9 t-80 -139.94 -25.83 0.8 Allowed 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 114.217 -1.356 . . . . 2.2400000000000002 109.444 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.614 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.0 OUTLIER -88.47 163.2 16.05 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.291 0.567 . . . . 0.80000000000000004 111.271 -176.101 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.28 78.01 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 113.175 0.805 . . . . 0.88 113.175 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.584 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.504 -0.76 . . . . 1.3 110.041 164.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.341 -0.244 . . . . 5.6100000000000003 110.341 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.1 p 50.58 36.78 14.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.639 0.733 . . . . 2.7599999999999998 110.377 -170.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.516 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 27.4 m-20 -113.15 -168.01 1.27 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.885 -1.052 . . . . 1.8300000000000001 109.436 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.3 mt -87.04 -75.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-O 120.866 0.365 . . . . 0.5 110.266 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -100.54 -73.85 0.63 Allowed 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 116.206 -0.452 . . . . 1.55 111.341 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.58 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -122.75 0.34 9.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 107.167 -1.419 . . . . 0.22 107.167 175.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.598 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.76 -176.15 2.3 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 113.081 -1.872 . . . . 0.14000000000000001 109.223 -171.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.714 HG22 ' H ' ' A' ' 188' ' ' VAL . 7.3 m -126.58 171.49 11.05 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.832 0.825 . . . . 0.20000000000000001 112.516 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.786 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 58.4 t -82.53 134.86 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 114.073 -1.422 . . . . 0.10000000000000001 109.218 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.65 16.86 80.38 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 113.914 -1.494 . . . . 0.14000000000000001 110.539 -170.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 187' ' ' THR . 2.0 tt0 -74.66 -51.16 15.14 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.008 -0.738 . . . . 0.90000000000000002 109.008 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.57 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 113.667 -1.606 . . . . 0.22 111.582 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -149.42 -149.53 0.3 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.106 -1.406 . . . . 0.34999999999999998 109.054 -175.064 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.452 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 4.8 mttp -134.96 148.5 50.03 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.381 0.61 . . . . 3.77 110.515 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 224' ' ' ILE . 9.3 p -134.87 151.16 30.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.732 -1.122 . . . . 1.6599999999999999 108.439 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.657 ' HE3' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -100.41 111.18 23.41 Favored 'General case' 0 N--CA 1.397 -3.087 0 CA-C-O 123.256 1.503 . . . . 3.46 108.181 173.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.636 ' HB3' ' HE3' ' A' ' 201' ' ' MET . . . -121.86 100.95 7.27 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.131 -1.85 . . . . 1.3200000000000001 109.492 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 198' ' ' GLN . . . 99.04 32.23 5.94 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.168 -1.173 . . . . 2.1200000000000001 110.168 -169.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' ' 197' ' ' GLY . 42.5 tt0 77.95 -18.15 0.52 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.578 0.751 . . . . 3.46 112.237 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 69.5 m-20 -112.97 138.28 50.08 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.29 -0.256 . . . . 2.0299999999999998 111.064 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -69.21 146.26 52.53 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.958 0.885 . . . . 0.96999999999999997 109.913 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.65 ' SD ' ' HB3' ' A' ' 217' ' ' LEU . 51.0 ttm -115.28 -83.7 0.62 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.888 -1.506 . . . . 1.6499999999999999 110.046 -167.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 1.1 m-20 142.73 122.58 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 126.181 1.793 . . . . 1.8600000000000001 106.378 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.765 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -148.43 150.36 33.35 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 119.185 -1.006 . . . . 0.14999999999999999 112.37 -172.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 26.9 m -113.55 129.1 56.62 Favored 'General case' 0 C--O 1.21 -1.015 0 C-N-CA 120.69 -0.404 . . . . 0.13 111.909 -173.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.786 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 88.1 t -66.92 122.12 17.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 112.602 0.593 . . . . 0.070000000000000007 112.602 -172.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -106.65 -34.25 7.38 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.701 0.762 . . . . 0.59999999999999998 109.564 176.455 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.667 ' O ' HG12 ' A' ' 213' ' ' VAL . 24.3 tt0 -153.44 155.19 35.85 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 104.81 -2.293 . . . . 2.2000000000000002 104.81 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.591 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.89 159.87 20.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 120.739 0.304 . . . . 0.14999999999999999 111.543 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 58.2 p -112.59 -166.99 1.13 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.303 -0.408 . . . . 0.17999999999999999 110.174 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -52.21 -28.74 19.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.548 0.573 . . . . 3.8199999999999998 112.548 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.693 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 8.9 t0 -158.42 -28.6 0.08 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.98 -1.119 . . . . 1.6699999999999999 107.98 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.597 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -91.51 -149.72 24.21 Favored Glycine 0 CA--C 1.473 -2.538 0 N-CA-C 108.025 -2.03 . . . . 0.10000000000000001 108.025 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -144.37 -174.32 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 C-N-CA 119.56 -0.856 . . . . 0.089999999999999997 111.218 -178.042 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.493 ' H ' HG12 ' A' ' 213' ' ' VAL . 40.4 ttt180 -133.9 90.71 2.73 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.904 -1.517 . . . . 3.3900000000000001 106.904 162.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.765 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 23.3 m -90.14 179.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 114.041 -1.436 . . . . 0.12 110.718 -174.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -106.22 109.46 21.41 Favored 'General case' 0 N--CA 1.422 -1.846 0 O-C-N 124.118 0.886 . . . . 1.6899999999999999 108.743 173.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 221' ' ' MET . 9.5 mp -70.46 144.39 51.47 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.952 0.882 . . . . 0.32000000000000001 112.12 -173.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 13.4 t-20 -66.5 -30.6 70.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.012 -1.449 . . . . 1.28 109.782 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 23.7 m -65.59 -14.32 60.87 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.643 -0.708 . . . . 1.1100000000000001 109.859 169.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 96.32 33.27 6.3 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.323 -0.942 . . . . 0.68000000000000005 112.268 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.719 ' HB3' HD22 ' A' ' 217' ' ' LEU . 27.8 ttp -110.55 -164.9 0.95 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.465 -1.309 . . . . 1.5600000000000001 107.465 174.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 80.6 p -165.48 128.31 2.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.719 -0.845 . . . . 0.90000000000000002 108.719 176.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 222' ' ' SER . 64.6 tp 167.47 -44.48 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.297 1.221 . . . . 0.38 114.297 -162.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.74 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.288 0.2 OUTLIER 35.07 -93.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.246 1.018 . . . . 0.23000000000000001 113.245 -157.267 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 226' ' ' ARG . 7.2 p 159.7 -156.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 119.053 0.842 . . . . 0.80000000000000004 110.086 -164.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 1.005 ' H ' HG22 ' A' ' 225' ' ' VAL . 28.9 ttt180 -97.64 164.52 12.38 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.201 -1.037 . . . . 3.5299999999999998 108.201 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -71.55 -15.58 62.29 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.552 -0.749 . . . . 0.29999999999999999 112.63 -170.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -103.0 26.85 7.68 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.659 1.218 . . . . 2.5699999999999998 109.185 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.657 ' O ' ' HE3' ' A' ' 195' ' ' LYS . 0.3 OUTLIER -138.25 -24.96 0.96 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.618 -1.628 . . . . 2.2400000000000002 110.306 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.597 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.3 pp -94.1 163.86 13.3 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.151 0.501 . . . . 0.80000000000000004 110.9 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.79 76.63 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 113.033 0.753 . . . . 0.88 113.033 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.583 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.388 -0.815 . . . . 1.3 110.296 165.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.856 -0.424 . . . . 5.6100000000000003 109.856 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.9 t 71.6 28.25 2.83 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.845 0.715 . . . . 2.7599999999999998 109.262 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.427 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 12.7 m-20 -130.02 167.57 18.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.57 -0.9 . . . . 1.8300000000000001 108.57 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.0 mt -78.49 -72.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 109.221 -0.659 . . . . 0.5 109.221 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.2 m -102.79 -74.44 0.63 Allowed 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.617 -0.719 . . . . 1.55 111.451 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.609 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -120.99 0.28 10.2 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.219 -1.4 . . . . 0.22 107.219 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.626 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -170.85 -176.82 2.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.017 -1.902 . . . . 0.14000000000000001 109.356 -172.043 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 188' ' ' VAL . 7.4 m -125.98 171.73 10.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.845 0.831 . . . . 0.20000000000000001 112.207 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.79 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 61.3 t -81.01 137.15 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.187 -1.369 . . . . 0.10000000000000001 109.449 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 72.8 15.93 78.06 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 113.994 -1.457 . . . . 0.14000000000000001 110.488 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 187' ' ' THR . 2.4 tt0 -71.43 -51.71 22.48 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.855 -0.795 . . . . 0.90000000000000002 108.855 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 73.46 128.69 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.678 -1.601 . . . . 0.22 111.602 178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.611 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -152.35 -147.2 0.22 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.772 -1.558 . . . . 0.34999999999999998 108.669 -174.398 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.458 ' HG2' ' HB1' ' A' ' 200' ' ' ALA . 1.1 mppt? -118.39 160.34 21.85 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.537 -0.912 . . . . 3.77 108.537 170.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.638 HG21 HD21 ' A' ' 217' ' ' LEU . 1.2 p -105.42 -33.66 2.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 122.43 1.109 . . . . 1.6599999999999999 110.757 -173.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 23.4 ttmt 57.28 89.1 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 112.187 -2.279 . . . . 3.46 109.742 -170.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -90.02 71.18 7.44 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 112.721 -2.036 . . . . 1.3200000000000001 109.757 -170.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.21 -105.49 1.77 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.135 -0.939 . . . . 2.1200000000000001 111.716 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -100.59 -22.89 14.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.456 0.646 . . . . 3.46 110.998 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 88.4 m-20 -120.3 159.95 23.99 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.424 -0.807 . . . . 2.0299999999999998 111.636 -170.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -84.09 166.69 17.46 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.944 -0.571 . . . . 0.96999999999999997 109.583 176.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.736 ' HG2' ' OG ' ' A' ' 219' ' ' SER . 39.8 tpp -141.86 -91.66 0.14 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.611 -1.255 . . . . 1.6499999999999999 107.611 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.567 ' OD1' ' HB2' ' A' ' 218' ' ' ASN . 9.0 p-10 162.54 141.26 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.327 -1.36 . . . . 1.8600000000000001 107.327 172.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.737 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -158.15 152.06 23.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 120.275 -0.57 . . . . 0.14999999999999999 111.852 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 16.6 m -117.47 129.83 56.07 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 121.06 0.457 . . . . 0.13 112.163 -174.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.79 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 94.9 t -65.33 121.32 14.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.763 0.653 . . . . 0.070000000000000007 112.763 -171.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -102.86 -36.89 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.59999999999999998 109.675 176.004 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.642 ' O ' HG12 ' A' ' 213' ' ' VAL . 28.3 tt0 -156.69 155.98 32.63 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 105.469 -2.048 . . . . 2.2000000000000002 105.469 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.582 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.24 160.63 19.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 112.037 0.384 . . . . 0.14999999999999999 112.037 -173.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 26.9 p -110.82 -162.29 0.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.35 -0.611 . . . . 0.17999999999999999 109.35 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.475 ' HG3' ' OD1' ' A' ' 211' ' ' ASP . 40.8 pttt -59.82 -30.72 69.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.073 0.463 . . . . 3.8199999999999998 110.674 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.646 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 1.7 m-20 -151.27 -35.08 0.14 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.272 -1.01 . . . . 1.6699999999999999 108.272 -173.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.583 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.7 -153.07 29.96 Favored Glycine 0 CA--C 1.474 -2.49 0 N-CA-C 107.804 -2.119 . . . . 0.10000000000000001 107.804 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.661 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -146.04 -177.11 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.486 0 C-N-CA 119.861 -0.736 . . . . 0.089999999999999997 110.678 -176.213 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.482 ' HG3' ' HA ' ' A' ' 223' ' ' LEU . 71.1 ttt180 -129.01 91.05 3.13 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.034 -1.469 . . . . 3.3900000000000001 107.034 157.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.737 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 20.7 m -86.89 177.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.052 -1.431 . . . . 0.12 110.31 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 21.0 tm0? -102.77 107.66 18.61 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.432 -0.951 . . . . 1.6899999999999999 108.432 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.708 HD22 ' HB3' ' A' ' 221' ' ' MET . 6.8 mp -70.3 133.49 47.02 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.312 0.577 . . . . 0.32000000000000001 109.827 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.567 ' HB2' ' OD1' ' A' ' 202' ' ' ASP . 23.2 m120 -76.86 -14.15 59.92 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.772 -1.104 . . . . 1.28 108.699 176.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.736 ' OG ' ' HG2' ' A' ' 201' ' ' MET . 59.4 m -57.31 -24.84 57.63 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 114.973 -1.012 . . . . 1.1100000000000001 108.31 162.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.44 23.56 6.25 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 113.983 -1.462 . . . . 0.68000000000000005 112.879 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.708 ' HB3' HD22 ' A' ' 217' ' ' LEU . 20.3 ttp -118.32 -162.15 0.87 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.018 -0.734 . . . . 1.5600000000000001 109.018 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 85.5 p -164.91 126.49 2.11 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.992 -1.114 . . . . 0.90000000000000002 107.992 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 222' ' ' SER . 49.6 tp 166.77 -38.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.68 0.993 . . . . 0.38 113.68 -163.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.719 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.265 0.5 OUTLIER 36.29 -89.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 124.213 1.005 . . . . 0.23000000000000001 112.717 -157.778 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.021 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.2 p 159.07 -155.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.454 0.645 . . . . 0.80000000000000004 110.358 -164.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 1.021 ' H ' HG22 ' A' ' 225' ' ' VAL . 8.5 tpp180 -102.78 159.37 15.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.904 -1.147 . . . . 3.5299999999999998 107.904 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.646 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -68.15 -13.87 62.55 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.443 0.535 . . . . 0.29999999999999999 112.443 -171.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.07 17.2 16.03 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.994 0.902 . . . . 2.5699999999999998 110.691 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.68 -25.6 2.1 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.402 -1.272 . . . . 2.2400000000000002 111.008 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.583 HD21 ' HA2' ' A' ' 212' ' ' GLY . 0.9 OUTLIER -90.35 155.27 19.08 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.373 0.606 . . . . 0.80000000000000004 111.222 -173.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 193' ' ' LYS . 17.1 m -129.67 73.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.198 -0.91 . . . . 0.88 112.787 -177.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.374 -0.83 . . . . 1.3 111.151 167.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 121.516 0.674 . . . . 5.6100000000000003 111.07 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.3 m -90.35 25.15 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.669 -0.696 . . . . 2.7599999999999998 110.184 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.618 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 13.7 m-20 71.78 137.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.83 -1.077 . . . . 1.8300000000000001 111.696 175.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 26.7 mt -76.8 -51.55 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 114.984 -1.007 . . . . 0.5 109.829 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.1 t -118.89 -73.21 0.65 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.459 -0.791 . . . . 1.55 110.732 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.584 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -123.86 0.3 8.59 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.131 -1.433 . . . . 0.22 107.131 173.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.598 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.8 -178.38 2.94 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 112.881 -1.963 . . . . 0.14000000000000001 108.984 -171.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.713 HG22 ' H ' ' A' ' 188' ' ' VAL . 5.7 m -123.35 171.18 9.62 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.868 0.842 . . . . 0.20000000000000001 112.331 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.783 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 50.4 t -81.51 134.52 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.244 -1.343 . . . . 0.10000000000000001 109.081 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.97 16.87 80.33 Favored Glycine 0 C--N 1.303 -1.254 0 CA-C-N 114.245 -1.343 . . . . 0.14000000000000001 110.428 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 187' ' ' THR . 2.1 tt0 -71.28 -53.32 14.68 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.816 -0.809 . . . . 0.90000000000000002 108.816 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.53 128.49 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.419 -1.718 . . . . 0.22 111.815 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.624 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -151.45 -149.08 0.29 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 113.808 -1.542 . . . . 0.34999999999999998 109.255 -174.285 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.482 ' HG2' ' HB1' ' A' ' 200' ' ' ALA . 14.3 mptt -121.41 154.12 36.94 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.591 -0.892 . . . . 3.77 108.591 173.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 1.4 p -100.47 -33.69 3.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 122.431 1.11 . . . . 1.6599999999999999 110.463 -173.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 23.1 ttmt 55.59 87.93 0.05 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 112.214 -2.267 . . . . 3.46 110.493 -174.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.97 104.45 14.66 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 112.388 -2.187 . . . . 1.3200000000000001 109.79 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.16 50.07 11.23 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.696 -0.764 . . . . 2.1200000000000001 111.571 -175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 72.28 -38.1 0.41 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.471 0.708 . . . . 3.46 112.375 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -79.26 135.35 36.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.111 0.482 . . . . 2.0299999999999998 110.744 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -78.58 155.07 29.84 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.187 -0.671 . . . . 0.96999999999999997 109.187 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.577 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 45.5 tpp -136.04 -82.19 0.39 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.463 -0.94 . . . . 1.6499999999999999 108.463 -172.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 10.3 t70 159.6 153.99 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 105.954 -1.869 . . . . 1.8600000000000001 105.954 171.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.786 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -165.54 149.25 8.17 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 118.624 0.647 . . . . 0.14999999999999999 111.396 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 16.9 m -118.22 129.46 55.5 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-O 121.181 0.515 . . . . 0.13 111.771 -174.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.783 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 95.2 t -66.21 122.45 17.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 113.192 0.812 . . . . 0.070000000000000007 113.192 -170.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.485 HD21 ' NE2' ' A' ' 216' ' ' GLN . 0.0 OUTLIER -103.69 -36.0 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.207 -0.906 . . . . 0.59999999999999998 110.0 175.059 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.666 ' O ' HG12 ' A' ' 213' ' ' VAL . 27.1 tt0 -155.14 158.24 38.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.405 -2.072 . . . . 2.2000000000000002 105.405 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.612 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.96 158.37 23.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 111.937 0.347 . . . . 0.14999999999999999 111.937 -175.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 32.6 p -114.62 -164.08 0.91 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.437 -0.505 . . . . 0.17999999999999999 112.124 -174.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -48.09 -29.67 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.325 -0.852 . . . . 3.8199999999999998 112.572 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.647 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 9.2 t0 -168.35 -22.54 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.159 -1.052 . . . . 1.6699999999999999 108.159 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.642 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.39 -149.43 25.15 Favored Glycine 0 CA--C 1.475 -2.462 0 N-CA-C 107.873 -2.091 . . . . 0.10000000000000001 107.873 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -145.92 -176.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 C-N-CA 119.893 -0.723 . . . . 0.089999999999999997 111.065 -177.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.45 ' H ' HG12 ' A' ' 213' ' ' VAL . 65.9 ttt180 -131.33 94.73 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.997 -1.483 . . . . 3.3900000000000001 106.997 161.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.786 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 28.5 m -95.02 -179.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 114.15 -1.386 . . . . 0.12 110.932 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.485 ' NE2' HD21 ' A' ' 206' ' ' LEU . 6.9 tp-100 -103.09 101.74 11.72 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.553 -1.277 . . . . 1.6899999999999999 107.553 172.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.776 HD22 ' HB3' ' A' ' 221' ' ' MET . 9.9 mp -64.18 139.12 58.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.099 0.952 . . . . 0.32000000000000001 111.604 -174.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.64 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 19.2 t-20 -72.6 -21.1 61.18 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.352 -1.749 . . . . 1.28 107.549 172.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.408 ' OG ' ' HG2' ' A' ' 201' ' ' MET . 6.5 m -58.99 -20.19 50.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.351 -1.749 . . . . 1.1100000000000001 109.172 165.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 99.19 25.68 9.34 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.868 -1.06 . . . . 0.68000000000000005 112.415 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.776 ' HB3' HD22 ' A' ' 217' ' ' LEU . 19.1 ttp -126.34 -159.22 0.9 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.13 -0.693 . . . . 1.5600000000000001 109.13 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.72 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 14.5 m -162.31 129.25 3.72 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.609 -1.256 . . . . 0.90000000000000002 107.609 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 222' ' ' SER . 62.4 tp 164.4 -43.61 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.893 1.071 . . . . 0.38 113.893 -164.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.727 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.285 0.2 OUTLIER 33.29 -90.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.387 1.075 . . . . 0.23000000000000001 113.058 -155.925 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.964 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.3 p 158.52 -156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 118.888 0.767 . . . . 0.80000000000000004 109.995 -166.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.964 ' H ' HG22 ' A' ' 225' ' ' VAL . 30.6 ttt180 -102.6 163.24 12.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.194 -1.039 . . . . 3.5299999999999998 108.194 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -67.73 -16.82 64.32 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.174 0.805 . . . . 0.29999999999999999 113.174 -168.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 228' ' ' GLU . 31.5 tt0 -99.64 16.55 23.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.689 1.233 . . . . 2.5699999999999998 110.002 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.423 ' HB3' HG11 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -126.49 -28.03 3.09 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.838 -1.528 . . . . 2.2400000000000002 111.166 178.105 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.642 HD21 ' HA2' ' A' ' 212' ' ' GLY . 0.8 OUTLIER -90.78 166.77 12.93 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 121.35 0.595 . . . . 0.80000000000000004 111.244 -172.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 193' ' ' LYS . 16.8 m -135.92 76.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.14 -0.936 . . . . 0.88 112.654 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.624 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.448 -0.787 . . . . 1.3 110.038 165.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.125 0.488 . . . . 5.6100000000000003 110.218 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.8 t -106.8 16.04 24.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.605 0.717 . . . . 2.7599999999999998 109.512 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.577 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 9.3 m-20 -125.71 -168.42 1.84 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.381 -0.827 . . . . 1.8300000000000001 109.367 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.2 mt -92.06 -72.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.267 0.556 . . . . 0.5 110.432 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.461 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 96.5 p -90.79 -82.67 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.134 0.968 . . . . 1.55 110.38 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.461 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -122.12 -2.81 9.09 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.149 -2.167 . . . . 0.22 105.149 171.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.677 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -158.09 -177.23 6.4 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 113.484 -1.689 . . . . 0.14000000000000001 110.613 -175.036 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.7 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.7 m -125.65 171.13 10.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.785 0.802 . . . . 0.20000000000000001 112.675 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.787 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 48.9 t -82.65 134.22 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.354 -1.294 . . . . 0.10000000000000001 109.563 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.9 79.32 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.05 -1.432 . . . . 0.14000000000000001 110.406 -170.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 187' ' ' THR . 3.0 tt0 -73.03 -52.33 14.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.335 -0.617 . . . . 0.90000000000000002 109.335 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 77.09 129.64 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.058 -1.428 . . . . 0.22 111.703 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -153.56 -149.71 0.3 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.844 -1.525 . . . . 0.34999999999999998 109.338 -173.171 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.597 ' HB3' HG23 ' A' ' 231' ' ' VAL . 12.2 tttt -137.29 144.21 42.55 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.081 -0.509 . . . . 3.77 110.492 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 12.9 p -123.13 155.33 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.717 -0.674 . . . . 1.6599999999999999 109.428 176.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.838 ' HA ' ' H ' ' A' ' 200' ' ' ALA . 0.0 OUTLIER -80.39 96.57 6.74 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.749 0.785 . . . . 3.46 110.79 -178.394 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.06 152.31 29.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.952 -1.476 . . . . 1.3200000000000001 110.344 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.52 -105.43 1.86 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.038 -0.601 . . . . 2.1200000000000001 112.627 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -93.68 28.16 2.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.126 0.965 . . . . 3.46 109.179 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 59.96 132.17 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 114.53 -1.214 . . . . 2.0299999999999998 112.395 -171.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.838 ' H ' ' HA ' ' A' ' 195' ' ' LYS . . . 46.69 111.74 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.108 -1.86 . . . . 0.96999999999999997 111.804 -164.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.542 ' HG3' ' HB3' ' A' ' 218' ' ' ASN . 38.6 tpp -107.08 -73.24 0.69 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.857 -1.52 . . . . 1.6499999999999999 109.896 -166.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 19.0 t70 147.84 145.16 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 112.819 -1.991 . . . . 1.8600000000000001 105.936 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.814 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -164.31 151.76 11.97 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 120.224 -0.59 . . . . 0.14999999999999999 112.154 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 15.6 m -120.9 128.9 53.21 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 120.822 0.344 . . . . 0.13 111.423 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.787 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 95.7 t -64.76 122.53 15.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.46 0.911 . . . . 0.070000000000000007 113.46 -171.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -103.21 -40.05 6.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.15 -0.932 . . . . 0.59999999999999998 109.697 174.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.708 ' O ' HG12 ' A' ' 213' ' ' VAL . 23.6 mt-10 -149.37 157.06 43.0 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 104.833 -2.284 . . . . 2.2000000000000002 104.833 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.663 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -121.23 160.86 21.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 112.4 0.519 . . . . 0.14999999999999999 112.4 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.409 ' N ' HG22 ' A' ' 208' ' ' ILE . 30.0 p -110.98 -160.13 0.7 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.947 -0.57 . . . . 0.17999999999999999 109.943 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 210' ' ' LYS . 59.7 mmtt -64.32 -27.51 69.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.134 0.42 . . . . 3.8199999999999998 112.134 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.714 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 9.7 t0 -153.89 -31.43 0.12 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.767 -1.198 . . . . 1.6699999999999999 107.767 -174.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.521 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -98.11 -148.81 24.21 Favored Glycine 0 CA--C 1.476 -2.383 0 N-CA-C 108.302 -1.919 . . . . 0.10000000000000001 108.302 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -148.47 -177.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 CA-C-O 121.74 0.781 . . . . 0.089999999999999997 111.837 -176.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 214' ' ' ARG . 25.4 ttt85 -127.63 94.86 4.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.841 -1.541 . . . . 3.3900000000000001 106.841 156.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.814 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 25.8 m -88.64 -177.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 114.319 -1.31 . . . . 0.12 110.526 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 1.3 tm0? -105.11 113.21 26.67 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.868 -1.16 . . . . 1.6899999999999999 107.868 169.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.818 HD22 ' HB3' ' A' ' 221' ' ' MET . 11.2 mp -73.41 147.07 44.6 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.891 -0.724 . . . . 0.32000000000000001 110.725 -174.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 0.2 OUTLIER -64.28 -30.91 71.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.978 -1.01 . . . . 1.28 108.4 175.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.9 m -63.67 -17.42 62.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.693 -1.14 . . . . 1.1100000000000001 109.702 169.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 86.5 29.35 24.66 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 114.983 -1.008 . . . . 0.68000000000000005 112.178 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.818 ' HB3' HD22 ' A' ' 217' ' ' LEU . 33.6 ttm -92.64 -58.89 2.21 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.549 -0.461 . . . . 1.5600000000000001 111.675 -174.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 40.2 m 76.94 123.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.212 -0.904 . . . . 0.90000000000000002 110.707 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 222' ' ' SER . 46.1 tp 159.31 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.07 -0.968 . . . . 0.38 113.452 -163.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.771 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.314 0.1 OUTLIER 31.75 -96.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.61 1.164 . . . . 0.23000000000000001 113.396 -156.733 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.954 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.9 p 158.63 -157.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 119.323 0.965 . . . . 0.80000000000000004 109.842 -165.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.954 ' H ' HG22 ' A' ' 225' ' ' VAL . 1.1 ptp180 -98.77 161.82 13.44 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.28 -0.873 . . . . 3.5299999999999998 108.884 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -73.0 -15.05 61.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.626 0.602 . . . . 0.29999999999999999 112.626 -167.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 226' ' ' ARG . 31.1 tt0 -105.08 31.6 4.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.532 1.158 . . . . 2.5699999999999998 108.773 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.51 ' CG ' HG21 ' A' ' 225' ' ' VAL . 35.3 t-80 -144.99 -25.77 0.49 Allowed 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 113.797 -1.547 . . . . 2.2400000000000002 109.137 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 226' ' ' ARG . 1.3 pp -88.82 164.25 15.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 120.72 0.295 . . . . 0.80000000000000004 110.316 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 193' ' ' LYS . 19.6 m -127.34 63.71 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 122.192 0.996 . . . . 0.88 112.105 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.697 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 114.523 -1.217 . . . . 1.3 110.828 170.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 121.495 0.664 . . . . 5.6100000000000003 110.752 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 12.2 p -141.39 17.2 2.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.267 -0.879 . . . . 2.7599999999999998 109.636 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.574 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 44.1 m-20 74.15 159.62 0.22 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.469 -1.241 . . . . 1.8300000000000001 111.132 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.4 mt -73.98 -72.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 115.952 -0.567 . . . . 0.5 110.438 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 53.9 p -95.38 -76.27 0.5 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.003 0.906 . . . . 1.55 110.504 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.487 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -126.14 -2.6 7.0 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 104.843 -2.28 . . . . 0.22 104.843 172.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.635 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -162.63 -177.32 5.51 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.31 -1.768 . . . . 0.14000000000000001 109.863 -174.247 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.697 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.5 m -124.76 170.99 10.48 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.951 0.881 . . . . 0.20000000000000001 112.552 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.783 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 47.6 t -81.49 134.06 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 114.176 -1.375 . . . . 0.10000000000000001 108.916 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.39 17.76 79.79 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.177 -1.374 . . . . 0.14000000000000001 110.614 -170.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -73.39 -48.97 29.72 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.914 -0.773 . . . . 0.90000000000000002 108.914 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.58 128.74 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.119 -1.4 . . . . 0.22 111.091 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.692 HD11 HG11 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -151.55 -149.23 0.29 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.121 -1.4 . . . . 0.34999999999999998 109.587 -174.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.588 ' HB3' HG23 ' A' ' 231' ' ' VAL . 0.0 OUTLIER -128.06 150.56 49.89 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.25 0.548 . . . . 3.77 110.164 179.386 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 6.3 p -127.08 148.82 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 115.046 -0.979 . . . . 1.6599999999999999 109.307 174.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.611 ' HD3' ' N ' ' A' ' 200' ' ' ALA . 0.2 OUTLIER -89.48 88.11 7.33 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.809 -0.811 . . . . 3.46 108.809 178.682 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -110.8 99.62 8.52 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.895 -1.048 . . . . 1.3200000000000001 110.097 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 82.71 48.25 5.6 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.796 -0.922 . . . . 2.1200000000000001 110.796 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 74.76 -20.25 0.34 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.364 0.666 . . . . 3.46 112.438 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -114.64 138.79 50.25 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.255 0.465 . . . . 2.0299999999999998 112.255 -174.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -70.16 123.93 22.85 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.095 -1.076 . . . . 0.96999999999999997 108.095 173.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.6 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 43.8 tpp -101.88 -76.0 0.58 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.528 -1.214 . . . . 1.6499999999999999 109.579 -166.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 201' ' ' MET . 9.5 t70 155.84 147.38 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.245 -1.798 . . . . 1.8600000000000001 106.312 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.745 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -164.57 151.47 11.2 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 120.245 -0.582 . . . . 0.14999999999999999 111.512 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 19.8 m -119.72 127.35 52.77 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.523 -0.471 . . . . 0.13 112.148 -174.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.783 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 81.1 t -64.27 123.22 16.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 113.208 0.818 . . . . 0.070000000000000007 113.208 -170.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -35.17 7.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.782 -0.644 . . . . 0.59999999999999998 109.493 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.631 ' O ' HG12 ' A' ' 213' ' ' VAL . 26.2 tt0 -153.3 154.23 34.18 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 105.261 -2.126 . . . . 2.2000000000000002 105.261 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.606 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.33 160.0 21.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 112.148 0.425 . . . . 0.14999999999999999 112.148 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 208' ' ' ILE . 31.0 p -112.65 -162.95 0.82 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.001 -0.545 . . . . 0.17999999999999999 110.917 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -48.72 -35.28 13.73 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.652 0.595 . . . . 3.8199999999999998 112.189 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.539 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 0.9 OUTLIER -168.22 -13.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.692 0.758 . . . . 1.6699999999999999 109.541 -175.667 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.708 ' HA2' HD11 ' A' ' 230' ' ' LEU . . . -96.63 -152.38 28.83 Favored Glycine 0 CA--C 1.48 -2.152 0 N-CA-C 107.437 -2.265 . . . . 0.10000000000000001 107.437 171.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.691 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -147.11 -176.77 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 C-N-CA 120.037 -0.665 . . . . 0.089999999999999997 111.334 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.455 ' H ' HG12 ' A' ' 213' ' ' VAL . 25.4 ttt180 -131.16 91.63 3.07 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.326 -1.361 . . . . 3.3900000000000001 107.326 159.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.745 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 20.6 m -91.31 179.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 113.712 -1.585 . . . . 0.12 110.515 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 7.0 tm0? -104.31 107.55 18.52 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.751 -0.833 . . . . 1.6899999999999999 108.751 173.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 221' ' ' MET . 8.4 mp -70.42 134.52 47.9 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.861 0.839 . . . . 0.32000000000000001 111.165 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.502 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 41.9 t30 -71.45 -20.48 62.09 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.574 -1.648 . . . . 1.28 108.823 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.585 ' OG ' ' HG2' ' A' ' 201' ' ' MET . 67.1 m -62.37 -24.04 67.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.551 -1.204 . . . . 1.1100000000000001 109.442 166.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 112.31 21.88 6.05 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.741 -1.118 . . . . 0.68000000000000005 113.358 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' MET . . . . . 0.651 ' HB3' HD22 ' A' ' 217' ' ' LEU . 25.0 ttp -116.25 -162.95 0.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.029 -0.73 . . . . 1.5600000000000001 109.029 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 40.6 m -161.16 127.21 3.84 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.662 -1.236 . . . . 0.90000000000000002 107.662 175.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 222' ' ' SER . 49.4 tp 165.64 -40.16 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.424 1.268 . . . . 0.38 114.424 -164.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 1.017 HD13 HD22 ' A' ' 230' ' ' LEU 0.283 0.2 OUTLIER 34.48 -89.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.225 1.01 . . . . 0.23000000000000001 112.511 -156.295 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.972 HG22 ' H ' ' A' ' 226' ' ' ARG . 11.5 p 157.85 -155.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.976 -0.749 . . . . 0.80000000000000004 108.976 -169.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.972 ' H ' HG22 ' A' ' 225' ' ' VAL . 13.4 ttm180 -103.3 160.04 15.03 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.026 -0.731 . . . . 3.5299999999999998 109.026 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -50.43 -31.7 15.75 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.122 0.786 . . . . 0.29999999999999999 113.122 -171.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -93.09 29.47 1.85 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.528 1.156 . . . . 2.5699999999999998 109.183 -169.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.506 ' CG ' HG21 ' A' ' 225' ' ' VAL . 63.8 t-80 -146.73 -18.86 0.42 Allowed 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 113.818 -1.537 . . . . 2.2400000000000002 110.398 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.017 HD22 HD13 ' A' ' 224' ' ' ILE . 0.7 OUTLIER -62.58 151.55 37.51 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.59 -0.522 . . . . 0.80000000000000004 109.59 174.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 193' ' ' LYS . 24.7 m -128.03 49.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.577 1.18 . . . . 0.88 110.7 172.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.652 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 113.365 -1.743 . . . . 1.3 111.197 173.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.608 0.242 . . . . 5.6100000000000003 110.538 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.3 t 64.27 19.29 11.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.836 -0.62 . . . . 2.7599999999999998 109.487 -176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.684 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 36.7 m-20 69.25 147.71 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.644 -1.162 . . . . 1.8300000000000001 110.921 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 31.5 mt -67.23 -66.45 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.03 0.443 . . . . 0.5 110.237 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 44.8 m -108.17 -72.35 0.73 Allowed 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.891 -0.595 . . . . 1.55 111.436 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.607 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -124.41 0.47 8.29 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.898 -1.519 . . . . 0.22 106.898 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 185' ' ' ALA . 0.5 OUTLIER -171.21 -179.18 2.6 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 112.81 -1.995 . . . . 0.14000000000000001 108.985 -172.227 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.8 m -122.33 171.71 8.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.861 0.839 . . . . 0.20000000000000001 112.09 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.766 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 58.2 t -81.08 133.74 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 114.247 -1.342 . . . . 0.10000000000000001 108.805 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.17 19.26 79.84 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.322 -1.308 . . . . 0.14000000000000001 110.527 -170.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.6 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -74.29 -51.52 15.0 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.47 -0.567 . . . . 0.90000000000000002 109.47 178.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.3 126.11 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 113.991 -1.459 . . . . 0.22 111.718 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 192' ' ' LEU . 0.1 OUTLIER -159.33 -149.02 0.19 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.512 -1.222 . . . . 0.34999999999999998 111.178 -173.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.658 ' HG3' ' HB1' ' A' ' 200' ' ' ALA . 6.7 ttpt -114.69 146.15 41.23 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.651 0.739 . . . . 3.77 111.019 -173.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.542 HG21 HD21 ' A' ' 217' ' ' LEU . 1.5 p -113.94 -34.13 2.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.129 -1.396 . . . . 1.6599999999999999 109.64 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 19.1 ttmt 60.37 99.21 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 111.692 -2.504 . . . . 3.46 110.68 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.66 88.91 2.84 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.749 -1.569 . . . . 1.3200000000000001 110.755 -173.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.32 54.85 1.53 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.866 -0.683 . . . . 2.1200000000000001 111.903 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 73.76 -27.88 0.19 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.395 0.678 . . . . 3.46 112.703 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -106.09 153.63 21.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.819 -0.437 . . . . 2.0299999999999998 109.819 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.658 ' HB1' ' HG3' ' A' ' 193' ' ' LYS . . . -69.89 170.75 10.54 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.723 0.773 . . . . 0.96999999999999997 109.168 174.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.635 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 30.7 tpp -146.91 -57.79 0.27 Allowed 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.679 -1.146 . . . . 1.6499999999999999 110.634 -165.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.635 ' HB2' ' O ' ' A' ' 201' ' ' MET . 3.2 m-20 108.39 136.22 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 111.51 -2.586 . . . . 1.8600000000000001 107.939 178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.702 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -151.41 148.61 28.31 Favored 'General case' 0 N--CA 1.422 -1.828 0 C-N-CA 120.673 -0.411 . . . . 0.14999999999999999 110.459 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 22.7 m -114.45 127.79 56.01 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.132 0.491 . . . . 0.13 111.525 -170.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.766 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 87.2 t -65.32 121.76 14.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 112.8 0.667 . . . . 0.070000000000000007 112.8 -170.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -104.06 -35.96 7.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.867 0.841 . . . . 0.59999999999999998 109.643 175.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.706 ' O ' HG12 ' A' ' 213' ' ' VAL . 37.3 mt-10 -151.1 158.84 44.55 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 105.601 -2.0 . . . . 2.2000000000000002 105.601 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.59 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -123.35 155.43 29.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 O-C-N 123.558 0.536 . . . . 0.14999999999999999 111.767 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.7 p -108.14 -160.78 0.74 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.627 -0.715 . . . . 0.17999999999999999 110.536 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -51.04 -37.8 47.6 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.298 0.571 . . . . 3.8199999999999998 110.899 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.586 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 3.5 t0 -161.17 -19.75 0.05 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.991 -1.004 . . . . 1.6699999999999999 109.315 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.603 ' HA2' HD11 ' A' ' 230' ' ' LEU . . . -94.36 -153.1 30.0 Favored Glycine 0 CA--C 1.478 -2.227 0 N-CA-C 107.936 -2.066 . . . . 0.10000000000000001 107.936 173.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -145.65 -178.83 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.487 0 C-N-CA 119.905 -0.718 . . . . 0.089999999999999997 111.149 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.426 ' H ' HG12 ' A' ' 213' ' ' VAL . 85.3 mtt180 -130.18 86.57 2.41 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 106.873 -1.528 . . . . 3.3900000000000001 106.873 163.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.714 HG22 ' HB ' ' A' ' 224' ' ' ILE . 25.5 m -87.51 178.65 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 114.838 -1.074 . . . . 0.12 111.859 -174.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 0.7 OUTLIER -105.2 112.12 25.13 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.216 -0.902 . . . . 1.6899999999999999 108.969 173.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 221' ' ' MET . 8.4 mp -71.34 138.75 49.5 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.688 0.756 . . . . 0.32000000000000001 111.752 -174.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -71.2 -16.78 62.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.608 -1.633 . . . . 1.28 109.249 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 71.8 m -67.97 -24.96 65.21 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.897 -1.047 . . . . 1.1100000000000001 109.562 166.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 110.16 25.25 5.39 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.258 -0.883 . . . . 0.68000000000000005 112.308 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.611 ' HB3' HD22 ' A' ' 217' ' ' LEU . 27.7 ttp -115.12 -163.12 0.86 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.315 -0.995 . . . . 1.5600000000000001 108.315 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 17.9 m -160.84 126.43 3.84 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.407 -0.96 . . . . 0.90000000000000002 108.407 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 214' ' ' ARG . 37.9 tp 176.2 -44.99 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.826 1.417 . . . . 0.38 114.826 -168.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.973 HD13 HD22 ' A' ' 230' ' ' LEU 0.329 0.1 OUTLIER 34.28 -97.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.188 0.995 . . . . 0.23000000000000001 113.446 -154.547 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.032 HG22 ' H ' ' A' ' 226' ' ' ARG . 14.9 p 160.42 -158.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 118.994 0.815 . . . . 0.80000000000000004 109.581 -160.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 1.032 ' H ' HG22 ' A' ' 225' ' ' VAL . 20.2 ttm180 -105.89 161.24 14.62 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.333 -0.988 . . . . 3.5299999999999998 108.333 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.586 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -55.51 -20.86 14.3 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 113.695 0.998 . . . . 0.29999999999999999 113.695 -166.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -92.24 19.1 7.33 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 122.385 1.088 . . . . 2.5699999999999998 110.181 -173.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.648 ' HB3' HG11 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -136.5 -19.24 1.42 Allowed 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 113.741 -1.572 . . . . 2.2400000000000002 111.082 -178.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.973 HD22 HD13 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -82.0 141.07 33.57 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 120.817 0.342 . . . . 0.80000000000000004 110.218 175.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' CG2' ' HD3' ' A' ' 193' ' ' LYS . 20.6 m -123.52 69.01 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 122.005 0.907 . . . . 0.88 111.221 170.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.552 ' CE2' HD12 ' A' ' 230' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.439 -0.997 0 CA-C-N 114.859 -1.064 . . . . 1.3 111.177 172.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.326 0.584 . . . . 5.6100000000000003 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 9.0 p -99.8 14.88 28.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.703 -0.681 . . . . 2.7599999999999998 109.23 174.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.571 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 27.0 m-20 72.58 142.83 0.06 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.292 -1.322 . . . . 1.8300000000000001 111.146 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.622 ' HB ' HD12 ' A' ' 208' ' ' ILE . 4.0 mm -73.62 -50.86 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 108.768 -0.827 . . . . 0.5 108.768 172.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 29.5 t -125.44 -78.23 0.59 Allowed 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.816 -1.084 . . . . 1.55 110.737 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.566 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -116.93 0.37 12.43 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.006 -1.479 . . . . 0.22 107.006 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.603 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.24 -179.25 3.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 112.664 -2.062 . . . . 0.14000000000000001 108.563 -171.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.723 HG22 ' H ' ' A' ' 188' ' ' VAL . 5.3 m -122.62 170.99 9.46 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.909 0.861 . . . . 0.20000000000000001 112.806 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.783 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.4 t -84.54 131.52 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.173 -1.376 . . . . 0.10000000000000001 109.162 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.83 18.23 79.06 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 113.975 -1.466 . . . . 0.14000000000000001 110.471 -169.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -73.46 -53.15 11.33 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.092 -0.707 . . . . 0.90000000000000002 109.092 178.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.47 128.71 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.487 -1.688 . . . . 0.22 111.698 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.616 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -150.42 -151.03 0.37 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 113.842 -1.526 . . . . 0.34999999999999998 108.839 -174.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.419 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 15.5 mttt -136.71 146.54 45.98 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.678 -0.692 . . . . 3.77 109.928 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 9.1 p -127.33 148.14 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 115.901 -0.59 . . . . 1.6599999999999999 110.278 176.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 199' ' ' ASN . 3.6 ttmt -95.68 91.58 6.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.724 -0.843 . . . . 3.46 108.724 -175.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.486 ' HB3' ' HE3' ' A' ' 201' ' ' MET . . . -116.51 89.32 3.08 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.47 -0.786 . . . . 1.3200000000000001 110.57 -176.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 198' ' ' GLN . . . 104.05 44.54 1.61 Allowed Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.291 -0.868 . . . . 2.1200000000000001 111.301 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.434 ' HB3' ' O ' ' A' ' 197' ' ' GLY . 10.2 tt0 77.89 -23.92 0.23 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.622 0.769 . . . . 3.46 112.287 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 16.6 m120 -115.64 143.63 45.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.907 0.385 . . . . 2.0299999999999998 111.888 -173.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -74.13 131.8 41.64 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.645 -0.872 . . . . 0.96999999999999997 108.645 173.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 217' ' ' LEU . 54.4 ttm -91.67 -85.16 0.25 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.198 -1.364 . . . . 1.6499999999999999 110.964 -166.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 146.75 110.21 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 125.891 1.676 . . . . 1.8600000000000001 106.915 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.818 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -143.69 147.99 35.08 Favored 'General case' 0 N--CA 1.423 -1.793 0 C-N-CA 119.975 -0.69 . . . . 0.14999999999999999 111.988 -169.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 21.9 m -116.49 128.37 55.4 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-O 120.974 0.416 . . . . 0.13 112.052 -172.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.783 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 94.3 t -64.89 120.92 12.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 113.252 0.834 . . . . 0.070000000000000007 113.252 -171.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -101.72 -36.33 8.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.456 -0.793 . . . . 0.59999999999999998 109.999 175.219 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.649 ' O ' HG12 ' A' ' 213' ' ' VAL . 28.8 tt0 -157.47 157.68 34.33 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 105.316 -2.105 . . . . 2.2000000000000002 105.316 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.622 HD12 ' HB ' ' A' ' 183' ' ' ILE . 1.4 mt -119.01 158.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 112.104 0.409 . . . . 0.14999999999999999 112.104 -173.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 61.8 p -111.86 -160.78 0.73 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.159 -0.473 . . . . 0.17999999999999999 111.387 -174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -53.68 -30.46 43.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.733 -0.667 . . . . 3.8199999999999998 111.985 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.677 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 8.9 t0 -163.57 -25.84 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.022 -1.103 . . . . 1.6699999999999999 108.022 -177.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.586 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.53 -148.56 23.83 Favored Glycine 0 CA--C 1.475 -2.443 0 N-CA-C 107.836 -2.106 . . . . 0.10000000000000001 107.836 177.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -146.29 -177.06 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.599 0 C-N-CA 119.886 -0.726 . . . . 0.089999999999999997 111.011 -178.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.412 ' H ' HG12 ' A' ' 213' ' ' VAL . 58.4 ttt180 -130.14 90.83 3.01 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.066 -1.457 . . . . 3.3900000000000001 107.066 158.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.818 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 22.1 m -87.35 -176.95 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 CA-C-N 113.966 -1.47 . . . . 0.12 109.969 -176.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -105.24 112.41 25.51 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 108.024 -1.102 . . . . 1.6899999999999999 108.024 169.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.742 ' HB2' ' H ' ' A' ' 221' ' ' MET . 10.2 mp -70.96 155.5 40.74 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.632 -0.827 . . . . 0.32000000000000001 110.889 -174.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.48 ' HB3' ' HG2' ' A' ' 201' ' ' MET . 15.6 t-20 -60.46 -36.46 78.3 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.724 -0.671 . . . . 1.28 109.418 173.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 66.4 m -70.62 -7.98 48.28 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.477 -0.783 . . . . 1.1100000000000001 110.253 170.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 74.51 37.1 47.52 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 114.968 -1.015 . . . . 0.68000000000000005 112.902 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.742 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 4.4 mtp -84.55 -50.48 7.67 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 122.018 0.914 . . . . 1.5600000000000001 109.732 -176.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.784 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 19.4 m 70.89 117.75 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 112.82 -1.991 . . . . 0.90000000000000002 111.186 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 222' ' ' SER . 57.8 tp 162.77 -40.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.819 -1.082 . . . . 0.38 113.533 -161.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.764 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.288 0.2 OUTLIER 32.99 -92.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.522 1.129 . . . . 0.23000000000000001 113.249 -157.666 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.992 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.8 p 160.71 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 118.925 0.784 . . . . 0.80000000000000004 110.341 -165.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.992 ' H ' HG22 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -99.66 154.1 18.55 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.636 -1.166 . . . . 3.5299999999999998 108.293 178.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -61.56 -18.14 58.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 114.042 1.127 . . . . 0.29999999999999999 114.042 -170.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -102.76 31.47 4.13 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 122.787 1.28 . . . . 2.5699999999999998 108.936 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.443 ' HB3' HG21 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -140.59 -25.02 0.77 Allowed 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 113.747 -1.57 . . . . 2.2400000000000002 110.549 178.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.586 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.2 pp -93.29 163.84 13.45 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 116.056 -0.52 . . . . 0.80000000000000004 110.994 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.86 72.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 113.439 0.903 . . . . 0.88 113.439 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.582 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.896 0 CA-C-N 115.115 -0.948 . . . . 1.3 110.697 164.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 121.153 0.501 . . . . 5.6100000000000003 110.367 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.0 t -118.95 20.63 12.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.683 -0.69 . . . . 2.7599999999999998 109.234 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.719 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 51.2 m-20 73.1 143.7 0.07 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 114.704 -1.135 . . . . 1.8300000000000001 110.944 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.8 mt -73.48 -49.89 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.547 -0.751 . . . . 0.5 110.325 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 t -124.36 -74.44 0.61 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.527 -0.76 . . . . 1.55 111.276 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.559 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -121.88 0.55 9.76 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 106.383 -1.71 . . . . 0.22 106.383 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.593 HD11 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -170.12 179.68 3.44 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.851 -1.977 . . . . 0.14000000000000001 109.342 -171.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.725 HG22 ' H ' ' A' ' 188' ' ' VAL . 4.5 m -121.18 170.91 9.11 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.808 0.813 . . . . 0.20000000000000001 112.353 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.783 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 50.5 t -83.49 131.5 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 114.183 -1.371 . . . . 0.10000000000000001 109.017 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.04 16.83 79.29 Favored Glycine 0 C--N 1.301 -1.366 0 CA-C-N 114.159 -1.382 . . . . 0.14000000000000001 110.691 -169.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.417 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 2.1 tt0 -72.85 -50.26 25.05 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.927 -0.768 . . . . 0.90000000000000002 108.927 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 71.99 124.94 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.089 -1.414 . . . . 0.22 111.794 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.61 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -145.86 -149.99 0.31 Allowed 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 113.687 -1.597 . . . . 0.34999999999999998 108.779 -174.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.46 ' HB2' HG22 ' A' ' 231' ' ' VAL . 0.0 OUTLIER -127.13 145.96 50.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.33 0.586 . . . . 3.77 110.547 177.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 5.0 p -115.88 146.92 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.841 -1.072 . . . . 1.6599999999999999 109.357 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.551 ' HD3' ' N ' ' A' ' 200' ' ' ALA . 0.0 OUTLIER -89.75 91.58 8.7 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.38 -0.97 . . . . 3.46 108.38 177.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -115.51 96.28 5.56 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.962 -1.017 . . . . 1.3200000000000001 109.967 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 199' ' ' ASN . . . 94.84 38.71 4.83 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.034 -0.827 . . . . 2.1200000000000001 111.034 -174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 73.82 -18.3 0.4 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.649 0.78 . . . . 3.46 111.974 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 197' ' ' GLY . 39.4 m-80 -111.39 142.06 44.14 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.033 -0.531 . . . . 2.0299999999999998 111.059 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -71.5 132.79 45.22 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.241 -1.022 . . . . 0.96999999999999997 108.241 173.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.544 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 37.6 tpp -107.02 -76.99 0.6 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.726 -1.125 . . . . 1.6499999999999999 109.61 -169.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 4.2 t70 162.04 149.71 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 105.384 -2.08 . . . . 1.8600000000000001 105.384 174.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.833 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -165.21 149.68 8.87 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 118.974 0.806 . . . . 0.14999999999999999 111.774 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 21.1 m -117.96 126.93 53.28 Favored 'General case' 0 C--O 1.211 -0.922 0 C-N-CA 120.454 -0.498 . . . . 0.13 112.143 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.783 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 99.9 t -64.39 121.5 13.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 113.248 0.833 . . . . 0.070000000000000007 113.248 -169.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -104.94 -35.07 7.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.629 -0.714 . . . . 0.59999999999999998 110.059 175.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.712 ' O ' HG12 ' A' ' 213' ' ' VAL . 29.0 tt0 -153.6 156.81 38.66 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.128 -2.175 . . . . 2.2000000000000002 105.128 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.575 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.13 160.68 20.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 112.135 0.42 . . . . 0.14999999999999999 112.135 -175.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 29.5 p -115.39 -160.86 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.349 -0.387 . . . . 0.17999999999999999 111.571 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -53.44 -31.58 46.02 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.824 -0.626 . . . . 3.8199999999999998 111.727 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 2.0 t70 -164.61 -22.04 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.61 -0.885 . . . . 1.6699999999999999 108.61 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.523 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -94.39 -150.91 27.64 Favored Glycine 0 CA--C 1.475 -2.437 0 N-CA-C 107.784 -2.126 . . . . 0.10000000000000001 107.784 175.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -146.83 -177.08 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.64 0 C-N-CA 119.797 -0.761 . . . . 0.089999999999999997 111.077 -176.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 42.2 ttt-85 -129.78 92.25 3.29 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.085 -1.45 . . . . 3.3900000000000001 107.085 159.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.833 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 23.3 m -90.58 -176.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 114.325 -1.307 . . . . 0.12 110.612 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.5 OUTLIER -105.43 106.65 17.24 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.339 -0.846 . . . . 1.6899999999999999 108.718 170.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.621 ' HB2' ' H ' ' A' ' 221' ' ' MET . 8.9 mp -66.28 140.97 58.16 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.943 0.878 . . . . 0.32000000000000001 111.555 -174.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.616 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 23.6 t-20 -75.75 -18.94 59.38 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.612 -1.631 . . . . 1.28 108.378 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 37.4 m -63.98 -17.17 63.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.35 -1.295 . . . . 1.1100000000000001 108.914 164.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.05 17.16 16.9 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 114.695 -1.138 . . . . 0.68000000000000005 113.303 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.621 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 18.4 ttp -111.39 -159.25 0.67 Allowed 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.069 -0.715 . . . . 1.5600000000000001 109.069 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 20.0 m -161.77 128.98 3.94 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.586 -1.264 . . . . 0.90000000000000002 107.586 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 222' ' ' SER . 39.6 tp 162.97 -38.66 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.815 1.043 . . . . 0.38 113.815 -165.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.76 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.279 0.2 OUTLIER 34.22 -91.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.525 1.13 . . . . 0.23000000000000001 112.973 -157.258 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.947 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.3 p 160.09 -156.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 118.548 0.613 . . . . 0.80000000000000004 109.584 -164.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.947 ' H ' HG22 ' A' ' 225' ' ' VAL . 14.3 ttm180 -104.34 163.46 12.41 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.442 -0.948 . . . . 3.5299999999999998 108.442 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -66.93 -17.27 64.83 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.275 0.843 . . . . 0.29999999999999999 113.275 -170.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.57 25.11 8.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 122.575 1.179 . . . . 2.5699999999999998 109.315 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.492 ' HB3' HG21 ' A' ' 225' ' ' VAL . 0.9 OUTLIER -140.02 -22.24 0.86 Allowed 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 113.769 -1.56 . . . . 2.2400000000000002 111.238 -179.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.523 HD21 ' HA2' ' A' ' 212' ' ' GLY . 0.8 OUTLIER -92.28 171.38 9.1 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-O 121.179 0.514 . . . . 0.80000000000000004 111.414 -176.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 231' ' ' VAL . 0.2 OUTLIER -136.98 93.81 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 CA-C-O 122.455 1.121 . . . . 0.88 109.857 176.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.833 -1.076 . . . . 1.3 110.173 161.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.58 -0.155 . . . . 5.6100000000000003 110.58 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.9 t 70.4 13.95 7.47 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.803 0.689 . . . . 2.7599999999999998 110.701 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.594 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 23.2 m-20 69.43 157.47 0.15 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.195 -0.911 . . . . 1.8300000000000001 111.545 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.4 mt -77.67 -66.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.887 -0.597 . . . . 0.5 110.529 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 93.9 p -94.94 -79.48 0.43 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.414 1.102 . . . . 1.55 110.717 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.451 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -126.15 -1.73 7.05 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 105.059 -2.2 . . . . 0.22 105.059 171.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.617 HD21 HG22 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -160.22 -178.0 6.66 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 113.658 -1.61 . . . . 0.14000000000000001 110.575 -175.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.72 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.2 m -124.18 172.01 9.38 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.189 -0.914 . . . . 0.20000000000000001 112.58 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.799 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 48.6 t -84.19 132.92 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 CA-C-N 114.267 -1.333 . . . . 0.10000000000000001 109.762 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.89 14.92 82.09 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.027 -1.442 . . . . 0.14000000000000001 110.68 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.536 HE22 ' HB3' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -72.71 -51.24 20.07 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.076 0.465 . . . . 0.90000000000000002 109.752 -178.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 77.68 128.46 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.26 -1.336 . . . . 0.22 112.051 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.646 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -156.22 -150.02 0.27 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.194 -1.366 . . . . 0.34999999999999998 110.464 -173.301 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 22.5 ttpt -111.33 144.41 40.56 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.526 -0.761 . . . . 3.77 110.467 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.61 HG21 HD21 ' A' ' 217' ' ' LEU . 1.5 p -106.07 -32.74 2.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 122.615 1.198 . . . . 1.6599999999999999 109.295 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 1.2 ttpp 62.2 97.45 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 111.708 -2.496 . . . . 3.46 110.309 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -111.23 116.78 31.62 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.964 -1.471 . . . . 1.3200000000000001 110.066 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 76.29 48.54 9.34 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.729 -0.748 . . . . 2.1200000000000001 111.791 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 73.88 -31.58 0.22 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.355 0.662 . . . . 3.46 112.67 178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 12.3 m120 -99.56 168.25 10.08 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.265 -0.272 . . . . 2.0299999999999998 110.265 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -71.19 177.39 3.85 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.502 0.668 . . . . 0.96999999999999997 109.706 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.535 ' O ' ' HB3' ' A' ' 202' ' ' ASP . 38.5 tpp -154.03 -66.12 0.14 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.195 -0.911 . . . . 1.6499999999999999 109.796 -170.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.535 ' HB3' ' O ' ' A' ' 201' ' ' MET . 0.7 OUTLIER 122.79 141.37 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 126.597 2.436 . . . . 1.8600000000000001 108.071 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.787 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -160.67 148.34 15.95 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 116.106 -0.497 . . . . 0.14999999999999999 111.299 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 20.9 m -119.27 127.38 53.18 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 112.441 0.534 . . . . 0.13 112.441 -170.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.799 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 98.4 t -61.86 122.81 13.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.405 0.891 . . . . 0.070000000000000007 113.405 -170.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -105.58 -37.57 6.73 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.461 -0.791 . . . . 0.59999999999999998 109.873 174.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.674 ' O ' HG12 ' A' ' 213' ' ' VAL . 6.5 tp10 -152.09 154.21 35.46 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 105.118 -2.178 . . . . 2.2000000000000002 105.118 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.625 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -117.17 162.21 15.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 112.653 0.612 . . . . 0.14999999999999999 112.653 -174.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.426 ' N ' HG22 ' A' ' 208' ' ' ILE . 30.3 p -112.41 -161.49 0.76 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.939 -0.573 . . . . 0.17999999999999999 109.938 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 210' ' ' LYS . 12.6 mptt -63.31 -29.45 70.76 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.766 0.317 . . . . 3.8199999999999998 111.567 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.659 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 8.1 p-10 -151.01 -33.7 0.15 Allowed 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.589 -0.893 . . . . 1.6699999999999999 108.589 -172.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.564 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -98.49 -146.78 21.15 Favored Glycine 0 CA--C 1.47 -2.75 0 N-CA-C 107.981 -2.048 . . . . 0.10000000000000001 107.981 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.715 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -149.29 -175.11 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.667 0 C-N-CA 119.846 -0.742 . . . . 0.089999999999999997 111.725 -177.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.425 ' H ' HG12 ' A' ' 213' ' ' VAL . 16.1 ttt180 -130.06 94.18 3.65 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.985 -1.487 . . . . 3.3900000000000001 106.985 158.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.787 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 23.9 m -90.91 -179.17 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 114.274 -1.33 . . . . 0.12 110.748 -176.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 0.7 OUTLIER -104.09 110.8 23.12 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.538 -0.912 . . . . 1.6899999999999999 108.538 172.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.643 HD22 ' HB3' ' A' ' 221' ' ' MET . 8.8 mp -68.7 143.67 54.66 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.597 0.713 . . . . 0.32000000000000001 111.571 -175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.512 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 11.0 t-20 -65.3 -30.78 71.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.116 -1.402 . . . . 1.28 108.569 176.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.8 m -57.59 -22.53 45.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.265 -1.334 . . . . 1.1100000000000001 109.651 169.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.81 19.97 10.44 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.935 -1.03 . . . . 0.68000000000000005 112.426 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.643 ' HB3' HD22 ' A' ' 217' ' ' LEU . 19.7 ttp -108.63 -161.2 0.75 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.283 -1.006 . . . . 1.5600000000000001 108.283 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.702 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 13.6 m -163.11 128.55 3.16 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.692 -0.855 . . . . 0.90000000000000002 108.692 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 222' ' ' SER . 61.4 tp 167.36 -42.18 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.224 1.194 . . . . 0.38 114.224 -166.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.75 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.274 0.1 OUTLIER 35.25 -93.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.487 1.115 . . . . 0.23000000000000001 113.938 -158.869 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.994 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.7 p 160.91 -158.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 118.636 0.653 . . . . 0.80000000000000004 110.494 -162.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.994 ' H ' HG22 ' A' ' 225' ' ' VAL . 7.0 ptp180 -105.27 165.17 11.3 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.96 -1.018 . . . . 3.5299999999999998 109.484 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -69.23 -17.76 63.81 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.307 -0.86 . . . . 0.29999999999999999 112.806 -166.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.459 ' H ' ' HG3' ' A' ' 226' ' ' ARG . 36.4 tt0 -101.2 25.65 7.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.749 1.262 . . . . 2.5699999999999998 109.201 -178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.419 ' HB3' HG21 ' A' ' 225' ' ' VAL . 1.2 m-70 -135.76 -25.25 1.28 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.721 -1.581 . . . . 2.2400000000000002 110.809 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.564 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.0 OUTLIER -93.91 160.58 14.67 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.048 0.452 . . . . 0.80000000000000004 111.084 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 231' ' ' VAL . 30.3 m -131.62 82.5 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.939 0.876 . . . . 0.88 111.814 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.536 ' HB3' HE22 ' A' ' 190' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.557 -0.747 . . . . 1.3 111.561 172.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 121.648 0.737 . . . . 5.6100000000000003 110.293 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.0 p -130.19 26.55 5.15 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.129 -0.941 . . . . 2.7599999999999998 109.666 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -47.5 126.82 10.39 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.342 1.068 . . . . 1.8300000000000001 112.501 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 22.5 mt -78.29 -51.55 17.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 113.23 -1.805 . . . . 0.5 109.042 172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' A' ' 211' ' ' ASP . 47.3 t -112.75 -80.97 0.59 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.816 -1.084 . . . . 1.55 110.187 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.542 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -116.85 -0.34 12.29 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.915 -1.513 . . . . 0.22 106.915 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.573 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -168.02 -178.59 3.79 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 113.29 -1.777 . . . . 0.14000000000000001 109.797 -170.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 188' ' ' VAL . 2.2 m -119.37 170.4 9.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.798 0.809 . . . . 0.20000000000000001 112.836 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.79 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 43.4 t -86.18 132.61 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 114.124 -1.398 . . . . 0.10000000000000001 108.67 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.98 19.64 79.76 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.466 -1.243 . . . . 0.14000000000000001 110.248 -169.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.436 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 2.1 tt0 -74.44 -47.03 36.13 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.739 -0.837 . . . . 0.90000000000000002 108.739 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 69.94 125.86 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.16 -1.382 . . . . 0.22 111.574 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -146.8 -149.51 0.29 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 113.885 -1.507 . . . . 0.34999999999999998 108.904 -175.126 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 202' ' ' ASP . 13.5 mttt -127.92 140.8 51.79 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 115.934 -0.575 . . . . 3.77 110.307 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.714 HG11 ' HG ' ' A' ' 217' ' ' LEU . 6.3 p -110.16 141.53 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-O 121.607 0.717 . . . . 1.6599999999999999 109.493 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.529 ' H ' ' HG3' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -76.98 50.99 0.76 Allowed 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 124.615 1.166 . . . . 3.46 111.578 177.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -61.72 102.93 0.29 Allowed 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 113.496 -1.684 . . . . 1.3200000000000001 110.374 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 79.78 27.34 54.09 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.14 -0.784 . . . . 2.1200000000000001 111.14 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 71.78 2.04 4.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.934 0.894 . . . . 3.46 111.112 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 199' ' ' ASN . 0.9 OUTLIER -106.09 129.9 54.09 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.373 -0.83 . . . . 2.0299999999999998 109.629 176.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.421 ' HB1' ' HD3' ' A' ' 193' ' ' LYS . . . -70.74 118.45 13.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 122.364 1.078 . . . . 0.96999999999999997 109.464 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.584 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 30.0 tpp -102.3 -79.15 0.53 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.335 -1.757 . . . . 1.6499999999999999 110.253 -166.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 201' ' ' MET . 3.7 t70 158.29 142.46 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 113.714 -1.584 . . . . 1.8600000000000001 106.979 176.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.796 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -163.56 150.54 12.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 120.315 -0.554 . . . . 0.14999999999999999 112.151 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 18.9 m -117.49 127.12 53.69 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.67 -0.412 . . . . 0.13 112.032 -175.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.79 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 91.0 t -63.85 122.25 14.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 113.025 0.75 . . . . 0.070000000000000007 113.025 -171.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -103.16 -35.17 8.58 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.473 -0.785 . . . . 0.59999999999999998 109.76 175.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.676 ' O ' HG12 ' A' ' 213' ' ' VAL . 8.1 tp10 -159.03 157.57 31.46 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.904 -1.887 . . . . 2.2000000000000002 105.904 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.625 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -118.66 157.37 20.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 112.426 0.528 . . . . 0.14999999999999999 112.426 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 39.5 p -111.43 -158.51 0.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.77 -0.65 . . . . 0.17999999999999999 111.476 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -59.96 -25.81 65.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 3.8199999999999998 112.015 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.727 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 5.4 t0 -163.2 -29.44 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 107.292 -1.373 . . . . 1.6699999999999999 107.292 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.598 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -95.56 -149.36 25.57 Favored Glycine 0 CA--C 1.474 -2.48 0 N-CA-C 108.134 -1.986 . . . . 0.10000000000000001 108.134 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -146.47 -177.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.601 0 C-N-CA 119.903 -0.719 . . . . 0.089999999999999997 111.211 -177.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -128.96 93.17 3.54 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.833 -1.543 . . . . 3.3900000000000001 106.833 158.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.796 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 23.8 m -88.8 -177.16 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-N 114.089 -1.414 . . . . 0.12 110.108 -177.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.463 ' HA ' ' OG ' ' A' ' 222' ' ' SER . 0.8 OUTLIER -104.07 113.23 26.62 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 108.093 -1.077 . . . . 1.6899999999999999 108.093 170.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 221' ' ' MET . 11.1 mp -75.95 142.89 41.87 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 119.744 -0.782 . . . . 0.32000000000000001 110.823 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -66.01 -31.57 72.54 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.537 -1.21 . . . . 1.28 108.334 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.5 m -60.85 -20.12 61.23 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.48 -1.236 . . . . 1.1100000000000001 109.902 169.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 91.82 29.97 11.09 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 114.654 -1.157 . . . . 0.68000000000000005 112.117 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.856 ' HB3' HD22 ' A' ' 217' ' ' LEU . 36.6 ttm -94.87 -62.69 1.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.451 -0.5 . . . . 1.5600000000000001 111.941 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 23.8 m 76.72 123.15 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.085 0.865 . . . . 0.90000000000000002 110.675 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 222' ' ' SER . 57.2 tp 157.01 -38.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.333 -0.849 . . . . 0.38 113.049 -162.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.778 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.3 0.2 OUTLIER 33.47 -93.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.864 1.266 . . . . 0.23000000000000001 113.307 -157.23 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.953 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.5 p 160.51 -156.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 118.887 0.767 . . . . 0.80000000000000004 109.656 -165.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.953 ' H ' HG22 ' A' ' 225' ' ' VAL . 35.5 ttt180 -103.05 164.01 11.87 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.14 -1.059 . . . . 3.5299999999999998 108.14 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -72.05 -14.72 61.94 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.719 0.637 . . . . 0.29999999999999999 112.719 -166.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -101.02 25.05 8.5 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.666 1.222 . . . . 2.5699999999999998 109.215 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.422 ' HB3' HG21 ' A' ' 225' ' ' VAL . 0.7 OUTLIER -137.67 -24.02 1.05 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.775 -1.557 . . . . 2.2400000000000002 110.818 178.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.598 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.2 pp -94.16 164.99 12.83 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 116.163 -0.471 . . . . 0.80000000000000004 110.79 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 18.5 m -134.16 73.18 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 113.356 0.873 . . . . 0.88 113.356 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.583 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.039 0 CA-C-N 115.689 -0.687 . . . . 1.3 110.301 165.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.562 0.696 . . . . 5.6100000000000003 110.787 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.0 m -89.69 27.71 1.47 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.333 -0.849 . . . . 2.7599999999999998 110.302 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.578 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 11.0 m-20 72.4 141.88 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.092 -0.958 . . . . 1.8300000000000001 111.337 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 9.6 mt -76.42 -49.31 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 115.738 -0.665 . . . . 0.5 109.305 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 211' ' ' ASP . 35.5 t -124.95 -77.04 0.59 Allowed 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.344 -0.844 . . . . 1.55 111.132 176.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.588 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -117.41 -0.08 12.05 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.107 -1.442 . . . . 0.22 107.107 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.591 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.78 -178.8 3.08 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 112.791 -2.004 . . . . 0.14000000000000001 109.07 -171.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.1 m -124.38 171.13 10.16 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.881 0.848 . . . . 0.20000000000000001 112.243 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.771 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 61.7 t -82.92 131.84 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.139 -1.391 . . . . 0.10000000000000001 109.411 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.1 14.3 80.77 Favored Glycine 0 C--N 1.302 -1.342 0 CA-C-N 113.955 -1.475 . . . . 0.14000000000000001 110.725 -169.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.584 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -70.7 -51.8 25.19 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.847 -0.798 . . . . 0.90000000000000002 108.847 -178.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.83 125.82 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.377 -1.738 . . . . 0.22 111.593 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 192' ' ' LEU . 0.1 OUTLIER -152.4 -146.98 0.21 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 113.687 -1.597 . . . . 0.34999999999999998 109.209 -174.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.495 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 10.3 mtmt -130.26 149.33 52.01 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.541 0.686 . . . . 3.77 111.065 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 8.1 p -116.63 149.01 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-N 114.633 -1.167 . . . . 1.6599999999999999 108.191 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 4.3 ttmt -101.06 89.27 3.76 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.265 -1.013 . . . . 3.46 108.265 176.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -85.3 73.06 10.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.681 -1.145 . . . . 1.3200000000000001 109.584 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 113.2 -103.46 1.39 Allowed Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.911 -1.04 . . . . 2.1200000000000001 111.188 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -110.15 -18.0 13.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.515 0.674 . . . . 3.46 110.765 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -117.75 142.3 47.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.779 -0.646 . . . . 2.0299999999999998 112.312 -171.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -74.71 144.07 43.87 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.976 -1.12 . . . . 0.96999999999999997 107.976 170.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.495 ' HG3' ' HB3' ' A' ' 218' ' ' ASN . 34.7 tpp -117.28 -79.03 0.58 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.959 -1.019 . . . . 1.6499999999999999 109.347 -171.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 0.9 OUTLIER 162.95 151.32 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 106.707 -1.59 . . . . 1.8600000000000001 106.707 173.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.791 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -165.82 151.66 9.15 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 118.814 0.734 . . . . 0.14999999999999999 112.141 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 17.4 m -115.67 129.78 56.61 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 120.979 0.418 . . . . 0.13 111.635 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.771 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 86.3 t -69.0 118.97 14.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 112.911 0.708 . . . . 0.070000000000000007 112.911 -171.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 216' ' ' GLN . 8.3 mt -101.94 -36.14 8.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.274 0.559 . . . . 0.59999999999999998 110.771 174.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.702 ' O ' HG12 ' A' ' 213' ' ' VAL . 40.1 mt-10 -150.35 162.17 41.05 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 105.501 -2.037 . . . . 2.2000000000000002 105.501 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.589 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -126.16 155.28 36.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 123.373 0.421 . . . . 0.14999999999999999 111.987 -175.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.6 p -111.05 -160.95 0.73 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.949 -0.569 . . . . 0.17999999999999999 111.422 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -49.8 -35.47 22.83 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.385 -0.825 . . . . 3.8199999999999998 111.626 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.694 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 5.3 t70 -162.1 -24.19 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.02 -1.104 . . . . 1.6699999999999999 108.02 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.619 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.43 -150.14 26.24 Favored Glycine 0 CA--C 1.473 -2.574 0 N-CA-C 108.085 -2.006 . . . . 0.10000000000000001 108.085 176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -144.37 -178.33 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.697 0 C-N-CA 119.787 -0.765 . . . . 0.089999999999999997 111.139 -177.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.418 ' H ' HG12 ' A' ' 213' ' ' VAL . 23.7 ttt85 -129.6 91.79 3.22 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.119 -1.438 . . . . 3.3900000000000001 107.119 159.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.791 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 25.8 m -89.11 -176.45 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.881 -1.509 . . . . 0.12 110.297 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.499 ' HB2' HD21 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -104.06 108.71 20.19 Favored 'General case' 0 N--CA 1.425 -1.703 0 O-C-N 124.196 0.935 . . . . 1.6899999999999999 108.549 168.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.603 ' HB2' ' H ' ' A' ' 221' ' ' MET . 8.5 mp -67.74 138.1 55.97 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.805 0.812 . . . . 0.32000000000000001 111.593 -175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.495 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 24.8 t-20 -72.37 -21.66 61.26 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.758 -1.565 . . . . 1.28 108.642 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.453 ' OG ' ' HG2' ' A' ' 201' ' ' MET . 17.8 m -60.84 -19.03 59.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.646 -1.161 . . . . 1.1100000000000001 109.036 166.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 108.01 14.86 15.85 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.729 -1.123 . . . . 0.68000000000000005 112.633 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.603 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 26.9 ttm -103.59 -146.24 0.37 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.39 0.614 . . . . 1.5600000000000001 109.759 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 69.0 m 176.61 123.4 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 126.171 1.788 . . . . 0.90000000000000002 107.134 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 222' ' ' SER . 33.2 tp 160.89 -40.93 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.402 0.89 . . . . 0.38 113.402 -161.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.739 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.289 0.2 OUTLIER 32.54 -91.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.523 1.129 . . . . 0.23000000000000001 112.924 -155.814 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.959 HG22 ' H ' ' A' ' 226' ' ' ARG . 7.3 p 159.03 -153.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 118.788 0.722 . . . . 0.80000000000000004 109.16 -167.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.959 ' H ' HG22 ' A' ' 225' ' ' VAL . 8.4 mtt180 -104.32 162.15 13.46 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.496 -0.774 . . . . 3.5299999999999998 109.023 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -67.91 -16.29 64.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.61 -0.723 . . . . 0.29999999999999999 112.597 -169.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -101.18 28.1 5.63 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 122.254 1.026 . . . . 2.5699999999999998 109.745 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.489 ' CG ' HG21 ' A' ' 225' ' ' VAL . 12.1 t60 -143.85 -25.41 0.56 Allowed 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 114.231 -1.349 . . . . 2.2400000000000002 109.635 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.619 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.1 pp -89.93 170.38 10.42 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.042 0.448 . . . . 0.80000000000000004 111.319 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.76 77.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 113.406 0.891 . . . . 0.88 113.406 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 232' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.714 -0.66 . . . . 1.3 109.834 163.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.63 0.728 . . . . 5.6100000000000003 109.939 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.5 m -130.41 30.33 4.74 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.39 -0.823 . . . . 2.7599999999999998 109.429 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.614 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 9.5 m-20 -111.19 -159.46 0.68 Allowed 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 114.99 -1.004 . . . . 1.8300000000000001 109.281 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 188' ' ' VAL . 6.0 mt -84.68 -62.96 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-O 120.999 0.428 . . . . 0.5 110.107 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.6 t -118.37 -73.66 0.64 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.76 -0.655 . . . . 1.55 110.677 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.638 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -120.4 0.81 10.63 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 107.079 -1.452 . . . . 0.22 107.079 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 185' ' ' ALA . 0.5 OUTLIER -170.35 -179.91 3.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.968 -1.924 . . . . 0.14000000000000001 109.382 -170.071 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.707 HG22 ' H ' ' A' ' 188' ' ' VAL . 7.6 m -123.99 170.84 10.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.892 0.853 . . . . 0.20000000000000001 111.994 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.784 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 61.0 t -80.76 132.85 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 114.256 -1.338 . . . . 0.10000000000000001 109.384 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.24 15.46 80.98 Favored Glycine 0 C--N 1.302 -1.331 0 CA-C-N 113.806 -1.543 . . . . 0.14000000000000001 110.815 -170.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 190' ' ' GLN . 2.1 tt0 -70.11 -49.13 53.88 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.603 -0.518 . . . . 0.90000000000000002 109.603 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 74.76 125.28 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.576 -1.193 . . . . 0.22 112.092 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.602 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -161.24 -150.97 0.21 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.147 -1.388 . . . . 0.34999999999999998 111.199 -172.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' A' ' 231' ' ' VAL . 0.0 OUTLIER -114.87 144.36 43.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.33 0.586 . . . . 3.77 110.808 -173.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.539 HG11 ' HG ' ' A' ' 217' ' ' LEU . 2.2 p -111.6 -37.6 2.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.633 1.206 . . . . 1.6599999999999999 110.097 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 21.1 ttmt 54.52 99.86 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 112.047 -2.342 . . . . 3.46 111.074 -171.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.524 ' HB3' ' HE3' ' A' ' 201' ' ' MET . . . -134.78 109.17 8.39 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.634 -1.621 . . . . 1.3200000000000001 110.246 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.33 41.06 2.28 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.917 -0.659 . . . . 2.1200000000000001 111.687 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.455 HE21 ' HB2' ' A' ' 198' ' ' GLN . 0.2 OUTLIER 62.35 12.67 5.42 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.277 0.631 . . . . 3.46 111.87 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 36.0 m-80 -145.56 151.53 38.27 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.957 -0.565 . . . . 2.0299999999999998 110.401 -174.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -76.56 156.13 33.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.521 -0.918 . . . . 0.96999999999999997 108.521 173.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.547 ' O ' ' HB3' ' A' ' 202' ' ' ASP . 51.8 ttm -129.15 -58.01 1.14 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.759 -1.11 . . . . 1.6499999999999999 110.116 -164.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 3.0 t70 101.16 126.35 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 111.209 -2.723 . . . . 1.8600000000000001 109.153 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.721 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -145.94 148.78 33.14 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.112 -1.404 . . . . 0.14999999999999999 111.086 -168.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 25.9 m -115.56 124.98 52.37 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-O 120.92 0.391 . . . . 0.13 112.001 -169.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.784 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 87.8 t -59.22 122.93 10.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 113.046 0.758 . . . . 0.070000000000000007 113.046 -171.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.415 HD21 ' OE1' ' A' ' 216' ' ' GLN . 0.0 OUTLIER -104.89 -39.96 6.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.569 -0.741 . . . . 0.59999999999999998 109.877 173.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.716 ' O ' HG12 ' A' ' 213' ' ' VAL . 20.3 mt-10 -148.19 153.58 38.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.268 -2.123 . . . . 2.2000000000000002 105.268 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.57 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -117.31 157.27 18.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 O-C-N 123.313 0.383 . . . . 0.14999999999999999 111.924 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 30.5 p -112.57 -164.34 0.91 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.585 . . . . 0.17999999999999999 111.365 -176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' A' ' 210' ' ' LYS . 14.3 pttt -53.43 -25.17 14.86 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.868 0.692 . . . . 3.8199999999999998 112.868 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.716 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 19.6 t0 -166.23 -26.0 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.784 -1.191 . . . . 1.6699999999999999 107.784 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.56 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -94.16 -148.88 24.6 Favored Glycine 0 CA--C 1.475 -2.423 0 N-CA-C 107.86 -2.096 . . . . 0.10000000000000001 107.86 177.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -147.8 -176.15 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 C-N-CA 119.897 -0.721 . . . . 0.089999999999999997 111.198 -178.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 223' ' ' LEU . 26.6 ttp180 -131.14 94.04 3.5 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.331 -1.359 . . . . 3.3900000000000001 107.331 159.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.833 ' O ' ' HA ' ' A' ' 222' ' ' SER . 28.1 m -89.58 178.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 114.46 -1.246 . . . . 0.12 111.783 -175.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 204' ' ' THR . 22.3 tp60 -101.84 104.44 15.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.189 -1.041 . . . . 1.6899999999999999 108.189 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.645 ' HB2' ' H ' ' A' ' 221' ' ' MET . 9.2 mp -62.86 146.91 51.68 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.575 0.702 . . . . 0.32000000000000001 111.82 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 1.7 t-20 -63.04 -30.33 71.51 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.117 -1.402 . . . . 1.28 109.562 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 39.7 m -68.53 -15.28 63.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.449 -0.796 . . . . 1.1100000000000001 110.056 170.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.52 24.1 9.67 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.453 -0.794 . . . . 0.68000000000000005 112.776 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.645 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 28.7 ttp -104.84 -166.1 1.2 Allowed 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.763 -1.199 . . . . 1.5600000000000001 107.763 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.833 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 1.5 m -157.26 131.38 8.32 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.007 -0.738 . . . . 0.90000000000000002 109.007 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.504 ' N ' ' HG3' ' A' ' 214' ' ' ARG . 57.5 tp 170.39 -44.25 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.995 1.109 . . . . 0.38 113.995 -168.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.726 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.281 0.2 OUTLIER 33.67 -98.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.105 0.962 . . . . 0.23000000000000001 113.553 -158.185 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.725 ' N ' HG23 ' A' ' 224' ' ' ILE . 12.8 m 178.94 -164.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.877 0.846 . . . . 0.80000000000000004 111.176 -158.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.442 ' H ' ' HB ' ' A' ' 225' ' ' VAL . 8.6 tpt85 -97.16 165.96 11.8 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.867 -1.901 . . . . 3.5299999999999998 105.867 166.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -69.64 -14.38 62.79 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.216 0.531 . . . . 0.29999999999999999 112.392 -172.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.77 24.99 5.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.047 0.927 . . . . 2.5699999999999998 110.278 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.442 ' HB3' HG11 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -135.03 -23.84 1.49 Allowed 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 114.33 -1.305 . . . . 2.2400000000000002 111.062 179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.56 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.1 pp -94.78 153.35 17.8 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 122.995 0.518 . . . . 0.80000000000000004 111.114 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.537 HG22 ' HE3' ' A' ' 193' ' ' LYS . 21.5 m -126.62 65.02 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.765 0.793 . . . . 0.88 112.402 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 232' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.17 -0.923 . . . . 1.3 111.806 172.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.489 0.661 . . . . 5.6100000000000003 111.158 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 72.0 m -119.12 17.98 13.14 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.902 -0.59 . . . . 2.7599999999999998 109.865 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.686 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 39.7 m-20 73.95 153.11 0.14 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 114.986 -1.007 . . . . 1.8300000000000001 111.101 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.93 -68.49 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.543 0.687 . . . . 0.5 109.962 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 211' ' ' ASP . 96.7 p -95.27 -80.34 0.42 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-O 122.376 1.084 . . . . 1.55 110.746 -176.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.516 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -125.39 -2.27 7.49 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 105.02 -2.215 . . . . 0.22 105.02 173.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.719 HD13 HD21 ' A' ' 192' ' ' LEU . 0.5 OUTLIER -162.1 177.72 9.45 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 113.187 -1.824 . . . . 0.14000000000000001 109.351 -173.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 188' ' ' VAL . 4.1 m -121.44 173.48 7.35 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.64 0.733 . . . . 0.20000000000000001 111.919 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.768 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 41.2 t -82.76 130.71 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 114.941 -1.027 . . . . 0.10000000000000001 109.056 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.55 15.7 81.08 Favored Glycine 0 C--N 1.303 -1.267 0 CA-C-N 114.265 -1.334 . . . . 0.14000000000000001 110.52 -169.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -44.53 38.51 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.382 -0.599 . . . . 0.90000000000000002 109.382 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.63 131.25 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 124.375 1.047 . . . . 0.22 111.623 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.719 HD21 HD13 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -152.08 -148.87 0.27 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 113.991 -1.459 . . . . 0.34999999999999998 109.396 -174.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.584 ' HB3' HG23 ' A' ' 231' ' ' VAL . 14.7 tttt -135.96 140.9 44.33 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 116.129 -0.487 . . . . 3.77 109.895 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.526 HG11 ' HG ' ' A' ' 217' ' ' LEU . 8.3 p -126.12 150.38 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 121.187 0.518 . . . . 1.6599999999999999 109.97 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.462 ' H ' ' HG3' ' A' ' 195' ' ' LYS . 0.1 OUTLIER -74.28 48.19 0.32 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 125.445 1.498 . . . . 3.46 112.45 -179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.513 ' HB2' HG13 ' A' ' 194' ' ' VAL . . . -69.34 103.57 2.02 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 113.42 -1.718 . . . . 1.3200000000000001 110.756 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 86.89 32.18 15.6 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.511 -0.768 . . . . 2.1200000000000001 111.221 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 71.98 10.87 6.16 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.147 0.975 . . . . 3.46 111.194 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.413 ' C ' ' HA ' ' A' ' 195' ' ' LYS . 39.2 m-80 -132.94 131.75 41.18 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.593 -0.73 . . . . 2.0299999999999998 111.081 -176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -63.5 116.02 5.2 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 122.19 0.995 . . . . 0.96999999999999997 108.826 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.629 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 34.7 tpp -104.6 -77.59 0.58 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.47 -1.695 . . . . 1.6499999999999999 110.556 -164.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.629 ' HB2' ' O ' ' A' ' 201' ' ' MET . 4.2 t70 151.52 140.79 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 113.304 -1.771 . . . . 1.8600000000000001 106.587 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.77 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -160.87 150.95 17.6 Favored 'General case' 0 N--CA 1.433 -1.321 0 C-N-CA 120.44 -0.504 . . . . 0.14999999999999999 111.169 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 17.1 m -119.79 127.52 52.87 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.638 -0.425 . . . . 0.13 111.805 -174.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.768 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 89.5 t -63.24 123.04 15.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 113.927 1.084 . . . . 0.070000000000000007 113.927 -170.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -101.9 -38.67 7.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.814 -1.084 . . . . 0.59999999999999998 109.721 175.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.576 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -158.31 150.08 21.44 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 105.395 -2.076 . . . . 2.2000000000000002 105.395 -178.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.622 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -114.67 161.31 13.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 112.918 0.71 . . . . 0.14999999999999999 112.918 -171.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.434 ' N ' HG22 ' A' ' 208' ' ' ILE . 31.9 p -112.65 -163.07 0.83 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.806 -0.634 . . . . 0.17999999999999999 110.231 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -51.77 -37.49 51.56 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.324 0.583 . . . . 3.8199999999999998 111.128 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.638 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 0.4 OUTLIER -156.7 -24.63 0.1 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.778 -0.823 . . . . 1.6699999999999999 108.778 -173.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.558 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -94.83 -151.36 28.25 Favored Glycine 0 CA--C 1.477 -2.31 0 N-CA-C 107.619 -2.193 . . . . 0.10000000000000001 107.619 176.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.743 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -150.52 -176.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 C-N-CA 119.811 -0.755 . . . . 0.089999999999999997 111.516 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -128.9 90.77 3.1 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.608 -1.627 . . . . 3.3900000000000001 106.608 158.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 222' ' ' SER . 26.5 m -86.2 -177.74 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 114.587 -1.188 . . . . 0.12 111.333 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 204' ' ' THR . 31.6 tp60 -102.69 106.64 17.32 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.517 -1.22 . . . . 1.6899999999999999 107.976 171.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.883 HD22 ' HB3' ' A' ' 221' ' ' MET . 10.9 mp -71.19 144.52 50.12 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 119.542 -0.863 . . . . 0.32000000000000001 110.462 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -67.38 -27.88 67.47 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.406 -1.27 . . . . 1.28 108.685 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 41.0 m -67.21 -16.36 64.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.645 -1.161 . . . . 1.1100000000000001 109.772 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 88.57 30.99 14.03 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 114.887 -1.051 . . . . 0.68000000000000005 112.457 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.883 ' HB3' HD22 ' A' ' 217' ' ' LEU . 5.5 tpp -90.04 -63.63 1.25 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.548 0.573 . . . . 1.5600000000000001 112.548 -175.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.79 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 18.3 m 78.29 122.46 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.282 1.033 . . . . 0.90000000000000002 110.634 -172.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 222' ' ' SER . 61.4 tp 159.06 -41.99 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.257 0.973 . . . . 0.38 113.176 -166.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.773 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.293 0.2 OUTLIER 31.64 -92.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.44 1.096 . . . . 0.23000000000000001 113.082 -156.466 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.94 HG22 ' H ' ' A' ' 226' ' ' ARG . 10.0 p 157.25 -158.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 119.027 0.83 . . . . 0.80000000000000004 110.189 -167.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.94 ' H ' HG22 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -95.6 153.03 17.92 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.665 -1.152 . . . . 3.5299999999999998 108.355 178.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -61.57 -19.43 62.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.337 0.865 . . . . 0.29999999999999999 113.337 -173.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -101.8 27.09 6.75 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 122.441 1.115 . . . . 2.5699999999999998 109.086 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.434 ' HB3' HG21 ' A' ' 225' ' ' VAL . 0.8 OUTLIER -139.17 -22.39 0.93 Allowed 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.698 -1.592 . . . . 2.2400000000000002 110.693 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.558 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.2 pp -95.47 173.2 7.63 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 116.593 -0.276 . . . . 0.80000000000000004 110.513 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 193' ' ' LYS . 23.9 m -137.96 72.51 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.686 0.755 . . . . 0.88 112.392 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.695 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.304 -0.855 . . . . 1.3 111.104 170.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.886 0.374 . . . . 5.6100000000000003 110.47 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.9 p -113.76 17.62 17.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.166 0.508 . . . . 2.7599999999999998 110.626 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.516 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 3.6 p30 -159.72 160.64 34.29 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.748 -0.66 . . . . 1.8300000000000001 110.128 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 19.6 mt -88.48 -56.42 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 CA-C-N 115.248 -0.887 . . . . 0.5 109.018 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 94.3 p -105.29 -78.29 0.57 Allowed 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 122.192 0.996 . . . . 1.55 110.503 -177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.47 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -126.23 -2.84 6.93 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 104.95 -2.241 . . . . 0.22 104.95 172.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.622 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -161.02 -178.58 6.88 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.42 -1.718 . . . . 0.14000000000000001 110.283 -173.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.5 m -125.39 170.74 11.06 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 122.102 0.953 . . . . 0.20000000000000001 112.592 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.805 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.5 t -82.81 131.2 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 113.957 -1.474 . . . . 0.10000000000000001 109.516 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.56 13.96 80.75 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.941 -1.481 . . . . 0.14000000000000001 110.958 -170.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 1.6 tt0 -73.52 -47.02 44.2 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.656 -0.498 . . . . 0.90000000000000002 109.656 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 70.97 123.44 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.75 -1.114 . . . . 0.22 111.891 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.649 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -156.62 -157.52 0.71 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.195 -1.366 . . . . 0.34999999999999998 111.372 -171.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.461 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 29.8 ttmt -109.06 142.61 39.52 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.973 0.892 . . . . 3.77 111.234 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.473 HG11 ' HG ' ' A' ' 217' ' ' LEU . 1.5 p -113.06 -32.14 2.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 113.542 -1.663 . . . . 1.6599999999999999 108.849 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 25.1 ttmt 59.19 95.36 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 111.092 -2.776 . . . . 3.46 110.555 -176.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.401 ' HB3' ' HE3' ' A' ' 201' ' ' MET . . . -103.08 97.14 7.28 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.704 -1.589 . . . . 1.3200000000000001 110.852 -174.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 198' ' ' GLN . . . 85.03 55.72 2.58 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.89 -0.671 . . . . 2.1200000000000001 112.172 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 197' ' ' GLY . 26.7 tt0 74.01 -35.44 0.31 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.17 0.588 . . . . 3.46 112.522 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -96.09 158.97 15.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.81 -0.441 . . . . 2.0299999999999998 109.81 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -71.73 177.05 4.38 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.703 0.763 . . . . 0.96999999999999997 109.436 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.753 ' SD ' ' HB3' ' A' ' 218' ' ' ASN . 37.4 tpp -146.29 -55.65 0.27 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.896 -1.047 . . . . 1.6499999999999999 110.287 -168.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 201' ' ' MET . 17.6 m-20 97.03 105.27 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.472 -2.149 . . . . 1.8600000000000001 109.165 174.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.777 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -128.38 147.93 50.66 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.121 -0.945 . . . . 0.14999999999999999 110.664 -167.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 40.6 m -116.18 125.24 52.02 Favored 'General case' 0 C--O 1.211 -0.921 0 C-N-CA 120.378 -0.529 . . . . 0.13 112.272 -170.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.805 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 85.3 t -61.73 121.49 10.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 112.917 0.71 . . . . 0.070000000000000007 112.917 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -102.63 -36.51 8.31 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.627 -0.715 . . . . 0.59999999999999998 110.067 175.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.646 ' O ' HG12 ' A' ' 213' ' ' VAL . 35.1 tt0 -156.81 157.12 34.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.267 -2.123 . . . . 2.2000000000000002 105.267 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.624 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.48 160.27 19.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 112.63 0.604 . . . . 0.14999999999999999 112.63 -172.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 34.0 p -112.11 -161.66 0.76 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.802 -0.636 . . . . 0.17999999999999999 110.609 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.7 mmtm -56.51 -30.0 62.5 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.389 0.515 . . . . 3.8199999999999998 112.389 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.651 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 4.3 t0 -161.88 -24.35 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.332 -0.988 . . . . 1.6699999999999999 108.332 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.608 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -98.07 -149.31 24.88 Favored Glycine 0 CA--C 1.473 -2.561 0 N-CA-C 107.685 -2.166 . . . . 0.10000000000000001 107.685 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.659 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -149.04 -175.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 C-N-CA 119.881 -0.728 . . . . 0.089999999999999997 111.695 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.475 ' HG3' ' HA ' ' A' ' 223' ' ' LEU . 29.6 ttt-85 -129.94 93.33 3.48 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.229 -1.397 . . . . 3.3900000000000001 107.229 157.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.778 HG22 ' HB ' ' A' ' 224' ' ' ILE . 19.9 m -87.22 179.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 CA-C-N 114.061 -1.427 . . . . 0.12 110.415 -177.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -100.39 113.47 26.24 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 107.707 -1.22 . . . . 1.6899999999999999 107.707 172.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.716 HD12 HG23 ' A' ' 215' ' ' VAL . 9.8 mp -72.87 144.58 47.37 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.86 -0.736 . . . . 0.32000000000000001 109.571 -175.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.753 ' HB3' ' SD ' ' A' ' 201' ' ' MET . 15.9 t-20 -67.57 -22.9 65.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.175 -0.92 . . . . 1.28 108.662 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 22.0 m -66.42 -18.29 65.27 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.671 -1.149 . . . . 1.1100000000000001 109.768 167.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 86.27 32.89 15.48 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.887 -1.051 . . . . 0.68000000000000005 111.22 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.627 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 14.5 ttt -102.08 -54.02 2.8 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 112.359 0.503 . . . . 1.5600000000000001 112.359 -172.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 28.0 m 77.04 125.39 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.495 0.718 . . . . 0.90000000000000002 112.092 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 222' ' ' SER . 39.1 tp 158.98 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.968 -1.015 . . . . 0.38 113.574 -168.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.778 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.297 0.1 OUTLIER 34.53 -93.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 124.635 1.174 . . . . 0.23000000000000001 113.481 -157.737 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.95 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.7 p 162.12 -153.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 119.139 0.881 . . . . 0.80000000000000004 110.416 -164.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.95 ' H ' HG22 ' A' ' 225' ' ' VAL . 0.8 OUTLIER -108.06 159.59 16.45 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.833 -1.076 . . . . 3.5299999999999998 108.55 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -64.7 -16.4 62.83 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.534 0.939 . . . . 0.29999999999999999 113.534 -170.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -100.52 29.97 4.16 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.603 1.192 . . . . 2.5699999999999998 109.526 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.641 ' CG ' HG21 ' A' ' 225' ' ' VAL . 11.2 t60 -137.19 -31.79 0.81 Allowed 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.012 -1.449 . . . . 2.2400000000000002 109.372 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 230' ' ' LEU . 1.2 pp -86.8 154.41 20.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.252 -0.431 . . . . 0.80000000000000004 109.965 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.432 ' CG2' ' HD2' ' A' ' 193' ' ' LYS . 18.7 m -127.69 47.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 122.172 0.986 . . . . 0.88 112.488 -177.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.62 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.713 0 CA-C-N 113.647 -1.615 . . . . 1.3 112.086 174.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 121.046 0.45 . . . . 5.6100000000000003 110.012 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.1 t -101.61 13.95 33.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.415 0.626 . . . . 2.7599999999999998 109.757 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.445 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 6.9 m-20 -130.07 -169.77 2.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.677 -0.86 . . . . 1.8300000000000001 108.677 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 19.7 mt -84.76 -73.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.191 0.519 . . . . 0.5 110.159 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.455 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 99.9 p -97.78 -80.23 0.45 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.269 1.033 . . . . 1.55 110.48 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.466 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -121.29 -3.81 9.46 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 105.013 -2.217 . . . . 0.22 105.013 171.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.541 HD11 ' CG1' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -159.85 -174.95 4.85 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 113.393 -1.73 . . . . 0.14000000000000001 110.706 -173.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 188' ' ' VAL . 7.1 m -128.51 170.85 12.69 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.024 -0.989 . . . . 0.20000000000000001 112.543 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.794 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 57.7 t -81.78 133.4 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.111 -1.404 . . . . 0.10000000000000001 109.366 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 78.95 13.66 82.83 Favored Glycine 0 C--N 1.303 -1.276 0 CA-C-N 114.031 -1.441 . . . . 0.14000000000000001 110.903 -170.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.441 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 2.6 tt0 -72.53 -49.95 29.17 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.606 -0.438 . . . . 0.90000000000000002 109.846 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.15 127.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.573 -1.194 . . . . 0.22 112.006 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.618 HD13 HD12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -154.95 -149.75 0.28 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.49 -1.232 . . . . 0.34999999999999998 110.45 -174.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.602 ' HB3' HG22 ' A' ' 231' ' ' VAL . 0.0 OUTLIER -122.93 146.22 47.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.612 0.72 . . . . 3.77 111.778 -176.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.436 ' HB ' HG12 ' A' ' 224' ' ' ILE . 6.9 p -132.74 145.82 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 CA-C-N 114.134 -1.394 . . . . 1.6599999999999999 107.718 163.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.578 ' HE2' ' N ' ' A' ' 200' ' ' ALA . 9.4 ttmt -102.23 95.56 6.39 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.295 -1.002 . . . . 3.46 108.295 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -96.02 73.48 3.0 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.69 -1.141 . . . . 1.3200000000000001 109.671 -175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 119.3 -114.42 2.77 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.856 -1.065 . . . . 2.1200000000000001 110.964 -175.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -99.53 -23.88 14.94 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.468 0.651 . . . . 3.46 110.767 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 39.2 m-80 -112.83 149.2 33.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.375 -0.83 . . . . 2.0299999999999998 112.004 -170.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.578 ' N ' ' HE2' ' A' ' 195' ' ' LYS . . . -75.55 151.18 37.95 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.927 -1.509 . . . . 0.96999999999999997 106.927 166.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.633 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 46.1 tpp -108.08 -59.29 1.87 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.443 -1.253 . . . . 1.6499999999999999 110.375 -163.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 201' ' ' MET . 0.9 OUTLIER 95.24 109.54 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 111.815 -2.448 . . . . 1.8600000000000001 108.104 -178.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.707 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -139.81 152.42 46.52 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.768 -1.106 . . . . 0.14999999999999999 110.658 -161.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 18.3 m -117.63 129.46 55.76 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 121.088 0.47 . . . . 0.13 111.716 -171.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.794 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 86.1 t -64.7 122.25 15.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.979 0.733 . . . . 0.070000000000000007 112.979 -170.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.44 HD21 ' OE1' ' A' ' 216' ' ' GLN . 0.0 OUTLIER -103.95 -39.23 6.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.699 0.762 . . . . 0.59999999999999998 109.484 174.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.704 ' O ' HG12 ' A' ' 213' ' ' VAL . 18.2 mt-10 -148.75 156.19 42.02 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 104.786 -2.302 . . . . 2.2000000000000002 104.786 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.612 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.54 161.73 19.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 112.42 0.526 . . . . 0.14999999999999999 112.42 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.434 ' N ' HG22 ' A' ' 208' ' ' ILE . 31.4 p -112.45 -163.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 0.17999999999999999 110.247 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -58.1 -27.39 63.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.875 0.694 . . . . 3.8199999999999998 112.875 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.634 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 4.9 t0 -159.75 -27.77 0.07 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.154 -1.054 . . . . 1.6699999999999999 108.154 -174.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.516 ' HA2' HD11 ' A' ' 230' ' ' LEU . . . -96.84 -151.08 27.62 Favored Glycine 0 CA--C 1.475 -2.456 0 N-CA-C 107.842 -2.103 . . . . 0.10000000000000001 107.842 177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -145.79 -174.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 C-N-CA 119.769 -0.772 . . . . 0.089999999999999997 111.45 -178.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.496 ' H ' HG12 ' A' ' 213' ' ' VAL . 72.8 mtm-85 -134.26 81.69 1.93 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.973 -1.491 . . . . 3.3900000000000001 106.973 164.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.742 HG22 ' HB ' ' A' ' 224' ' ' ILE . 26.5 m -80.93 -177.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 114.15 -1.386 . . . . 0.12 112.165 -173.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 204' ' ' THR . 26.4 tp60 -104.83 116.59 32.26 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.623 -1.251 . . . . 1.6899999999999999 107.623 171.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.802 HD22 ' HB3' ' A' ' 221' ' ' MET . 10.9 mp -76.57 150.34 36.52 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.39 -0.924 . . . . 0.32000000000000001 111.257 -174.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.583 ' HB3' ' SD ' ' A' ' 201' ' ' MET . 21.7 t-20 -52.67 -43.54 65.62 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.734 -1.121 . . . . 1.28 109.368 174.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 58.3 m -67.12 -11.55 57.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.16 -0.927 . . . . 1.1100000000000001 111.806 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.21 35.13 18.78 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.607 -0.806 . . . . 0.68000000000000005 111.87 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.802 ' HB3' HD22 ' A' ' 217' ' ' LEU . 18.3 tpp -85.12 -56.33 3.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.45 0.643 . . . . 1.5600000000000001 110.93 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 59.7 p 71.19 120.88 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.454 -1.703 . . . . 0.90000000000000002 110.793 -175.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 222' ' ' SER . 51.9 tp 166.1 -42.45 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.283 1.216 . . . . 0.38 114.283 -168.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.965 HD13 HD22 ' A' ' 230' ' ' LEU 0.341 0.1 OUTLIER 31.75 -99.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.498 1.119 . . . . 0.23000000000000001 113.558 -154.433 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.072 HG22 ' H ' ' A' ' 226' ' ' ARG . 12.1 p 162.51 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.45 1.023 . . . . 0.80000000000000004 109.984 -160.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 1.072 ' H ' HG22 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -106.05 152.58 23.2 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.25 -0.886 . . . . 3.5299999999999998 108.756 -178.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.634 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -51.5 -24.0 4.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.187 1.18 . . . . 0.29999999999999999 114.187 -167.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -94.31 26.45 3.35 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.838 1.304 . . . . 2.5699999999999998 109.224 -174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.549 ' CG ' HG21 ' A' ' 225' ' ' VAL . 16.5 t60 -139.44 -21.1 0.93 Allowed 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 113.842 -1.526 . . . . 2.2400000000000002 109.63 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.965 HD22 HD13 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -82.14 144.88 30.44 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.828 -0.434 . . . . 0.80000000000000004 109.828 171.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.602 HG22 ' HB3' ' A' ' 193' ' ' LYS . 25.0 m -120.67 66.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 122.422 1.106 . . . . 0.88 111.582 171.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.64 ' CE2' HD12 ' A' ' 230' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.144 0 CA-C-N 115.154 -0.93 . . . . 1.3 110.797 171.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.153 -0.314 . . . . 5.6100000000000003 110.153 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 87.9 p 52.73 30.51 8.97 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.677 0.791 . . . . 2.7599999999999998 110.594 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.444 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 4.5 m-20 -77.19 139.32 39.87 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.446 -0.797 . . . . 1.8300000000000001 109.625 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.1 mt -70.71 -62.78 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.942 -1.027 . . . . 0.5 109.234 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 74.0 m -108.34 -78.78 0.58 Allowed 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.411 -0.813 . . . . 1.55 111.295 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.618 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -117.12 -0.71 12.04 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.866 -1.531 . . . . 0.22 106.866 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.618 HD23 ' HB3' ' A' ' 185' ' ' ALA . 0.5 OUTLIER -169.31 -178.51 3.18 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 113.111 -1.859 . . . . 0.14000000000000001 109.497 -171.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.724 HG22 ' H ' ' A' ' 188' ' ' VAL . 3.6 m -123.34 171.94 9.04 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.794 0.807 . . . . 0.20000000000000001 112.587 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.775 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.4 t -84.71 135.66 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-N 114.477 -1.238 . . . . 0.10000000000000001 108.917 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 71.89 18.66 77.74 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 114.374 -1.285 . . . . 0.14000000000000001 110.186 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -72.38 -53.23 12.87 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.44 -0.948 . . . . 0.90000000000000002 108.44 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 73.32 127.66 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 113.282 -1.781 . . . . 0.22 111.351 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 192' ' ' LEU . 0.0 OUTLIER -148.3 -151.58 0.4 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.662 -1.608 . . . . 0.34999999999999998 108.532 -174.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.545 ' HD2' ' HB1' ' A' ' 200' ' ' ALA . 12.5 mtmt -129.32 148.15 51.21 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.547 -0.751 . . . . 3.77 109.629 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.409 ' O ' ' HB3' ' A' ' 195' ' ' LYS . 1.2 p -96.85 -32.84 4.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.857 -1.065 . . . . 1.6599999999999999 112.077 -167.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 4.5 tppp? 60.5 96.43 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.447 -1.706 . . . . 3.46 109.604 -172.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -130.05 114.75 16.17 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.181 -1.372 . . . . 1.3200000000000001 110.396 -173.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.0 48.04 17.16 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.621 -0.8 . . . . 2.1200000000000001 111.747 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 75.3 -26.16 0.2 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.538 0.735 . . . . 3.46 112.478 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -106.47 150.52 26.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.96 0.41 . . . . 2.0299999999999998 111.308 -177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 193' ' ' LYS . . . -78.23 151.35 33.17 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.573 -0.899 . . . . 0.96999999999999997 108.573 173.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.67 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 40.6 tpp -127.01 -80.63 0.6 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.548 -0.908 . . . . 1.6499999999999999 108.548 -167.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 201' ' ' MET . 3.3 t70 151.75 146.99 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.311 -1.737 . . . . 1.8600000000000001 106.311 170.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.852 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -158.9 148.24 18.88 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 119.933 -0.707 . . . . 0.14999999999999999 112.095 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 22.8 m -119.24 127.19 53.02 Favored 'General case' 0 C--O 1.21 -0.975 0 C-N-CA 120.457 -0.497 . . . . 0.13 112.2 -175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.775 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 85.6 t -65.55 121.05 13.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 113.014 0.746 . . . . 0.070000000000000007 113.014 -170.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -101.55 -37.84 8.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.201 -0.909 . . . . 0.59999999999999998 109.827 175.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.624 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.4 OUTLIER -157.69 151.71 24.35 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 105.116 -2.179 . . . . 2.2000000000000002 105.116 -178.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.61 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -115.92 160.98 14.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 112.372 0.508 . . . . 0.14999999999999999 112.372 -172.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.4 p -112.74 -172.03 1.97 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.617 -0.882 . . . . 0.17999999999999999 108.617 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.72 ' HG3' ' OD1' ' A' ' 211' ' ' ASP . 13.2 pttp -55.41 -28.04 51.61 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.654 0.613 . . . . 3.8199999999999998 112.654 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.72 ' OD1' ' HG3' ' A' ' 210' ' ' LYS . 6.6 p-10 -149.66 -33.21 0.2 Allowed 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.971 -0.751 . . . . 1.6699999999999999 108.971 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.563 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -98.29 -153.0 28.45 Favored Glycine 0 CA--C 1.476 -2.349 0 N-CA-C 108.009 -2.036 . . . . 0.10000000000000001 108.009 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.636 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -147.08 -176.76 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.499 0 C-N-CA 119.874 -0.731 . . . . 0.089999999999999997 110.81 -176.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -128.5 87.7 2.63 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.549 -1.648 . . . . 3.3900000000000001 106.549 158.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.852 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 22.6 m -83.2 -177.19 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.347 -1.297 . . . . 0.12 110.469 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 0.8 OUTLIER -103.84 115.49 30.56 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.888 -1.051 . . . . 1.6899999999999999 108.261 168.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 221' ' ' MET . 11.0 mp -76.79 144.04 39.43 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 119.899 -0.721 . . . . 0.32000000000000001 110.634 -175.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.584 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 12.8 t-20 -66.13 -28.17 68.6 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.41 -1.268 . . . . 1.28 108.802 178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.6 m -65.69 -18.52 65.39 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.427 -1.26 . . . . 1.1100000000000001 109.587 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 92.44 26.12 18.99 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 114.809 -1.087 . . . . 0.68000000000000005 112.435 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.785 ' HB3' HD22 ' A' ' 217' ' ' LEU . 2.5 tpp -88.53 -63.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.73 -0.388 . . . . 1.5600000000000001 111.9 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 25.7 m 75.93 122.19 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.031 -0.986 . . . . 0.90000000000000002 110.589 -175.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 222' ' ' SER . 52.4 tp 156.32 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.192 0.932 . . . . 0.38 112.946 -163.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.793 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.303 0.2 OUTLIER 32.92 -94.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.573 1.149 . . . . 0.23000000000000001 113.217 -156.575 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.969 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.8 p 159.94 -152.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 118.794 0.725 . . . . 0.80000000000000004 110.417 -162.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.969 ' H ' HG22 ' A' ' 225' ' ' VAL . 18.6 mtm180 -105.33 164.3 11.96 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.763 -1.108 . . . . 3.5299999999999998 109.315 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -69.48 -17.54 63.62 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.339 -0.846 . . . . 0.29999999999999999 112.329 -171.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -101.68 28.02 5.94 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.509 1.147 . . . . 2.5699999999999998 109.442 -177.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.62 ' CG ' HG21 ' A' ' 225' ' ' VAL . 7.9 t60 -137.03 -34.37 0.73 Allowed 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 113.957 -1.474 . . . . 2.2400000000000002 109.309 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 226' ' ' ARG . 1.0 OUTLIER -83.28 157.61 22.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 116.014 -0.539 . . . . 0.80000000000000004 111.221 -171.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 14.7 m -128.25 72.77 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.277 0.843 . . . . 0.88 113.277 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.545 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-N 115.438 -0.801 . . . . 1.3 110.772 165.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 121.324 0.583 . . . . 5.6100000000000003 111.378 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.0 t -91.8 15.6 12.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.899 -0.778 . . . . 2.7599999999999998 108.899 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.409 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 1.6 p30 -157.27 147.68 21.1 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 114.825 -1.08 . . . . 1.8300000000000001 110.129 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 32.8 mt -82.36 -56.63 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.291 -0.868 . . . . 0.5 108.824 171.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 80.2 p -101.81 -82.76 0.47 Allowed 'General case' 0 N--CA 1.424 -1.739 0 CA-C-O 122.421 1.105 . . . . 1.55 110.312 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.433 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -122.81 -2.98 8.72 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 105.089 -2.189 . . . . 0.22 105.089 170.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.581 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.6 OUTLIER -159.28 -177.24 6.31 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.489 -1.687 . . . . 0.14000000000000001 110.462 -175.036 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.0 m -125.96 170.93 11.2 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.084 0.945 . . . . 0.20000000000000001 112.808 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.798 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.1 t -80.75 134.44 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-N 114.151 -1.386 . . . . 0.10000000000000001 109.277 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.58 15.39 81.59 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.243 -1.344 . . . . 0.14000000000000001 110.641 -170.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.507 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 3.1 tt0 -73.28 -49.7 26.24 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 120.312 -0.555 . . . . 0.90000000000000002 109.604 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.561 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 71.71 124.12 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.207 -1.361 . . . . 0.22 111.846 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.663 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -150.13 -152.3 0.43 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.603 -1.18 . . . . 0.34999999999999998 111.001 -173.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.596 ' HE3' ' HB2' ' A' ' 195' ' ' LYS . 0.5 OUTLIER -115.46 139.98 49.56 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.33 -0.85 . . . . 3.77 110.32 -177.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.52 HG11 ' HG ' ' A' ' 217' ' ' LEU . 1.1 p -112.27 -31.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 113.92 -1.491 . . . . 1.6599999999999999 110.306 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.596 ' HB2' ' HE3' ' A' ' 193' ' ' LYS . 0.5 OUTLIER 62.42 108.36 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 111.87 -2.423 . . . . 3.46 110.228 -166.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -123.15 89.11 3.05 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.056 -0.975 . . . . 1.3200000000000001 110.372 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.05 49.3 0.83 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.807 -0.633 . . . . 2.1200000000000001 112.281 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 64.5 2.62 1.64 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.242 0.617 . . . . 3.46 112.416 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 42.5 m-80 -138.21 161.72 36.12 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.067 -0.716 . . . . 2.0299999999999998 109.067 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -69.3 172.9 6.33 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.456 0.646 . . . . 0.96999999999999997 109.643 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.631 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 35.6 tpp -147.88 -59.19 0.25 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.42 -0.809 . . . . 1.6499999999999999 110.95 -166.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 2.1 m-20 104.59 115.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 112.127 -2.306 . . . . 1.8600000000000001 109.269 177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.691 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -135.87 146.63 47.63 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.876 -0.602 . . . . 0.14999999999999999 110.177 -172.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 19.0 m -112.75 130.21 56.15 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.383 -0.527 . . . . 0.13 111.475 -168.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.798 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 91.7 t -66.11 120.03 12.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 112.773 0.657 . . . . 0.070000000000000007 112.773 -172.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -101.52 -40.24 7.14 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.302 -0.863 . . . . 0.59999999999999998 109.489 175.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.688 ' O ' HG12 ' A' ' 213' ' ' VAL . 24.3 mt-10 -150.28 155.52 39.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.091 -2.188 . . . . 2.2000000000000002 105.091 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.646 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.85 160.38 20.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 112.634 0.605 . . . . 0.14999999999999999 112.634 -175.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.418 ' N ' HG22 ' A' ' 208' ' ' ILE . 37.6 p -113.27 -167.07 1.14 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.835 -0.62 . . . . 0.17999999999999999 109.839 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -58.67 -27.73 65.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.83 0.347 . . . . 3.8199999999999998 111.679 -175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.724 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 9.0 t0 -150.51 -35.39 0.15 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.668 -1.234 . . . . 1.6699999999999999 107.668 -173.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.61 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -96.01 -146.87 21.71 Favored Glycine 0 CA--C 1.476 -2.383 0 N-CA-C 108.682 -1.767 . . . . 0.10000000000000001 108.682 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.772 ' CB ' HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -145.51 -170.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.555 0 C-N-CA 119.893 -0.723 . . . . 0.089999999999999997 112.003 -179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.463 ' H ' HG12 ' A' ' 213' ' ' VAL . 18.0 mmm180 -137.5 81.89 1.89 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.15 -1.426 . . . . 3.3900000000000001 107.15 162.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.792 HG22 ' HB ' ' A' ' 224' ' ' ILE . 34.0 m -81.87 -177.69 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.484 -0.78 . . . . 0.12 113.043 -175.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -106.52 114.53 28.7 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 113.986 -1.461 . . . . 1.6899999999999999 108.708 173.268 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.557 ' HB2' ' H ' ' A' ' 221' ' ' MET . 9.6 mp -72.52 145.29 47.57 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.656 0.741 . . . . 0.32000000000000001 112.134 -175.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.724 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 20.5 t-20 -66.13 -28.62 68.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.878 -1.51 . . . . 1.28 108.679 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.9 m -62.37 -18.48 61.63 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.496 -1.229 . . . . 1.1100000000000001 109.775 169.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.73 21.71 12.06 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.317 -0.856 . . . . 0.68000000000000005 112.153 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.557 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 26.4 ttp -108.71 -163.37 0.87 Allowed 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 107.509 -1.293 . . . . 1.5600000000000001 107.509 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 10.0 m -157.8 129.28 6.77 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.99 -1.115 . . . . 0.90000000000000002 107.99 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 214' ' ' ARG . 48.2 tp 178.22 -55.56 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 114.228 1.196 . . . . 0.38 114.228 -168.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.792 ' HB ' HG22 ' A' ' 215' ' ' VAL . 0.4 OUTLIER 49.08 -99.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.376 1.07 . . . . 0.23000000000000001 112.25 -161.141 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.991 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.7 p 156.84 -159.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 118.777 0.717 . . . . 0.80000000000000004 109.214 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.991 ' H ' HG22 ' A' ' 225' ' ' VAL . 15.5 ptt180 -97.38 163.17 12.99 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.501 -0.772 . . . . 3.5299999999999998 109.146 176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -71.19 -15.39 62.47 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 112.743 0.646 . . . . 0.29999999999999999 112.743 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.482 ' H ' ' HG3' ' A' ' 226' ' ' ARG . 11.6 tp10 -98.95 28.61 4.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.859 1.314 . . . . 2.5699999999999998 109.011 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.57 ' HB3' HG11 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -136.56 -29.96 0.93 Allowed 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.504 -1.68 . . . . 2.2400000000000002 110.575 177.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.61 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.1 pp -90.49 155.58 18.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 116.168 -0.469 . . . . 0.80000000000000004 111.316 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.501 HG22 ' HD2' ' A' ' 193' ' ' LYS . 19.3 m -129.43 88.3 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.886 0.851 . . . . 0.88 111.827 173.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.557 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.152 -0.928 . . . . 1.3 110.998 171.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 63.9 t . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 109.844 -0.428 . . . . 5.6100000000000003 109.844 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.8 t 70.8 27.27 3.6 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.813 0.696 . . . . 2.7599999999999998 109.382 -173.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.451 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 16.7 m-20 -121.26 -161.17 0.89 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.256 -0.884 . . . . 1.8300000000000001 108.721 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.584 HD12 HG23 ' A' ' 188' ' ' VAL . 14.4 mt -87.02 -61.69 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 121.407 0.622 . . . . 0.5 109.964 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 7.8 t -117.08 -77.21 0.57 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.453 -0.794 . . . . 1.55 110.375 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.59 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -120.04 -1.05 10.44 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.889 -1.522 . . . . 0.22 106.889 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.607 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -166.36 -175.39 3.23 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 112.627 -2.079 . . . . 0.14000000000000001 109.21 -171.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 188' ' ' VAL . 5.9 m -125.44 172.26 9.8 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.402 -0.817 . . . . 0.20000000000000001 112.514 177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.796 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 48.5 t -83.17 135.12 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 114.494 -1.23 . . . . 0.10000000000000001 109.38 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.71 14.79 81.07 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.176 -1.375 . . . . 0.14000000000000001 110.45 -170.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -69.85 -50.46 42.42 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.926 -0.768 . . . . 0.90000000000000002 108.926 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 73.71 127.27 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 113.42 -1.718 . . . . 0.22 111.68 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.618 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -148.97 -149.42 0.3 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.929 -1.487 . . . . 0.34999999999999998 108.845 -174.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.465 ' HB3' ' HB1' ' A' ' 200' ' ' ALA . 11.3 mttp -135.79 148.27 48.68 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.87 0.843 . . . . 3.77 111.71 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 7.9 p -121.3 151.54 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 114.121 -1.4 . . . . 1.6599999999999999 108.414 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 1.2 ttmt -92.87 85.16 5.09 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.194 -0.669 . . . . 3.46 109.194 -178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.5 82.59 2.18 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.699 -0.682 . . . . 1.3200000000000001 110.396 -173.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.74 47.75 1.16 Allowed Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.427 -0.806 . . . . 2.1200000000000001 111.61 -177.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 75.19 -19.85 0.37 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.564 0.746 . . . . 3.46 112.305 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -117.56 142.35 47.29 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.201 -0.454 . . . . 2.0299999999999998 110.986 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -68.89 132.89 47.47 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.472 -0.936 . . . . 0.96999999999999997 108.472 172.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.636 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 12.3 ttm -106.16 -79.16 0.57 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.566 -1.197 . . . . 1.6499999999999999 109.33 -168.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.636 ' HB2' ' O ' ' A' ' 201' ' ' MET . 4.0 t70 161.73 149.54 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.275 -1.38 . . . . 1.8600000000000001 107.275 171.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.805 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -162.92 149.67 12.76 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.393 -0.523 . . . . 0.14999999999999999 111.742 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 20.7 m -118.79 126.65 52.33 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 120.558 -0.457 . . . . 0.13 112.009 -174.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.796 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 96.0 t -62.84 123.41 15.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 113.373 0.879 . . . . 0.070000000000000007 113.373 -170.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -104.89 -34.43 8.05 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.408 -0.815 . . . . 0.59999999999999998 110.092 175.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.562 ' O ' HG12 ' A' ' 213' ' ' VAL . 0.3 OUTLIER -161.53 149.21 14.95 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 105.477 -2.046 . . . . 2.2000000000000002 105.477 -178.058 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.59 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -114.71 156.43 15.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 112.837 0.68 . . . . 0.14999999999999999 112.837 -172.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.4 p -111.98 -161.0 0.73 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.569 0.581 . . . . 0.17999999999999999 112.569 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -44.46 -37.99 3.8 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 114.902 -1.045 . . . . 3.8199999999999998 111.582 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.666 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 2.1 t70 -162.84 -25.71 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.614 -1.254 . . . . 1.6699999999999999 107.614 -175.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.45 -149.75 25.65 Favored Glycine 0 CA--C 1.474 -2.501 0 N-CA-C 108.165 -1.974 . . . . 0.10000000000000001 108.165 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.659 ' CG1' HG13 ' A' ' 205' ' ' VAL . 0.2 OUTLIER -145.41 -177.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.638 0 C-N-CA 119.826 -0.75 . . . . 0.089999999999999997 111.052 -177.038 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 223' ' ' LEU . 98.5 mtt180 -128.76 82.1 2.06 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 106.935 -1.505 . . . . 3.3900000000000001 106.935 162.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.805 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 26.9 m -80.65 -176.57 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 114.761 -1.109 . . . . 0.12 111.599 -173.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 204' ' ' THR . 11.0 tm0? -104.84 109.84 21.96 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.332 -1.304 . . . . 1.6899999999999999 108.193 170.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.771 HD22 ' HB3' ' A' ' 221' ' ' MET . 11.0 mp -74.07 140.19 45.16 Favored 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 119.571 -0.852 . . . . 0.32000000000000001 110.918 -172.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 66.2 t30 -73.9 -18.82 60.86 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.915 -1.493 . . . . 1.28 107.168 173.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.31 -22.33 63.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 113.232 -1.804 . . . . 1.1100000000000001 109.06 165.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 88.2 31.05 15.03 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 114.001 -1.454 . . . . 0.68000000000000005 111.876 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.771 ' HB3' HD22 ' A' ' 217' ' ' LEU . 1.5 tpp -107.73 -63.61 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.452 0.538 . . . . 1.5600000000000001 112.452 -173.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.561 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 26.7 m 79.73 122.07 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.897 -1.047 . . . . 0.90000000000000002 110.577 -172.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 222' ' ' SER . 56.9 tp 161.98 -41.32 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.842 1.053 . . . . 0.38 113.842 -166.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.799 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.333 0.1 OUTLIER 33.85 -97.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.985 1.314 . . . . 0.23000000000000001 114.098 -157.568 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.931 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.9 p 159.61 -156.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 119.308 0.958 . . . . 0.80000000000000004 109.833 -165.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.931 ' H ' HG22 ' A' ' 225' ' ' VAL . 5.2 ptp180 -101.89 159.88 14.96 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 115.577 -0.738 . . . . 3.5299999999999998 109.135 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -68.03 -19.58 64.92 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.082 0.771 . . . . 0.29999999999999999 113.082 -164.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.505 ' HG2' ' CD ' ' A' ' 226' ' ' ARG . 13.8 pt-20 -99.83 24.41 8.46 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 122.198 0.999 . . . . 2.5699999999999998 109.802 -177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.59 ' CD2' HG21 ' A' ' 225' ' ' VAL . 8.6 t60 -138.18 -24.5 0.98 Allowed 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.053 -1.43 . . . . 2.2400000000000002 109.178 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.4 pp -92.82 166.78 12.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 116.17 -0.468 . . . . 0.80000000000000004 110.709 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 11.9 m -130.33 83.4 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 113.242 0.83 . . . . 0.88 113.242 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.618 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.69 -0.672 . . . . 1.3 109.778 161.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.355 -0.239 . . . . 5.6100000000000003 110.355 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.0 t 71.16 29.49 2.86 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.956 0.785 . . . . 2.7599999999999998 109.693 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.513 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 37.9 m-20 -121.75 -170.61 2.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.357 -0.838 . . . . 1.8300000000000001 109.395 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 29.8 mt -79.22 -80.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 120.758 0.314 . . . . 0.5 110.458 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.3 m -95.95 -68.78 0.78 Allowed 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.318 0.58 . . . . 1.55 110.939 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.535 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -128.39 0.36 5.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.911 -1.515 . . . . 0.22 106.911 173.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.594 HD21 HG22 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.13 -176.72 2.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.347 -1.751 . . . . 0.14000000000000001 109.42 -171.336 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 188' ' ' VAL . 8.2 m -126.28 170.81 11.5 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.965 0.888 . . . . 0.20000000000000001 112.435 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.774 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 47.7 t -82.15 133.89 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 113.992 -1.458 . . . . 0.10000000000000001 109.077 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.68 18.97 80.05 Favored Glycine 0 N--CA 1.433 -1.558 0 CA-C-N 113.965 -1.47 . . . . 0.14000000000000001 110.434 -170.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.441 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 3.8 tt0 -70.42 -48.94 53.67 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.81 -0.811 . . . . 0.90000000000000002 108.81 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 67.86 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 113.806 -1.543 . . . . 0.22 111.689 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.627 HD11 HG11 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -149.98 -147.8 0.24 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.289 -1.778 . . . . 0.34999999999999998 109.516 -174.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 0.8 OUTLIER -122.4 157.66 31.38 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.506 0.669 . . . . 3.77 110.621 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.717 HG11 ' HG ' ' A' ' 217' ' ' LEU . 9.9 p -134.11 150.96 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.462 -1.31 . . . . 1.6599999999999999 107.462 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -91.14 87.59 6.61 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.77 -0.826 . . . . 3.46 108.77 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -108.57 95.92 5.99 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.668 -0.696 . . . . 1.3200000000000001 109.981 -176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.8 37.01 4.06 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.259 -0.737 . . . . 2.1200000000000001 111.259 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 72.49 0.01 3.46 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.711 0.767 . . . . 3.46 111.938 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -132.89 141.24 48.29 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.076 -0.511 . . . . 2.0299999999999998 111.036 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -67.34 127.41 32.58 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.31 -0.996 . . . . 0.96999999999999997 108.31 175.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.566 ' HG2' ' HB3' ' A' ' 218' ' ' ASN . 6.0 ttm -108.06 -76.33 0.61 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.053 -1.431 . . . . 1.6499999999999999 109.412 -166.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 14.1 t70 160.89 149.81 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 106.311 -1.737 . . . . 1.8600000000000001 106.311 173.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.793 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -165.08 149.9 9.19 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 120.336 -0.545 . . . . 0.14999999999999999 111.676 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 22.1 m -117.54 127.57 54.12 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 120.897 0.38 . . . . 0.13 111.617 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.774 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 91.9 t -67.03 116.3 6.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 112.929 0.715 . . . . 0.070000000000000007 112.929 -172.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.681 ' CD2' ' HB2' ' A' ' 216' ' ' GLN . 0.2 OUTLIER -96.56 -38.56 9.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.544 -0.753 . . . . 0.59999999999999998 110.839 172.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.635 ' O ' HG12 ' A' ' 213' ' ' VAL . 29.0 tt0 -153.69 156.03 37.08 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 105.472 -2.047 . . . . 2.2000000000000002 105.472 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.577 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -118.84 161.87 17.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 111.873 0.323 . . . . 0.14999999999999999 111.873 -174.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 44.2 p -113.83 -164.09 0.9 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.281 -0.418 . . . . 0.17999999999999999 110.487 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -49.45 -34.7 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.476 0.485 . . . . 3.8199999999999998 111.834 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.639 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 0.4 OUTLIER -159.82 -25.82 0.07 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.447 -0.946 . . . . 1.6699999999999999 108.447 -174.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.619 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.57 -151.82 28.52 Favored Glycine 0 CA--C 1.474 -2.471 0 N-CA-C 107.672 -2.171 . . . . 0.10000000000000001 107.672 176.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.652 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -145.08 -176.78 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.65 0 C-N-CA 119.677 -0.809 . . . . 0.089999999999999997 110.757 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.449 ' H ' HG12 ' A' ' 213' ' ' VAL . 24.0 ttp180 -130.4 85.44 2.29 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.614 -1.625 . . . . 3.3900000000000001 106.614 159.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.793 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 26.1 m -80.48 177.16 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 114.018 -1.446 . . . . 0.12 109.315 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.681 ' HB2' ' CD2' ' A' ' 206' ' ' LEU . 0.9 OUTLIER -107.05 113.14 26.43 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 107.263 -1.384 . . . . 1.6899999999999999 107.263 171.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.717 ' HG ' HG11 ' A' ' 194' ' ' VAL . 9.5 mp -70.65 147.3 49.3 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.52 -0.764 . . . . 0.32000000000000001 112.288 -171.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.605 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 5.9 t-20 -71.55 -20.35 62.04 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.117 -1.401 . . . . 1.28 107.904 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.53 -21.19 65.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 113.982 -1.463 . . . . 1.1100000000000001 108.929 166.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 95.68 22.43 21.22 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 114.477 -1.238 . . . . 0.68000000000000005 112.01 -177.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.629 ' H ' ' HB2' ' A' ' 217' ' ' LEU . 19.8 ttp -109.08 -162.06 0.79 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.949 -1.13 . . . . 1.5600000000000001 107.949 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 9.7 m -162.15 128.98 3.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.798 -1.186 . . . . 0.90000000000000002 107.798 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 222' ' ' SER . 43.1 tp 166.38 -41.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.909 1.077 . . . . 0.38 113.909 -165.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.771 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.276 0.4 OUTLIER 33.74 -89.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.369 1.068 . . . . 0.23000000000000001 113.158 -156.806 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.961 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.5 p 159.7 -156.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.549 -0.538 . . . . 0.80000000000000004 109.549 -164.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.961 ' H ' HG22 ' A' ' 225' ' ' VAL . 18.1 ttm180 -106.59 165.82 11.01 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.482 -0.933 . . . . 3.5299999999999998 108.482 178.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -68.78 -16.87 63.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.754 0.65 . . . . 0.29999999999999999 112.754 -167.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -100.26 25.02 7.99 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.581 1.181 . . . . 2.5699999999999998 109.441 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.472 ' HB3' HG21 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -139.17 -24.06 0.89 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 113.994 -1.457 . . . . 2.2400000000000002 111.238 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.619 HD21 ' HA2' ' A' ' 212' ' ' GLY . 0.9 OUTLIER -92.9 161.21 14.57 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-O 121.072 0.463 . . . . 0.80000000000000004 111.094 -175.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.23 73.28 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 113.202 0.815 . . . . 0.88 113.202 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 232' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.448 -0.787 . . . . 1.3 110.475 166.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 121.029 0.443 . . . . 5.6100000000000003 110.079 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.3 t -116.37 14.62 15.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.569 0.7 . . . . 2.7599999999999998 109.902 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.5 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 28.4 m-20 -136.45 158.36 44.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.972 -0.751 . . . . 1.8300000000000001 108.972 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 33.3 mt -81.91 -68.93 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.189 0.518 . . . . 0.5 110.048 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 92.9 p -92.89 -79.31 0.4 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.074 0.94 . . . . 1.55 110.304 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.46 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -124.68 -2.37 7.87 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 105.035 -2.209 . . . . 0.22 105.035 171.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.608 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -161.36 -176.1 5.19 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 113.586 -1.643 . . . . 0.14000000000000001 110.328 -174.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.691 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.7 m -126.75 170.89 11.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.936 0.874 . . . . 0.20000000000000001 112.636 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.792 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 46.9 t -81.89 133.46 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 114.125 -1.398 . . . . 0.10000000000000001 109.338 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.26 18.84 79.87 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 114.254 -1.339 . . . . 0.14000000000000001 110.359 -169.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.4 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 1.7 tt0 -73.62 -49.25 27.03 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.638 -0.875 . . . . 0.90000000000000002 108.638 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 71.85 127.78 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.839 -1.528 . . . . 0.22 111.337 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.586 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -149.4 -150.87 0.37 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 113.824 -1.535 . . . . 0.34999999999999998 108.99 -175.091 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 202' ' ' ASP . 13.8 mttt -131.06 146.51 52.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.489 0.661 . . . . 3.77 110.492 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.67 HG11 ' HG ' ' A' ' 217' ' ' LEU . 10.0 p -121.9 150.54 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.717 -1.129 . . . . 1.6599999999999999 108.051 175.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 200' ' ' ALA . 3.1 ttmt -91.9 81.63 5.16 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.482 -0.562 . . . . 3.46 109.482 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -98.95 99.47 10.52 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.472 -0.786 . . . . 1.3200000000000001 110.099 -174.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 94.15 34.08 6.61 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.125 -0.79 . . . . 2.1200000000000001 111.125 -173.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.408 HE21 ' HB3' ' A' ' 198' ' ' GLN . 0.0 OUTLIER 70.34 9.1 6.88 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.316 0.646 . . . . 3.46 111.867 179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -134.72 131.07 37.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.517 -0.31 . . . . 2.0299999999999998 110.871 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -64.13 122.62 17.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.974 0.892 . . . . 0.96999999999999997 109.195 176.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.494 ' HG2' ' HB3' ' A' ' 218' ' ' ASN . 15.3 ttm -107.1 -75.24 0.64 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.926 -1.488 . . . . 1.6499999999999999 110.028 -164.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 193' ' ' LYS . 2.9 t70 159.39 150.29 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 113.623 -1.626 . . . . 1.8600000000000001 107.989 174.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.793 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -165.23 150.35 9.25 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 120.642 -0.423 . . . . 0.14999999999999999 111.655 178.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 17.9 m -119.34 130.44 55.36 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 120.629 -0.428 . . . . 0.13 111.554 -175.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.792 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 86.0 t -66.99 121.59 16.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 112.883 0.697 . . . . 0.070000000000000007 112.883 -171.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -102.46 -38.96 7.34 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.384 -0.826 . . . . 0.59999999999999998 109.479 175.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.643 ' O ' HG12 ' A' ' 213' ' ' VAL . 24.5 mt-10 -152.47 157.25 40.89 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 105.192 -2.151 . . . . 2.2000000000000002 105.192 -178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.632 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -122.23 159.68 25.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 112.595 0.591 . . . . 0.14999999999999999 112.595 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 208' ' ' ILE . 32.9 p -111.72 -164.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.605 . . . . 0.17999999999999999 110.78 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -53.7 -31.31 47.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.286 0.476 . . . . 3.8199999999999998 112.286 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.675 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 0.6 OUTLIER -158.35 -27.24 0.08 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.263 -1.014 . . . . 1.6699999999999999 108.263 -174.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.614 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -95.76 -150.45 27.02 Favored Glycine 0 CA--C 1.474 -2.502 0 N-CA-C 108.032 -2.027 . . . . 0.10000000000000001 108.032 178.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.678 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -146.01 -176.5 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.526 0 C-N-CA 119.867 -0.733 . . . . 0.089999999999999997 111.08 -177.691 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.466 ' H ' HG12 ' A' ' 213' ' ' VAL . 62.3 mtp180 -132.51 80.83 1.92 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.068 -1.456 . . . . 3.3900000000000001 107.068 164.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.793 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 27.0 m -82.48 -178.0 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 114.524 -1.217 . . . . 0.12 111.88 -173.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 0.3 OUTLIER -106.56 109.34 21.23 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.839 -1.073 . . . . 1.6899999999999999 108.733 170.253 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.716 HD22 ' HB3' ' A' ' 221' ' ' MET . 8.8 mp -69.08 143.83 54.12 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.847 0.832 . . . . 0.32000000000000001 111.515 -174.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.494 ' HB3' ' HG2' ' A' ' 201' ' ' MET . 17.5 t-20 -70.12 -23.94 63.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.788 -1.551 . . . . 1.28 107.792 175.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.66 -26.66 45.74 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 113.917 -1.492 . . . . 1.1100000000000001 109.005 166.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.84 21.84 11.72 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 114.025 -1.443 . . . . 0.68000000000000005 111.262 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.716 ' HB3' HD22 ' A' ' 217' ' ' LEU . 32.1 ttm -105.95 -167.01 1.26 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.467 -1.308 . . . . 1.5600000000000001 107.467 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 18.2 m -159.51 124.16 3.98 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.387 -0.968 . . . . 0.90000000000000002 108.387 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 214' ' ' ARG . 62.5 tp 172.18 -43.18 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.324 1.231 . . . . 0.38 114.324 -167.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.755 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.302 0.1 OUTLIER 36.09 -93.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.358 1.063 . . . . 0.23000000000000001 113.089 -155.728 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.969 HG22 ' H ' ' A' ' 226' ' ' ARG . 7.1 p 158.89 -152.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 118.884 0.765 . . . . 0.80000000000000004 109.654 -166.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.969 ' H ' HG22 ' A' ' 225' ' ' VAL . 10.3 ttt180 -107.69 162.13 14.25 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.313 -0.995 . . . . 3.5299999999999998 108.313 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -66.84 -17.85 65.09 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.803 0.668 . . . . 0.29999999999999999 112.803 -167.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.62 20.48 11.79 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 122.064 0.935 . . . . 2.5699999999999998 110.518 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.545 ' CG ' HG21 ' A' ' 225' ' ' VAL . 7.4 t60 -139.94 -25.83 0.8 Allowed 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 114.217 -1.356 . . . . 2.2400000000000002 109.444 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.614 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.0 OUTLIER -88.47 163.2 16.05 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.291 0.567 . . . . 0.80000000000000004 111.271 -176.101 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.28 78.01 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 113.175 0.805 . . . . 0.88 113.175 -178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.584 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.504 -0.76 . . . . 1.3 110.041 164.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.341 -0.244 . . . . 5.6100000000000003 110.341 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 56.1 p 50.58 36.78 14.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.639 0.733 . . . . 2.7599999999999998 110.377 -170.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.516 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 27.4 m-20 -113.15 -168.01 1.27 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.885 -1.052 . . . . 1.8300000000000001 109.436 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.3 mt -87.04 -75.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-O 120.866 0.365 . . . . 0.5 110.266 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -100.54 -73.85 0.63 Allowed 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 116.206 -0.452 . . . . 1.55 111.341 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.58 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -122.75 0.34 9.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 107.167 -1.419 . . . . 0.22 107.167 175.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.598 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.76 -176.15 2.3 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 113.081 -1.872 . . . . 0.14000000000000001 109.223 -171.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.714 HG22 ' H ' ' A' ' 188' ' ' VAL . 7.3 m -126.58 171.49 11.05 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.832 0.825 . . . . 0.20000000000000001 112.516 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.786 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 58.4 t -82.53 134.86 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 114.073 -1.422 . . . . 0.10000000000000001 109.218 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 75.65 16.86 80.38 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 113.914 -1.494 . . . . 0.14000000000000001 110.539 -170.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.517 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -74.66 -51.16 15.14 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 109.008 -0.738 . . . . 0.90000000000000002 109.008 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.57 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 113.667 -1.606 . . . . 0.22 111.582 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -149.42 -149.53 0.3 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.106 -1.406 . . . . 0.34999999999999998 109.054 -175.064 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.452 ' H ' ' HB2' ' A' ' 192' ' ' LEU . 4.8 mttp -134.96 148.5 50.03 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.381 0.61 . . . . 3.77 110.515 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' A' ' 224' ' ' ILE . 9.3 p -134.87 151.16 30.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.732 -1.122 . . . . 1.6599999999999999 108.439 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.657 ' HE3' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -100.41 111.18 23.41 Favored 'General case' 0 N--CA 1.397 -3.087 0 CA-C-O 123.256 1.503 . . . . 3.46 108.181 173.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.636 ' HB3' ' HE3' ' A' ' 201' ' ' MET . . . -121.86 100.95 7.27 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.131 -1.85 . . . . 1.3200000000000001 109.492 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 198' ' ' GLN . . . 99.04 32.23 5.94 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 110.168 -1.173 . . . . 2.1200000000000001 110.168 -169.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' ' 197' ' ' GLY . 42.5 tt0 77.95 -18.15 0.52 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.578 0.751 . . . . 3.46 112.237 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 10.8 m120 -112.97 138.28 50.08 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.29 -0.256 . . . . 2.0299999999999998 111.064 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -69.21 146.26 52.53 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.958 0.885 . . . . 0.96999999999999997 109.913 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.65 ' SD ' ' HB3' ' A' ' 217' ' ' LEU . 51.0 ttm -115.28 -83.7 0.62 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.888 -1.506 . . . . 1.6499999999999999 110.046 -167.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 218' ' ' ASN . 1.1 m-20 142.73 122.58 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 126.181 1.793 . . . . 1.8600000000000001 106.378 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.765 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -148.43 150.36 33.35 Favored 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 119.185 -1.006 . . . . 0.14999999999999999 112.37 -172.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 26.9 m -113.55 129.1 56.62 Favored 'General case' 0 C--O 1.21 -1.015 0 C-N-CA 120.69 -0.404 . . . . 0.13 111.909 -173.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.786 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 88.1 t -66.92 122.12 17.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 112.602 0.593 . . . . 0.070000000000000007 112.602 -172.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -106.65 -34.25 7.38 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.701 0.762 . . . . 0.59999999999999998 109.564 176.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.667 ' O ' HG12 ' A' ' 213' ' ' VAL . 24.3 tt0 -153.44 155.19 35.85 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 104.81 -2.293 . . . . 2.2000000000000002 104.81 -177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.591 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.89 159.87 20.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-O 120.739 0.304 . . . . 0.14999999999999999 111.543 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 58.2 p -112.59 -166.99 1.13 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 116.303 -0.408 . . . . 0.17999999999999999 110.174 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -52.21 -28.74 19.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.548 0.573 . . . . 3.8199999999999998 112.548 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.693 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 8.9 t0 -158.42 -28.6 0.08 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.98 -1.119 . . . . 1.6699999999999999 107.98 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.597 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -91.51 -149.72 24.21 Favored Glycine 0 CA--C 1.473 -2.538 0 N-CA-C 108.025 -2.03 . . . . 0.10000000000000001 108.025 178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -144.37 -174.32 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.612 0 C-N-CA 119.56 -0.856 . . . . 0.089999999999999997 111.218 -178.042 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.493 ' H ' HG12 ' A' ' 213' ' ' VAL . 40.4 ttt180 -133.9 90.71 2.73 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.904 -1.517 . . . . 3.3900000000000001 106.904 162.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.765 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 23.3 m -90.14 179.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 114.041 -1.436 . . . . 0.12 110.718 -174.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -106.22 109.46 21.41 Favored 'General case' 0 N--CA 1.422 -1.846 0 O-C-N 124.118 0.886 . . . . 1.6899999999999999 108.743 173.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.719 HD22 ' HB3' ' A' ' 221' ' ' MET . 9.5 mp -70.46 144.39 51.47 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.952 0.882 . . . . 0.32000000000000001 112.12 -173.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 202' ' ' ASP . 13.4 t-20 -66.5 -30.6 70.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.012 -1.449 . . . . 1.28 109.782 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 23.7 m -65.59 -14.32 60.87 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.643 -0.708 . . . . 1.1100000000000001 109.859 169.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 96.32 33.27 6.3 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.323 -0.942 . . . . 0.68000000000000005 112.268 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.719 ' HB3' HD22 ' A' ' 217' ' ' LEU . 27.8 ttp -110.55 -164.9 0.95 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.465 -1.309 . . . . 1.5600000000000001 107.465 174.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 80.6 p -165.48 128.31 2.14 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.719 -0.845 . . . . 0.90000000000000002 108.719 176.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 222' ' ' SER . 64.6 tp 167.47 -44.48 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.297 1.221 . . . . 0.38 114.297 -162.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.74 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.288 0.2 OUTLIER 35.07 -93.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.246 1.018 . . . . 0.23000000000000001 113.245 -157.267 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 226' ' ' ARG . 7.2 p 159.7 -156.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 119.053 0.842 . . . . 0.80000000000000004 110.086 -164.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 1.005 ' H ' HG22 ' A' ' 225' ' ' VAL . 28.9 ttt180 -97.64 164.52 12.38 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.201 -1.037 . . . . 3.5299999999999998 108.201 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -71.55 -15.58 62.29 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.552 -0.749 . . . . 0.29999999999999999 112.63 -170.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -103.0 26.85 7.68 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.659 1.218 . . . . 2.5699999999999998 109.185 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.657 ' O ' ' HE3' ' A' ' 195' ' ' LYS . 0.3 OUTLIER -138.25 -24.96 0.96 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.618 -1.628 . . . . 2.2400000000000002 110.306 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.597 HD21 ' HA2' ' A' ' 212' ' ' GLY . 1.3 pp -94.1 163.86 13.3 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.151 0.501 . . . . 0.80000000000000004 110.9 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 16.0 m -131.79 76.63 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 113.033 0.753 . . . . 0.88 113.033 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.583 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.388 -0.815 . . . . 1.3 110.296 165.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.856 -0.424 . . . . 5.6100000000000003 109.856 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.9 t 71.6 28.25 2.83 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.845 0.715 . . . . 2.7599999999999998 109.262 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.427 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 12.7 m-20 -130.02 167.57 18.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.57 -0.9 . . . . 1.8300000000000001 108.57 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 30.0 mt -78.49 -72.67 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 109.221 -0.659 . . . . 0.5 109.221 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.2 m -102.79 -74.44 0.63 Allowed 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.617 -0.719 . . . . 1.55 111.451 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.609 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -120.99 0.28 10.2 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.219 -1.4 . . . . 0.22 107.219 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.626 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -170.85 -176.82 2.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.017 -1.902 . . . . 0.14000000000000001 109.356 -172.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 188' ' ' VAL . 7.4 m -125.98 171.73 10.53 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.845 0.831 . . . . 0.20000000000000001 112.207 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.79 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 61.3 t -81.01 137.15 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.187 -1.369 . . . . 0.10000000000000001 109.449 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 72.8 15.93 78.06 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 113.994 -1.457 . . . . 0.14000000000000001 110.488 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -71.43 -51.71 22.48 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.855 -0.795 . . . . 0.90000000000000002 108.855 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 73.46 128.69 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.678 -1.601 . . . . 0.22 111.602 178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.611 ' CD1' HG11 ' A' ' 215' ' ' VAL . 0.0 OUTLIER -152.35 -147.2 0.22 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.772 -1.558 . . . . 0.34999999999999998 108.669 -174.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.458 ' HG2' ' HB1' ' A' ' 200' ' ' ALA . 1.1 mppt? -118.39 160.34 21.85 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.537 -0.912 . . . . 3.77 108.537 170.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.638 HG21 HD21 ' A' ' 217' ' ' LEU . 1.2 p -105.42 -33.66 2.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 122.43 1.109 . . . . 1.6599999999999999 110.757 -173.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 23.4 ttmt 57.28 89.1 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 112.187 -2.279 . . . . 3.46 109.742 -170.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -90.02 71.18 7.44 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 112.721 -2.036 . . . . 1.3200000000000001 109.757 -170.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 112.21 -105.49 1.77 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.135 -0.939 . . . . 2.1200000000000001 111.716 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -100.59 -22.89 14.81 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.456 0.646 . . . . 3.46 110.998 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 195' ' ' LYS . 88.4 m-20 -120.3 159.95 23.99 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.424 -0.807 . . . . 2.0299999999999998 111.636 -170.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -84.09 166.69 17.46 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.944 -0.571 . . . . 0.96999999999999997 109.583 176.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.736 ' HG2' ' OG ' ' A' ' 219' ' ' SER . 39.8 tpp -141.86 -91.66 0.14 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.611 -1.255 . . . . 1.6499999999999999 107.611 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.602 ' C ' HD22 ' A' ' 218' ' ' ASN . 9.0 p-10 162.54 141.26 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.327 -1.36 . . . . 1.8600000000000001 107.327 172.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.737 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -158.15 152.06 23.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 120.275 -0.57 . . . . 0.14999999999999999 111.852 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 16.6 m -117.47 129.83 56.07 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-O 121.06 0.457 . . . . 0.13 112.163 -174.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.79 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 94.9 t -65.33 121.32 14.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.763 0.653 . . . . 0.070000000000000007 112.763 -171.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -102.86 -36.89 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.59999999999999998 109.675 176.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.642 ' O ' HG12 ' A' ' 213' ' ' VAL . 28.3 tt0 -156.69 155.98 32.63 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 105.469 -2.048 . . . . 2.2000000000000002 105.469 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.582 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -119.24 160.63 19.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 112.037 0.384 . . . . 0.14999999999999999 112.037 -173.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 26.9 p -110.82 -162.29 0.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.35 -0.611 . . . . 0.17999999999999999 109.35 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.475 ' HG3' ' OD1' ' A' ' 211' ' ' ASP . 40.8 pttt -59.82 -30.72 69.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.073 0.463 . . . . 3.8199999999999998 110.674 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.646 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 1.7 m-20 -151.27 -35.08 0.14 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.272 -1.01 . . . . 1.6699999999999999 108.272 -173.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.583 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.7 -153.07 29.96 Favored Glycine 0 CA--C 1.474 -2.49 0 N-CA-C 107.804 -2.119 . . . . 0.10000000000000001 107.804 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.661 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -146.04 -177.11 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.486 0 C-N-CA 119.861 -0.736 . . . . 0.089999999999999997 110.678 -176.213 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.482 ' HG3' ' HA ' ' A' ' 223' ' ' LEU . 71.1 ttt180 -129.01 91.05 3.13 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.034 -1.469 . . . . 3.3900000000000001 107.034 157.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.737 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 20.7 m -86.89 177.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 114.052 -1.431 . . . . 0.12 110.31 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 0.7 OUTLIER -102.77 107.66 18.61 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.432 -0.951 . . . . 1.6899999999999999 108.432 173.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.708 HD22 ' HB3' ' A' ' 221' ' ' MET . 6.8 mp -70.3 133.49 47.02 Favored 'General case' 0 CA--C 1.491 -1.323 0 CA-C-O 121.312 0.577 . . . . 0.32000000000000001 109.827 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.602 HD22 ' C ' ' A' ' 202' ' ' ASP . 59.0 m-80 -76.86 -14.15 59.92 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.772 -1.104 . . . . 1.28 108.699 176.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.736 ' OG ' ' HG2' ' A' ' 201' ' ' MET . 59.4 m -57.31 -24.84 57.63 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 114.973 -1.012 . . . . 1.1100000000000001 108.31 162.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.44 23.56 6.25 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 113.983 -1.462 . . . . 0.68000000000000005 112.879 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.708 ' HB3' HD22 ' A' ' 217' ' ' LEU . 20.3 ttp -118.32 -162.15 0.87 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.018 -0.734 . . . . 1.5600000000000001 109.018 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 85.5 p -164.91 126.49 2.11 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.992 -1.114 . . . . 0.90000000000000002 107.992 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 222' ' ' SER . 49.6 tp 166.77 -38.07 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.68 0.993 . . . . 0.38 113.68 -163.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.719 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.265 0.5 OUTLIER 36.29 -89.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 124.213 1.005 . . . . 0.23000000000000001 112.717 -157.778 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.021 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.2 p 159.07 -155.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.454 0.645 . . . . 0.80000000000000004 110.358 -164.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 1.021 ' H ' HG22 ' A' ' 225' ' ' VAL . 8.5 tpp180 -102.78 159.37 15.54 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.904 -1.147 . . . . 3.5299999999999998 107.904 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.646 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -68.15 -13.87 62.55 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.443 0.535 . . . . 0.29999999999999999 112.443 -171.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.07 17.2 16.03 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.994 0.902 . . . . 2.5699999999999998 110.691 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.68 -25.6 2.1 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.402 -1.272 . . . . 2.2400000000000002 111.008 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.583 HD21 ' HA2' ' A' ' 212' ' ' GLY . 0.9 OUTLIER -90.35 155.27 19.08 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.373 0.606 . . . . 0.80000000000000004 111.222 -173.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 193' ' ' LYS . 17.1 m -129.67 73.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.198 -0.91 . . . . 0.88 112.787 -177.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.374 -0.83 . . . . 1.3 111.151 167.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 121.516 0.674 . . . . 5.6100000000000003 111.07 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.3 m -90.35 25.15 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.669 -0.696 . . . . 2.7599999999999998 110.184 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.618 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 13.7 m-20 71.78 137.12 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.83 -1.077 . . . . 1.8300000000000001 111.696 175.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 26.7 mt -76.8 -51.55 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 CA-C-N 114.984 -1.007 . . . . 0.5 109.829 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.1 t -118.89 -73.21 0.65 Allowed 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.459 -0.791 . . . . 1.55 110.732 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.584 ' HB3' HD23 ' A' ' 186' ' ' LEU . . . -123.86 0.3 8.59 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 107.131 -1.433 . . . . 0.22 107.131 173.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.598 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -169.8 -178.38 2.94 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 112.881 -1.963 . . . . 0.14000000000000001 108.984 -171.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.713 HG22 ' H ' ' A' ' 188' ' ' VAL . 5.7 m -123.35 171.18 9.62 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.868 0.842 . . . . 0.20000000000000001 112.331 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.783 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 50.4 t -81.51 134.52 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 114.244 -1.343 . . . . 0.10000000000000001 109.081 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.97 16.87 80.33 Favored Glycine 0 C--N 1.303 -1.254 0 CA-C-N 114.245 -1.343 . . . . 0.14000000000000001 110.428 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -71.28 -53.32 14.68 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.816 -0.809 . . . . 0.90000000000000002 108.816 179.39 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 75.53 128.49 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 113.419 -1.718 . . . . 0.22 111.815 178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.624 ' HB3' ' HA ' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -151.45 -149.08 0.29 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 113.808 -1.542 . . . . 0.34999999999999998 109.255 -174.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.482 ' HG2' ' HB1' ' A' ' 200' ' ' ALA . 14.3 mptt -121.41 154.12 36.94 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.591 -0.892 . . . . 3.77 108.591 173.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 1.4 p -100.47 -33.69 3.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 122.431 1.11 . . . . 1.6599999999999999 110.463 -173.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 200' ' ' ALA . 23.1 ttmt 55.59 87.93 0.05 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 112.214 -2.267 . . . . 3.46 110.493 -174.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -102.97 104.45 14.66 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 112.388 -2.187 . . . . 1.3200000000000001 109.79 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.16 50.07 11.23 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.696 -0.764 . . . . 2.1200000000000001 111.571 -175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 72.28 -38.1 0.41 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.471 0.708 . . . . 3.46 112.375 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -79.26 135.35 36.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.111 0.482 . . . . 2.0299999999999998 110.744 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 195' ' ' LYS . . . -78.58 155.07 29.84 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 109.187 -0.671 . . . . 0.96999999999999997 109.187 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.577 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 45.5 tpp -136.04 -82.19 0.39 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.463 -0.94 . . . . 1.6499999999999999 108.463 -172.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 10.3 t70 159.6 153.99 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 105.954 -1.869 . . . . 1.8600000000000001 105.954 171.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.786 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -165.54 149.25 8.17 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 118.624 0.647 . . . . 0.14999999999999999 111.396 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 16.9 m -118.22 129.46 55.5 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-O 121.181 0.515 . . . . 0.13 111.771 -174.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.783 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 95.2 t -66.21 122.45 17.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 113.192 0.812 . . . . 0.070000000000000007 113.192 -170.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.69 -36.0 8.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.207 -0.906 . . . . 0.59999999999999998 110.0 175.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.666 ' O ' HG12 ' A' ' 213' ' ' VAL . 27.1 tt0 -155.14 158.24 38.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.405 -2.072 . . . . 2.2000000000000002 105.405 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.612 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.96 158.37 23.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 111.937 0.347 . . . . 0.14999999999999999 111.937 -175.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 32.6 p -114.62 -164.08 0.91 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.437 -0.505 . . . . 0.17999999999999999 112.124 -174.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -48.09 -29.67 3.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.325 -0.852 . . . . 3.8199999999999998 112.572 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.647 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 9.2 t0 -168.35 -22.54 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.159 -1.052 . . . . 1.6699999999999999 108.159 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.642 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -93.39 -149.43 25.15 Favored Glycine 0 CA--C 1.475 -2.462 0 N-CA-C 107.873 -2.091 . . . . 0.10000000000000001 107.873 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -145.92 -176.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 C-N-CA 119.893 -0.723 . . . . 0.089999999999999997 111.065 -177.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.45 ' H ' HG12 ' A' ' 213' ' ' VAL . 65.9 ttt180 -131.33 94.73 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.997 -1.483 . . . . 3.3900000000000001 106.997 161.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.786 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 28.5 m -95.02 -179.84 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 114.15 -1.386 . . . . 0.12 110.932 -173.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 204' ' ' THR . 32.2 tp60 -103.09 101.74 11.72 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 107.553 -1.277 . . . . 1.6899999999999999 107.553 172.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.776 HD22 ' HB3' ' A' ' 221' ' ' MET . 9.9 mp -64.18 139.12 58.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.099 0.952 . . . . 0.32000000000000001 111.604 -174.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.64 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 19.2 t-20 -72.6 -21.1 61.18 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.352 -1.749 . . . . 1.28 107.549 172.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.408 ' OG ' ' HG2' ' A' ' 201' ' ' MET . 6.5 m -58.99 -20.19 50.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.351 -1.749 . . . . 1.1100000000000001 109.172 165.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 99.19 25.68 9.34 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.868 -1.06 . . . . 0.68000000000000005 112.415 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.776 ' HB3' HD22 ' A' ' 217' ' ' LEU . 19.1 ttp -126.34 -159.22 0.9 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.13 -0.693 . . . . 1.5600000000000001 109.13 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.72 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 14.5 m -162.31 129.25 3.72 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.609 -1.256 . . . . 0.90000000000000002 107.609 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 222' ' ' SER . 62.4 tp 164.4 -43.61 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.893 1.071 . . . . 0.38 113.893 -164.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.727 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.285 0.2 OUTLIER 33.29 -90.99 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.387 1.075 . . . . 0.23000000000000001 113.058 -155.925 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.964 HG22 ' H ' ' A' ' 226' ' ' ARG . 8.3 p 158.52 -156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 118.888 0.767 . . . . 0.80000000000000004 109.995 -166.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.964 ' H ' HG22 ' A' ' 225' ' ' VAL . 30.6 ttt180 -102.6 163.24 12.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.194 -1.039 . . . . 3.5299999999999998 108.194 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -67.73 -16.82 64.32 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.174 0.805 . . . . 0.29999999999999999 113.174 -168.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 228' ' ' GLU . 31.5 tt0 -99.64 16.55 23.08 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.689 1.233 . . . . 2.5699999999999998 110.002 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.423 ' HB3' HG11 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -126.49 -28.03 3.09 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.838 -1.528 . . . . 2.2400000000000002 111.166 178.105 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.642 HD21 ' HA2' ' A' ' 212' ' ' GLY . 0.8 OUTLIER -90.78 166.77 12.93 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 121.35 0.595 . . . . 0.80000000000000004 111.244 -172.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 193' ' ' LYS . 16.8 m -135.92 76.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.14 -0.936 . . . . 0.88 112.654 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.624 ' HA ' ' HB3' ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.448 -0.787 . . . . 1.3 110.038 165.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 121.125 0.488 . . . . 5.6100000000000003 110.218 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 20.8 t -106.8 16.04 24.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.605 0.717 . . . . 2.7599999999999998 109.512 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.577 ' HB3' ' C ' ' A' ' 186' ' ' LEU . 9.3 m-20 -125.71 -168.42 1.84 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.381 -0.827 . . . . 1.8300000000000001 109.367 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 16.2 mt -92.06 -72.61 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-O 121.267 0.556 . . . . 0.5 110.432 176.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.461 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 96.5 p -90.79 -82.67 0.28 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.134 0.968 . . . . 1.55 110.38 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.461 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -122.12 -2.81 9.09 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 105.149 -2.167 . . . . 0.22 105.149 171.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.677 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -158.09 -177.23 6.4 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 113.484 -1.689 . . . . 0.14000000000000001 110.613 -175.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.7 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.7 m -125.65 171.13 10.84 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.785 0.802 . . . . 0.20000000000000001 112.675 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.787 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 48.9 t -82.65 134.22 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.354 -1.294 . . . . 0.10000000000000001 109.563 -178.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 73.69 17.9 79.32 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.05 -1.432 . . . . 0.14000000000000001 110.406 -170.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 187' ' ' THR . 0.0 OUTLIER -73.03 -52.33 14.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 109.335 -0.617 . . . . 0.90000000000000002 109.335 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 77.09 129.64 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.058 -1.428 . . . . 0.22 111.703 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.697 HD23 ' HB3' ' A' ' 232' ' ' PHE . 0.0 OUTLIER -153.56 -149.71 0.3 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.844 -1.525 . . . . 0.34999999999999998 109.338 -173.171 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.597 ' HB3' HG23 ' A' ' 231' ' ' VAL . 12.2 tttt -137.29 144.21 42.55 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.081 -0.509 . . . . 3.77 110.492 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 12.9 p -123.13 155.33 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.717 -0.674 . . . . 1.6599999999999999 109.428 176.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.838 ' HA ' ' H ' ' A' ' 200' ' ' ALA . 0.0 OUTLIER -80.39 96.57 6.74 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.749 0.785 . . . . 3.46 110.79 -178.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -155.06 152.31 29.41 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 113.952 -1.476 . . . . 1.3200000000000001 110.344 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 74.52 -105.43 1.86 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.038 -0.601 . . . . 2.1200000000000001 112.627 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -93.68 28.16 2.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.126 0.965 . . . . 3.46 109.179 176.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 59.96 132.17 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 114.53 -1.214 . . . . 2.0299999999999998 112.395 -171.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.838 ' H ' ' HA ' ' A' ' 195' ' ' LYS . . . 46.69 111.74 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.108 -1.86 . . . . 0.96999999999999997 111.804 -164.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.542 ' HG3' ' HB3' ' A' ' 218' ' ' ASN . 38.6 tpp -107.08 -73.24 0.69 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 113.857 -1.52 . . . . 1.6499999999999999 109.896 -166.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 218' ' ' ASN . 19.0 t70 147.84 145.16 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.954 0 CA-C-N 112.819 -1.991 . . . . 1.8600000000000001 105.936 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.814 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -164.31 151.76 11.97 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 120.224 -0.59 . . . . 0.14999999999999999 112.154 -178.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 15.6 m -120.9 128.9 53.21 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 120.822 0.344 . . . . 0.13 111.423 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.787 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 95.7 t -64.76 122.53 15.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.46 0.911 . . . . 0.070000000000000007 113.46 -171.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 204' ' ' THR . 0.0 OUTLIER -103.21 -40.05 6.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.15 -0.932 . . . . 0.59999999999999998 109.697 174.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.708 ' O ' HG12 ' A' ' 213' ' ' VAL . 23.6 mt-10 -149.37 157.06 43.0 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 104.833 -2.284 . . . . 2.2000000000000002 104.833 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.663 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -121.23 160.86 21.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 112.4 0.519 . . . . 0.14999999999999999 112.4 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.409 ' N ' HG22 ' A' ' 208' ' ' ILE . 30.0 p -110.98 -160.13 0.7 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.947 -0.57 . . . . 0.17999999999999999 109.943 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 210' ' ' LYS . 59.7 mmtt -64.32 -27.51 69.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.134 0.42 . . . . 3.8199999999999998 112.134 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.714 ' O ' ' HB2' ' A' ' 227' ' ' ALA . 9.7 t0 -153.89 -31.43 0.12 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.767 -1.198 . . . . 1.6699999999999999 107.767 -174.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.521 ' HA2' HD21 ' A' ' 230' ' ' LEU . . . -98.11 -148.81 24.21 Favored Glycine 0 CA--C 1.476 -2.383 0 N-CA-C 108.302 -1.919 . . . . 0.10000000000000001 108.302 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -148.47 -177.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.465 0 CA-C-O 121.74 0.781 . . . . 0.089999999999999997 111.837 -176.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 214' ' ' ARG . 25.4 ttt85 -127.63 94.86 4.07 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.841 -1.541 . . . . 3.3900000000000001 106.841 156.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.814 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 25.8 m -88.64 -177.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 114.319 -1.31 . . . . 0.12 110.526 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 0.0 OUTLIER -105.11 113.21 26.67 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.868 -1.16 . . . . 1.6899999999999999 107.868 169.405 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.818 HD22 ' HB3' ' A' ' 221' ' ' MET . 11.2 mp -73.41 147.07 44.6 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.891 -0.724 . . . . 0.32000000000000001 110.725 -174.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 45.2 t-20 -64.28 -30.91 71.95 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.978 -1.01 . . . . 1.28 108.4 175.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.9 m -63.67 -17.42 62.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.693 -1.14 . . . . 1.1100000000000001 109.702 169.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 217' ' ' LEU . . . 86.5 29.35 24.66 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 114.983 -1.008 . . . . 0.68000000000000005 112.178 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.818 ' HB3' HD22 ' A' ' 217' ' ' LEU . 33.6 ttm -92.64 -58.89 2.21 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.549 -0.461 . . . . 1.5600000000000001 111.675 -174.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.67 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 40.2 m 76.94 123.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.212 -0.904 . . . . 0.90000000000000002 110.707 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.564 ' HB2' ' O ' ' A' ' 222' ' ' SER . 46.1 tp 159.31 -42.12 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.07 -0.968 . . . . 0.38 113.452 -163.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.771 ' HB ' HG22 ' A' ' 215' ' ' VAL 0.314 0.1 OUTLIER 31.75 -96.63 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 124.61 1.164 . . . . 0.23000000000000001 113.396 -156.733 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.954 HG22 ' H ' ' A' ' 226' ' ' ARG . 9.9 p 158.63 -157.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 119.323 0.965 . . . . 0.80000000000000004 109.842 -165.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.954 ' H ' HG22 ' A' ' 225' ' ' VAL . 1.1 ptp180 -98.77 161.82 13.44 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.28 -0.873 . . . . 3.5299999999999998 108.884 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 211' ' ' ASP . . . -73.0 -15.05 61.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.626 0.602 . . . . 0.29999999999999999 112.626 -167.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.501 ' H ' ' HG3' ' A' ' 226' ' ' ARG . 31.1 tt0 -105.08 31.6 4.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 122.532 1.158 . . . . 2.5699999999999998 108.773 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.556 ' CD2' HG21 ' A' ' 225' ' ' VAL . 7.7 t60 -144.99 -25.77 0.49 Allowed 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 113.797 -1.547 . . . . 2.2400000000000002 109.137 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 226' ' ' ARG . 1.3 pp -88.82 164.25 15.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 120.72 0.295 . . . . 0.80000000000000004 110.316 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.597 HG23 ' HB3' ' A' ' 193' ' ' LYS . 19.6 m -127.34 63.71 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 122.192 0.996 . . . . 0.88 112.105 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.697 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 114.523 -1.217 . . . . 1.3 110.828 170.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 121.495 0.664 . . . . 5.6100000000000003 110.752 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 12.2 p -141.39 17.2 2.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.267 -0.879 . . . . 2.7599999999999998 109.636 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.574 ' HA ' ' OG1' ' A' ' 187' ' ' THR . 44.1 m-20 74.15 159.62 0.22 Allowed 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.469 -1.241 . . . . 1.8300000000000001 111.132 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 40.4 mt -73.98 -72.42 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-N 115.952 -0.567 . . . . 0.5 110.438 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.487 ' OG ' ' N ' ' A' ' 185' ' ' ALA . 53.9 p -95.38 -76.27 0.5 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.003 0.906 . . . . 1.55 110.504 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.487 ' N ' ' OG ' ' A' ' 184' ' ' SER . . . -126.14 -2.6 7.0 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 104.843 -2.28 . . . . 0.22 104.843 172.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.635 HD11 ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -162.63 -177.32 5.51 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.31 -1.768 . . . . 0.14000000000000001 109.863 -174.247 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.697 HG22 ' H ' ' A' ' 188' ' ' VAL . 6.5 m -124.76 170.99 10.48 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.951 0.881 . . . . 0.20000000000000001 112.552 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.783 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 47.6 t -81.49 134.06 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-N 114.176 -1.375 . . . . 0.10000000000000001 108.916 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.39 17.76 79.79 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 114.177 -1.374 . . . . 0.14000000000000001 110.614 -170.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' A' ' 186' ' ' LEU . 2.0 tt0 -73.39 -48.97 29.72 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.914 -0.773 . . . . 0.90000000000000002 108.914 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 204' ' ' THR . . . 72.58 128.74 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.119 -1.4 . . . . 0.22 111.091 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.692 HD11 HG11 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -151.55 -149.23 0.29 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.121 -1.4 . . . . 0.34999999999999998 109.587 -174.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.588 ' HB3' HG23 ' A' ' 231' ' ' VAL . 0.0 OUTLIER -128.06 150.56 49.89 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.25 0.548 . . . . 3.77 110.164 179.386 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.628 ' O ' ' HA ' ' A' ' 200' ' ' ALA . 6.3 p -127.08 148.82 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 115.046 -0.979 . . . . 1.6599999999999999 109.307 174.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.611 ' HD3' ' N ' ' A' ' 200' ' ' ALA . 0.2 OUTLIER -89.48 88.11 7.33 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.809 -0.811 . . . . 3.46 108.809 178.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -110.8 99.62 8.52 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.895 -1.048 . . . . 1.3200000000000001 110.097 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 82.71 48.25 5.6 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.796 -0.922 . . . . 2.1200000000000001 110.796 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 74.76 -20.25 0.34 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.364 0.666 . . . . 3.46 112.438 177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -114.64 138.79 50.25 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.255 0.465 . . . . 2.0299999999999998 112.255 -174.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 194' ' ' VAL . . . -70.16 123.93 22.85 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.095 -1.076 . . . . 0.96999999999999997 108.095 173.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.6 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 43.8 tpp -101.88 -76.0 0.58 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.528 -1.214 . . . . 1.6499999999999999 109.579 -166.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 201' ' ' MET . 9.5 t70 155.84 147.38 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.245 -1.798 . . . . 1.8600000000000001 106.312 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.745 ' HB1' ' CG2' ' A' ' 215' ' ' VAL . . . -164.57 151.47 11.2 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 120.245 -0.582 . . . . 0.14999999999999999 111.512 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 191' ' ' ALA . 19.8 m -119.72 127.35 52.77 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.523 -0.471 . . . . 0.13 112.148 -174.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.783 ' CG1' ' HA ' ' A' ' 188' ' ' VAL . 81.1 t -64.27 123.22 16.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 113.208 0.818 . . . . 0.070000000000000007 113.208 -170.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.56 -35.17 7.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.782 -0.644 . . . . 0.59999999999999998 109.493 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.631 ' O ' HG12 ' A' ' 213' ' ' VAL . 26.2 tt0 -153.3 154.23 34.18 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 105.261 -2.126 . . . . 2.2000000000000002 105.261 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.606 HD11 ' C ' ' A' ' 187' ' ' THR . 1.4 mt -120.33 160.0 21.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 112.148 0.425 . . . . 0.14999999999999999 112.148 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 208' ' ' ILE . 31.0 p -112.65 -162.95 0.82 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.001 -0.545 . . . . 0.17999999999999999 110.917 -177.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -48.72 -35.28 13.73 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.652 0.595 . . . . 3.8199999999999998 112.189 177.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.539 ' C ' ' HB2' ' A' ' 227' ' ' ALA . 0.9 OUTLIER -168.22 -13.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.692 0.758 . . . . 1.6699999999999999 109.541 -175.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.708 ' HA2' HD11 ' A' ' 230' ' ' LEU . . . -96.63 -152.38 28.83 Favored Glycine 0 CA--C 1.48 -2.152 0 N-CA-C 107.437 -2.265 . . . . 0.10000000000000001 107.437 171.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.691 HG23 HG21 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -147.11 -176.77 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 C-N-CA 120.037 -0.665 . . . . 0.089999999999999997 111.334 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.455 ' H ' HG12 ' A' ' 213' ' ' VAL . 25.4 ttt180 -131.16 91.63 3.07 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.326 -1.361 . . . . 3.3900000000000001 107.326 159.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.745 ' CG2' ' HB1' ' A' ' 203' ' ' ALA . 20.6 m -91.31 179.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 113.712 -1.585 . . . . 0.12 110.515 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 203' ' ' ALA . 7.0 tm0? -104.31 107.55 18.52 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.751 -0.833 . . . . 1.6899999999999999 108.751 173.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 221' ' ' MET . 8.4 mp -70.42 134.52 47.9 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.861 0.839 . . . . 0.32000000000000001 111.165 -173.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.502 ' HB3' ' HG3' ' A' ' 201' ' ' MET . 41.9 t30 -71.45 -20.48 62.09 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.574 -1.648 . . . . 1.28 108.823 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.585 ' OG ' ' HG2' ' A' ' 201' ' ' MET . 67.1 m -62.37 -24.04 67.14 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.551 -1.204 . . . . 1.1100000000000001 109.442 166.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 112.31 21.88 6.05 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.741 -1.118 . . . . 0.68000000000000005 113.358 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' MET . . . . . 0.651 ' HB3' HD22 ' A' ' 217' ' ' LEU . 25.0 ttp -116.25 -162.95 0.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.029 -0.73 . . . . 1.5600000000000001 109.029 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' A' ' 215' ' ' VAL . 40.6 m -161.16 127.21 3.84 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 107.662 -1.236 . . . . 0.90000000000000002 107.662 175.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 222' ' ' SER . 49.4 tp 165.64 -40.16 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.424 1.268 . . . . 0.38 114.424 -164.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 1.017 HD13 HD22 ' A' ' 230' ' ' LEU 0.283 0.2 OUTLIER 34.48 -89.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.225 1.01 . . . . 0.23000000000000001 112.511 -156.295 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.972 HG22 ' H ' ' A' ' 226' ' ' ARG . 11.5 p 157.85 -155.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 108.976 -0.749 . . . . 0.80000000000000004 108.976 -169.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.972 ' H ' HG22 ' A' ' 225' ' ' VAL . 13.4 ttm180 -103.3 160.04 15.03 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.026 -0.731 . . . . 3.5299999999999998 109.026 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' A' ' 211' ' ' ASP . . . -50.43 -31.7 15.75 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.122 0.786 . . . . 0.29999999999999999 113.122 -171.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -93.09 29.47 1.85 Allowed 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 122.528 1.156 . . . . 2.5699999999999998 109.183 -169.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.506 ' CG ' HG21 ' A' ' 225' ' ' VAL . 15.4 t60 -146.73 -18.86 0.42 Allowed 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 113.818 -1.537 . . . . 2.2400000000000002 110.398 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.017 HD22 HD13 ' A' ' 224' ' ' ILE . 0.7 OUTLIER -62.58 151.55 37.51 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.59 -0.522 . . . . 0.80000000000000004 109.59 174.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.588 HG23 ' HB3' ' A' ' 193' ' ' LYS . 24.7 m -128.03 49.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.577 1.18 . . . . 0.88 110.7 172.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.652 ' HB3' HD23 ' A' ' 192' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 113.365 -1.743 . . . . 1.3 111.197 173.974 . . . . . . . . 2 2 . 1 stop_ save_